<?xml version="1.0" encoding="utf-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title><![CDATA[Biotechnology - Newslocker]]></title><link>https://www.newslocker.com/en-us/profession/biotechnology/</link><atom:link rel="self" href="https://www.newslocker.com/en-us/profession/biotechnology/rss/1000/" /><atom:link rel="hub" href="http://pubsubhubbub.appspot.com" /><description><![CDATA[Find your latest Biotechnology news with just one click. Don't miss out on anything happening in your profession!]]></description><language>en-us</language><copyright>Copyright (C) 2026 newslocker.com</copyright><lastBuildDate>Sun, 31 May 2026 18:07:00 +0200</lastBuildDate><item><title><![CDATA[China’s Rise in Drug Development Looms Over U.S.]]></title><description><![CDATA[Clinical trials in China are getting attention at an international oncology gathering in Chicago. China&rsquo;s surging biotechnology industry is fueling alarm that U.S. dominance in the field is waning.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/chinas-rise-in-drug-development-looms-over-us/</link><pubDate>Sun, 31 May 2026 18:07:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/chinas-rise-in-drug-development-looms-over-us/</guid></item><item><title><![CDATA[Reprogramming halophilic life for low-salt biomanufacturing]]></title><description><![CDATA[By reengineering Halomonas bluephagenesis to grow and produce polyhydroxybutyrate under low-salinity, open conditions, Sun et al. transform salinity from a fixed physiological constraint into a bioprocess variable. This study reframes halophilic chassis design for more flexible and sustainable industrial biomanufacturing.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/reprogramming-halophilic-life-for-low-salt-biomanufacturing/</link><pubDate>Sat, 16 May 2026 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/reprogramming-halophilic-life-for-low-salt-biomanufacturing/</guid></item><item><title><![CDATA[Blue at the edge]]></title><description><![CDATA[‘Blue at the Edge’ was created using C-phycocyanin (C-PC)-containing total soluble protein extract from extremophilic Galdieria. The painting portrays a moonlit desert, a quiet terrain that appears lifeless, but in a vibrant living blue made from algae. This visual contrasts the acidic, high-temperature environments where Galdieria thrives—inhospitable habitats that actually sustain metabolically versatile life. This alga thrives under elevated CO2 in complete darkness and very low pH on a]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/blue-at-the-edge/</link><pubDate>Thu, 07 May 2026 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/blue-at-the-edge/</guid></item><item><title><![CDATA[The Rich and Powerful Want to Live Forever]]></title><description><![CDATA[From the Kremlin to Silicon Valley, some of the most powerful people in the world now want something more: eternal life.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/the-rich-and-powerful-want-to-live-forever/</link><pubDate>Fri, 24 Apr 2026 11:02:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/the-rich-and-powerful-want-to-live-forever/</guid></item><item><title><![CDATA[Scientific breakthrough versus successful startup: teaching scientists to navigate bench to business]]></title><description><![CDATA[Scientific breakthroughs infrequently translate into startups without structured training. Stanford’s BioEntrepreneurship Bootcamp teaches a practical framework for navigating bench-to-business translation. The curriculum integrates instruction on intellectual property, team formation, risk assessments, milestone-based funding, and investor communication, with the goal of equipping scientists to advance discoveries into viable ventures.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/scientific-breakthrough-versus-successful-startup-teaching-scientists-to-navigate-bench-to-business/</link><pubDate>Wed, 08 Apr 2026 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/scientific-breakthrough-versus-successful-startup-teaching-scientists-to-navigate-bench-to-business/</guid></item><item><title><![CDATA[How to Turn a Chicken Egg Into a Drug Factory]]></title><description><![CDATA[A biotech start-up is testing a novel way of efficiently producing pharmaceutical drugs.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/how-to-turn-a-chicken-egg-into-a-drug-factory/</link><pubDate>Thu, 26 Mar 2026 14:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/how-to-turn-a-chicken-egg-into-a-drug-factory/</guid></item><item><title><![CDATA[Utilizing biomolecular condensates as electrochemical reactors]]></title><description><![CDATA[Liquid–liquid phase separation and biomolecular condensates have received massive fundamental research interest in recent years. Yu et al. engineered self-assembling, genetically encoded biomaterials that function as electrochemical reactors. Their work demonstrates the great utility of these materials in nanoparticle synthesis, pollutant degradation, and inhibition of bacteria through artificial ferroptosis.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/utilizing-biomolecular-condensates-as-electrochemical-reactors/</link><pubDate>Wed, 25 Mar 2026 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/utilizing-biomolecular-condensates-as-electrochemical-reactors/</guid></item><item><title><![CDATA[David Botstein, Gene-Mapping Pioneer, Dies at 83]]></title><description><![CDATA[His method of locating genes in human DNA allowed researchers to find disease-causing genes, and later to map the entire, sprawling human genome.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/david-botstein-gene-mapping-pioneer-dies-at-83/</link><pubDate>Fri, 20 Mar 2026 22:25:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/david-botstein-gene-mapping-pioneer-dies-at-83/</guid></item><item><title><![CDATA[Omega-based mini prime- and base-editing systems in Escherichia coli]]></title><description><![CDATA[Obligate mobile element-guided activity-based prime-editing and base-editing systems represent a significant advancement in gene editing and targeted mutagenesis, enabling precise, programmable mutations in target genes. These compact, high-efficiency systems seamlessly integrate with multiple high-throughput screening technologies, significantly accelerating directed evolution processes and offering powerful tools for genetic engineering and biotechnological applications.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/omega-based-mini-prime-and-base-editing-systems-in-escherichia-coli/</link><pubDate>Mon, 16 Mar 2026 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/omega-based-mini-prime-and-base-editing-systems-in-escherichia-coli/</guid></item><item><title><![CDATA[Characterization and engineering of highly efficient Cas12j genome editors]]></title><description><![CDATA[This study identifies and engineers compact Cas12j genome editors from viral metagenomes. By enhancing their activity through exonuclease fusion and enabling precise base editing via deaminase coupling in mammalian cells, these advances expand the CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) toolbox and support the development of genome-editing strategies suited for delivery-constrained therapeutic applications.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/characterization-and-engineering-of-highly-efficient-cas12j-genome-editors/</link><pubDate>Fri, 13 Mar 2026 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/characterization-and-engineering-of-highly-efficient-cas12j-genome-editors/</guid></item><item><title><![CDATA[A new strategy to stabilize gene circuits]]></title><description><![CDATA[The stability of synthetic gene circuits is limited by cellular growth and division. Zhang et al. demonstrated how engineered condensates of transcription factors can stabilize gene expression and enhance bio-based production. This work establishes the spatial organization of transcription factors through phase separation as a powerful strategy for robust gene expression.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/a-new-strategy-to-stabilize-gene-circuits/</link><pubDate>Fri, 13 Mar 2026 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/a-new-strategy-to-stabilize-gene-circuits/</guid></item><item><title><![CDATA[Control of properties and nutrient content of cultivated foie gras tissues via scaffold and media factors]]></title><description><![CDATA[We present a proof-of-concept avian cultivated fatty liver prototype inspired by foie gras, using edible, plant-based 3D scaffolds to support chicken hepatocyte lipogenesis. The system reproduces key physical and chemical features of foie gras while enabling nutritional enhancement, providing a scalable and ethical foundation for future species-specific cultivated foie gras development.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/control-of-properties-and-nutrient-content-of-cultivated-foie-gras-tissues-via-scaffold-and-media-factors/</link><pubDate>Thu, 12 Mar 2026 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/control-of-properties-and-nutrient-content-of-cultivated-foie-gras-tissues-via-scaffold-and-media-factors/</guid></item><item><title><![CDATA[F.D.A. Faces Upset Over Denials of New Drugs]]></title><description><![CDATA[Agency officials promise fast reviews of new treatments while vowing they will not be a &ldquo;rubber stamp&rdquo; for the industry. But patients with rare diseases view recent decisions as signs that the doors are closing on their options.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/fda-faces-upset-over-denials-of-new-drugs/</link><pubDate>Thu, 05 Mar 2026 11:01:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/fda-faces-upset-over-denials-of-new-drugs/</guid></item><item><title><![CDATA[Henrietta Lacks’s Family Settles Suit With Novartis Over Use of Her Cells]]></title><description><![CDATA[Ms. Lacks&rsquo;s family accused Novartis of profiting from her cells, which were taken from her without her consent in 1951, when she was dying of cervical cancer.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/henrietta-lackss-family-settles-suit-with-novartis-over-use-of-her-cells/</link><pubDate>Fri, 27 Feb 2026 22:47:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/henrietta-lackss-family-settles-suit-with-novartis-over-use-of-her-cells/</guid></item><item><title><![CDATA[Industrial perspective validation of a neutralizer-free l-lactic acid production process by engineered acid-tolerant yeast Pichia kudriavzevii]]></title><description><![CDATA[l-Lactic acid (l-LA) is one of the most important three-carbon chemicals in the world. Its crucial role as the precursor of polylactic acid (PLA) (see Glossary) has led to a soaring demand for l-LA [1]. The global demand for l-LA is estimated to reach $2.67 billion by 2030, at a compound annual growth rate of 11.2% from 2024 to 2030 (https://www.qyresearch.com/industry-news/7036/l-lactic-acid). Microbial fermentation is an industrial production strategy for l-LA. Corbion, NatureWorks, and Henan]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/industrial-perspective-validation-of-a-neutralizer-free-l-lactic-acid-production-process-by-engineered-acid-tolerant-yeast-pichia-kudriavzevii/</link><pubDate>Fri, 27 Feb 2026 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/industrial-perspective-validation-of-a-neutralizer-free-l-lactic-acid-production-process-by-engineered-acid-tolerant-yeast-pichia-kudriavzevii/</guid></item><item><title><![CDATA[Establishment of a nonhomologous end joining-mediated genomic library in Fusarium fujikuroi for high-level production of gibberellic acid]]></title><description><![CDATA[NHEJ-mediated genome-wide insertional mutagenesis enables rapid discovery of functional genetic targets and stable integration sites in Fusarium fujikuroi, providing a versatile platform for metabolic engineering and strain improvement.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/establishment-of-a-nonhomologous-end-joining-mediated-genomic-library-in-fusarium-fujikuroi-for-high-level-production-of-gibberellic-acid/</link><pubDate>Thu, 26 Feb 2026 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/establishment-of-a-nonhomologous-end-joining-mediated-genomic-library-in-fusarium-fujikuroi-for-high-level-production-of-gibberellic-acid/</guid></item><item><title><![CDATA[Biosensor-guided indexing of genome evolution for boosting microbial chemical synthesis]]></title><description><![CDATA[This study developed a biosensor-driven genome evolution (BRIDGE) workflow that enables marker-free engineering of microbial hosts. As an example, protocatechuic acid (PCA) overproduction in Pseudomonas putida was achieved by BRIDGE. Considering the great variety of available biosensors, BRIDGE may represent a generalizable framework for biosensor-driven evolution of microbial cell factories.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/biosensor-guided-indexing-of-genome-evolution-for-boosting-microbial-chemical-synthesis/</link><pubDate>Tue, 24 Feb 2026 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/biosensor-guided-indexing-of-genome-evolution-for-boosting-microbial-chemical-synthesis/</guid></item><item><title><![CDATA[Growth-coupled evolution accelerates efficient biosynthesis of natural products]]></title><description><![CDATA[Microbial natural product biosynthesis often suffers from metabolic burden and genetic instability. Bushin et al. introduce a synthetic C1 feedback loop that couples xanthommatin production to cell survival, enabling adaptive laboratory evolution to achieve gram-scale production. This strategy offers a generalizable route to engineer cell factories for complex natural products.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/growth-coupled-evolution-accelerates-efficient-biosynthesis-of-natural-products/</link><pubDate>Fri, 13 Feb 2026 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/growth-coupled-evolution-accelerates-efficient-biosynthesis-of-natural-products/</guid></item><item><title><![CDATA[Engineering Halomonas for low-salt, open, and unsterile production of polyhydroxybutyrate]]></title><description><![CDATA[Wild-type Halomonas bluephagenesis TD1.0 was engineered to generate an iterative SSM series highly adapted to low-salinity conditions. The multiple strategy approach included genetic engineering, adaptive evolution, production module, and process engineering. Together, these synergistic strategies enabled the construction of broadly salinity-adaptive Halomonas chassis suitable for low-salinity, open, and nonsterile biomanufacturing.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/engineering-halomonas-for-low-salt-open-and-unsterile-production-of-polyhydroxybutyrate/</link><pubDate>Wed, 11 Feb 2026 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/engineering-halomonas-for-low-salt-open-and-unsterile-production-of-polyhydroxybutyrate/</guid></item><item><title><![CDATA[In vivo continuous evolution via phenotypic sorting to alleviate metabolic bottlenecks in β-alanine production]]></title><description><![CDATA[This study uses a T7 RNA polymerase-deaminase fusion editor-based in vivo evolution platform, coupled with a biosensor for simultaneous mutagenesis and screening, to enhance the activity of the rate-limiting enzyme in β-alanine biosynthesis, thereby offering a scalable strategy for optimizing microbial cell factories.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/in-vivo-continuous-evolution-via-phenotypic-sorting-to-alleviate-metabolic-bottlenecks-in-alanine-production/</link><pubDate>Sun, 01 Feb 2026 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/in-vivo-continuous-evolution-via-phenotypic-sorting-to-alleviate-metabolic-bottlenecks-in-alanine-production/</guid></item><item><title><![CDATA[An immune-inspired intelligent aptasensor with broad detection capability]]></title><description><![CDATA[Biosensor performance is constrained by suboptimal aptamers and conventional aptamer-material combinations. This study introduces an immunity-inspired biomimetic strategy fundamentally refactor aptamer engineering. A core biosensing mechanism is established through target-induced self-assembly of DNA nanosphere-Cu(II) nanozymes. Integrated with a smartphone-based detection platform, the aptamer-nanozyme-based biosensor demonstrates broad detection capabilities.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/an-immune-inspired-intelligent-aptasensor-with-broad-detection-capability/</link><pubDate>Fri, 30 Jan 2026 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/an-immune-inspired-intelligent-aptasensor-with-broad-detection-capability/</guid></item><item><title><![CDATA[Elucidation of odd-chain dicarboxylate metabolism in Acinetobacter baylyi and application to polyethylene upcycling]]></title><description><![CDATA[An integrated approach combines chemical degradation and biological conversion of postconsumer polyethylene waste into a value-added bioproduct in the nonmodel bacterium Acinetobacter baylyi ADP1. This study provides the genetic basis for applying synthetic biology and systems biology to construct a versatile microbial chassis for bio-upcycling plastic waste, thereby contributing to sustainable biomanufacturing.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/elucidation-of-odd-chain-dicarboxylate-metabolism-in-acinetobacter-baylyi-and-application-to-polyethylene-upcycling/</link><pubDate>Wed, 28 Jan 2026 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/elucidation-of-odd-chain-dicarboxylate-metabolism-in-acinetobacter-baylyi-and-application-to-polyethylene-upcycling/</guid></item><item><title><![CDATA[Broadening art–science collaboration in biotechnology: integrating design]]></title><description><![CDATA[This article extends recent conversations on art–science collaboration in biotechnology to include design and biodesign. We highlight the rise of biodesign, tinkering with design, and more-than-human approaches in fostering innovative, sustainable outcomes for contemporary biotechnology, illustrating these opportunities through case studies in transdisciplinary partnership.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/broadening-artscience-collaboration-in-biotechnology-integrating-design/</link><pubDate>Fri, 23 Jan 2026 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/broadening-artscience-collaboration-in-biotechnology-integrating-design/</guid></item><item><title><![CDATA[Systematic engineering of Micromonospora echinospora cell factory for gentamicin C1a overproduction]]></title><description><![CDATA[Xu et al. establish an integrated strain–process engineering framework for efficient gentamicin C1a biomanufacturing. By combining genome-scale metabolic modeling, multi-gene regulatory optimization, metabolomics-guided flux analysis, and Bayesian-driven fed-batch control with in situ adsorption, the study reveals redox and energy metabolism as key constraints and enhances yield and productivity.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/systematic-engineering-of-micromonospora-echinospora-cell-factory-for-gentamicin-c1a-overproduction/</link><pubDate>Mon, 19 Jan 2026 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/systematic-engineering-of-micromonospora-echinospora-cell-factory-for-gentamicin-c1a-overproduction/</guid></item><item><title><![CDATA[Image-guided volumetric bioprinting]]></title><description><![CDATA[Image-guided volumetric bioprinting allows for the adaptive fabrication of complex structures for tissue engineering. Seminal work by Florczak et al. introduces Generative, Adaptive, Context-Aware 3D Printing, a workflow that uses computer vision to automatically generate functional, vascular-like networks that conform to living cells within hydrogels, improving their functionality.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/image-guided-volumetric-bioprinting/</link><pubDate>Mon, 19 Jan 2026 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/image-guided-volumetric-bioprinting/</guid></item><item><title><![CDATA[Precision insect control using programmable modular phage therapy platforms]]></title><description><![CDATA[The Modular Phage-based Symbiont Targeting system targets gut symbionts of Spodoptera frugiperda, rapidly reversing insecticide resistance. It reduces chemical pesticide use and residue while increasing control efficacy, offering a precise, adaptable, and eco-friendly solution for sustainable management of resistant agricultural pests.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/precision-insect-control-using-programmable-modular-phage-therapy-platforms/</link><pubDate>Sun, 18 Jan 2026 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/precision-insect-control-using-programmable-modular-phage-therapy-platforms/</guid></item><item><title><![CDATA[Engineered coatings containing cyclic peptides from cyanobacteria delay the development of a stable macrofouling community]]></title><description><![CDATA[Bio-based antifouling coatings incorporating cyanobacterial natural products inhibit biofilm formation and mussel larval settlement at lab scale, outperforming a commercial biocide under real marine conditions by promoting an antifouling–effective biome. This technology provides a promising route toward sustainable, eco-safe antifouling solutions with potential applications across marine ecological management.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/engineered-coatings-containing-cyclic-peptides-from-cyanobacteria-delay-the-development-of-a-stable-macrofouling-community/</link><pubDate>Tue, 13 Jan 2026 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/engineered-coatings-containing-cyclic-peptides-from-cyanobacteria-delay-the-development-of-a-stable-macrofouling-community/</guid></item><item><title><![CDATA[Connector-enabled integration of Golden Gate Assembly and yeast recombination for streamlined multigene pathway construction in the biofoundry workflow]]></title><description><![CDATA[Microbial bioconversion is a key driver in the modern biotechnology industry, enabling sustainable production of foods, chemicals, fuels, and nutraceuticals [1–3]. Central to this capability is metabolic engineering, which strategically rewires microbial metabolism to synthesize value-added bioproducts [4]. Achieving high-yield production of molecules of interest in microbial hosts often requires introducing heterologous metabolic pathways, enhancing precursor supply, eliminating competing rea]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/connector-enabled-integration-of-golden-gate-assembly-and-yeast-recombination-for-streamlined-multigene-pathway-construction-in-the-biofoundry-workflow/</link><pubDate>Tue, 13 Jan 2026 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/connector-enabled-integration-of-golden-gate-assembly-and-yeast-recombination-for-streamlined-multigene-pathway-construction-in-the-biofoundry-workflow/</guid></item><item><title><![CDATA[In situ engineering of synthetic yeast consortia for cross-species metabolic conversion of crude glycerol and byproducts into circular renewable bioenergy]]></title><description><![CDATA[Shi et al. engineer a synthetic yeast consortium to valorize crude glycerol, a biodiesel waste, into isopropanol. By integrating metabolic cross-feeding with in situ cell pairing and immobilization, this platform establishes a robust, scalable route for transforming industrial byproducts into sustainable energy resources.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/in-situ-engineering-of-synthetic-yeast-consortia-for-cross-species-metabolic-conversion-of-crude-glycerol-and-byproducts-into-circular-renewable-bioenergy/</link><pubDate>Fri, 09 Jan 2026 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/in-situ-engineering-of-synthetic-yeast-consortia-for-cross-species-metabolic-conversion-of-crude-glycerol-and-byproducts-into-circular-renewable-bioenergy/</guid></item><item><title><![CDATA[Pipeline and insulated dual-reporter system to predict and quantify strong terminators from RNA-seq datasets for metabolic engineering]]></title><description><![CDATA[Limited research on transcription termination and a few terminators hinder the efficient construction of microbial cell factories (MCFs). This study develops a pipeline to predict strong genome-wide terminators using RNA-seq data and an insulated dual-reporter system (IDRS) for quantification, offering integrated tools for precise transcription regulation in MCFs.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/pipeline-and-insulated-dual-reporter-system-to-predict-and-quantify-strong-terminators-from-rna-seq-datasets-for-metabolic-engineering/</link><pubDate>Fri, 02 Jan 2026 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/pipeline-and-insulated-dual-reporter-system-to-predict-and-quantify-strong-terminators-from-rna-seq-datasets-for-metabolic-engineering/</guid></item><item><title><![CDATA[Exploring substrate cofeeding for enhanced acetogenic C1 bioconversion with AneVO, a low-cost anaerobic parallel bioreactor platform]]></title><description><![CDATA[We developed AneVO, a low-cost benchtop system for growing oxygen-sensitive bacteria, and used it to discover that combining methanol and carbon monoxide as feedstocks synergistically improves microbial growth and chemical production. This advance could enable more sustainable, efficient biomanufacturing of fuels and chemicals from renewable carbon sources.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/exploring-substrate-cofeeding-for-enhanced-acetogenic-c1-bioconversion-with-anevo-a-low-cost-anaerobic-parallel-bioreactor-platform/</link><pubDate>Sun, 28 Dec 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/exploring-substrate-cofeeding-for-enhanced-acetogenic-c1-bioconversion-with-anevo-a-low-cost-anaerobic-parallel-bioreactor-platform/</guid></item><item><title><![CDATA[Reimagining colour with synthetic biology]]></title><description><![CDATA[Colour is an integral part of the consumer experience, added to most products we use in our daily lives. Globally, approximately 2 million tons of petroleum-based synthetic dyes and pigments are produced each year, with 40% consumed by the textile industry alone. While the production of these dyes and pigments has a considerable environmental footprint, their application as dyes, inks, and coatings is even larger, requiring significant amounts of heat, energy, and auxiliary chemicals to achieve]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/reimagining-colour-with-synthetic-biology/</link><pubDate>Thu, 18 Dec 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/reimagining-colour-with-synthetic-biology/</guid></item><item><title><![CDATA[Industrialization of 3D hiPSC-cardiac microtissues for high-throughput cardiac safety and drug discovery screening]]></title><description><![CDATA[This work establishes scalable, automated methods for producing and screening 3D human stem cell–derived heart tissues. High-throughput screening of more than 2000 compounds shows that this model can predict drug effects on heart rhythm and contractility, paving the way for its use in drug safety and discovery pipelines.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/industrialization-of-3d-hipsc-cardiac-microtissues-for-high-throughput-cardiac-safety-and-drug-discovery-screening/</link><pubDate>Thu, 18 Dec 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/industrialization-of-3d-hipsc-cardiac-microtissues-for-high-throughput-cardiac-safety-and-drug-discovery-screening/</guid></item><item><title><![CDATA[Holistic ecosystem strategies for boosting biopharma start-up success]]></title><description><![CDATA[Biopharma start-ups drive pharmaceutical innovation, relying on local ecosystems that connect key actors, resources, and enabling factors. This article synthesizes literature and expert insights into a framework that outlines five pillars—networks, technology transfer, funding, education, and culture—to guide policymakers and stakeholders in building thriving biopharma clusters and accelerating innovation.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/holistic-ecosystem-strategies-for-boosting-biopharma-start-up-success/</link><pubDate>Thu, 18 Dec 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/holistic-ecosystem-strategies-for-boosting-biopharma-start-up-success/</guid></item><item><title><![CDATA[Techno-economic assessment-guided biofoundry for microbial strain development]]></title><description><![CDATA[A robotics-assisted biofoundry platform was applied to synthetic biology, using robot-assisted module (RAM)-based workflows optimized with the Experiment Price Index (EPI). Demonstrated through the development of biofoundry workflows, the EPI framework was further extended to techno-economic analysis for evaluating annual biofoundry operations.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/techno-economic-assessment-guided-biofoundry-for-microbial-strain-development/</link><pubDate>Mon, 01 Dec 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/techno-economic-assessment-guided-biofoundry-for-microbial-strain-development/</guid></item><item><title><![CDATA[Discovery, characterization, and application of chromosomal integration sites in the hyperthermophilic archaeon Sulfolobus islandicus]]></title><description><![CDATA[Integration sites in Sulfolobus islandicus M.16.4 were identified using the CRISPR-COPIES pipeline, prioritized with multi-omics data, and validated with a β-galactosidase assay. These characterized sites expand the genetic toolbox for Sulfolobus and enable its domestication for industrial biotechnology and drug delivery applications.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/discovery-characterization-and-application-of-chromosomal-integration-sites-in-the-hyperthermophilic-archaeon-sulfolobus-islandicus/</link><pubDate>Mon, 01 Dec 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/discovery-characterization-and-application-of-chromosomal-integration-sites-in-the-hyperthermophilic-archaeon-sulfolobus-islandicus/</guid></item><item><title><![CDATA[Comparison of technologies for manufacturing extracellular vesicles for therapeutic applications]]></title><description><![CDATA[Yield and contents of extracellular vesicles (EVs) are impacted more by cell culture method than donor variability. Three culture methods are compared, finding that microcarriers are the most scalable and reproducible. Microcarrier-derived EVs also yield more proangiogenic, antiapoptotic, and immunomodulatory proteins and RNAs, which may lead to enhanced therapeutic outcomes.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/comparison-of-technologies-for-manufacturing-extracellular-vesicles-for-therapeutic-applications/</link><pubDate>Sat, 29 Nov 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/comparison-of-technologies-for-manufacturing-extracellular-vesicles-for-therapeutic-applications/</guid></item><item><title><![CDATA[Glutaraldehyde-induced porcine model mimics human chronic wounds: insights into pathophysiology and therapeutic applications]]></title><description><![CDATA[This study introduces a novel porcine model of chronic wounds mimicking human pathology, enabling better evaluation of therapies. It offers insights into wound mechanisms, critical for developing more effective treatments to improve healing outcomes in patients with chronic wounds, including diabetic foot ulcers and venous leg ulcers.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/glutaraldehyde-induced-porcine-model-mimics-human-chronic-wounds-insights-into-pathophysiology-and-therapeutic-applications/</link><pubDate>Fri, 28 Nov 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/glutaraldehyde-induced-porcine-model-mimics-human-chronic-wounds-insights-into-pathophysiology-and-therapeutic-applications/</guid></item><item><title><![CDATA[Leveraging stability dynamics of spore germination for microbially enhanced mineralization of bioconcrete]]></title><description><![CDATA[The current study attempts to mitigate the huge carbon footprint generated by the construction industry during cement production. This was achieved by using EPS-coated bacterial spores to make bioconcrete structures. These spores led to microbially enhanced biomineralization that resulted in self-healing of bioconcrete and improved mechanical properties.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/leveraging-stability-dynamics-of-spore-germination-for-microbially-enhanced-mineralization-of-bioconcrete/</link><pubDate>Thu, 27 Nov 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/leveraging-stability-dynamics-of-spore-germination-for-microbially-enhanced-mineralization-of-bioconcrete/</guid></item><item><title><![CDATA[Gene therapy strategies in tissue engineering: advances and applications for regenerative therapy]]></title><description><![CDATA[Gene therapy has emerged as a promising strategy for tissue regeneration, offering the potential to address the limitations of conventional treatments. In this review we present an overview of applications of gene therapy in tissue regeneration, emphasizing recent advancements and future directions. Our work addresses gaps in the current literature by examining developments in molecular biology and genetics, such as clustered regularly interspaced short palindromic repeats (CRISPR) gene editing,]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/gene-therapy-strategies-in-tissue-engineering-advances-and-applications-for-regenerative-therapy/</link><pubDate>Thu, 27 Nov 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/gene-therapy-strategies-in-tissue-engineering-advances-and-applications-for-regenerative-therapy/</guid></item><item><title><![CDATA[Creating artificial miR2118a/b to boost yield and broad-spectrum resistance in soybean via CRISPR/Cas9-targeted mutation]]></title><description><![CDATA[This study uses clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein (Cas9) to mutate miR2118a/b-5p, generating amiR2118a/b mutants, altering pre-amiR2118a/b structures, reducing the levels of mature miR2118a/b and phased small interfering RNAs (phasiRNAs), upregulating growth/defense-related genes under normal and Pseudomonas syringae pv. glycinea (Psg)-infected conditions, and enhancing soybean field yield and broad-spectrum resistance, thus offering a n]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/creating-artificial-mir2118ab-to-boost-yield-and-broad-spectrum-resistance-in-soybean-via-crisprcas9-targeted-mutation/</link><pubDate>Thu, 27 Nov 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/creating-artificial-mir2118ab-to-boost-yield-and-broad-spectrum-resistance-in-soybean-via-crisprcas9-targeted-mutation/</guid></item><item><title><![CDATA[Kleptosomes: biotechnological blueprints for organelle engineering]]></title><description><![CDATA[Kleptosomes – specialized organelles in sea slugs that hijack chloroplasts – illuminate pathways for synthetic organelle engineering. Their unique mechanisms of organelle integration, energy coupling, and stress-responsive adaptation offer potential blueprints for bioenergy and medical applications, merging fundamental research and cutting-edge biotechnology to address global sustainability and health challenges.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/kleptosomes-biotechnological-blueprints-for-organelle-engineering/</link><pubDate>Wed, 26 Nov 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/kleptosomes-biotechnological-blueprints-for-organelle-engineering/</guid></item><item><title><![CDATA[New technologies for production of recombinant spider silk]]></title><description><![CDATA[Natural spider silk cannot be harvested on a commercial scale due to the spiders' cannibalistic nature. Recombinant spider silk provides a scalable alternative to traditional silk production by using microbial fermentation of spider silk proteins, overcoming the challenge of farming spiders, thereby making spider silk – a holy grail of biomaterials – available on a large scale. This biotechnology-based approach replicates the properties of natural spider silk for diverse applications, includ]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/new-technologies-for-production-of-recombinant-spider-silk/</link><pubDate>Tue, 25 Nov 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/new-technologies-for-production-of-recombinant-spider-silk/</guid></item><item><title><![CDATA[Intramuscular delivery of mRNA-encoded single-chain variable fragments prevents myotoxin II-induced skeletal muscle damage in a preclinical model]]></title><description><![CDATA[Snakebites cause over 140 000 deaths and 400 000 disabilities globally each year. Prompt treatment is essential to prevent the severe effects of envenomings. In this study, we examined the potential benefits of using mRNA technology to express toxin-specific antibody fragments in local tissues and showed their effectiveness in reducing venom-induced muscle damage.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/intramuscular-delivery-of-mrna-encoded-single-chain-variable-fragments-prevents-myotoxin-ii-induced-skeletal-muscle-damage-in-a-preclinical-model/</link><pubDate>Mon, 24 Nov 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/intramuscular-delivery-of-mrna-encoded-single-chain-variable-fragments-prevents-myotoxin-ii-induced-skeletal-muscle-damage-in-a-preclinical-model/</guid></item><item><title><![CDATA[Elevated carbon dioxide stimulates efficient organic carbon consumption for the unicellular alga Galdieria]]></title><description><![CDATA[Contrary to standard fermentation, elevated CO2 triggers efficient organic-carbon consumption in Galdieria during heterotrophy, enabling high-yield biomass and timing C-phycocyanin accumulation. Stable-isotope analysis revealed CO2 as a metabolic trigger, rather than a carbon source, but illumination can enable mixotrophic carbon consumption and increased substrate to biomass ratios.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/elevated-carbon-dioxide-stimulates-efficient-organic-carbon-consumption-for-the-unicellular-alga-galdieria/</link><pubDate>Sat, 22 Nov 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/elevated-carbon-dioxide-stimulates-efficient-organic-carbon-consumption-for-the-unicellular-alga-galdieria/</guid></item><item><title><![CDATA[Coexistence and collaboration: engineering encapsulation for whole-cell biosensors]]></title><description><![CDATA[The emerging field of biosensors exploits the abilities of cells to identify specific molecules, presenting improved sensitivity, specificity, and limit of detection. Whole-cell biosensors (WCB) are organisms specifically engineered to detect a target analyte and express a reporter in response. In biomanufacturing, they can be used for monitoring of key substrate and metabolite concentrations or strain engineering, while in medicine, they can be used to diagnose disease or report on human–micr]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/coexistence-and-collaboration-engineering-encapsulation-for-whole-cell-biosensors/</link><pubDate>Fri, 21 Nov 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/coexistence-and-collaboration-engineering-encapsulation-for-whole-cell-biosensors/</guid></item><item><title><![CDATA[Solar-driven PHB synthesis from wastewater by engineered semiconductor–bacteria biohybrids]]></title><description><![CDATA[Industrial wastewater contaminated with sulfate, heavy metal ions, and complex organic compounds poses a significant threat to the environment [1]. Although chemical or physical methods, including chemical coagulation, advanced oxidation, and membrane separation, have been used to treat sulfate-rich metal-laden wastewater (SRMLW), such biological treatment presents economic and environmental challenges when degrading sulfate and removing metal ions from SRMLW [2]. SRB can utilize sulfate as the]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/solar-driven-phb-synthesis-from-wastewater-by-engineered-semiconductorbacteria-biohybrids/</link><pubDate>Thu, 20 Nov 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/solar-driven-phb-synthesis-from-wastewater-by-engineered-semiconductorbacteria-biohybrids/</guid></item><item><title><![CDATA[Dual enhancement of mycoprotein nutrition and sustainability via CRISPR-mediated metabolic engineering of Fusarium venenatum]]></title><description><![CDATA[Improvements in nutrition and sustainability for Fusarium venenatum mycoprotein (MP) has been achieved through CRISPR/Cas9 gene knockout technology without introducing exogenous genes. The gene-edited strain exhibits favorable performance at industrial fermentation scale. This work provides compelling evidence for the functional enhancement of environmentally friendly gene-edited MP foods.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/dual-enhancement-of-mycoprotein-nutrition-and-sustainability-via-crispr-mediated-metabolic-engineering-of-fusarium-venenatum/</link><pubDate>Wed, 19 Nov 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/dual-enhancement-of-mycoprotein-nutrition-and-sustainability-via-crispr-mediated-metabolic-engineering-of-fusarium-venenatum/</guid></item><item><title><![CDATA[Scientists Grow More Hopeful About Ending a Global Organ Shortage]]></title><description><![CDATA[At an international conference, researchers at the forefront of animal-human transplantation compared notes and allowed themselves the first real optimism in decades.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/scientists-grow-more-hopeful-about-ending-a-global-organ-shortage/</link><pubDate>Wed, 12 Nov 2025 11:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/scientists-grow-more-hopeful-about-ending-a-global-organ-shortage/</guid></item><item><title><![CDATA[One-pot production of colored bacterial cellulose]]></title><description><![CDATA[Zhou et al. report the one-pot production of colored bacterial cellulose (BC) as a sustainable alternative to petroleum-based fabrics. Metabolic engineering enhanced colorant yields, while co-culture optimization enabled the first reported production of multicolored BC, presenting a promising strategy for eco-friendly textile manufacturing.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/one-pot-production-of-colored-bacterial-cellulose/</link><pubDate>Wed, 12 Nov 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/one-pot-production-of-colored-bacterial-cellulose/</guid></item><item><title><![CDATA[China busca conquistar el envejecimiento]]></title><description><![CDATA[Los laboratorios de longevidad, las &ldquo;islas de la inmortalidad&rdquo; y las pastillas de semillas de uva forman parte del proyecto chino para vencer al envejecimiento.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/china-busca-conquistar-el-envejecimiento/</link><pubDate>Tue, 11 Nov 2025 19:59:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/china-busca-conquistar-el-envejecimiento/</guid></item><item><title><![CDATA[La búsqueda de China de conquistar el envejecimiento]]></title><description><![CDATA[Los laboratorios de longevidad, las &ldquo;islas de la inmortalidad&rdquo; y pastillas de semillas de uva forman parte del proyecto chino para vencer al envejecimiento.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/la-bsqueda-de-china-de-conquistar-el-envejecimiento/</link><pubDate>Mon, 10 Nov 2025 19:24:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/la-bsqueda-de-china-de-conquistar-el-envejecimiento/</guid></item><item><title><![CDATA[Inside China’s Quest to Defy Aging with Longevity Labs and ‘Immortality Islands’]]></title><description><![CDATA[Longevity labs, &ldquo;immortality islands&rdquo; and grapeseed pills are part of China&rsquo;s national project to conquer aging, despite sometimes shaky science and extravagant claims.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/inside-chinas-quest-to-defy-aging-with-longevity-labs-and-immortality-islands/</link><pubDate>Sat, 08 Nov 2025 06:05:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/inside-chinas-quest-to-defy-aging-with-longevity-labs-and-immortality-islands/</guid></item><item><title><![CDATA[Toward standardization of upscaled manufacturing of extracellular vesicles in hollow-fiber bioreactors]]></title><description><![CDATA[Hollow-fiber bioreactor cultivation enables scalable and standardized production of extracellular vesicles from dental pulp stem cells (DPSC-EVs). The system preserves their angiogenic and anti-inflammatory functions while enhancing manufacturing consistency. This strategy enhances the translational potential of DPSC-EVs, supporting their consistent and scalable use in regenerative therapies.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/toward-standardization-of-upscaled-manufacturing-of-extracellular-vesicles-in-hollow-fiber-bioreactors/</link><pubDate>Fri, 07 Nov 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/toward-standardization-of-upscaled-manufacturing-of-extracellular-vesicles-in-hollow-fiber-bioreactors/</guid></item><item><title><![CDATA[Recycling CO2 into bioingredients: towards synthetic photo/litho-mixotrophy]]></title><description><![CDATA[Advances in carbon capture and gas fermentation technologies enable the sustainable production of one-carbon (C1) and C2 organic molecules, such as formate and acetate, by recycling CO2 and organic wastes. Refining C1 and C2 feedstocks into food and other organic ingredients is essential for establishing a carbon-neutral economy. However, current C1/C2-utilizing microbial refinery platforms have yet to achieve ideal carbon efficiency at industrial scales. We critically review progress in innovat]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/recycling-co2-into-bioingredients-towards-synthetic-photolitho-mixotrophy/</link><pubDate>Thu, 06 Nov 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/recycling-co2-into-bioingredients-towards-synthetic-photolitho-mixotrophy/</guid></item><item><title><![CDATA[Integrated Tn-seq and MAGE-assisted rapid genome engineering targeting in Escherichia coli]]></title><description><![CDATA[We developed an integrated platform that combines in situ transposon mutagenesis, biosensor-guided selection, and multiplex automated genome engineering. This approach significantly accelerates the identification of novel knockout target genes and their combinatorial effects, thereby facilitating efficient microbial engineering for enhancing valuable biochemical production.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/integrated-tn-seq-and-mage-assisted-rapid-genome-engineering-targeting-in-escherichia-coli/</link><pubDate>Thu, 06 Nov 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/integrated-tn-seq-and-mage-assisted-rapid-genome-engineering-targeting-in-escherichia-coli/</guid></item><item><title><![CDATA[Connectogenomics: edges-first spatial biology]]></title><description><![CDATA[Spatial omics maps cell types and spatial context together. Current methods fall into two streams: mapping coordinates (where things are) and measuring connections between cells that are in contact or close proximity. We introduce the term connectogenomics as a practical umbrella for sequencing assays that directly record such contacts as a network. Combining coordinates with measured contacts lets us verify whether apparent neighbors truly interact and turn network features – such as contact]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/connectogenomics-edges-first-spatial-biology/</link><pubDate>Thu, 06 Nov 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/connectogenomics-edges-first-spatial-biology/</guid></item><item><title><![CDATA[Dynamic regulation of oleaginous yeast metabolism for chemical production]]></title><description><![CDATA[Dynamic regulation enables precise, signal-responsive control of metabolism in oleaginous yeasts, overcoming limitations of static engineering. By leveraging metabolite and spatiotemporal cues, these systems decouple growth from production and enhance the yield of target chemicals. Integrating such strategies holds promise for building robust and high-performance oleaginous yeast cell factories.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/dynamic-regulation-of-oleaginous-yeast-metabolism-for-chemical-production/</link><pubDate>Mon, 03 Nov 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/dynamic-regulation-of-oleaginous-yeast-metabolism-for-chemical-production/</guid></item><item><title><![CDATA[F.D.A. Moves to Speed Approvals for Cheaper Copycat Drugs]]></title><description><![CDATA[The agency announced moves to cut regulatory obstacles for the makers of biosimilar drugs, which are akin to generics and may help lower drug costs.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/fda-moves-to-speed-approvals-for-cheaper-copycat-drugs/</link><pubDate>Thu, 30 Oct 2025 17:13:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/fda-moves-to-speed-approvals-for-cheaper-copycat-drugs/</guid></item><item><title><![CDATA[Upscaled open-culture production of microbial flocculants from industrial wastewaters]]></title><description><![CDATA[There is an increasing need for finding cost-effective alternatives to synthetic polymers. We demonstrate sustained production of microbial exopolymers from wastewater, with flocculating properties comparable to commercial polyacrylamide. This technology enables upcycling of residual feedstocks to increase circularity in water treatment and avoid chemicals with negative health and environmental impacts.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/upscaled-open-culture-production-of-microbial-flocculants-from-industrial-wastewaters/</link><pubDate>Thu, 30 Oct 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/upscaled-open-culture-production-of-microbial-flocculants-from-industrial-wastewaters/</guid></item><item><title><![CDATA[Towards the ethical development of functional genomics research]]></title><description><![CDATA[Contemporary functional genomics researchers have sought to couple high-throughput experimental technologies with computational methodologies. However, the ethical issues associated with bench science at the early stages of the artificial intelligence (AI) lifecycle have received less attention and merit further examination, as addressing issues early on can mitigate downstream challenges in healthcare.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/towards-the-ethical-development-of-functional-genomics-research/</link><pubDate>Thu, 30 Oct 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/towards-the-ethical-development-of-functional-genomics-research/</guid></item><item><title><![CDATA[Precision tumor immunotherapy via a dual-gated macrophage–bacterial activation platform]]></title><description><![CDATA[This study developed Macrophage-Bacteria encapsulation Lytic Autoactivated Synergistic Therapeutics (M-BLAST), a dual-gated system using engineered macrophages to deliver attenuated Salmonella to tumors. Local near-infrared irradiation at the tumor site triggers a heat shock promoter-mediated pyroptosis in macrophages, leading to synchronized bacterial burst release and a cascade of antitumor immune activation, while effectively minimizing off-target effects.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/precision-tumor-immunotherapy-via-a-dual-gated-macrophagebacterial-activation-platform/</link><pubDate>Thu, 30 Oct 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/precision-tumor-immunotherapy-via-a-dual-gated-macrophagebacterial-activation-platform/</guid></item><item><title><![CDATA[Genome-scale CRISPRi and base-editing libraries for genetic decoding and strain engineering in Shewanella]]></title><description><![CDATA[Shewanella oneidensis, an electroactive microbe, was equipped with genome-scale clustered regularly interspaced short palindromic repeats (CRISPR) interference and base-editing libraries to systematically link genes to phenotypes. These tools revealed candidate essential genes and expanded substrate utilization for electricity generation, providing a versatile framework for functional genomics and microbial engineering in bioelectrochemical applications.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/genome-scale-crispri-and-base-editing-libraries-for-genetic-decoding-and-strain-engineering-in-shewanella/</link><pubDate>Thu, 30 Oct 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/genome-scale-crispri-and-base-editing-libraries-for-genetic-decoding-and-strain-engineering-in-shewanella/</guid></item><item><title><![CDATA[Cryobioprinted human tumor models with shelf-stable programmability]]></title><description><![CDATA[Storable pancreatic tumor–stroma models were fabricated using tissue-specific and cryoprotective bioinks. Cryobioprinting and cryopreservation did not significantly affect the bioengineered constructs, given that thawed 3D in vitro models retained key hallmarks found in the native neoplasia.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/cryobioprinted-human-tumor-models-with-shelf-stable-programmability/</link><pubDate>Wed, 29 Oct 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/cryobioprinted-human-tumor-models-with-shelf-stable-programmability/</guid></item><item><title><![CDATA[A durable hydrogel-encapsulated biohybrid for sustainable triclosan bioremediation]]></title><description><![CDATA[An engineered Pseudomonas knackmussii encapsulated in a magnetic biochar–hydrogel achieves stable triclosan removal by coupling adsorption with biodegradation. This biohybrid platform ensures biosafety, operational resilience, and scalability, offering a generalizable strategy for emerging contaminant remediation.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/a-durable-hydrogel-encapsulated-biohybrid-for-sustainable-triclosan-bioremediation/</link><pubDate>Wed, 29 Oct 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/a-durable-hydrogel-encapsulated-biohybrid-for-sustainable-triclosan-bioremediation/</guid></item><item><title><![CDATA[Engineering M13 phages: surface and morphological strategies for programmable applications]]></title><description><![CDATA[Bacteriophage M13 is a structurally ordered filamentous phage that has long served as a versatile bio-nanotemplate for various applications. To adapt to different applications, it is essential to modify and tailor the properties of M13 phages. This review introduces surface-engineering strategies for enhancing the chemical diversity of M13 phages through physical, chemical, and genetic modifications, and uses pVIII protein as a representative example. In addition, it provides a systematic and co]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/engineering-m13-phages-surface-and-morphological-strategies-for-programmable-applications/</link><pubDate>Tue, 28 Oct 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/engineering-m13-phages-surface-and-morphological-strategies-for-programmable-applications/</guid></item><item><title><![CDATA[Organ-on-chip technologies at the cancer–thrombosis interface]]></title><description><![CDATA[Cancer-associated thrombosis (CAT) is the second leading cause of death among cancer patients, driven by tumour–haemostasis interactions. While traditional models have proven invaluable to study this process, they often fail to replicate its complexity. Organ-on-chip (OoC) offers a promising alternative, potentially enhancing understanding of CAT mechanisms and advancing therapeutic strategies.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/organ-on-chip-technologies-at-the-cancerthrombosis-interface/</link><pubDate>Sat, 25 Oct 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/organ-on-chip-technologies-at-the-cancerthrombosis-interface/</guid></item><item><title><![CDATA[Efficient ergothioneine production through reconstruction of the methyl and sulfur supply systems in Escherichia coli]]></title><description><![CDATA[We developed a cost-effective ergothioneine biosynthesis strategy in Escherichia coli by integrating a betaine-driven methyl supply and inorganic sulfur module, eliminating costly amino acid supplementation. This approach enhances yields, lowers costs, and establishes a versatile platform for producing diverse methyl- and sulfur-containing natural products with broad biomanufacturing potential.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/efficient-ergothioneine-production-through-reconstruction-of-the-methyl-and-sulfur-supply-systems-in-escherichia-coli/</link><pubDate>Sat, 25 Oct 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/efficient-ergothioneine-production-through-reconstruction-of-the-methyl-and-sulfur-supply-systems-in-escherichia-coli/</guid></item><item><title><![CDATA[Rewiring microbial metabolism through post-translational switches]]></title><description><![CDATA[Recent advances in post-translational regulatory tools have enabled precise and rapid control of metabolic flux in microbial cell factories. In this review, we systematically summarize current post-translational regulatory tools for modulating the abundance, localization, and activity of key metabolic enzymes. We first discuss protein degradation tags for tunable control of enzyme levels. Then, we discuss spatial regulation through natural and synthetic subcellular compartments. We also highligh]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/rewiring-microbial-metabolism-through-post-translational-switches/</link><pubDate>Thu, 23 Oct 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/rewiring-microbial-metabolism-through-post-translational-switches/</guid></item><item><title><![CDATA[DNAJC14 gene-edited pigs are resistant to classical pestiviruses]]></title><description><![CDATA[CRISPR/Cas9 editing of pig DNAJC14 resulted in animals that were completely resistant to in vivo challenge with classical swine fever virus, highlighting the pivotal role of this host protein in classical pestivirus infections and providing a novel strategy to improve livestock health, enhance animal welfare, and reduce economic losses.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/dnajc14-gene-edited-pigs-are-resistant-to-classical-pestiviruses/</link><pubDate>Wed, 22 Oct 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/dnajc14-gene-edited-pigs-are-resistant-to-classical-pestiviruses/</guid></item><item><title><![CDATA[Cultured fruit: growing fruit without plants]]></title><description><![CDATA[Dominant forms of agriculture burden our environment, and food production is threatened by climate change. In this opinion article we introduce a paradigm shift in food production by describing a method to cultivate fruit without having to grow plants, and outline remaining scientific challenges. ‘Cultured fruit’ is less vulnerable to climate change, and can drastically improve sustainability, but only if non-agricultural sources of sugar are used to fuel fruit growth. Lessons for industrial]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/cultured-fruit-growing-fruit-without-plants/</link><pubDate>Wed, 22 Oct 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/cultured-fruit-growing-fruit-without-plants/</guid></item><item><title><![CDATA[Rewiring holobiont systems with synthetic biology]]></title><description><![CDATA[Holobionts are complex communities comprising a host and its diverse microbiota. Their intricate relationships are crucial for biological processes like nutrient uptake, immune function, and environmental adaptation. However, understanding these complex interactions remains challenging. We review how synthetic biology can help address these challenges. We highlight advances in bacterial biosensor design, engineering interkingdom communication, surface display, and clustered regularly interspaced]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/rewiring-holobiont-systems-with-synthetic-biology/</link><pubDate>Fri, 17 Oct 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/rewiring-holobiont-systems-with-synthetic-biology/</guid></item><item><title><![CDATA[Phyllis Gardner, Early Skeptic of Theranos, Dies at 75]]></title><description><![CDATA[A pharmacologist, she was certain Elizabeth Holmes&rsquo;s blood-testing idea would fail, and spoke up about it. At first, few listened.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/phyllis-gardner-early-skeptic-of-theranos-dies-at-75/</link><pubDate>Mon, 13 Oct 2025 17:59:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/phyllis-gardner-early-skeptic-of-theranos-dies-at-75/</guid></item><item><title><![CDATA[The A.I. Prompt That Could End the World]]></title><description><![CDATA[A destructive A.I., like a nuclear bomb, is now a concrete possibility; the question is whether anyone will be reckless enough to build one.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/the-ai-prompt-that-could-end-the-world/</link><pubDate>Sat, 11 Oct 2025 04:06:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/the-ai-prompt-that-could-end-the-world/</guid></item><item><title><![CDATA[De-extinction and beyond: trait design powered by generative AI]]></title><description><![CDATA[Functional de-extinction is the process of creating organisms with traits resembling those of extinct species that benefit modern ecosystems. Advances in genome-wide sequencing, gene editing and traditional cloning technologies have substantially accelerated progress toward de-extinction. However, beyond ongoing ethical debates, this field still faces significant technical challenges. In this opinion, we outline current de-extinction strategies and discuss their advantages and limitations. We th]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/de-extinction-and-beyond-trait-design-powered-by-generative-ai/</link><pubDate>Sat, 11 Oct 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/de-extinction-and-beyond-trait-design-powered-by-generative-ai/</guid></item><item><title><![CDATA[Chloroplast engineering for enhancing photosynthetic efficiency and agronomic traits]]></title><description><![CDATA[Plant chloroplast, the vital organelle that performs photosynthesis, is essential for sustaining life on Earth. It not only converts light energy into food while releasing O2 in the process, but also consumes CO2, thereby reducing the pace of climate warming. Stresses such as heat, oxidative stress, fluctuating light, and herbicides negatively impact the photosynthetic potential of chloroplasts. Hence, concerted research efforts have focused on chloroplast engineering to improve the photosynthet]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/chloroplast-engineering-for-enhancing-photosynthetic-efficiency-and-agronomic-traits/</link><pubDate>Wed, 08 Oct 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/chloroplast-engineering-for-enhancing-photosynthetic-efficiency-and-agronomic-traits/</guid></item><item><title><![CDATA[Governance strategies for biological AI: beyond the dual-use dilemma]]></title><description><![CDATA[A common framing for governing artificial intelligence (AI) in the biological sciences is to focus on risk mitigation owing to the technology’s potential ‘dual-use’ for both beneficial and harmful applications. This is a reactive policy approach, and a broader framing that urges policymakers to actively champion the benefits alongside mitigating risks is needed, including through targeted investments aimed at securing public priorities.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/governance-strategies-for-biological-ai-beyond-the-dual-use-dilemma/</link><pubDate>Mon, 06 Oct 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/governance-strategies-for-biological-ai-beyond-the-dual-use-dilemma/</guid></item><item><title><![CDATA[A reversible genetic NOR gate in plants using translational repression]]></title><description><![CDATA[A reversible genetic NOR circuit is implemented in tobacco plants, with exposure to chemical inducers as inputs and GFP as output. A mathematical model of the circuit’s mechanism is proposed and validated. The design methodology is versatile and analogous to electronic circuit design, enabling easy adaptation to other applications]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/a-reversible-genetic-nor-gate-in-plants-using-translational-repression/</link><pubDate>Mon, 06 Oct 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/a-reversible-genetic-nor-gate-in-plants-using-translational-repression/</guid></item><item><title><![CDATA[Small but mighty: emerging roles of uORFs in plants]]></title><description><![CDATA[The discovery and manipulation of upstream open reading frames (uORFs) represent a promising frontier in plant biotechnology, offering strategies to enhance disease resistance and crop resilience. Here, we explore the role of uORFs in regulating gene expression under biotic stress and discuss approaches to engineer uORFs for sustainable agriculture and precision breeding.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/small-but-mighty-emerging-roles-of-uorfs-in-plants/</link><pubDate>Fri, 03 Oct 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/small-but-mighty-emerging-roles-of-uorfs-in-plants/</guid></item><item><title><![CDATA[Bioinspired thermoreversible bioink orchestrates focal adhesion-dependent osteogenesis]]></title><description><![CDATA[A bioinspired, multi-material bioprinting platform integrates a bone extracellular matrix–mimetic bioink with a load-bearing calcium phosphate phase, achieving mechanical strength 200× greater compared with conventional bioprints. By leveraging focal adhesion to orchestrate osteogenesis, this modular, bioresorbable platform bridges mechanical integrity and biological function for personalized, load-bearing bone reconstruction.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/bioinspired-thermoreversible-bioink-orchestrates-focal-adhesion-dependent-osteogenesis/</link><pubDate>Thu, 02 Oct 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/bioinspired-thermoreversible-bioink-orchestrates-focal-adhesion-dependent-osteogenesis/</guid></item><item><title><![CDATA[How a kidney microenvironment atlas can advance kidney tissue engineering]]></title><description><![CDATA[Despite advances in cellular knowledge through kidney cell and protein atlases, tissue-engineered kidney models remain functionally incomplete. A major gap lies in our limited knowledge of the extracellular matrix (ECM) and the mechanical properties of the kidney microenvironment – key factors that influence cell behavior, differentiation, and function. Current data, that are often based on animal models, lack human-specific, segment-level, and disease-related insights regarding the ECM and me]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/how-a-kidney-microenvironment-atlas-can-advance-kidney-tissue-engineering/</link><pubDate>Wed, 01 Oct 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/how-a-kidney-microenvironment-atlas-can-advance-kidney-tissue-engineering/</guid></item><item><title><![CDATA[Trump’s Pharma Tariffs Spare Richest Drugmakers]]></title><description><![CDATA[The details of the president&rsquo;s proposed tariffs were not clear. But it seemed that many big companies would qualify for exemptions.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/trumps-pharma-tariffs-spare-richest-drugmakers/</link><pubDate>Sat, 27 Sep 2025 01:05:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/trumps-pharma-tariffs-spare-richest-drugmakers/</guid></item><item><title><![CDATA[Rational bioengineering of polysaccharide in designing of microbiome modulation]]></title><description><![CDATA[Targeted modulation of the gut microbiome offers significant promise for preventing and treating diverse diseases; yet, enhancing the efficacy of these interventions remains challenging. Polysaccharides have emerged as potent microbiome modulators, functioning as prebiotics that selectively promote beneficial bacterial growth and metabolite production. Their resistance to gastric degradation and selective intestinal fermentation enhance the precision of microbiome modulation while facilitating d]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/rational-bioengineering-of-polysaccharide-in-designing-of-microbiome-modulation/</link><pubDate>Thu, 25 Sep 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/rational-bioengineering-of-polysaccharide-in-designing-of-microbiome-modulation/</guid></item><item><title><![CDATA[Nanobodies: a new frontier in plant disease management]]></title><description><![CDATA[Nanobodies (Nbs) offer high potency, specificity, stability, and engineering versatility. Although well established in biomedicine, their use in crop protection is only emerging. In this forum, we summarize key advances in Nb-based immune receptors, antiviral and antifungal agents, and diagnostic tools, while discussing associated challenges and prospects in plant disease management.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/nanobodies-a-new-frontier-in-plant-disease-management/</link><pubDate>Thu, 25 Sep 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/nanobodies-a-new-frontier-in-plant-disease-management/</guid></item><item><title><![CDATA[Microalgae-made biopharmaceuticals and their potential role in the One Health approach]]></title><description><![CDATA[Biopharmaceuticals play a crucial role in the One Health approach by providing preventive and therapeutic solutions that support both human and animal health. The microalgae-based platform for producing biopharmaceuticals offers low production costs, benefiting both sectors, and thus represents a promising strategy to advance the One Health initiative. Over the past decade, significant progress has been made in genetic engineering and bioprocessing of algal systems; however, no microalgae-made b]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/microalgae-made-biopharmaceuticals-and-their-potential-role-in-the-one-health-approach/</link><pubDate>Thu, 25 Sep 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/microalgae-made-biopharmaceuticals-and-their-potential-role-in-the-one-health-approach/</guid></item><item><title><![CDATA[Emerging applications of carbon dots in plant (epi)genomics]]></title><description><![CDATA[Carbon dots (CDs) have broad applications across life sciences. This forum highlights the most recent breakthroughs of CDs in plant genomics and epigenomics, including gene transcription, their roles as carriers for delivering DNA, RNA, and agrochemicals in gene expression/silencing, and their utility in genomic and epigenomic studies. Potential future directions are proposed.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/emerging-applications-of-carbon-dots-in-plant-epigenomics/</link><pubDate>Thu, 25 Sep 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/emerging-applications-of-carbon-dots-in-plant-epigenomics/</guid></item><item><title><![CDATA[Brown adipose tissue engineering: advances, challenges, and future directions]]></title><description><![CDATA[Obesity is a major health issue as it increases the risk of developing chronic diseases, including cardiovascular disorders, diabetes, and certain types of cancer. Brown adipose tissue (BAT) is a promising target for obesity treatment due to its ability to burn fat and create heat via non-shivering thermogenesis. The development of BAT models for therapeutic use has become possible through recent advances in tissue engineering, including stem cell-based methods, 3D bioprinting, and organoid syst]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/brown-adipose-tissue-engineering-advances-challenges-and-future-directions/</link><pubDate>Thu, 25 Sep 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/brown-adipose-tissue-engineering-advances-challenges-and-future-directions/</guid></item><item><title><![CDATA[Virus-like particles as modular interfaces for biomaterial functionalization]]></title><description><![CDATA[This study showcases virus-like particles (VLPs) as customizable nanoscale scaffolds for biomaterial surface functionalization. Using modified VLPs, we achieve high density display and confinement of bioactive peptides, offering a modular, animal-free, and cost-effective alternative to native extracellular matrix (ECM) proteins in tissue engineering and regenerative medicine.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/virus-like-particles-as-modular-interfaces-for-biomaterial-functionalization/</link><pubDate>Tue, 23 Sep 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/virus-like-particles-as-modular-interfaces-for-biomaterial-functionalization/</guid></item><item><title><![CDATA[Staying productive under pressure: systems evaluations of β-carotene production in Yarrowia lipolytica under continuous fermentation]]></title><description><![CDATA[This integrative experimental and modeling study explores how fermentation conditions affect β-carotene production in Yarrowia lipolytica. Oil-based feedstocks enhance stability in continuous fermentation compared with glucose, while high-yielding laboratory strains often falter in industrial bioreactors, where faster-growing but less productive variants dominate under stress and determine long-term outcomes.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/staying-productive-under-pressure-systems-evaluations-of-carotene-production-in-yarrowia-lipolytica-under-continuous-fermentation/</link><pubDate>Mon, 22 Sep 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/staying-productive-under-pressure-systems-evaluations-of-carotene-production-in-yarrowia-lipolytica-under-continuous-fermentation/</guid></item><item><title><![CDATA[Are amyloid-based materials conducive to tissue engineering?]]></title><description><![CDATA[Amyloid fibrils, known for their stable, cross-β-sheet structure, are involved in both pathological conditions and functional biological processes. While implicated in disease pathogenesis, such as Alzheimer's and Parkinson’s, they also play roles in normal cellular functions, such as biofilm formation, melanin polymerization, and hormone storage. Amyloid-based biomaterials have gained attention for their stability, mechanical strength, unique surface properties, and structural versatility, m]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/are-amyloid-based-materials-conducive-to-tissue-engineering/</link><pubDate>Fri, 19 Sep 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/are-amyloid-based-materials-conducive-to-tissue-engineering/</guid></item><item><title><![CDATA[A practical guide to spatial transcriptomics: lessons from over 1000 samples]]></title><description><![CDATA[Spatial transcriptomics (ST) enables the  in situ mapping of gene expression, revolutionizing our ability to study tissue organization and cellular interactions. However, many groups struggle with practical barriers to implementation, including platform selection, sample quality, and experimental scalability. We provide a practical guide to ST, informed by the processing and analysis of over 1000 spatial samples across multiple ST platforms. We outline best practices for experimental design, t]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/a-practical-guide-to-spatial-transcriptomics-lessons-from-over-1000-samples/</link><pubDate>Fri, 19 Sep 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/a-practical-guide-to-spatial-transcriptomics-lessons-from-over-1000-samples/</guid></item><item><title><![CDATA[Microbial tools and regulatory innovations for climate-resilient winemaking]]></title><description><![CDATA[Climate-induced acidity loss threatens wine quality, prompting sustainable microbial acidification strategies using Lachancea thermotolerans. This yeast naturally reduces pH and ethanol, aligns with consumer preferences, and benefits from omics-driven selection and enabling policy frameworks. Adaptation requires coordinated biotechnological innovation, institutional backing, and clear consumer communication to maintain sustainability and competitiveness.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/microbial-tools-and-regulatory-innovations-for-climate-resilient-winemaking/</link><pubDate>Thu, 18 Sep 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/microbial-tools-and-regulatory-innovations-for-climate-resilient-winemaking/</guid></item><item><title><![CDATA[Towards scalable anammox: mechanistic insights and emerging strategies]]></title><description><![CDATA[Anammox-based systems are promising wastewater treatment processes that utilize anaerobic ammonium oxidation (anammox) bacteria to remove nitrogen. These systems offer energy-efficient and carbon-neutral alternatives to conventional biological treatments but their practical application faces challenges, including limited total nitrogen (TN)-removal efficiency and sensitivity to adverse conditions. Recent research has explored innovative strategies to overcome these limitations, such as multi-met]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/towards-scalable-anammox-mechanistic-insights-and-emerging-strategies/</link><pubDate>Wed, 17 Sep 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/towards-scalable-anammox-mechanistic-insights-and-emerging-strategies/</guid></item><item><title><![CDATA[Nanobotic microbiomes against emerging vascular pathogens in agriculture]]></title><description><![CDATA[Vascular diseases in plants are exceptionally difficult to control. Escalating global climate change further increases the risks of outbreaks from existing and emerging pathogens. Nano-enabled microbiome engineering (NME) represents an innovative framework for targeted vascular plant pathogen control, offering a sustainable platform to enhance agricultural resilience and productivity.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/nanobotic-microbiomes-against-emerging-vascular-pathogens-in-agriculture/</link><pubDate>Wed, 17 Sep 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/nanobotic-microbiomes-against-emerging-vascular-pathogens-in-agriculture/</guid></item><item><title><![CDATA[U.S. Drugmakers Warn White House of Chaos as Trump Weighs Curbs on China]]></title><description><![CDATA[Behind the scenes, major pharmaceutical companies and Trump-tied billionaires are furiously lobbying in opposite directions over proposed anti-China measures.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/us-drugmakers-warn-white-house-of-chaos-as-trump-weighs-curbs-on-china/</link><pubDate>Sat, 13 Sep 2025 04:21:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/us-drugmakers-warn-white-house-of-chaos-as-trump-weighs-curbs-on-china/</guid></item><item><title><![CDATA[The metabolic guide to space survival]]></title><description><![CDATA[The Metabolic Guide to Space Survival (https://kristinapulejkova.com/the-metabolic-guide-to-space-survival/) is a multidisciplinary exploration of microbial life as a key to long-term survival in space. Framed through the voice of fictional character Chief Bioengineer Mira Kordan, the work unfolds across a speculative design toolkit, a narrative guidebook, and an architectural installation animated by holographic projections of Mira navigating life in zero gravity. The piece was created by Londo]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/the-metabolic-guide-to-space-survival/</link><pubDate>Sat, 13 Sep 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/the-metabolic-guide-to-space-survival/</guid></item><item><title><![CDATA[Semi-automated biofoundry workflows for sequence coevolution-guided isoprene synthase engineering]]></title><description><![CDATA[We developed biofoundry workflows for efficient enzyme engineering, integrating a simple and accessible computational tool with automation to reduce time and resources. Using this approach, isoprene synthase was engineered for enhanced catalytic efficiency and thermostability, and also enhanced methane-to-isoprene conversion when applied to methanotrophs, highlighting its potential for methane-based biomanufacturing.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/semi-automated-biofoundry-workflows-for-sequence-coevolution-guided-isoprene-synthase-engineering/</link><pubDate>Fri, 12 Sep 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/semi-automated-biofoundry-workflows-for-sequence-coevolution-guided-isoprene-synthase-engineering/</guid></item><item><title><![CDATA[Sustainable protection of multiple hosts against polyphagous pests using Plant Probiotic-Based Gene Silencing]]></title><description><![CDATA[RNAi controls pests efficiently but faces limitations in managing polyphagous species due to insufficient persistence or narrow-spectrum plant protection. Plant Probiotic-based Gene Silencing uses engineered probiotics that can colonize various plants to deliver dsRNA, enabling sustainable protection of multiple host plants of polyphagous pests.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/sustainable-protection-of-multiple-hosts-against-polyphagous-pests-using-plant-probiotic-based-gene-silencing/</link><pubDate>Wed, 10 Sep 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/sustainable-protection-of-multiple-hosts-against-polyphagous-pests-using-plant-probiotic-based-gene-silencing/</guid></item><item><title><![CDATA[Ethical and legal considerations of digital animal models: pioneering reduction and replacement]]></title><description><![CDATA[The development of digital animal models represents a promising avenue for advancing the ethical principles of reduction and replacement in biomedical research. This paper discusses the potential of models built upon artificial intelligence (AI)-generated synthetic datasets simulating the characteristics and behaviors of model organisms, reducing reliance on live animals in research.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/ethical-and-legal-considerations-of-digital-animal-models-pioneering-reduction-and-replacement/</link><pubDate>Wed, 10 Sep 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/ethical-and-legal-considerations-of-digital-animal-models-pioneering-reduction-and-replacement/</guid></item><item><title><![CDATA[Food production from air: gas precision fermentation with hydrogen-oxidising bacteria]]></title><description><![CDATA[The breach of six planetary boundaries highlights the need for sustainable food production. Aerobic hydrogen-oxidising bacteria (HOBs) convert atmospheric CO2 and green hydrogen (H2) into biomass via gas fermentation, a process already used for food-grade single-cell protein production. This approach enables a supply chain independent of agriculture, requiring minimal land and water, with potential for carbon-neutral production and carbon capture. To expand beyond single-cell protein, HOBs must]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/food-production-from-air-gas-precision-fermentation-with-hydrogen-oxidising-bacteria/</link><pubDate>Tue, 09 Sep 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/food-production-from-air-gas-precision-fermentation-with-hydrogen-oxidising-bacteria/</guid></item><item><title><![CDATA[Metabolic and immunomodulatory control of type 2 diabetes via generating cellular itaconate reservoirs by inflammatory-targeting gene-therapy nanovesicles]]></title><description><![CDATA[NOD-like receptor (NLR) family pyrin domain-containing 3 (NLRP3)+ macrophage accumulation in tissue promotes type 2 diabetes (T2D) progression. However, there is no precise, comprehensive, broad-spectrum inhibitor of the NLRP3 inflammasome for T2D therapy. We developed gene-therapy nanovesicles to regulate cellular itaconate production and mitochondrial function. This technology enables metabolic and immunomodulatory control of T2D.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/metabolic-and-immunomodulatory-control-of-type-2-diabetes-via-generating-cellular-itaconate-reservoirs-by-inflammatory-targeting-gene-therapy-nanovesicles/</link><pubDate>Mon, 08 Sep 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/metabolic-and-immunomodulatory-control-of-type-2-diabetes-via-generating-cellular-itaconate-reservoirs-by-inflammatory-targeting-gene-therapy-nanovesicles/</guid></item><item><title><![CDATA[Making cow-free caseins and casein micelles]]></title><description><![CDATA[A key step in the precision fermentation of casein proteins is correct phosphorylation to generate one or more short linear sequence motifs (SLiMs) containing three or more phosphorylated seryl residues. The work of Balasubramanian et al. takes us a step closer to that goal by showing that two bacterial phosphokinases are promising alternatives to the mammalian Golgi phosphokinases and casein kinase-II.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/making-cow-free-caseins-and-casein-micelles/</link><pubDate>Mon, 08 Sep 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/making-cow-free-caseins-and-casein-micelles/</guid></item><item><title><![CDATA[Flying seed-inspired sensors for remote environmental monitoring on Earth and beyond]]></title><description><![CDATA[Exploring mobility beyond traditional robotic systems such as walking, swimming, and jumping, flight through dispersal, gliding, or hovering remains an untapped frontier for advanced stimulus-responsive and -sensing materials. Nature-inspired engineering has been a foundational aspect of robotic innovations, and biohybrid and biomimetic flying seeds are now becoming a significant example of this concept. By mimicking the aerodynamic properties and dispersal mechanisms of natural seeds, semi- and]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/flying-seed-inspired-sensors-for-remote-environmental-monitoring-on-earth-and-beyond/</link><pubDate>Sat, 06 Sep 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/flying-seed-inspired-sensors-for-remote-environmental-monitoring-on-earth-and-beyond/</guid></item><item><title><![CDATA[Engineering chimeric signaling proteins for microbial whole-cell biosensors: from design to deployment]]></title><description><![CDATA[Microbial whole-cell biosensors (MWCBs) harness living cells to detect analytes and produce measurable outputs, enabling continuous, low-cost, and in situ sensing. Central to MWCB function are modular sensing architectures, which can be reprogrammed to respond to diverse signals. Particularly, two-component systems (TCSs) and allosteric transcription factors (aTFs) offer modular, engineerable frameworks for building chimeric proteins. Recent advances in domain swapping, fusion point selection, a]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/engineering-chimeric-signaling-proteins-for-microbial-whole-cell-biosensors-from-design-to-deployment/</link><pubDate>Tue, 02 Sep 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/engineering-chimeric-signaling-proteins-for-microbial-whole-cell-biosensors-from-design-to-deployment/</guid></item><item><title><![CDATA[Highly efficient prime editors for mammalian genome editing based on porcine retrovirus reverse transcriptase]]></title><description><![CDATA[This study developed a highly efficient prime editing system (pvPE) based on porcine endogenous retroviral reverse transcriptase. Through extensive engineering and nocodazole treatment, pvPE achieved robust multigene editing in porcine fibroblasts, which generated Alzheimer’s disease pig models, offering a versatile platform for agricultural and biomedical applications.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/highly-efficient-prime-editors-for-mammalian-genome-editing-based-on-porcine-retrovirus-reverse-transcriptase/</link><pubDate>Sat, 30 Aug 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/highly-efficient-prime-editors-for-mammalian-genome-editing-based-on-porcine-retrovirus-reverse-transcriptase/</guid></item><item><title><![CDATA[Targeting RAS-mutant cancer cells using a synthetic RAS-activated cancer killing system]]></title><description><![CDATA[The RAS-activated cancer killing (RACK) system rewires cancer cells to self-destruct by leveraging their own oncogenic RAS signals. This synthetic circuit eradicates resistant tumors, including historically ‘undruggable’ mutants, while sparing healthy tissue, offering a smart and adaptable strategy to outpace cancer evolution.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/targeting-ras-mutant-cancer-cells-using-a-synthetic-ras-activated-cancer-killing-system/</link><pubDate>Fri, 29 Aug 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/targeting-ras-mutant-cancer-cells-using-a-synthetic-ras-activated-cancer-killing-system/</guid></item><item><title><![CDATA[Membrane-targeted DNA frameworks with biodegradability recover cellular function and morphology from frozen cells]]></title><description><![CDATA[DNA frameworks, nanostructures engineered from DNA, preserve cells by anchoring to membranes, inhibiting cellular ice growth, and degrading autonomously after thawing. These biodegradable cryoprotectants outperform conventional agents, improve recovery and function of frozen macrophage cells, and offer a promising strategy for biopreservation in research and therapeutic applications.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/membrane-targeted-dna-frameworks-with-biodegradability-recover-cellular-function-and-morphology-from-frozen-cells/</link><pubDate>Fri, 29 Aug 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/membrane-targeted-dna-frameworks-with-biodegradability-recover-cellular-function-and-morphology-from-frozen-cells/</guid></item><item><title><![CDATA[Extended human lymph node explants for evaluation of adaptive immunity]]></title><description><![CDATA[This study presents a hydrogel-based platform that preserves patient-derived lymph node slices ex vivo, maintaining viability, architecture, and immune function. The model enables robust responses to tumor dissociates and mRNA vaccines, offering a powerful tool for studying human immunity and accelerating vaccine and immunotherapy development.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/extended-human-lymph-node-explants-for-evaluation-of-adaptive-immunity/</link><pubDate>Fri, 29 Aug 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/extended-human-lymph-node-explants-for-evaluation-of-adaptive-immunity/</guid></item><item><title><![CDATA[Engineering infrared light detection in blind human retina using ultrasensitive human TRPV1 channels]]></title><description><![CDATA[We engineered a human transient receptor potential vanilloid 1 (TRPV1) variant the thermal threshold of which matches near-infrared microheating. Delivered by adeno-associated virus (AAV) to blind human retina, the novel single-component channel elicited robust, graded infrared responses without foreign proteins or nanoparticles, offering an opsin-free route to vision restoration and a platform for broader clinical-use thermal neuromodulation.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/engineering-infrared-light-detection-in-blind-human-retina-using-ultrasensitive-human-trpv1-channels/</link><pubDate>Fri, 29 Aug 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/engineering-infrared-light-detection-in-blind-human-retina-using-ultrasensitive-human-trpv1-channels/</guid></item><item><title><![CDATA[Development of a high-efficiency N-acetylneuraminic acid production platform through multi-pathway synergistic engineering]]></title><description><![CDATA[This study leverages artificial intelligence (AI)-driven enzyme mining and metabolic reprogramming for precise precursor control, alongside dual-carbon source synergy, establishing a cost-effective N-acetylneuraminic acid (NeuAc) biomanufacturing platform. This systematic synthetic biotechnology framework not only elevates NeuAc yields, but also offers generalizable solutions to persistent bottlenecks in microbial-based bioproduction.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/development-of-a-high-efficiency-n-acetylneuraminic-acid-production-platform-through-multi-pathway-synergistic-engineering/</link><pubDate>Fri, 29 Aug 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/development-of-a-high-efficiency-n-acetylneuraminic-acid-production-platform-through-multi-pathway-synergistic-engineering/</guid></item><item><title><![CDATA[Biomechanics in miniature: microfluidic-based in vitro modeling to decipher mechanobiological phenomena]]></title><description><![CDATA[Mechanobiology is a rapidly advancing field, offering innovative insights and therapeutic strategies for a range of pathophysiological conditions. Central to this progress is the ability to replicate complex cellular and tissue microenvironments in vitro. Microfluidic systems, with their precision-engineered designs, dynamic fluid control, and spatial manipulation, serve as versatile platforms for this purpose. By effectively integrating modeling and sensing capabilities, these systems further p]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/biomechanics-in-miniature-microfluidic-based-in-vitro-modeling-to-decipher-mechanobiological-phenomena/</link><pubDate>Fri, 29 Aug 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/biomechanics-in-miniature-microfluidic-based-in-vitro-modeling-to-decipher-mechanobiological-phenomena/</guid></item><item><title><![CDATA[Towards gene editing and torrefaction pretreatment for biochar functionalization]]></title><description><![CDATA[The global demand for sustainable materials and carbon-neutral technologies drives innovations in biochar, a carbon-rich material for energy storage, pollution mitigation, and carbon sequestration. Conventional biochar, limited by poor conductivity and porosity, relies on fossil fuel–dependent activation. Recent advances in gene-editing technologies enable the precise reduction of lignin and enhance cellulose in woody biomass, improving its processability for biochar production. Furthermore, c]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/towards-gene-editing-and-torrefaction-pretreatment-for-biochar-functionalization/</link><pubDate>Thu, 28 Aug 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/towards-gene-editing-and-torrefaction-pretreatment-for-biochar-functionalization/</guid></item><item><title><![CDATA[Engineered RNA nanostructures for scalable and efficient RNAi-based pesticides]]></title><description><![CDATA[Engineered self-assembled RNA nanostructures (SARNs) overcome challenges in RNAi-based pest control by enhancing stability, delivery, and gene silencing efficiency. A scalable, cost-effective production framework supports the practical deployment of SARN pesticides, with applications extending to sustainable agriculture and RNA-based therapeutics.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/engineered-rna-nanostructures-for-scalable-and-efficient-rnai-based-pesticides/</link><pubDate>Mon, 25 Aug 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/engineered-rna-nanostructures-for-scalable-and-efficient-rnai-based-pesticides/</guid></item><item><title><![CDATA[Next-generation electroactive biomaterials-integrated bioelectronics for advanced healthcare management]]></title><description><![CDATA[The evolution of smart biomaterials is revolutionizing healthcare through synergistic integration of real-time diagnostic monitoring and regenerative therapies. Current bioelectronic systems demonstrate remarkable capabilities in disease detection and physiological tracking. Nevertheless, the clinical translation of these biomaterials remains impeded by inadequate tissue-inductive capacity and mechanical incompatibility with host tissues. Emerging fourth-generation electroactive biomaterials (EB]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/next-generation-electroactive-biomaterials-integrated-bioelectronics-for-advanced-healthcare-management/</link><pubDate>Fri, 22 Aug 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/next-generation-electroactive-biomaterials-integrated-bioelectronics-for-advanced-healthcare-management/</guid></item><item><title><![CDATA[Bridging the path to multiplexed molecular diagnostics]]></title><description><![CDATA[Bridge amplification of nucleic acids exploits the use of surface-tethered forward and reverse primers to allow amplification to occur on a 2D surface, in a spatially controlled manner, facilitating multiplexed reactions for the detection of nucleic acid targets with a variety of applications from personalized medicine to advanced forensics.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/bridging-the-path-to-multiplexed-molecular-diagnostics/</link><pubDate>Fri, 22 Aug 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/bridging-the-path-to-multiplexed-molecular-diagnostics/</guid></item><item><title><![CDATA[Advanced mass spectrometry techniques for monitoring biopharmaceutical host cell proteins]]></title><description><![CDATA[Residual host cell proteins (HCPs) in biologic drug products can compromise safety or stability and must be carefully monitored. While traditional immunoassays remain essential, they often lack specificity or coverage. Mass spectrometry (MS) offers a complementary approach by enabling direct identification and quantification of individual HCPs throughout development. This review highlights recent advances in MS technologies and workflows relevant to HCP detection, including new data acquisition]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/advanced-mass-spectrometry-techniques-for-monitoring-biopharmaceutical-host-cell-proteins/</link><pubDate>Fri, 22 Aug 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/advanced-mass-spectrometry-techniques-for-monitoring-biopharmaceutical-host-cell-proteins/</guid></item><item><title><![CDATA[A prescription for plastic waste]]></title><description><![CDATA[In a recent study, Johnson et al. demonstrated a potentially generalizable strategy to bioremediate and upcycle plastic waste by interfacing a chemical reaction not typically found in nature with Escherichia coli. They further applied this approach to synthesize paracetamol (acetaminophen), one of the most widely used over-the-counter active pharmaceutical ingredients.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/a-prescription-for-plastic-waste/</link><pubDate>Thu, 21 Aug 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/a-prescription-for-plastic-waste/</guid></item><item><title><![CDATA[Strengthening the competitiveness of EU in vitro biotechnologies]]></title><description><![CDATA[The EU has been a leader in research and development of in vitro biotechnology (IVB), such as human 3D cell and tissue models used in disease research and drug development. However, it is struggling to convert scientific discoveries into business creation and competitiveness within a rapidly growing international market.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/strengthening-the-competitiveness-of-eu-in-vitro-biotechnologies/</link><pubDate>Wed, 20 Aug 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/strengthening-the-competitiveness-of-eu-in-vitro-biotechnologies/</guid></item><item><title><![CDATA[Improved provenance tracking by documenting plasmids within their own sequence]]></title><description><![CDATA[In a recent article, Hernandez et al. introduced a framework for plasmid self-documentation. It uses the data storage capabilities of the DNA of a plasmid to capture either direct documentation or a reference to full documentation. The approach is robust and experimentally verified to both write information to, and read information from, the plasmid of interest.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/improved-provenance-tracking-by-documenting-plasmids-within-their-own-sequence/</link><pubDate>Tue, 19 Aug 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/improved-provenance-tracking-by-documenting-plasmids-within-their-own-sequence/</guid></item><item><title><![CDATA[America Is Giving Up a Lifesaving Medical Breakthrough: mRNA]]></title><description><![CDATA[Giving up on mRNA is a dangerous decision.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/america-is-giving-up-a-lifesaving-medical-breakthrough-mrna/</link><pubDate>Mon, 18 Aug 2025 19:19:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/america-is-giving-up-a-lifesaving-medical-breakthrough-mrna/</guid></item><item><title><![CDATA[China’s Biotech Is Cheaper and Faster Than America’s]]></title><description><![CDATA[China&rsquo;s biotechnology sector has established a bright future by focusing not on breakthrough cures and treatments but on speed and efficiency.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/chinas-biotech-is-cheaper-and-faster-than-americas/</link><pubDate>Sun, 17 Aug 2025 22:50:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/chinas-biotech-is-cheaper-and-faster-than-americas/</guid></item><item><title><![CDATA[Microbial production of D-mannose and D-sedoheptulose with tunable ratios]]></title><description><![CDATA[Escherichia coli was engineered to co-produce D-mannose and D-sedoheptulose from D-glucose using a phosphorylation–dephosphorylation strategy. The optimized strain enabled efficient production with tunable product ratios. D-mannose is a low-calorie sweetener, while D-sedoheptulose modulates sugar metabolism, enabling new applications in food and health.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/microbial-production-of-d-mannose-and-d-sedoheptulose-with-tunable-ratios/</link><pubDate>Fri, 15 Aug 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/microbial-production-of-d-mannose-and-d-sedoheptulose-with-tunable-ratios/</guid></item><item><title><![CDATA[Harnessing Streptomyces–plant interactions for agricultural natural product discovery]]></title><description><![CDATA[Agricultural natural products (agri-NPs) from Streptomyces are a reservoir for green pesticide development, which is critical for global crop protection and food security. However, the discovery of novel agri-NPs with tailored bioactivity is challenging. In this forum article, we focus on specialized agri-NP discovery by harnessing interactions between Streptomyces and plants.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/harnessing-streptomycesplant-interactions-for-agricultural-natural-product-discovery/</link><pubDate>Thu, 07 Aug 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/harnessing-streptomycesplant-interactions-for-agricultural-natural-product-discovery/</guid></item><item><title><![CDATA[Flux sampling and context-specific genome-scale metabolic models for biotechnological applications]]></title><description><![CDATA[Genome-scale metabolic models are used in fields ranging from metabolic engineering to drug discovery and microbiome design. Although these models are often used to predict putatively optimal states, some applications, including modeling human tissues for drug development and microbial communities for synthetic ecology, may require sampling the whole space of feasible fluxes to obtain distributions of biologically relevant states. Additionally, many applications involve using transcriptomic or p]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/flux-sampling-and-context-specific-genome-scale-metabolic-models-for-biotechnological-applications/</link><pubDate>Thu, 07 Aug 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/flux-sampling-and-context-specific-genome-scale-metabolic-models-for-biotechnological-applications/</guid></item><item><title><![CDATA[Splice, exchange, extend: precision editing of native proteins in live cells]]></title><description><![CDATA[Beyer et al. and Hua et al. developed platforms for precise chemical editing of proteins in living mammalian cells. These approaches enabled site-specific tagging at diverse protein sites without disrupting function. Demonstrated on several key proteins, this technology opens new possibilities for studying protein dynamics and functions in live cells.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/splice-exchange-extend-precision-editing-of-native-proteins-in-live-cells/</link><pubDate>Sat, 02 Aug 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/splice-exchange-extend-precision-editing-of-native-proteins-in-live-cells/</guid></item><item><title><![CDATA[A six-tiered framework for evaluating AI models from repeatability to replaceability]]></title><description><![CDATA[Artificial intelligence (AI) is rapidly transforming biotechnology and medicine. But evaluating its safety, effectiveness, and generalizability is increasingly challenging, especially for complex generative models. Traditional evaluation metrics often fall short in high-stakes applications where reliability and adaptability are critical. We propose a six-tiered framework to guide AI evaluation across the dimensions of repeatability, reproducibility, robustness, rigidity, reusability, and replace]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/a-six-tiered-framework-for-evaluating-ai-models-from-repeatability-to-replaceability/</link><pubDate>Thu, 31 Jul 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/a-six-tiered-framework-for-evaluating-ai-models-from-repeatability-to-replaceability/</guid></item><item><title><![CDATA[AI sheds new light on genome editing]]></title><description><![CDATA[Artificial intelligence (AI) has revolutionized life sciences, driving transformative advances in engineering clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated (Cas)-based genome editors for therapeutic and agricultural applications. Recent breakthroughs demonstrate how deep learning accelerates the discovery, engineering, and design of next-generation genome editing tools. In this review, we explore how AI-driven approaches are supercharging genome editing in]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/ai-sheds-new-light-on-genome-editing/</link><pubDate>Wed, 30 Jul 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/ai-sheds-new-light-on-genome-editing/</guid></item><item><title><![CDATA[Third-generation novel technologies for gene editing]]></title><description><![CDATA[Gene editing technologies have revolutionized the field of biotechnology. CRISPR-Cas methods using RNA-guided enzymes are the most used gene editing tools and have produced gene-edited crops (rice, wheat, corn, etc.) and human therapeutics (Casgevy, approved for commercial use; Vertex Pharmaceuticals). However, these systems have some limitations, including the requirement of a protospacer adjacent motif sequence, generation of undesirable double-strand breaks (DSBs), and the inability to edit l]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/third-generation-novel-technologies-for-gene-editing/</link><pubDate>Tue, 29 Jul 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/third-generation-novel-technologies-for-gene-editing/</guid></item><item><title><![CDATA[Functional substrate-enhanced bioprinting technology for next-generation organ-on-a-chip: from fabrication to functionalization]]></title><description><![CDATA[The integration of bioprinting with advanced substrate technologies offers a transformative approach to tissue engineering, providing vital insight into the development of complex organ-on-a-chip systems. Bioprinting enables the creation of sophisticated microscale biological structures, with the receiving substrate playing a critical role beyond merely supporting the printed constructs. This review explores how substrates enhance both the fabrication precision and functionality of bioprinted ti]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/functional-substrate-enhanced-bioprinting-technology-for-next-generation-organ-on-a-chip-from-fabrication-to-functionalization/</link><pubDate>Tue, 29 Jul 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/functional-substrate-enhanced-bioprinting-technology-for-next-generation-organ-on-a-chip-from-fabrication-to-functionalization/</guid></item><item><title><![CDATA[Electrifying food fermentations to promote sustainability]]></title><description><![CDATA[The important food microorganism Lactococcus lactis is limited by its fermentative metabolism and low energy yield. This limitation can be partially overcome by activating aerobic respiration which, in a food context, can be difficult to achieve as heme and oxygen must be supplied. Supplying oxygen is particularly challenging due to oxygen mass transfer limitations in food matrices. To address these challenges, we propose to use electro-fermentation to grow L. lactis anaerobically. We propose a]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/electrifying-food-fermentations-to-promote-sustainability/</link><pubDate>Tue, 29 Jul 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/electrifying-food-fermentations-to-promote-sustainability/</guid></item><item><title><![CDATA[William J. Rutter, Biotech Pioneer of Gene-Based Medicine, Dies at 97]]></title><description><![CDATA[His company, the Chiron Corporation, contributed important scientific discoveries toward treatments for H.I.V., hepatitis B, diabetes and more.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/william-j-rutter-biotech-pioneer-of-gene-based-medicine-dies-at-97/</link><pubDate>Sun, 27 Jul 2025 18:28:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/william-j-rutter-biotech-pioneer-of-gene-based-medicine-dies-at-97/</guid></item><item><title><![CDATA[Protein–glycan engineering in vaccine design: merging immune mechanisms with biotechnological innovation]]></title><description><![CDATA[Glycans are critical regulators of immune recognition, influencing pathogen detection and immune modulation. Despite their potential in vaccine design, challenges, such as glycan heterogeneity and immune evasion, persist. Recent advances in protein–glycan engineering, spanning clustered regularly interspaced short palindromic repeats (CRISPR)-based glycoediting, synthetic biology, and glycan-modified nanoparticles (NPs), are now enabling precise control of glycan structures to enhance antigen]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/proteinglycan-engineering-in-vaccine-design-merging-immune-mechanisms-with-biotechnological-innovation/</link><pubDate>Thu, 24 Jul 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/proteinglycan-engineering-in-vaccine-design-merging-immune-mechanisms-with-biotechnological-innovation/</guid></item><item><title><![CDATA[Organ-on-a-chip systems for modeling tumor and normal tissue microenvironments in radiotherapy research]]></title><description><![CDATA[Radiation therapy (RT) precisely targets tumors with ionizing radiation, aiming to achieve local control while minimizing collateral damage to surrounding healthy tissues. Radiation research is often carried out in animal models, but these suffer from ethical issues, high cost of operation, low throughput, and low correlation to responses in humans. The advent of microfluidic organ-on-a-chip (OoC) technology offers a promising alternative to precisely and reproducibly model the physiology of dif]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/organ-on-a-chip-systems-for-modeling-tumor-and-normal-tissue-microenvironments-in-radiotherapy-research/</link><pubDate>Thu, 24 Jul 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/organ-on-a-chip-systems-for-modeling-tumor-and-normal-tissue-microenvironments-in-radiotherapy-research/</guid></item><item><title><![CDATA[Advances and optimization strategies in prime editing of human pluripotent stem cells]]></title><description><![CDATA[Prime editing, first introduced in 2019, is a precise and efficient genome-editing technique with applications across various organisms and cell lines, including human pluripotent stem cells (hPSCs). Despite its revolutionary potential, prime editing of hPSCs often shows low efficiency, hindered by current delivery methods and DNA repair mechanisms. In this review, we explore prime editing of hPSCs, emphasizing the optimization necessary for creating ex vivo and in vitro disease models, which ar]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/advances-and-optimization-strategies-in-prime-editing-of-human-pluripotent-stem-cells/</link><pubDate>Thu, 24 Jul 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/advances-and-optimization-strategies-in-prime-editing-of-human-pluripotent-stem-cells/</guid></item><item><title><![CDATA[Zelig Eshhar, Who Engineered Immune Cells to Fight Cancer, Dies at 84]]></title><description><![CDATA[He made a conceptual leap in immunotherapy by creating a hybrid T-cell, known as CAR-T, that was genetically modified to destroy cancer cells.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/zelig-eshhar-who-engineered-immune-cells-to-fight-cancer-dies-at-84/</link><pubDate>Wed, 23 Jul 2025 16:31:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/zelig-eshhar-who-engineered-immune-cells-to-fight-cancer-dies-at-84/</guid></item><item><title><![CDATA[CRISPR/Cas-based personal glucose meters for nucleic acid detection]]></title><description><![CDATA[Through integration with clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein (Cas) systems, personal glucose meters (PGMs) have been repurposed to detect non-glucose targets. PGMs enable the intuitive readout of electrochemical signals, while CRISPR/Cas offers rapid detection and signal amplification capability. Their integration can realize point-of-care (POC) diagnostics. Herein, we critically discuss their advances, pitfalls, and future perspectives.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/crisprcas-based-personal-glucose-meters-for-nucleic-acid-detection/</link><pubDate>Wed, 23 Jul 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/crisprcas-based-personal-glucose-meters-for-nucleic-acid-detection/</guid></item><item><title><![CDATA[Challenges in realizing therapeutic antibody biosensing]]></title><description><![CDATA[Therapeutic monoclonal antibodies (mAbs) exhibit significant interindividual pharmacokinetic (PK) variability, necessitating therapeutic drug monitoring (TDM). However, current monitoring methods require complex and time-consuming laboratory analysis, making rapid dose adjustments challenging. This review discusses emerging technologies for on-site mAb monitoring, with a focus on recent advances in recognition elements and detection strategies. Novel recognition elements, such as anti-idiotype m]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/challenges-in-realizing-therapeutic-antibody-biosensing/</link><pubDate>Wed, 23 Jul 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/challenges-in-realizing-therapeutic-antibody-biosensing/</guid></item><item><title><![CDATA[Microbial cellulose production using ocean water: sustainable and cost-effective?]]></title><description><![CDATA[In a recent paper, Shankar et al. present a promising proof-of-concept for bacterial cellulose (BC) production, exhibiting competitive material properties, utilizing ocean water (OW) despite the challenges posed by high salinity. By reducing dependence on freshwater resources, the work highlights both ecological and economic benefits related to current BC production methods.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/microbial-cellulose-production-using-ocean-water-sustainable-and-cost-effective/</link><pubDate>Fri, 18 Jul 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/microbial-cellulose-production-using-ocean-water-sustainable-and-cost-effective/</guid></item><item><title><![CDATA[Biotechnological production of healthful conjugated fatty acids]]></title><description><![CDATA[Conjugated fatty acids (CFAs) are important for human health. They are traditionally obtained by extraction or chemical synthesis, but can alternatively be produced using biotechnology. Current efforts are aimed at improving the biotransformation process and capability for de novo biosynthesis. The next step is to make the process even more competitive.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/biotechnological-production-of-healthful-conjugated-fatty-acids/</link><pubDate>Fri, 18 Jul 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/biotechnological-production-of-healthful-conjugated-fatty-acids/</guid></item><item><title><![CDATA[Opto-CRISPR: new prospects for gene editing and regulation]]></title><description><![CDATA[Clustered regularly interspaced short palindromic repeats (CRISPR) technology represents a landmark advance in the field of gene editing. However, conventional CRISPR/Cas systems are limited by inadequate temporal and spatial control. In recent years, the development of optically controlled CRISPR (Opto-CRISPR) technology has offered a novel solution to this issue. As a combination of optogenetics and the CRISPR technology, the Opto-CRISPR technology enables dynamic space–time-specific gene ed]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/opto-crispr-new-prospects-for-gene-editing-and-regulation/</link><pubDate>Thu, 17 Jul 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/opto-crispr-new-prospects-for-gene-editing-and-regulation/</guid></item><item><title><![CDATA[Current status and future perspectives of vertical flow assays]]></title><description><![CDATA[Vertical flow assays (VFAs) have emerged as efficient diagnostic tools for point-of-care testing, offering rapid detection, high sensitivity, and multiplexing capabilities. By addressing key limitations of lateral flow assays, such as low specificity and cross-reactivity, VFAs enable simultaneous detection of multiple targets with improved accuracy and lower detection limits. Their applications span clinical diagnostics, pathogen detection, food safety, and agriculture. Recent advances, includin]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/current-status-and-future-perspectives-of-vertical-flow-assays/</link><pubDate>Mon, 14 Jul 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/current-status-and-future-perspectives-of-vertical-flow-assays/</guid></item><item><title><![CDATA[Innovative provisions for compliance in the recent WIPO treaty]]></title><description><![CDATA[The World Intellectual Property Organization (WIPO) treaty on ‘Intellectual Property, Genetic Resources, and Traditional Knowledge’ introduces novel clauses designed to enhance compliance through an unprecedented sanction mechanism. The treaty mandates penalties for non-disclosure, including administrative sanctions and potential patent revocation in cases of fraudulent intent, thereby setting a new standard for stronger compliance frameworks.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/innovative-provisions-for-compliance-in-the-recent-wipo-treaty/</link><pubDate>Sat, 12 Jul 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/innovative-provisions-for-compliance-in-the-recent-wipo-treaty/</guid></item><item><title><![CDATA[Escherichia coli selection strains for growth-coupled metabolic engineering]]></title><description><![CDATA[Synthetic metabolism has the potential to transform carbon capture, bioremediation, or bioproduction strategies. To transfer metabolic designs from an in vitro context to living model systems such as the bacterium Escherichia coli, metabolic engineers incentivize the maintenance and use of the introduced metabolic module by making cell survival dependent on it (growth-coupled selection). However, creating and characterizing appropriately rewired selection strains is nontrivial and requires labor]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/escherichia-coli-selection-strains-for-growth-coupled-metabolic-engineering/</link><pubDate>Sat, 12 Jul 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/escherichia-coli-selection-strains-for-growth-coupled-metabolic-engineering/</guid></item><item><title><![CDATA[Navigating microalgae under dynamic CO2 for waste-to-energy conversion]]></title><description><![CDATA[Carbon capture is an important mitigation strategy for the reduction of carbon in the atmosphere. Microalgae can simultaneously capture CO2 and valorize biomass, turning waste streams into sustainable bioenergy solutions. However, microalgae struggle when CO2 is either too scarce or too abundant. The scalability of microalgal carbon capture requires the development of strains that can sustain productivity and carbon conversion under fluctuating CO2 levels. In this review, we reframe CO2 assimila]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/navigating-microalgae-under-dynamic-co2-for-waste-to-energy-conversion/</link><pubDate>Fri, 11 Jul 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/navigating-microalgae-under-dynamic-co2-for-waste-to-energy-conversion/</guid></item><item><title><![CDATA[Towards a cultivated ribeye]]></title><description><![CDATA[To engineer full-thickness cultivated meat, a perfusable scaffold is required with a high density of capillaries that allow diffusion of oxygen, nutrients, and waste. Nie et al., established a remarkable feat of tissue engineering that provides important direction towards full-thickness cultivated meat.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/towards-a-cultivated-ribeye/</link><pubDate>Wed, 09 Jul 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/towards-a-cultivated-ribeye/</guid></item><item><title><![CDATA[A homologous recombination-proficient Yarrowia lipolytica chassis for multiplex genome manipulation]]></title><description><![CDATA[Yarrowia lipolytica, an industrial yeast historically challenging for precision genome editing, was engineered to favor homologous recombination (HR) repair while retaining its native fitness. This capacity facilitates Y. lipolytica-based basic research and modern biotechnology. The strategies developed in this study provide a reference for the genetic engineering of other nonhomologous end joining(NHEJ)-preferring organisms.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/a-homologous-recombination-proficient-yarrowia-lipolytica-chassis-for-multiplex-genome-manipulation/</link><pubDate>Tue, 08 Jul 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/a-homologous-recombination-proficient-yarrowia-lipolytica-chassis-for-multiplex-genome-manipulation/</guid></item><item><title><![CDATA[Renewable methanol as fermentation feedstock: the paraformaldehyde gambit]]></title><description><![CDATA[Renewable methanol is a promising feedstock for the bioproduction of single cell protein (SCP) and circular chemicals. Economic implementation is, however, burdensome due to the high oxygen demands inherently associated with methanol conversion. An alternative approach in circumventing this bottleneck via paraformaldehyde is proposed and discussed.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/renewable-methanol-as-fermentation-feedstock-the-paraformaldehyde-gambit/</link><pubDate>Mon, 07 Jul 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/renewable-methanol-as-fermentation-feedstock-the-paraformaldehyde-gambit/</guid></item><item><title><![CDATA[Tunable dynamic engineering of cellular NAD boosts the production of antibiotics in actinomycetes]]></title><description><![CDATA[By mining an alcohol dehydrogenase that can convert NADH to NAD+, we developed a strategy that dynamically adjusts the cellular NADH/NAD+ ratio to balance cell growth and antibiotic biosynthesis. This work establishes a NAD-based dynamic engineering strategy and provides an effective platform to boost secondary metabolite titers in actinomycetes.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/tunable-dynamic-engineering-of-cellular-nad-boosts-the-production-of-antibiotics-in-actinomycetes/</link><pubDate>Fri, 04 Jul 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/tunable-dynamic-engineering-of-cellular-nad-boosts-the-production-of-antibiotics-in-actinomycetes/</guid></item><item><title><![CDATA[Systematic engineering of synthetic serine cycles in Pseudomonas putida uncovers emergent topologies for methanol assimilation]]></title><description><![CDATA[To advance sustainable bioproduction, we engineered Pseudomonas putida for methanol assimilation via modular synthetic serine cycle variants. By combining native and synthetic functions, we enabled methanol-dependent serine biosynthesis and revealed new metabolic topologies, offering a blueprint for C1 assimilation in non-model, industrially relevant bacteria.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/systematic-engineering-of-synthetic-serine-cycles-in-pseudomonas-putida-uncovers-emergent-topologies-for-methanol-assimilation/</link><pubDate>Fri, 04 Jul 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/systematic-engineering-of-synthetic-serine-cycles-in-pseudomonas-putida-uncovers-emergent-topologies-for-methanol-assimilation/</guid></item><item><title><![CDATA[Peter Thiel and the Antichrist]]></title><description><![CDATA[The original tech right power player on A.I., Mars and immortality.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/peter-thiel-and-the-antichrist/</link><pubDate>Wed, 02 Jul 2025 15:49:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/peter-thiel-and-the-antichrist/</guid></item><item><title><![CDATA[Vector-free intra-airway in vivo epigenetic editing]]></title><description><![CDATA[We report vector-free epigenetic gene reactivation in vivo by specially configured recombinant proteins that do not require transgenesis, vectors, or packaging tools. By combining sequence-specific DNA-binding domains with epigenetically acting enzymes, these fusion chimeras attain local demethylation and targeted derepression of a selected gene when administered via aerosol and intranasal droplets.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/vector-free-intra-airway-in-vivo-epigenetic-editing/</link><pubDate>Wed, 02 Jul 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/vector-free-intra-airway-in-vivo-epigenetic-editing/</guid></item><item><title><![CDATA[Understanding the impact of antenatal corticosteroids via placenta and fetal lung microphysiological analysis platform (MAP) on a chip]]></title><description><![CDATA[We developed a placenta–fetal lung microphysiological platform to evaluate antenatal corticosteroid transport and fetal lung maturation. Our results indicate corticosteroid concentrations above 5 mM reduce placental cell viability without enhancing lung surfactant production, highlighting the importance of identifying optimal corticosteroid dosages to maximize therapeutic efficacy while minimizing adverse effects.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/understanding-the-impact-of-antenatal-corticosteroids-via-placenta-and-fetal-lung-microphysiological-analysis-platform-map-on-a-chip/</link><pubDate>Wed, 02 Jul 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/understanding-the-impact-of-antenatal-corticosteroids-via-placenta-and-fetal-lung-microphysiological-analysis-platform-map-on-a-chip/</guid></item><item><title><![CDATA[Production of phosphorylated and functional αs1-casein in Escherichia coli]]></title><description><![CDATA[The study demonstrates two strategies, phosphorylation of αs1-casein using Bacillus subtilis kinases and phosphomimetic substitution of αs1-casein, to generate functional recombinant αs1-casein in Escherichia coli. Mass spectrometry and two-dimensional gel electrophoresis (2DE) confirm site-specific phosphorylation, while functional assays reveal calcium-binding capacity and structural mimicry, offering a foundation for animal-free dairy protein innovation.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/production-of-phosphorylated-and-functional-s1-casein-in-escherichia-coli/</link><pubDate>Wed, 02 Jul 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/production-of-phosphorylated-and-functional-s1-casein-in-escherichia-coli/</guid></item><item><title><![CDATA[Engineering a novel adenine-sulfotransferase for efficient synthesis of PAPS and chondroitin sulfate in microbial cells]]></title><description><![CDATA[To address the critical bottleneck in the industrial production of sulfonated products, an enhanced synthesis pathway for the common sulfo donor 3′-phosphoadenosine-5′-phosphosulfate (PAPS) was developed. Through key enzyme mining and engineering, an efficient microbial platform was established for endogenous PAPS generation and de novo synthesis of sulfonated products.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/engineering-a-novel-adenine-sulfotransferase-for-efficient-synthesis-of-paps-and-chondroitin-sulfate-in-microbial-cells/</link><pubDate>Wed, 02 Jul 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/engineering-a-novel-adenine-sulfotransferase-for-efficient-synthesis-of-paps-and-chondroitin-sulfate-in-microbial-cells/</guid></item><item><title><![CDATA[Design of an intracellular aptamer-based fluorescent biosensor to track burden in Escherichia coli]]></title><description><![CDATA[Fluorogenic RNA aptamers are adopted to design a burden-responsive biosensor in Escherichia coli. While these aptamers can impact bacterial growth, the tRNA-Broc biosensor enables sensing of the burden imposed by different genetic constructs and identification of low-burden variants with improved performance.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/design-of-an-intracellular-aptamer-based-fluorescent-biosensor-to-track-burden-in-escherichia-coli/</link><pubDate>Wed, 02 Jul 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/design-of-an-intracellular-aptamer-based-fluorescent-biosensor-to-track-burden-in-escherichia-coli/</guid></item><item><title><![CDATA[The importance of fungal biotechnology for sustainable applications]]></title><description><![CDATA[Fungal biotechnology plays a vital role in advancing sustainability by offering innovative solutions for resource efficiency, environmental protection, and health improvements. Fungal systems are highly adaptable compared with other biotechnologies, with unique genomic and metabolic functions that enable the large-scale production of valuable compounds. This review emphasizes how fungal biotechnology contributes to global sustainability goals, particularly through artificial intelligence (AI)-dr]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/the-importance-of-fungal-biotechnology-for-sustainable-applications/</link><pubDate>Tue, 01 Jul 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/the-importance-of-fungal-biotechnology-for-sustainable-applications/</guid></item><item><title><![CDATA[Bioprinting of piezoresistive organohydrogel networks for advanced real-time mechanosensing in engineered tissue models]]></title><description><![CDATA[We present a biocompatible, stretchable hydrogel sensor co-printed with muscle tissue bioink, enabling real-time mechanical sensing in 3D cell cultures and engineered tissue. This approach advances tissue engineering by integrating soft electronics for real-time mechanical sensing and spatial force mapping in living constructs.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/bioprinting-of-piezoresistive-organohydrogel-networks-for-advanced-real-time-mechanosensing-in-engineered-tissue-models/</link><pubDate>Tue, 01 Jul 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/bioprinting-of-piezoresistive-organohydrogel-networks-for-advanced-real-time-mechanosensing-in-engineered-tissue-models/</guid></item><item><title><![CDATA[Advances in biomimetic carbonic anhydrase strategies for CO2 capture]]></title><description><![CDATA[Carbonic anhydrase (CA) enzymes hold strong potential in new biotechnological strategies for accelerated CO2 capture and conversion. Some CAs naturally tolerate the harsh conditions associated with carbon capture technologies; however, long-term durability, while maintaining high activity, presents significant challenges. This review offers an in-depth analysis of the CA enzymes that have been investigated for industrial carbon capture processes and highlights the key amino acids and structural]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/advances-in-biomimetic-carbonic-anhydrase-strategies-for-co2-capture/</link><pubDate>Tue, 01 Jul 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/advances-in-biomimetic-carbonic-anhydrase-strategies-for-co2-capture/</guid></item><item><title><![CDATA[3D extrusion bioprinting: rational bioink design and advanced fabrication techniques]]></title><description><![CDATA[The field of 3D extrusion bioprinting has rapidly evolved, presenting significant advancements in tissue engineering applications. Traditionally, the development of printable hydrogel formulations has relied more on empirical approaches rather than rational design principles. However, to better mimic the dynamic and spatiotemporal nature of the extracellular matrix (ECM), novel bioinks with tunable properties and synthetic flexibility are being developed. Simultaneously, variations of extrusion]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/3d-extrusion-bioprinting-rational-bioink-design-and-advanced-fabrication-techniques/</link><pubDate>Fri, 27 Jun 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/3d-extrusion-bioprinting-rational-bioink-design-and-advanced-fabrication-techniques/</guid></item><item><title><![CDATA[Pollutant degradation in saline wastewater using synthetic biology]]></title><description><![CDATA[Synthetic biology can endow microorganisms with novel capabilities. Su et al. developed an engineered strain of Vibrio natriegens that efficiently degrades complex organic pollutants in high-salinity environments. This technology offers a new biotechnological solution to urgent global environmental challenges, such as petrochemical wastewater discharges and marine oil spills.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/pollutant-degradation-in-saline-wastewater-using-synthetic-biology/</link><pubDate>Sat, 21 Jun 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/pollutant-degradation-in-saline-wastewater-using-synthetic-biology/</guid></item><item><title><![CDATA[Harnessing biotechnology for bee pollinator health]]></title><description><![CDATA[Bees are vital to global food security and biodiversity but their populations are threatened by a steady flux of interacting stressors. Current mitigation strategies are failing to address the complexity and scale of these threats. Biotechnology offers innovative solutions to protect essential pollination services and secure the future of beekeeping. Omic tools guided by artificial intelligence can unlock new possibilities for strengthening bee populations and improve their ability to adapt to e]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/harnessing-biotechnology-for-bee-pollinator-health/</link><pubDate>Sat, 21 Jun 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/harnessing-biotechnology-for-bee-pollinator-health/</guid></item><item><title><![CDATA[Challenges of alignment in synthetic cell research]]></title><description><![CDATA[Big Science projects are often troubled by misalignments. We analyze how synthetic cell researchers handle misalignments by performing alignment work. We find that alignment work renders Big Science feasible, but involves trade-offs, for example between short-term successes and long-term goals. We thus recommend attending to the politics of alignment work.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/challenges-of-alignment-in-synthetic-cell-research/</link><pubDate>Fri, 20 Jun 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/challenges-of-alignment-in-synthetic-cell-research/</guid></item><item><title><![CDATA[Application of bacterial extracellular vesicles in gastrointestinal diseases]]></title><description><![CDATA[Bacterial extracellular vesicles (BEVs) are nanoscale spherical particles with lipid bilayer membranes containing diverse functional components from their parent bacteria. They exert pivotal effects on bacteria–bacteria and host–bacteria communication. Analyzing the dynamic changes in the production and composition of BEVs provides insights into the relationship between gut microbiota and host health, offering valuable perspectives for diagnosing various gastrointestinal diseases. Furthermor]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/application-of-bacterial-extracellular-vesicles-in-gastrointestinal-diseases/</link><pubDate>Fri, 20 Jun 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/application-of-bacterial-extracellular-vesicles-in-gastrointestinal-diseases/</guid></item><item><title><![CDATA[Human bone marrow organoids: emerging progress but persisting challenges]]></title><description><![CDATA[Organoid systems hold promise as miniaturized in vitro platforms that model developmental and pathological processes. However, the engineering of human bone marrow organoids (BMOs) has been a long-standing challenge. Recently, the field has witnessed the emergence of BMO-like systems, a potential paradigm shift for the study of human hematopoiesis and associated niche elements. Published protocols rely on the mesodermal induction of iPSCs, establishing mesenchymal–vascular–hematopoietic tiss]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/human-bone-marrow-organoids-emerging-progress-but-persisting-challenges/</link><pubDate>Thu, 19 Jun 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/human-bone-marrow-organoids-emerging-progress-but-persisting-challenges/</guid></item><item><title><![CDATA[Scientific and public imaginations of xenobiology]]></title><description><![CDATA[Increasingly complex biotechnology endeavours, such as creating ‘unnatural’ life, warrant societal discussions on their applications and embedding. We explore ways in which xenobiologists imagine their work and relate that to public views. Techno-optimist scientific perspectives contrast with more ambivalent societal ones, calling for broader, value-centred debates and collaborative engagement efforts.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/scientific-and-public-imaginations-of-xenobiology/</link><pubDate>Wed, 18 Jun 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/scientific-and-public-imaginations-of-xenobiology/</guid></item><item><title><![CDATA[Redefining antibody cross-reactivity as an advantage for sensing and diagnostics]]></title><description><![CDATA[Cross-reactivity is viewed as a highly undesirable property of antibodies, with efforts focused on achieving high specificity and minimal crosstalk. Yet, in selective arrays, cross-reactivity can be a strength. The ability to bind to a range of antigens can be powerful if used strategically to distinguish complex samples. Chemometric and chemolfactory arrays rely on cross-reactivity to deliver powerful assays with capabilities that often outperform those of specific assays. Here, we argue that t]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/redefining-antibody-cross-reactivity-as-an-advantage-for-sensing-and-diagnostics/</link><pubDate>Wed, 18 Jun 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/redefining-antibody-cross-reactivity-as-an-advantage-for-sensing-and-diagnostics/</guid></item><item><title><![CDATA[Liquid biopsy for microbiome profiling through nucleotide analysis]]></title><description><![CDATA[Liquid biopsy for microbiome analysis is an emerging field that aims to study the composition and dynamics of microbial communities by analyzing biological fluids such as blood, urine, or saliva. This noninvasive method offers a useful approach to understanding microbiome dynamics. It provides insights into different pathologies, enables unbiased pathogen detection through noninvasive sampling, and offers rapid turnaround times. Clinical applications of liquid biopsy are emerging for microbiome]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/liquid-biopsy-for-microbiome-profiling-through-nucleotide-analysis/</link><pubDate>Wed, 18 Jun 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/liquid-biopsy-for-microbiome-profiling-through-nucleotide-analysis/</guid></item><item><title><![CDATA[High-performance nanobiosensing technologies for future diagnostic needs]]></title><description><![CDATA[Diagnostic sensor technologies lie at the core of the healthcare system and encompass disease screening, detection, and therapy monitoring. In past decades, many nanobiosensor technologies have emerged which rely on diverse principles using electrical, magnetic, mass-based, or photonic signal transduction methods. We provide an overview of recent and emerging nanobiosensing transduction technologies and illustrate the reported quantification capabilities for nucleic acids, proteins, and small mo]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/high-performance-nanobiosensing-technologies-for-future-diagnostic-needs/</link><pubDate>Wed, 18 Jun 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/high-performance-nanobiosensing-technologies-for-future-diagnostic-needs/</guid></item><item><title><![CDATA[Auricular repair: symphony between scaffolds and stem cells]]></title><description><![CDATA[Although stem cell technology has demonstrated considerable potential in correcting external auditory canal defects, conventional 2D differentiation techniques do not adequately replicate the in situ microenvironment, thereby hindering auricular chondrocyte differentiation. By contrast, 3D tissue-engineered scaffolds combined with bioprinting can delicately mimic the extracellular matrix (ECM), spatiotemporally releasing bioactive molecules in a controlled manner, thus enhancing stem cell differ]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/auricular-repair-symphony-between-scaffolds-and-stem-cells/</link><pubDate>Wed, 18 Jun 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/auricular-repair-symphony-between-scaffolds-and-stem-cells/</guid></item><item><title><![CDATA[Shifting the detection range of cell biosensors toward high concentrations using ligand-related exporters for applications]]></title><description><![CDATA[By integrating ligand-related exporters, this study enhances biosensor performance in high-concentration environments. The approach optimizes biosensors for screening high-yield strains and regulating quorum-sensing autolysis, with applications in industrial bioproduction and therapeutic delivery. This strategy provides a modular, adaptable framework for improving biosensor functionality across various biological systems.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/shifting-the-detection-range-of-cell-biosensors-toward-high-concentrations-using-ligand-related-exporters-for-applications/</link><pubDate>Tue, 17 Jun 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/shifting-the-detection-range-of-cell-biosensors-toward-high-concentrations-using-ligand-related-exporters-for-applications/</guid></item><item><title><![CDATA[Rapid selection of transgenic mammalian cells via diphtheria toxin resistance]]></title><description><![CDATA[SelecDT, a diphtheria toxin (DT)-based selection system, rapidly and efficiently selects transgene-positive mammalian cells up to 100%, outperforming traditional antibiotics. Its receptor-mediated mechanism, broad applicability, compatibility with existing protocols, and potential for integration with a variety of genome editing tools enhance its utility.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/rapid-selection-of-transgenic-mammalian-cells-via-diphtheria-toxin-resistance/</link><pubDate>Tue, 17 Jun 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/rapid-selection-of-transgenic-mammalian-cells-via-diphtheria-toxin-resistance/</guid></item><item><title><![CDATA[Biohybrid-engineered tissue platforms: bridging the gap in tissue engineering]]></title><description><![CDATA[Biohybrid-engineered tissue (BHET) platforms represent a cutting-edge development in tissue engineering by integrating electronic components with engineered biological tissues to enable real-time monitoring, precise modulation, and enhancement of tissue functionality. Recently, biofabrication and biofunctional material advances have facilitated the design of BHET platforms that respond to intricate biological and bioelectrical signals to replicate sophisticated physiological processes. BHET plat]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/biohybrid-engineered-tissue-platforms-bridging-the-gap-in-tissue-engineering/</link><pubDate>Tue, 17 Jun 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/biohybrid-engineered-tissue-platforms-bridging-the-gap-in-tissue-engineering/</guid></item><item><title><![CDATA[Inflammation-targeting and self-limited neutrophilic membrane-encapsulated teicoplanin for the treatment of infectious pneumonia]]></title><description><![CDATA[Teicoplanin-loaded neutrophil membrane-derived extracellular vesicles (Teic@NEV) represent a neutrophil-mimicking nanoplatform that concurrently eliminates methicillin-resistant Staphylococcus aureus (MRSA) infections and prevents inflammatory lung damage via targeted antibiotic delivery and pathological neutrophil swarm modulation, outperforming standard therapies.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/inflammation-targeting-and-self-limited-neutrophilic-membrane-encapsulated-teicoplanin-for-the-treatment-of-infectious-pneumonia/</link><pubDate>Sat, 14 Jun 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/inflammation-targeting-and-self-limited-neutrophilic-membrane-encapsulated-teicoplanin-for-the-treatment-of-infectious-pneumonia/</guid></item><item><title><![CDATA[Frog ‘N’ Roll: novel synthetic peptides selective against Gram-negative pathogens]]></title><description><![CDATA[Antimicrobial resistance (AMR) is a global public health concern that is becoming a ‘silent’ pandemic. Novel treatment strategies are urgently needed to counteract this growing threat. To this end, Ageitos et al. leverage the natural antibacterial armamentarium of frogs to develop novel optimized synthetic peptides selective against Gram-negative pathogens.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/frog-n-roll-novel-synthetic-peptides-selective-against-gram-negative-pathogens/</link><pubDate>Sat, 14 Jun 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/frog-n-roll-novel-synthetic-peptides-selective-against-gram-negative-pathogens/</guid></item><item><title><![CDATA[UFSC Biotech Network: a transdisciplinary platform for biotechnology innovation in Brazil]]></title><description><![CDATA[Biotech Network (Rede Biotech in Portuguese) is a crossdisciplinary initiative launched at the Federal University of Santa Catarina (UFSC) to foster innovative biotechnological solutions aligned with Brazil’s scientific, environmental, and societal challenges. Here, we highlight the structure, mission, and pioneering research efforts of the network, offering a model for integrated and sustainable biotechnology development in emerging economies.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/ufsc-biotech-network-a-transdisciplinary-platform-for-biotechnology-innovation-in-brazil/</link><pubDate>Tue, 10 Jun 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/ufsc-biotech-network-a-transdisciplinary-platform-for-biotechnology-innovation-in-brazil/</guid></item><item><title><![CDATA[The Spirit of Asilomar: lessons for the next era of biotechnology governance]]></title><description><![CDATA[The first Asilomar Conference on Recombinant DNA, held in February 1975, marked a unique moment in scientific history, when researchers took collective responsibility to set guidelines for their groundbreaking work. Fifty years later, as technologies like CRISPR, synthetic biology, mirror life, and artificial intelligence (AI)-driven bioengineering open unprecedented possibilities, a diverse group of stakeholders gathered again at the historic Asilomar Conference Grounds in Pacific Grove, Califo]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/the-spirit-of-asilomar-lessons-for-the-next-era-of-biotechnology-governance/</link><pubDate>Mon, 09 Jun 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/the-spirit-of-asilomar-lessons-for-the-next-era-of-biotechnology-governance/</guid></item><item><title><![CDATA[Engineered transcription factor-binding arrays for DNA-based gene expression control in mammalian cells]]></title><description><![CDATA[Arrays of transcription factor recognition elements, efficiently assembled in varying lengths, are tested in mammalian cells to engineer gene expression. Increasing array length or copy number enables more pronounced modulation of target genes, offering a versatile approach for precise genetic control.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/engineered-transcription-factor-binding-arrays-for-dna-based-gene-expression-control-in-mammalian-cells/</link><pubDate>Mon, 09 Jun 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/engineered-transcription-factor-binding-arrays-for-dna-based-gene-expression-control-in-mammalian-cells/</guid></item><item><title><![CDATA[Kennedy Says ‘Charlatans’ Are No Reason to Block Unproven Stem Cell Treatments]]></title><description><![CDATA[The U.S. health secretary said people should have access to experimental therapies including unregulated uses of stem cells. But some methods have resulted in blindness, tumors and other injuries.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/kennedy-says-charlatans-are-no-reason-to-block-unproven-stem-cell-treatments/</link><pubDate>Thu, 05 Jun 2025 18:07:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/kennedy-says-charlatans-are-no-reason-to-block-unproven-stem-cell-treatments/</guid></item><item><title><![CDATA[Accelerating promoter identification and design by deep learning]]></title><description><![CDATA[Promoters are DNA sequences that govern the location, direction, and strength of gene transcription, playing a pivotal role in cellular growth and lifespan. Engineered promoters facilitate precise control of recombinant protein expression and metabolic pathway modulation for natural product biosynthesis. Traditional methods such as rational design and directed evolution have established the foundation for promoter engineering, and recent advances in deep learning (DL) have revolutionized the fie]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/accelerating-promoter-identification-and-design-by-deep-learning/</link><pubDate>Wed, 04 Jun 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/accelerating-promoter-identification-and-design-by-deep-learning/</guid></item><item><title><![CDATA[Trends in sustainable single-cell protein from non-grain feedstocks]]></title><description><![CDATA[Amid growing global food demands and escalating environmental crises, sustainable protein production faces critical challenges. Traditional agriculture is failing to meet rising demands due to resource inefficiency and climate impacts. Advanced single-cell protein (SCP) produced through microbial fermentation of non-grain feedstocks offers a promising alternative. Current SCP advancements prioritize enhancing non-grain feedstock utilization, expanding multifunctional applications, and integratin]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/trends-in-sustainable-single-cell-protein-from-non-grain-feedstocks/</link><pubDate>Tue, 03 Jun 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/trends-in-sustainable-single-cell-protein-from-non-grain-feedstocks/</guid></item><item><title><![CDATA[Genome editing of epigenetic transgene silencing in Chlamydomonas reinhardtii]]></title><description><![CDATA[Green microalgal biotechnology is limited by strong transgene silencing. CRISPR-mediated combinatorial disruption of epigenetic factors in Chlamydomonas reinhardtii identified transgene silencing factors and improved transgene expression strength and stability. In addition, an intein-based split selectable marker system was established for dual-targeted CRISPR, reducing the need for selectable markers.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/genome-editing-of-epigenetic-transgene-silencing-in-chlamydomonas-reinhardtii/</link><pubDate>Fri, 30 May 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/genome-editing-of-epigenetic-transgene-silencing-in-chlamydomonas-reinhardtii/</guid></item><item><title><![CDATA[Glass fiber-interfaced CRISPR/Cas biosensing adaptable for diverse biomarker detection]]></title><description><![CDATA[A glass-fiber interfaced CRISPR/Cas biosensor introduces a universal reagent setting for multiplex detection of nucleic acids and proteins with exceptional sensitivity through cascade amplification. Compatible with portable fluorescence readers, this system delivers rapid results from only 5-μl samples, making it an ideal solution for point-of-care diagnostics and personalized medicine]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/glass-fiber-interfaced-crisprcas-biosensing-adaptable-for-diverse-biomarker-detection/</link><pubDate>Thu, 29 May 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/glass-fiber-interfaced-crisprcas-biosensing-adaptable-for-diverse-biomarker-detection/</guid></item><item><title><![CDATA[Without a trace: multiple knockout of CHO host cell hydrolases to prevent polysorbate degradation in biologics]]></title><description><![CDATA[Enzymatic degradation of polysorbates (PS) in biologic formulations is often caused by hydrolytic host cell proteins (HCPs) and can lead to particle formation and reduced shelf-life. Combining hydrolase knockouts in a single Chinese hamster ovary (CHO) host cell line enabled traceless enzyme removal and represented a big step toward the production of PS degradation-free biologics.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/without-a-trace-multiple-knockout-of-cho-host-cell-hydrolases-to-prevent-polysorbate-degradation-in-biologics/</link><pubDate>Wed, 28 May 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/without-a-trace-multiple-knockout-of-cho-host-cell-hydrolases-to-prevent-polysorbate-degradation-in-biologics/</guid></item><item><title><![CDATA[Scaling DNA engineering]]></title><description><![CDATA[DNA can be engineered to produce new biologics, gene therapies, and cellular therapies, and to reprogram organisms. Having the ability to engineer DNA at scale can accelerate the development of these applications. Existing technologies excel at short oligonucleotide synthesis by chemical or enzymatic methods (up to 2000 bp) and intermediate-size DNA assembly (up to 5–7 kb). Yet synthesizing sequence-validated longer DNA (&gt;10 kb) and/or constructing highly complex combinatorial DNA libraries]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/scaling-dna-engineering/</link><pubDate>Wed, 28 May 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/scaling-dna-engineering/</guid></item><item><title><![CDATA[Machine learning to predict de novo protein–protein interactions]]></title><description><![CDATA[Advances in machine learning for structural biology have dramatically enhanced our capacity to predict protein–protein interactions (PPIs). Here, we review recent developments in the computational prediction of PPIs, particularly focusing on innovations that enable interaction predictions that have no precedence in nature, termed de novo. We discuss novel machine learning algorithms for PPI prediction, including approaches based on co-folding and atomic graphs. We further highlight methods tha]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/machine-learning-to-predict-de-novo-proteinprotein-interactions/</link><pubDate>Mon, 26 May 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/machine-learning-to-predict-de-novo-proteinprotein-interactions/</guid></item><item><title><![CDATA[Speed breeding 3.0: mainstreaming light-driven plant breeding for sustainable genetic gains]]></title><description><![CDATA[Advances in photobiological tools are revolutionizing plant breeding by enabling precise control of light parameters, addressing yield stagnation, and mitigating climate challenges. Full-spectrum light-emitting diodes (LEDs) and optimized light protocols have significantly reduced breeding cycles. This review highlights light-driven strategies that are accessible and practical for plant breeders worldwide including the role of light spectrum, intensity, and photoperiod in acceleration of plant g]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/speed-breeding-30-mainstreaming-light-driven-plant-breeding-for-sustainable-genetic-gains/</link><pubDate>Fri, 23 May 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/speed-breeding-30-mainstreaming-light-driven-plant-breeding-for-sustainable-genetic-gains/</guid></item><item><title><![CDATA[Large-scale manufacturing of human gallbladder epithelial cell products and derived hepatocytes via a chemically defined approach]]></title><description><![CDATA[This study presents a chemically defined approach for producing human gallbladder epithelial cells in a good manufacturing practice-compliant facility. Independent cell banks are established from individual donors, ensuring the production of high-quality, animal-free cell products suitable for drug testing, disease modeling, and preclinical studies.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/large-scale-manufacturing-of-human-gallbladder-epithelial-cell-products-and-derived-hepatocytes-via-a-chemically-defined-approach/</link><pubDate>Tue, 20 May 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/large-scale-manufacturing-of-human-gallbladder-epithelial-cell-products-and-derived-hepatocytes-via-a-chemically-defined-approach/</guid></item><item><title><![CDATA[What would a hypothetical supercyanobacterium look like?]]></title><description><![CDATA[Over the past two decades, advances in molecular and microbiological methods have broadened the range of microorganisms used in biotechnology. Among them, phototrophic bacteria – especially cyanobacteria – are gaining attention for their potential in tackling climate change and producing biopharmaceuticals. While traditional strains such as Escherichia coli and Bacillus subtilis dominate the field, cyanobacteria offer unique features that present both challenges and opportunities, such as co]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/what-would-a-hypothetical-supercyanobacterium-look-like/</link><pubDate>Mon, 19 May 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/what-would-a-hypothetical-supercyanobacterium-look-like/</guid></item><item><title><![CDATA[Plant genome editing goes viral]]></title><description><![CDATA[In a recent study, Weiss et al. presented an RNA virus-based system that transmits the compact genome editor TnpB into Arabidopsis thaliana, resulting in transgene-free and heritable modifications. This innovation transforms DNA delivery methods in plant biotechnology, providing a more straightforward, scalable, and regulatory-compliant approach to genome engineering.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/plant-genome-editing-goes-viral/</link><pubDate>Mon, 19 May 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/plant-genome-editing-goes-viral/</guid></item><item><title><![CDATA[Mpox diagnosis at POC]]></title><description><![CDATA[The increasing number of Monkeypox (Mpox) cases in non-endemic countries resulted in the WHO declaring a public health emergency of international concern. Accurate and timely diagnosis of Mpox has a critical role in containing the spread of infection. Diagnosis currently relies on PCR, which requires trained personnel and complex laboratory infrastructure. Thus, the development of point-of-care (POC) tools are essential to facilitate rapid, accurate, and user-friendly diagnosis. Here, we review]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/mpox-diagnosis-at-poc/</link><pubDate>Mon, 19 May 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/mpox-diagnosis-at-poc/</guid></item><item><title><![CDATA[How transdisciplinarity can help biotech-driven biodiversity research]]></title><description><![CDATA[The Kunming-Montreal Global Biodiversity Framework marks a significant step toward conserving genetic diversity on a global scale. Sequencing advancements have broadened biodiversity studies by enabling the mapping of species distributions, increasing understanding of ecological interactions, and monitoring genetic diversity. However, these tools are hindered by inequalities and biases, particularly in biodiversity-rich developing countries. To navigate these challenges, we propose strategies us]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/how-transdisciplinarity-can-help-biotech-driven-biodiversity-research/</link><pubDate>Mon, 19 May 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/how-transdisciplinarity-can-help-biotech-driven-biodiversity-research/</guid></item><item><title><![CDATA[Emerging strategies to develop novel genetically encoded biosensors]]></title><description><![CDATA[The current biosensor inventory is inadequate for the multitude of metabolites and proteins needing detection. Assisted by new technologies and research paradigms such as multi-omics analysis and de novo protein design, emerging strategies provide a promising avenue for the development of novel, tailored genetically encoded biosensors for various applications.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/emerging-strategies-to-develop-novel-genetically-encoded-biosensors/</link><pubDate>Thu, 15 May 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/emerging-strategies-to-develop-novel-genetically-encoded-biosensors/</guid></item><item><title><![CDATA[CRISPR-based non-nucleic acid detection]]></title><description><![CDATA[Characterization of clustered regularly interspaced short palindromic repeat (CRISPR)-associated (Cas) trans-cleavage activities has initiated the era of next-generation CRISPR diagnostics. By using the trans-cleavage reaction for signal output, CRISPR systems have been engineered to detect non-nucleic acids (NNAs), including ions, inorganic small molecules, organic compounds, proteins, and bacteria. Diverse strategies are being used to specifically recognize NNAs and regulate Cas trans-cleavage]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/crispr-based-non-nucleic-acid-detection/</link><pubDate>Wed, 14 May 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/crispr-based-non-nucleic-acid-detection/</guid></item><item><title><![CDATA[Biomimetic chemical microhabitats enhance coral settlement]]></title><description><![CDATA[A hybrid biomaterial, SNAP-X, was engineered to mimic natural chemical landscapes, enhancing coral settlement by over 20-fold. By sustained cue release, this technology addresses recruitment failure on degraded reefs and has broader applications in marine ecology and biomaterials science.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/biomimetic-chemical-microhabitats-enhance-coral-settlement/</link><pubDate>Wed, 14 May 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/biomimetic-chemical-microhabitats-enhance-coral-settlement/</guid></item><item><title><![CDATA[Robert Shapiro, Who Made NutraSweet a Household Name, Dies at 86]]></title><description><![CDATA[His promotion of the sugar substitute was a success. But later, as head of Monsanto, he faced blowback after the company rushed into genetically altered products.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/robert-shapiro-who-made-nutrasweet-a-household-name-dies-at-86/</link><pubDate>Mon, 12 May 2025 17:15:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/robert-shapiro-who-made-nutrasweet-a-household-name-dies-at-86/</guid></item><item><title><![CDATA[Engineered thermoswitch in the baculovirus expression vector system for production of virus-like particle vaccines with minimized baculovirus contaminants]]></title><description><![CDATA[This work presents an innovative baculovirus expression system for virus-like-particle (VLP) vaccine production. A genetic thermoswitch was engineered in the baculovirus expression vector (BacFreets) to regulate baculovirus particle production. Temperature elevation from 27°C to 33°C results in a multilog reduction of co-produced baculovirus contaminants in the upstream VLP production phase.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/engineered-thermoswitch-in-the-baculovirus-expression-vector-system-for-production-of-virus-like-particle-vaccines-with-minimized-baculovirus-contaminants/</link><pubDate>Fri, 09 May 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/engineered-thermoswitch-in-the-baculovirus-expression-vector-system-for-production-of-virus-like-particle-vaccines-with-minimized-baculovirus-contaminants/</guid></item><item><title><![CDATA[Efficient and sustained photosynthetic hydrogen production by algae under high light intensity]]></title><description><![CDATA[We developed a smart algae/polymer hybrid system that enabled sustained photosynthetic hydrogen production under high light intensities (100–2000 μmol photons·m-2·s-1), overcame photoinhibition and oxygen-related challenges, and advances outdoor large-scale green hydrogen production.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/efficient-and-sustained-photosynthetic-hydrogen-production-by-algae-under-high-light-intensity/</link><pubDate>Thu, 08 May 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/efficient-and-sustained-photosynthetic-hydrogen-production-by-algae-under-high-light-intensity/</guid></item><item><title><![CDATA[An in vivo target mutagenesis system for multiple hosts]]></title><description><![CDATA[This study developed an in vivo targeted mutagenesis system for multiple hosts based on replication elements of broad host-range plasmids. This system is designed to accelerate the rapid evolution of proteins and metabolic pathways, further leveraging the performance advantages of unconventional hosts.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/an-in-vivo-target-mutagenesis-system-for-multiple-hosts/</link><pubDate>Thu, 08 May 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/an-in-vivo-target-mutagenesis-system-for-multiple-hosts/</guid></item><item><title><![CDATA[Self-documenting plasmids]]></title><description><![CDATA[Disconnect between plasmid molecules and their digital documentation is common. We developed self-documenting plasmids with certificates that encode documentation directly in the plasmid sequence or as a digital reference. This technology enables secure verification of plasmid accuracy, improved document sharing, and an avenue for asserting intellectual property rights over sequences.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/self-documenting-plasmids/</link><pubDate>Wed, 07 May 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/self-documenting-plasmids/</guid></item><item><title><![CDATA[Molecular process control for industrial biotechnology]]></title><description><![CDATA[The development of sustainable and economically competitive biotechnological processes is a central challenge of modern industrial biotechnology. Conventional strategies such as macroscopic and molecular bioprocess design are often insufficient to exploit their full potential. To circumvent this, molecular process control provides the missing link to further consolidate various optimization strategies to achieve multilayered process design. This review highlights the molecular mechanisms that ca]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/molecular-process-control-for-industrial-biotechnology/</link><pubDate>Tue, 06 May 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/molecular-process-control-for-industrial-biotechnology/</guid></item><item><title><![CDATA[Intelligent biomanufacturing of water-soluble vitamins]]></title><description><![CDATA[Given the crucial role of water-soluble vitamins in the human body and the rising demand for natural sources, their biosynthesis has gained the attention of researchers. This review offers a comprehensive look at recent progress in water-soluble vitamin biosynthesis, emphasizing synthetic biotechnology for green biomanufacturing. Specifically, it encompasses the optimization of biological components, pathways, and systems, as well as energy metabolism regulation, stress-tolerance enhancement, hi]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/intelligent-biomanufacturing-of-water-soluble-vitamins/</link><pubDate>Tue, 06 May 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/intelligent-biomanufacturing-of-water-soluble-vitamins/</guid></item><item><title><![CDATA[Regulatable C-X-C chemokine receptor type 4 in iPSC-derived NK cells improves bone marrow chemotaxis and targeting resident tumor]]></title><description><![CDATA[In this study, He et al. developed an optimized method that combines iPSC differentiation, chemotaxis regulation, and genetic engineering to produce a potential iPSC-derived nature killer cells product with enhanced therapeutic efficacy against bone marrow-resident tumors, such as acute myeloid leukemia and multiple myeloma.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/regulatable-c-x-c-chemokine-receptor-type-4-in-ipsc-derived-nk-cells-improves-bone-marrow-chemotaxis-and-targeting-resident-tumor/</link><pubDate>Wed, 30 Apr 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/regulatable-c-x-c-chemokine-receptor-type-4-in-ipsc-derived-nk-cells-improves-bone-marrow-chemotaxis-and-targeting-resident-tumor/</guid></item><item><title><![CDATA[The next Green Revolution: integrating crop architectype and physiotype]]></title><description><![CDATA[In the middle of the last century, the Green Revolution dramatically increased crop yields and transformed global agriculture. As current food production is increasingly challenged by the demands of the growing population, climate change, and environmental degradation, a new Green Revolution is urgently needed. This Review highlights recent progress in defining the morphological ideotypes of four major crops, and proposes essential physiological traits critical for crop improvement and environme]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/the-next-green-revolution-integrating-crop-architectype-and-physiotype/</link><pubDate>Tue, 29 Apr 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/the-next-green-revolution-integrating-crop-architectype-and-physiotype/</guid></item><item><title><![CDATA[A green light for phytosensors?]]></title><description><![CDATA[As sentinels, transgenic phytosensor plants alert farmers rapidly to stressful conditions in crop fields. However, if improperly managed, accidental commingling of phytosensor plants with the bulk harvest could disrupt trade and raises safety concerns. With these crops nearing commercialization, proper risk management, including segregation and risk analysis, is imperative.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/a-green-light-for-phytosensors/</link><pubDate>Fri, 25 Apr 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/a-green-light-for-phytosensors/</guid></item><item><title><![CDATA[Sebum analysis as an advantageous source of biomolecular information]]></title><description><![CDATA[Sebum, a valuable yet underexplored source of biomolecular information, offers non-invasive collection, but its analysis presents challenges due to its hydrophobic and viscous nature. This forum article highlights the challenges but immense potential of sebum analysis in shaping the next generation of diagnostics and other biotechnological applications.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/sebum-analysis-as-an-advantageous-source-of-biomolecular-information/</link><pubDate>Thu, 24 Apr 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/sebum-analysis-as-an-advantageous-source-of-biomolecular-information/</guid></item><item><title><![CDATA[pHNRhCas9NG, single expression cassette-based dual-component dual-transcription unit CRISPR/Cas9 system for plant genome editing]]></title><description><![CDATA[This study improved the clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 system to boost plant genome-editing efficiency and reliability. A new, scalable dual-component dual-transcription unit CRISPR/Cas9 tool, called pHNRhCas9NG, uses an artificial promoter P35SIC47 and increases the poly(A) tail length of Cas9 mRNA. This new system achieved almost 100% gene-editing efficiency in the tested plants.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/phnrhcas9ng-single-expression-cassette-based-dual-component-dual-transcription-unit-crisprcas9-system-for-plant-genome-editing/</link><pubDate>Thu, 24 Apr 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/phnrhcas9ng-single-expression-cassette-based-dual-component-dual-transcription-unit-crisprcas9-system-for-plant-genome-editing/</guid></item><item><title><![CDATA[A ventilated perfused lung model platform to dissect the response of the lungs to viral infection]]></title><description><![CDATA[Here, we present a positive-pressure ventilated, perfused alveolar in vitro platform to holistically study epithelial barrier remodeling in response to viral infection. This platform offers an alternative to animal models for studying host–pathogen interactions and respiratory disease mechanisms.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/a-ventilated-perfused-lung-model-platform-to-dissect-the-response-of-the-lungs-to-viral-infection/</link><pubDate>Thu, 24 Apr 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/a-ventilated-perfused-lung-model-platform-to-dissect-the-response-of-the-lungs-to-viral-infection/</guid></item><item><title><![CDATA[HHV-6 and HHV-7 reactivation in allogeneic CAR-T cell therapy]]></title><description><![CDATA[Autologous chimeric antigen receptor (CAR)-T cell therapy has revolutionized cancer treatment and allogeneic CAR-T cell therapy is poised to advance this revolution. CAR-T cell therapy faces some concerns regarding adventitious agents, which can threaten the safety of patients. Human herpesviruses 6 and 7 (HHV-6 and HHV-7) have become increasingly notable in this context, as they carry a risk with severe health consequences. This review explores these virus reactivations in CAR-T cell therapy an]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/hhv-6-and-hhv-7-reactivation-in-allogeneic-car-t-cell-therapy/</link><pubDate>Tue, 22 Apr 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/hhv-6-and-hhv-7-reactivation-in-allogeneic-car-t-cell-therapy/</guid></item><item><title><![CDATA[Bottom-up development of lipid-based synthetic cells for practical applications]]></title><description><![CDATA[Synthetic cells (SCs) can be engineered from the bottom up to recapitulate the functional properties of natural cells while performing specialized tasks such as drug delivery, biosensors, bioproduction, vaccine development, and even environmental remediation. Recent advances in synthetic biology, biomaterials, and microfluidics have enabled the development of increasingly sophisticated SCs. Transitioning from proof-of-concept demonstrations to practical applications requires a deep understanding]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/bottom-up-development-of-lipid-based-synthetic-cells-for-practical-applications/</link><pubDate>Mon, 21 Apr 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/bottom-up-development-of-lipid-based-synthetic-cells-for-practical-applications/</guid></item><item><title><![CDATA[Scalable tissue biofabrication via perfusable hollow fiber arrays for cultured meat applications]]></title><description><![CDATA[A HFB with highly uniform, densely packed semipermeable fibers, fabricated via high-resolution stereolithography, enables spatially uniform, leak-free perfusion under high pressure. Microfabricated anchors enhance cell alignment, while active perfusion improves tissue maturation, providing a scalable solution for large-scale engineered tissues and cultured meat production.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/scalable-tissue-biofabrication-via-perfusable-hollow-fiber-arrays-for-cultured-meat-applications/</link><pubDate>Wed, 16 Apr 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/scalable-tissue-biofabrication-via-perfusable-hollow-fiber-arrays-for-cultured-meat-applications/</guid></item><item><title><![CDATA[Robotic micromotors transforming oral drug administration]]></title><description><![CDATA[Oral medication is preferred for its convenience; however, efficient drug delivery remains challenging due to issues such as poor solubility, and absorption caused by mucosal barriers, which result in low bioavailability. In this review, we discuss new strategies integrating robotic capabilities into oral formulations to enhance drug delivery. Such robotic pill systems leverage the efficient propulsion of biological and synthetic micromotors to accelerate pill disintegration and overcome mucosal]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/robotic-micromotors-transforming-oral-drug-administration/</link><pubDate>Fri, 11 Apr 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/robotic-micromotors-transforming-oral-drug-administration/</guid></item><item><title><![CDATA[Brain organoids: building higher-order complexity and neural circuitry models]]></title><description><![CDATA[Brain organoids are 3D tissue models of the human brain that are derived from pluripotent stem cells (PSCs). They have enabled studies that were previously stymied by the inaccessibility of human brain tissue or the limitations of mouse models of some brain diseases. Despite their enormous potential, brain organoids have had significant limitations that prevented them from recapitulating the full complexity of the human brain and reduced their utility in disease studies. We describe recent progr]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/brain-organoids-building-higher-order-complexity-and-neural-circuitry-models/</link><pubDate>Fri, 11 Apr 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/brain-organoids-building-higher-order-complexity-and-neural-circuitry-models/</guid></item><item><title><![CDATA[Spatial omics for accelerating plant research and crop improvement]]></title><description><![CDATA[Plant cells communicate information to regulate developmental processes and respond to environmental stresses. This communication spans various ‘omics’ layers within a cell and operates through intricate regulatory networks. The emergence of spatial omics presents a promising approach to thoroughly analyze cells, allowing the combined analysis of diverse modalities either in parallel or on the same tissue section. Here, we provide an overview of recent advancements in spatial omics and delin]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/spatial-omics-for-accelerating-plant-research-and-crop-improvement/</link><pubDate>Thu, 10 Apr 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/spatial-omics-for-accelerating-plant-research-and-crop-improvement/</guid></item><item><title><![CDATA[Long-offset paired nicking-based efficient and precise strategy for in vivo targeted insertion]]></title><description><![CDATA[The long-offset paired nicking target integration (LOTI) strategy enables precise and efficient in vivo somatic cell gene integration, surpassing traditional nickase methods. It achieved 55% FIX activity recovery in a hemophilia B mouse model using a single plasmid dose, underscoring its potential for large-gene correction.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/long-offset-paired-nicking-based-efficient-and-precise-strategy-for-in-vivo-targeted-insertion/</link><pubDate>Mon, 07 Apr 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/long-offset-paired-nicking-based-efficient-and-precise-strategy-for-in-vivo-targeted-insertion/</guid></item><item><title><![CDATA[Emerging supramolecular and living materials in oral medicine]]></title><description><![CDATA[Conventional dental materials lack the ability to promote regeneration, necessitating innovative approaches for repairing dental, oral, and craniofacial (DOC) tissues. Supramolecular materials with reversible, tunable interactions, and engineered living materials (ELMs) that mimic natural tissue dynamics, present a promising pathway towards regenerative solutions in oral medicine. This review introduces the potential of these biomaterials, focusing on their applications in oral bioprinting, ther]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/emerging-supramolecular-and-living-materials-in-oral-medicine/</link><pubDate>Mon, 07 Apr 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/emerging-supramolecular-and-living-materials-in-oral-medicine/</guid></item><item><title><![CDATA[Advancing wheat breeding using rye: a key contribution to wheat breeding history]]></title><description><![CDATA[Rye (Secale cereale L.), a close relative of wheat (Triticum aestivum L.), has significantly contributed to wheat breeding, exemplified by the global utilization of T1RS·1BL translocation lines. This highlights the strategic importance of integrating elite genes from related species into modern crop-breeding programs. This review explores the historical contributions of rye to wheat breeding and its potential in future applications. We delve into the impact of biotechnological approaches in unl]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/advancing-wheat-breeding-using-rye-a-key-contribution-to-wheat-breeding-history/</link><pubDate>Mon, 07 Apr 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/advancing-wheat-breeding-using-rye-a-key-contribution-to-wheat-breeding-history/</guid></item><item><title><![CDATA[Improving plant C-to-G base editors with a cold-adapted glycosylase and TadA-8e variants]]></title><description><![CDATA[A series of uracil DNA glycosylases (UNG) and cytidine deaminases were screened for upgrading plant cytosine (C)-to-guanine (G) base editors (CGBE). An engineered CDc-CGBEco fusing with a cod UNG (coUNG) and a TadA-8e-derived cytidine deaminases (TadA-CDc) exhibited superior performance in C-to-G editing, showing reliable and heritable base editing in monocots and dicots.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/improving-plant-c-to-g-base-editors-with-a-cold-adapted-glycosylase-and-tada-8e-variants/</link><pubDate>Fri, 04 Apr 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/improving-plant-c-to-g-base-editors-with-a-cold-adapted-glycosylase-and-tada-8e-variants/</guid></item><item><title><![CDATA[Engineering advanced in vitro models of endothelial dysfunction]]></title><description><![CDATA[Endothelial dysfunction is an important initiator of cardiovascular disease, the leading cause of death globally, and often manifests in arterial regions with disturbed blood flow. Experimental model advances have crucially helped unravel physiological mechanisms. While in vivo models provide a dynamic environment, they often fail to mimic human physiology precisely and face significant ethical barriers. Advanced in vitro models, including organs-on-chips and bioreactors, combine human cells and]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/engineering-advanced-in-vitro-models-of-endothelial-dysfunction/</link><pubDate>Fri, 04 Apr 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/engineering-advanced-in-vitro-models-of-endothelial-dysfunction/</guid></item><item><title><![CDATA[Genomically recoded organisms: redefining and safeguarding biological systems]]></title><description><![CDATA[In a recent report, Grome et al. describe a genomically recoded Escherichia coli strain with a 62-codon genome and a single stop codon. This and other genomically recoded organisms (GROs), engineered with modified genetic vocabularies, enable the creation of novel proteins and biomaterials, while ensuring the safety and viability of GRO-based biomanufacturing.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/genomically-recoded-organisms-redefining-and-safeguarding-biological-systems/</link><pubDate>Thu, 03 Apr 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/genomically-recoded-organisms-redefining-and-safeguarding-biological-systems/</guid></item><item><title><![CDATA[Bioprinting and synthetic biology approaches to engineer functional endocrine pancreatic constructs]]></title><description><![CDATA[Diabetes is a complex disease affecting over 500 million people worldwide. Traditional approaches, such as insulin delivery, are mainstay treatments, but do not cure the disease. Recent advances in biofabrication and synthetic biology offer new hope for the development of tissue constructs recapitulating salient organ functions. Here, we discuss recent progress in bioprinting a functional endocrine pancreas, ranging from cell sources to main advances in biomaterials. We review innovative areas f]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/bioprinting-and-synthetic-biology-approaches-to-engineer-functional-endocrine-pancreatic-constructs/</link><pubDate>Thu, 03 Apr 2025 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/bioprinting-and-synthetic-biology-approaches-to-engineer-functional-endocrine-pancreatic-constructs/</guid></item><item><title><![CDATA[Process and quality considerations for recombinant adeno-associated virus manufacturing platforms]]></title><description><![CDATA[Recombinant adeno-associated virus (AAV) is a prominent gene therapy vector, offering a strong safety profile and sustained gene expression. Scaling up AAV manufacturing remains challenging due to its complex processes, high development costs, and the need for rigorous quality control. This review examines the most common AAV suspension production platforms, specifically transfection, infection, and stable producer cell lines (PCLs). For each platform, a list of common unit operations and typica]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/process-and-quality-considerations-for-recombinant-adeno-associated-virus-manufacturing-platforms/</link><pubDate>Thu, 27 Mar 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/process-and-quality-considerations-for-recombinant-adeno-associated-virus-manufacturing-platforms/</guid></item><item><title><![CDATA[Expediting genome synthesis of Corynebacterium glutamicum with an artificial chromosome vector]]></title><description><![CDATA[We developed an artificial chromosome plasmid (CAC) for large-scale genome replacement of Corynebacterium glutamicum, accelerating the genome synthesis for this organism. This work offers design principles for advancing de novo genome design and synthesis for industrially relevant Gram-positive microbes.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/expediting-genome-synthesis-of-corynebacterium-glutamicum-with-an-artificial-chromosome-vector/</link><pubDate>Thu, 27 Mar 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/expediting-genome-synthesis-of-corynebacterium-glutamicum-with-an-artificial-chromosome-vector/</guid></item><item><title><![CDATA[Enzyme functional classification using artificial intelligence]]></title><description><![CDATA[Enzymes are essential for cellular metabolism, and elucidating their functions is critical for advancing biochemical research. However, experimental methods are often time consuming and resource intensive. To address this, significant efforts have been directed toward applying artificial intelligence (AI) to enzyme function prediction, enabling high-throughput and scalable approaches. In this review, we discuss advances in AI-driven enzyme functional annotation, transitioning from traditional ma]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/enzyme-functional-classification-using-artificial-intelligence/</link><pubDate>Thu, 27 Mar 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/enzyme-functional-classification-using-artificial-intelligence/</guid></item><item><title><![CDATA[Challenges and design of nanobodies against arboviruses]]></title><description><![CDATA[Nanobodies (Nbs) show promise in combating arboviruses. Their small size and stability enable blood–brain barrier (BBB) penetration, cryptic epitope binding, and reduced antibody-dependent enhancement (ADE). This forum highlights Nb advantages, challenges, and innovative delivery methods, emphasizing their transformative potential in arbovirus therapeutics and diagnostics.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/challenges-and-design-of-nanobodies-against-arboviruses/</link><pubDate>Thu, 27 Mar 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/challenges-and-design-of-nanobodies-against-arboviruses/</guid></item><item><title><![CDATA[Frog-derived synthetic peptides display anti-infective activity against Gram-negative pathogens]]></title><description><![CDATA[Synthetic peptides, inspired by the natural defenses of amphibians, demonstrate selective activity against Gram-negative pathogens while sparing the gut microbiota and Gram-positive strains. Rationally designed peptides showed remarkable potency, exhibiting no signs of resistance or toxicity. These results underscore the potential of peptide-based antibiotics to tackle multidrug-resistant bacterial infections.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/frog-derived-synthetic-peptides-display-anti-infective-activity-against-gram-negative-pathogens/</link><pubDate>Tue, 25 Mar 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/frog-derived-synthetic-peptides-display-anti-infective-activity-against-gram-negative-pathogens/</guid></item><item><title><![CDATA[Academic entrepreneurship: promise and perils]]></title><description><![CDATA[As academic institutions strive to meet financial demands, a tantalizing opportunity posits that faculty have untapped treasures emanating from laboratories or astute clinical observations awaiting commercialization. ‘If only this alchemy could be turned into gold’, administrators muse. Understanding the complexities of academic entrepreneurship should provide words of caution and encouragement.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/academic-entrepreneurship-promise-and-perils/</link><pubDate>Tue, 25 Mar 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/academic-entrepreneurship-promise-and-perils/</guid></item><item><title><![CDATA[FDA Approved Artificial Blood Vessel Despite Warnings]]></title><description><![CDATA[The agency OK&rsquo;d an artificial vessel to restore blood flow in patients, even though its own scientists flagged questionable study results and potentially fatal ruptures of the product.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/fda-approved-artificial-blood-vessel-despite-warnings/</link><pubDate>Mon, 24 Mar 2025 20:20:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/fda-approved-artificial-blood-vessel-despite-warnings/</guid></item><item><title><![CDATA[FDA-Approved Artificial Blood Vessel Stirs Concerns]]></title><description><![CDATA[The F.D.A. approved an artificial vessel to restore blood flow in patients, despite its own scientists flagging questionable study results and potentially fatal ruptures of the product.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/fda-approved-artificial-blood-vessel-stirs-concerns/</link><pubDate>Mon, 24 Mar 2025 19:42:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/fda-approved-artificial-blood-vessel-stirs-concerns/</guid></item><item><title><![CDATA[Non-viable embryos created with synthetic DNA]]></title><description><![CDATA[It is plausible that in the future synthetic DNA (synDNA) technology could enable the creation of non-viable embryos for research, potentially bypassing ethical objections to embryo experimentation. This article explores how the technology might work, the ethical concerns it might mitigate, and the challenges that remain.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/non-viable-embryos-created-with-synthetic-dna/</link><pubDate>Mon, 24 Mar 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/non-viable-embryos-created-with-synthetic-dna/</guid></item><item><title><![CDATA[Unlocking the potential of stem-cell-derived ‘synthetic’ embryo models]]></title><description><![CDATA[Stem-cell-derived ‘synthetic’ embryo models represent a revolutionary avenue in developmental biology, offering unprecedented insights into embryogenesis and tissue formation. However, the majority of current research on embryo models resides predominantly in the engineering construction phase, with limited substantive applications. This review explores the utilization of these embryo models and their applications in deciphering fundamental developmental processes. We delve into the methodol]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/unlocking-the-potential-of-stem-cell-derived-synthetic-embryo-models/</link><pubDate>Sat, 15 Mar 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/unlocking-the-potential-of-stem-cell-derived-synthetic-embryo-models/</guid></item><item><title><![CDATA[Why Are States Banning Lab-Grown Meat?]]></title><description><![CDATA[Mississippi became the third state to ban cell-derived meat, a product not for sale in the United States. But not all livestock producers are opposed to cultivated protein.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/why-are-states-banning-lab-grown-meat/</link><pubDate>Fri, 14 Mar 2025 17:59:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/why-are-states-banning-lab-grown-meat/</guid></item><item><title><![CDATA[Who’s Afraid of Lab-Grown Meat?]]></title><description><![CDATA[Mississippi became the third state to ban cell-derived meat, a product not for sale in the United States. But not all livestock producers are opposed to cultivated protein.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/whos-afraid-of-lab-grown-meat/</link><pubDate>Fri, 14 Mar 2025 17:59:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/whos-afraid-of-lab-grown-meat/</guid></item><item><title><![CDATA[From academia to real-life biotech: ‘It takes a village’]]></title><description><![CDATA[Here, we describe a workshop that analyzed synthetic biology at the academia–industry interface. We discuss how research can mature into successful biotech ventures and the infrastructure to support the transfer. We conclude that ‘it takes a village’: all components are necessary and must collaborate to grow academic ideas into real-life technologies.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/from-academia-to-real-life-biotech-it-takes-a-village/</link><pubDate>Fri, 14 Mar 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/from-academia-to-real-life-biotech-it-takes-a-village/</guid></item><item><title><![CDATA[Streamlined and efficient genome editing in Cupriavidus necator H16 using an optimised SIBR-Cas system]]></title><description><![CDATA[This study developed two simple, efficient, and rapid genome editing tools termed Self-splicing Intron-Based Riboswitch-Cas9 (SIBR-Cas9) and SIBR2.0-Cas12a, for editing the genome of the industrially relevant microbial strain Cupriavidus necator H16. SIBR2.0 can additionally be used to control the expression of virtually any gene in mesophilic prokaryotes.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/streamlined-and-efficient-genome-editing-in-cupriavidus-necator-h16-using-an-optimised-sibr-cas-system/</link><pubDate>Thu, 13 Mar 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/streamlined-and-efficient-genome-editing-in-cupriavidus-necator-h16-using-an-optimised-sibr-cas-system/</guid></item><item><title><![CDATA[Light-induced programmable solid–liquid phase transition of biomolecular condensates for improved biosynthesis]]></title><description><![CDATA[A phase regulator, comprising the light-induced expression of a protease and its recognition sequence within intrinsically disordered proteins, was constructed to control the phase transition of biomolecular condensates. This regulator can maintain the fluidity of condensates throughout the biosynthesis process and program the solid–liquid phase transition.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/light-induced-programmable-solidliquid-phase-transition-of-biomolecular-condensates-for-improved-biosynthesis/</link><pubDate>Wed, 12 Mar 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/light-induced-programmable-solidliquid-phase-transition-of-biomolecular-condensates-for-improved-biosynthesis/</guid></item><item><title><![CDATA[SubtiToolKit: a bioengineering kit for Bacillus subtilis and Gram-positive bacteria]]></title><description><![CDATA[The SubtiToolKit (STK) is a high-efficiency Golden Gate (GG) cloning toolkit for Bacillus subtilis and Gram-positive bacteria. It contains pilot libraries of characterized parts, genetic devices for species-specific gene expression control, and a GeoBox with characterized plasmids and parts for Geobacillus spp., broadening synthetic biology applications across Gram-positive bacteria.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/subtitoolkit-a-bioengineering-kit-for-bacillus-subtilis-and-gram-positive-bacteria/</link><pubDate>Tue, 11 Mar 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/subtitoolkit-a-bioengineering-kit-for-bacillus-subtilis-and-gram-positive-bacteria/</guid></item><item><title><![CDATA[OMEGA-guided DNA polymerases enable random mutagenesis in a tunable window]]></title><description><![CDATA[Obligate mobile element guided activity (OMEGA)-R represents a significant progress in targeted gene random mutagenesis, integrating SpyCatcher-enIscB and PolI3M-TBD-SpyTag to streamline the generation of mutant libraries for genes of interest. This system is designed to seamlessly combine with downstream high-throughput screening technologies, thereby significantly accelerating the processes involved in directed evolution.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/omega-guided-dna-polymerases-enable-random-mutagenesis-in-a-tunable-window/</link><pubDate>Tue, 11 Mar 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/omega-guided-dna-polymerases-enable-random-mutagenesis-in-a-tunable-window/</guid></item><item><title><![CDATA[Inducible regulating homologous recombination enables precise genome editing in Pichia pastoris without perturbing cellular fitness]]></title><description><![CDATA[An anhydrotetracycline (aTc) inducible system was developed to dynamically overexpress homologous recombination-related genes for precise genome engineering in Pichia pastoris. By using this dynamic regulation system, the positive rate of precise gene editing reached 80%, without interrupting cellular growth or fatty alcohol production.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/inducible-regulating-homologous-recombination-enables-precise-genome-editing-in-pichia-pastoris-without-perturbing-cellular-fitness/</link><pubDate>Tue, 11 Mar 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/inducible-regulating-homologous-recombination-enables-precise-genome-editing-in-pichia-pastoris-without-perturbing-cellular-fitness/</guid></item><item><title><![CDATA[Engineering biological curvatures]]></title><description><![CDATA[The curvatures within the human body have essential functions, but their fabrication remains relatively unexplored. We re-emphasize the importance of curvatures in native biological tissues, present technologies to fabricate biomimetic curvatures, and discuss the challenges of integrating curvatures into biomanufacturing. Finally, we recommend how to incorporate curvatures into engineered tissues.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/engineering-biological-curvatures/</link><pubDate>Mon, 10 Mar 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/engineering-biological-curvatures/</guid></item><item><title><![CDATA[Protein-based molecular imprinting: gelatin nanotraps for interleukin-6 sequestration in inflammation cell models]]></title><description><![CDATA[Gelatin methacryloyl (GelMA) was harnessed to create nanotraps via molecular imprinting that were specifically designed to scavenge interleukin-6 (IL-6) in inflammation models. This innovative approach leverages safe and biocompatible protein-based biomaterials, paving the way for a novel class of therapeutic solutions with significant clinical potential.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/protein-based-molecular-imprinting-gelatin-nanotraps-for-interleukin-6-sequestration-in-inflammation-cell-models/</link><pubDate>Thu, 06 Mar 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/protein-based-molecular-imprinting-gelatin-nanotraps-for-interleukin-6-sequestration-in-inflammation-cell-models/</guid></item><item><title><![CDATA[Large language model for knowledge synthesis and AI-enhanced biomanufacturing]]></title><description><![CDATA[Large language models (LLMs) are transforming synthetic biology (SynBio) education and research. In this review we cover the advancements and potential impacts of LLMs in biomanufacturing. First, we summarize recent developments and compare the capabilities of US and Chinese models in addressing fundamental SynBio challenges. Second, we discuss the application of LLMs in extracting SynBio information from unstructured data, constructing knowledge graphs, and enabling retrieval-augmented generati]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/large-language-model-for-knowledge-synthesis-and-ai-enhanced-biomanufacturing/</link><pubDate>Wed, 05 Mar 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/large-language-model-for-knowledge-synthesis-and-ai-enhanced-biomanufacturing/</guid></item><item><title><![CDATA[Advances in induced anhydrobiosis for cell and gamete storage]]></title><description><![CDATA[It will appear strange to most readers, but lyophilization of spermatozoa was described by Chris Polge’s first article that demonstrated the viability of spermatozoa stored in liquid nitrogen (LN2). Since then, cryopreservation has become the only biobanking choice. The demonstration that lyophilized spermatozoa remain fertile has rekindled interest in noncryogenic biobanking. This perspective has recently been embraced by engineers, physicists, and anhydrobiotic physiologists, and their syner]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/advances-in-induced-anhydrobiosis-for-cell-and-gamete-storage/</link><pubDate>Wed, 05 Mar 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/advances-in-induced-anhydrobiosis-for-cell-and-gamete-storage/</guid></item><item><title><![CDATA[CarveAdornCurate: a versatile cloud-based platform for constructing multiscale metabolic models]]></title><description><![CDATA[We report a cloud-based platform called CarveAdornCurate (CAC) for constructing multiscale metabolic models without requiring high-quality metabolic networks as input. Accessible via a web browser, it enables remote access and integrates thermodynamics and enzyme costs for bottleneck analysis. The platform also guides the curation of existing models and is available online at www.carveadorncurate.com.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/carveadorncurate-a-versatile-cloud-based-platform-for-constructing-multiscale-metabolic-models/</link><pubDate>Tue, 04 Mar 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/carveadorncurate-a-versatile-cloud-based-platform-for-constructing-multiscale-metabolic-models/</guid></item><item><title><![CDATA[Risk-appropriate, science-based innovation regulations are important]]></title><description><![CDATA[Inappropriate and often politicized regulations in many countries have limited the global benefits of agricultural biotechnology. The Cartagena Protocol on Biosafety (CPB) has proven to be one of the biggest barriers to biotechnological innovations, especially for food-insecure countries. The global movement of international agreements, such as the CPB, Convention on Biological Diversity, and Global Biodiversity Framework, contribute to the erosion of evidence-based regulation, enabling the deve]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/risk-appropriate-science-based-innovation-regulations-are-important/</link><pubDate>Wed, 26 Feb 2025 16:39:40 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/risk-appropriate-science-based-innovation-regulations-are-important/</guid></item><item><title><![CDATA[Regulation of animal and plant agricultural biotechnology]]></title><description><![CDATA[Fifty years ago, scientists developed a regulatory framework for the safe use of recombinant DNA that focused on potential biosafety risks associated with the products of genetic engineering (GE). This morphed into an expensive and lengthy premarket risk assessment requirement for GE agricultural biotechnology products triggered solely by the fact that modern molecular technologies were involved in the development of those products. This has limited the commercialization of GE crop products prim]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/regulation-of-animal-and-plant-agricultural-biotechnology/</link><pubDate>Wed, 26 Feb 2025 16:39:40 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/regulation-of-animal-and-plant-agricultural-biotechnology/</guid></item><item><title><![CDATA[Recombinant DNA: unlocking untapped microbial potential for innovation in crop agriculture]]></title><description><![CDATA[The Asilomar Conference on Recombinant DNA, held in 1975, established guidelines for recombinant DNA (rDNA) research and laid the foundation for biotechnology regulations. While rDNA has driven significant advancements in pharmaceutical and crop biotechnology, the commercialization of plant-beneficial microbials developed using rDNA has lagged behind. This disparity may be attributed to a cumbersome regulatory framework shaped by the perception that rDNA products pose biosafety risks. To unlock]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/recombinant-dna-unlocking-untapped-microbial-potential-for-innovation-in-crop-agriculture/</link><pubDate>Wed, 26 Feb 2025 16:39:40 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/recombinant-dna-unlocking-untapped-microbial-potential-for-innovation-in-crop-agriculture/</guid></item><item><title><![CDATA[Innovation and biotechnology: 50 years after Asilomar]]></title><description><![CDATA[It was 50 years ago that the pioneers of modern biotechnology gathered in Asilomar, California to collectively discuss and share knowledge about the emerging technology that has become known as genetic modification. Bringing together the brightest and best minds that had been undertaking recombinant DNA experiments over the previous 2 to 3 years allowed the resulting guidelines that were developed for future experiments to be based on the most accurate and up-to-date science as was possible. The]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/innovation-and-biotechnology-50-years-after-asilomar/</link><pubDate>Wed, 26 Feb 2025 16:39:40 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/innovation-and-biotechnology-50-years-after-asilomar/</guid></item><item><title><![CDATA[Human health and genetic technology]]></title><description><![CDATA[The 1975 Asilomar conference contributed to the misperception that recombinant DNA (rDNA) technology is inherently risky to human health and the environment. It thus paved the way toward process-based regulation of genetically modified organisms (GMOs), such as in the EU. Initially, this regulatory approach obstructed technological uses of rDNA related to human health. However, regulators gradually softened the rules applicable to laboratories or industrial facilities. This encouraged R&amp;D an]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/human-health-and-genetic-technology/</link><pubDate>Wed, 26 Feb 2025 16:39:40 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/human-health-and-genetic-technology/</guid></item><item><title><![CDATA[Navigating B2B and B2C business models in biotechnology]]></title><description><![CDATA[Commercialising biotechnology innovations relies on selecting an appropriate business model. This article explores the nuances of the business-to-business and business-to-consumer pathways, highlighting key considerations for selecting the best model. It aims to provide entrepreneurs and stakeholders with actionable insights for navigating the biotech industry’s dynamic landscape.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/navigating-b2b-and-b2c-business-models-in-biotechnology/</link><pubDate>Fri, 21 Feb 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/navigating-b2b-and-b2c-business-models-in-biotechnology/</guid></item><item><title><![CDATA[Framing synthetic biology as an innovation-driven market]]></title><description><![CDATA[Synthetic biology can create knowledge and tools that enable products with attributes that fit into a sustainable bioeconomy. The specialised synthetic biology market is often conflated with the broader enabled products market. Here, we propose a framework of the synthetic biology market for a common understanding of its commercial potential.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/framing-synthetic-biology-as-an-innovation-driven-market/</link><pubDate>Thu, 20 Feb 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/framing-synthetic-biology-as-an-innovation-driven-market/</guid></item><item><title><![CDATA[Art–science collaborations in biotechnology research: a transdisciplinary approach]]></title><description><![CDATA[While funding agencies promote transdisciplinary approaches, significant barriers persist. Successful transdisciplinary research (TDR) demands embracing different ways of knowing, addressing power imbalances, and accepting slower, more complex research processes. Drawing from the experience with BactoHealing, the authors demonstrate how genuine transdisciplinarity requires courage, trust, and institutional support to challenge traditional frameworks.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/artscience-collaborations-in-biotechnology-research-a-transdisciplinary-approach/</link><pubDate>Thu, 20 Feb 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/artscience-collaborations-in-biotechnology-research-a-transdisciplinary-approach/</guid></item><item><title><![CDATA[Bioconversion yields must account for all carbon: hidden biases from complex media]]></title><description><![CDATA[Yield ratio is a critical parameter for quantifying bioprocess conversion efficiency. However, unquantified carbon in complex media formulations complicates yield calculations. We highlight the biases introduced by improperly neglecting all carbon-containing molecules. We recommend that yields be reported by accounting for all carbon and that media formulations are always stated.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/bioconversion-yields-must-account-for-all-carbon-hidden-biases-from-complex-media/</link><pubDate>Mon, 17 Feb 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/bioconversion-yields-must-account-for-all-carbon-hidden-biases-from-complex-media/</guid></item><item><title><![CDATA[Dynamic anaerobic digestion-based biorefineries for on-demand renewable energy and bioproducts in a circular bioeconomy]]></title><description><![CDATA[This study proposes a dynamic biorefinery model using anaerobic digestion to convert grass into bioproducts and bioenergy. A demand-driven operational strategy lets the biorefinery adapt outputs to changing market conditions. While currently unprofitable, the study supports anaerobic digestion-based biorefining in diversifying farm incomes and transitioning from fossil resources.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/dynamic-anaerobic-digestion-based-biorefineries-for-on-demand-renewable-energy-and-bioproducts-in-a-circular-bioeconomy/</link><pubDate>Fri, 14 Feb 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/dynamic-anaerobic-digestion-based-biorefineries-for-on-demand-renewable-energy-and-bioproducts-in-a-circular-bioeconomy/</guid></item><item><title><![CDATA[CRISPR/Cas9 editing of p-COUMAROYL-CoA:MONOLIGNOL TRANSFERASE 1 in maize alters phenolic metabolism, lignin structure, and lignin-first biomass processing]]></title><description><![CDATA[CRISPR/Cas9 editing of a single key gene in lignin biosynthesis in maize, p-COUMAROYL-CoA:MONOLIGNOL TRANSFERASE 1 (ZmPMT1), eliminates lignin p-coumaroylation and enhances guaiacyl lignin, enabling lignin-first biorefining for bio-based polyurethane precursors. This dual-purposed crop approach provides a sustainable feedstock for renewable chemicals in addition to food or feed production.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/crisprcas9-editing-of-p-coumaroyl-coamonolignol-transferase-1-in-maize-alters-phenolic-metabolism-lignin-structure-and-lignin-first-biomass-processing/</link><pubDate>Fri, 14 Feb 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/crisprcas9-editing-of-p-coumaroyl-coamonolignol-transferase-1-in-maize-alters-phenolic-metabolism-lignin-structure-and-lignin-first-biomass-processing/</guid></item><item><title><![CDATA[An epigenetic regulator synergizes with alphavirus-mediated gene therapy via biomimetic delivery for enhanced cancer therapy]]></title><description><![CDATA[We developed a biomimetic liposome gene delivery technology to integrate an epigenetic regulator, p53, and immune checkpoint modulation for enhancing tumor therapeutic effect. This opens new possibilities to the synergistic delivery of gene drugs in conjunction with epigenetic therapy strategies to treat both genetic diseases and cancer.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/an-epigenetic-regulator-synergizes-with-alphavirus-mediated-gene-therapy-via-biomimetic-delivery-for-enhanced-cancer-therapy/</link><pubDate>Fri, 14 Feb 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/an-epigenetic-regulator-synergizes-with-alphavirus-mediated-gene-therapy-via-biomimetic-delivery-for-enhanced-cancer-therapy/</guid></item><item><title><![CDATA[Advancing plant gene activation with CRISPR-Act3.0]]></title><description><![CDATA[The pioneering plant genome-engineering tool CRISPR-Act3.0 is promising for precise gene activation, but faces challenges, such as unstable structures and inconsistent gene activation in polyploid genomes. Here, we propose strategic modifications to render CRISPR-Act3.0 more resilient and adaptable, especially in complex plant genomes, where conventional methods have struggled.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/advancing-plant-gene-activation-with-crispr-act30/</link><pubDate>Wed, 12 Feb 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/advancing-plant-gene-activation-with-crispr-act30/</guid></item><item><title><![CDATA[dsRNAEngineer: a web-based tool of comprehensive dsRNA design for pest control]]></title><description><![CDATA[dsRNAEngineer incorporates hundreds of pest and non-pest transcriptomes to provide comprehensive dsRNA design for pest control. With the application of several RNA-based pesticides in the field, dsRNAEngineer illustrates a framework for designing pest-specific and biosafe dsRNA, which will greatly promote the development of RNAi biotechnology as a pest control strategy.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/dsrnaengineer-a-web-based-tool-of-comprehensive-dsrna-design-for-pest-control/</link><pubDate>Sat, 08 Feb 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/dsrnaengineer-a-web-based-tool-of-comprehensive-dsrna-design-for-pest-control/</guid></item><item><title><![CDATA[C1 photochemotrophy – rethinking one-carbon metabolism in phototrophs]]></title><description><![CDATA[Excessive CO2 emissions, caused by an imbalance between carbon oxidation and reduction, drive climate change. To address this, we propose photochemotrophic metabolism as an alternative to both canonical photosynthesis and synthetic one-carbon (C1) metabolism in heterotrophs. In photochemotrophy, naturally phototrophic microorganisms such as cyanobacteria serve as the chassis to assimilate chemically reduced and soluble C1 compounds such as formate or methanol by using carbon fixation cycles that]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/c1-photochemotrophy-rethinking-one-carbon-metabolism-in-phototrophs/</link><pubDate>Sat, 08 Feb 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/c1-photochemotrophy-rethinking-one-carbon-metabolism-in-phototrophs/</guid></item><item><title><![CDATA[Biotechnology research security: challenges in Latin America]]></title><description><![CDATA[Biotechnology research presents significant security challenges in Latin America. Protecting intellectual property, managing risk associated with dual-use technologies, and upholding research integrity and ethics are particularly challenging in emerging countries due to resource constraints, political instability, and regulatory shortcomings. Regional efforts are needed to foster secure research environments.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/biotechnology-research-security-challenges-in-latin-america/</link><pubDate>Tue, 04 Feb 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/biotechnology-research-security-challenges-in-latin-america/</guid></item><item><title><![CDATA[Artificial intelligence in biomaterials: a call for unified biocompatibility standards]]></title><description><![CDATA[A standardized definition of biocompatibility is essential for advancing biomaterials research. This letter emphasizes the need for clear guidelines and interdisciplinary frameworks in assessing biocompatibility, with artificial intelligence (AI) playing a pivotal role. Such an approach will facilitate research efforts and strengthen regulatory processes to develop next-generation biomaterials.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/artificial-intelligence-in-biomaterials-a-call-for-unified-biocompatibility-standards/</link><pubDate>Sat, 01 Feb 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/artificial-intelligence-in-biomaterials-a-call-for-unified-biocompatibility-standards/</guid></item><item><title><![CDATA[A forward-thinking biocompatibility assessment: drafting future considerations now]]></title><description><![CDATA[Prompted by the recently proposed conceptual redefinition of biocompatibility for machine learning (ML) and data-mining applications in biomaterials research [1], a tiered framework is proposed [2] incorporating clinical considerations to promote a standardized yet adaptable approach. Such a framework could facilitate the integration of biocompatibility data into ML algorithms, supporting predictive insights and biomaterial design [3,4]. However, further specificity in necessary to enhance clari]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/a-forward-thinking-biocompatibility-assessment-drafting-future-considerations-now/</link><pubDate>Sat, 01 Feb 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/a-forward-thinking-biocompatibility-assessment-drafting-future-considerations-now/</guid></item><item><title><![CDATA[Flow fermentation: microsystems for whole-cell bioproduction processes]]></title><description><![CDATA[Industrial biotechnology utilizes whole cells for the production of value-added goods in large-scale bioreactors. The miniaturization of bioreactors has greatly contributed to the understanding and optimization of bioprocesses. However, microsystems for the production of value-added goods have thus far only been established in chemistry and biocatalysis/biotransformation but are rarely applied for whole-cell bioprocesses. Here, we discuss the fundamental and translational aspects of how microsys]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/flow-fermentation-microsystems-for-whole-cell-bioproduction-processes/</link><pubDate>Thu, 30 Jan 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/flow-fermentation-microsystems-for-whole-cell-bioproduction-processes/</guid></item><item><title><![CDATA[Platelet extracellular vesicles-loaded hydrogel bandages for personalized wound care]]></title><description><![CDATA[Autologous or allogeneic platelet-derived extracellular vesicles (pEVs) show potential in enhancing tissue recovery and healing chronic wounds. pEVs promote neovascularization and cell migration while reducing inflammation, oxidative stress, and scarring. However, their efficacy in clinical settings is challenged by their susceptibility to washout by wound exudate. Hydrogel-based bandages are effective carriers that stabilize pEVs for optimal personalized wound care. These bandages can be tailor]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/platelet-extracellular-vesicles-loaded-hydrogel-bandages-for-personalized-wound-care/</link><pubDate>Fri, 24 Jan 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/platelet-extracellular-vesicles-loaded-hydrogel-bandages-for-personalized-wound-care/</guid></item><item><title><![CDATA[Understanding bacterial ecology to combat antibiotic resistance dissemination]]></title><description><![CDATA[The dissemination of antibiotic resistance from environmental sources is a growing concern. Despite the widespread occurrence of antibiotic resistance transmission events, there are actually multiple obstacles in the ecosystem that restrict the flow of bacteria and genes, in particular nonnegligible biological barriers. How these ecological factors help combat the dissemination of antibiotic resistance and relevant antibiotic resistance-diminishing organisms (ARDOs) deserves further exploration.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/understanding-bacterial-ecology-to-combat-antibiotic-resistance-dissemination/</link><pubDate>Thu, 23 Jan 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/understanding-bacterial-ecology-to-combat-antibiotic-resistance-dissemination/</guid></item><item><title><![CDATA[Distillation for in situ recovery of volatile fermentation products]]></title><description><![CDATA[Many fermentation products inhibit their own microbial production, which complicates industrial-scale fermentation development for these products. When a product is volatile, this inhibition can be circumvented by removing product during fermentation through evaporation in a loop around the bioreactor. Microbes can survive this loop if its temperature is reduced using vacuum. Then, regrowing of microbes is not required. From a separation efficiency viewpoint, the evaporation loop should not use]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/distillation-for-in-situ-recovery-of-volatile-fermentation-products/</link><pubDate>Thu, 23 Jan 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/distillation-for-in-situ-recovery-of-volatile-fermentation-products/</guid></item><item><title><![CDATA[Automated adjustment of metabolic niches enables the control of natural and engineered microbial co-cultures]]></title><description><![CDATA[The study introduces ‘automated adjustment of metabolic niches’ (AAMN), a feedback control method using substrate pulsing to stabilize co-cultures. AAMN enables control by promoting organism diversification to alternative metabolic niches. AAMN was proven effective during continuous bioproduction of p-coumaric acid, resulting in novel insights into microbial interactions within bioprocessing applications.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/automated-adjustment-of-metabolic-niches-enables-the-control-of-natural-and-engineered-microbial-co-cultures/</link><pubDate>Thu, 23 Jan 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/automated-adjustment-of-metabolic-niches-enables-the-control-of-natural-and-engineered-microbial-co-cultures/</guid></item><item><title><![CDATA[What Luxury Longevity Clinics Really Offer]]></title><description><![CDATA[People are paying thousands for exhaustive medical tests and treatments like plasma exchange and peptide therapy. How much does it benefit them?]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/what-luxury-longevity-clinics-really-offer/</link><pubDate>Wed, 22 Jan 2025 11:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/what-luxury-longevity-clinics-really-offer/</guid></item><item><title><![CDATA[High-throughput screening strategies for plastic-depolymerizing enzymes]]></title><description><![CDATA[A multitude of plastic-depolymerizing microorganisms and enzymes have been discovered in the plastisphere. Identifying and engineering such microbial strains and enzymes necessitate robust and high-throughput screening strategies for developing effective microbial solutions to counter the plastic accumulation problem and decouple the reliance on fossil resources. This review covers new methods and approaches for the effective high-throughput screening of depolymerizing enzymes for various plasti]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/high-throughput-screening-strategies-for-plastic-depolymerizing-enzymes/</link><pubDate>Tue, 21 Jan 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/high-throughput-screening-strategies-for-plastic-depolymerizing-enzymes/</guid></item><item><title><![CDATA[Ramaswamy Has a High-Profile Perch and a Raft of Potential Conflicts]]></title><description><![CDATA[Vivek Ramaswamy, Elon Musk&rsquo;s partner in an effort to cut government costs, could make decisions that ultimately make him and his investors richer.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/ramaswamy-has-a-high-profile-perch-and-a-raft-of-potential-conflicts/</link><pubDate>Wed, 15 Jan 2025 23:04:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/ramaswamy-has-a-high-profile-perch-and-a-raft-of-potential-conflicts/</guid></item><item><title><![CDATA[Using synthetic biology to express nitrogenase biosynthesis pathway in rice and to overcome barriers of nitrogenase instability in plant cytosol]]></title><description><![CDATA[We present the multigene assembly and introduction system for introducing a reconstituted nitrogenase biosynthesis pathway into rice. This approach provides significant potential for applications in introducing multiple genes into plants. Also, we provide an efficient way for identifying and overcoming instability of NifH and other prokaryotic proteins in plant cytosol.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/using-synthetic-biology-to-express-nitrogenase-biosynthesis-pathway-in-rice-and-to-overcome-barriers-of-nitrogenase-instability-in-plant-cytosol/</link><pubDate>Wed, 15 Jan 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/using-synthetic-biology-to-express-nitrogenase-biosynthesis-pathway-in-rice-and-to-overcome-barriers-of-nitrogenase-instability-in-plant-cytosol/</guid></item><item><title><![CDATA[Non-conventional yeasts: promising cell factories for organic acid bioproduction]]></title><description><![CDATA[Microbial production of organic acids has been hindered by the poor acid tolerance of microorganisms and the high costs of waste salt reprocessing. The robustness of non-conventional microorganisms in an acidic environment makes it possible to produce organic acids at low pH and greatly simplifies downstream processing. In this review we discuss the environmental adaptability features of non-conventional yeasts, as well as the latest developments in genomic engineering strategies that have facil]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/non-conventional-yeasts-promising-cell-factories-for-organic-acid-bioproduction/</link><pubDate>Fri, 10 Jan 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/non-conventional-yeasts-promising-cell-factories-for-organic-acid-bioproduction/</guid></item><item><title><![CDATA[Acetogenesis to ethanologenesis: facilitating NADH oxidation via reductive acetate uptake]]></title><description><![CDATA[Acetate is not always an end product in acetogenesis. This study identified butyrate production with acetate uptake, a finding that led to the development of a strain for ethanol production with complete acetate uptake. The shift from acetogenesis to ethanologenesis could reduce operating costs in downstream processed for commercial synthetic gas (syngas) fermentation.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/acetogenesis-to-ethanologenesis-facilitating-nadh-oxidation-via-reductive-acetate-uptake/</link><pubDate>Thu, 09 Jan 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/acetogenesis-to-ethanologenesis-facilitating-nadh-oxidation-via-reductive-acetate-uptake/</guid></item><item><title><![CDATA[Absolute quantification of cell-free DNA for prenatal genetics and oncology]]></title><description><![CDATA[Circulating cell-free DNA (cfDNA) are short, extracellular DNA fragments (&lt;200bp) that are found in body fluids such as blood, urine, and cerebral spinal fluid. cfDNA in blood primarily originates from apoptosis and has a short half-life of ~1–2 h. Thus, the concentration of cfDNA provides a real-time snapshot of cellular turnover due to diverse physiological and pathological processes. The accessibility of blood as a specimen type is also attractive for clinical translation as a convenient]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/absolute-quantification-of-cell-free-dna-for-prenatal-genetics-and-oncology/</link><pubDate>Thu, 09 Jan 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/absolute-quantification-of-cell-free-dna-for-prenatal-genetics-and-oncology/</guid></item><item><title><![CDATA[Programmable embedded bioprinting for one-step manufacturing of arterial models with customized contractile and metabolic functions]]></title><description><![CDATA[This work introduces a new method, voxel-based embedded construction for tailored orientational replication (‘VECTOR’), that can achieve macro-level circumferential orientation and micro-level cellular alignment. It can be used to fabricate in vitro arterial models with enhanced contractile and metabolic functions. Our study highlights the crucial role of anatomical structural similarity in replicating tissue function.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/programmable-embedded-bioprinting-for-one-step-manufacturing-of-arterial-models-with-customized-contractile-and-metabolic-functions/</link><pubDate>Tue, 07 Jan 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/programmable-embedded-bioprinting-for-one-step-manufacturing-of-arterial-models-with-customized-contractile-and-metabolic-functions/</guid></item><item><title><![CDATA[Bacterial proteome microarray technology in biomedical research]]></title><description><![CDATA[Bacterial proteome microarrays are high-throughput, adaptable tools that allow the simultaneous investigation of thousands of proteins from various bacterial species. These arrays are used to explore bacterial pathogenicity, pathogen–host interactions, and clinical diseases. Recent advancements have expanded their application to profiling human antibodies, identifying biomarkers for infectious and autoimmune diseases, and studying antimicrobial peptides (AMPs). This review highlights significa]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/bacterial-proteome-microarray-technology-in-biomedical-research/</link><pubDate>Fri, 03 Jan 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/bacterial-proteome-microarray-technology-in-biomedical-research/</guid></item><item><title><![CDATA[Vascularized human brain organoids: current possibilities and prospects]]></title><description><![CDATA[Human brain organoids (hBOs) are in vitro, 3D, self-organizing brain tissue structures increasingly used for modeling brain development and disease. Although they traditionally lack vasculature, recent bioengineering developments enable their vascularization, which partly recapitulates neurodevelopmental processes such as neural tube angiogenesis, formation of neurovascular unit (NVU)-like structures, and early barriergenesis. Although vascularized hBOs (vhBOs) are already used to model (defects]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/vascularized-human-brain-organoids-current-possibilities-and-prospects/</link><pubDate>Thu, 02 Jan 2025 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/vascularized-human-brain-organoids-current-possibilities-and-prospects/</guid></item><item><title><![CDATA[Renal-clearable probes for disease detection and monitoring]]></title><description><![CDATA[The demand for novel, minimally invasive, cost-effective, and easily readable diagnostic tools, primarily designed for the longitudinal monitoring of diseases and their treatments, has promoted the development of diagnostic systems that selectively target cells, tissues, or organs, at the same time minimizing their nonspecific accumulation, thus reducing the risk of toxicity and side effects. In this review, we explore the development of renal-clearable systems in non-invasive or minimally invas]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/renal-clearable-probes-for-disease-detection-and-monitoring/</link><pubDate>Mon, 30 Dec 2024 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/renal-clearable-probes-for-disease-detection-and-monitoring/</guid></item><item><title><![CDATA[Engineering immunity using metabolically active polymeric nanoparticles]]></title><description><![CDATA[Immune system functions play crucial roles in both health and disease, and these functions are regulated by their metabolic programming. The field of immune engineering has emerged to develop therapeutic strategies, including polymeric nanoparticles (NPs), that can direct immune cell phenotype and function by directing immunometabolic changes. Precise control of bioenergetic processes may offer the opportunity to prevent undesired immune activity and improve disease-specific outcomes. In this re]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/engineering-immunity-using-metabolically-active-polymeric-nanoparticles/</link><pubDate>Fri, 27 Dec 2024 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/engineering-immunity-using-metabolically-active-polymeric-nanoparticles/</guid></item><item><title><![CDATA[Programmable ultrasound-mediated swarms manipulation of bacteria–red blood cell microrobots for tumor-specific thrombosis and robust photothermal therapy]]></title><description><![CDATA[We report the development of dual-engine microrobots constructed from photosynthetic bacteria and red blood cells to actively target tumors and traverse tissue obstacles for deep penetration under ultrasound actuation. Programmed ultrasound-mediated bioswarm actuation specifically induced tumor-specific thrombosis, synergistically enhancing the antitumor effect of photothermal therapy.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/programmable-ultrasound-mediated-swarms-manipulation-of-bacteriared-blood-cell-microrobots-for-tumor-specific-thrombosis-and-robust-photothermal-therapy/</link><pubDate>Fri, 20 Dec 2024 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/programmable-ultrasound-mediated-swarms-manipulation-of-bacteriared-blood-cell-microrobots-for-tumor-specific-thrombosis-and-robust-photothermal-therapy/</guid></item><item><title><![CDATA[Reprogramming of Treg cell-derived small extracellular vesicles effectively prevents intestinal inflammation from PANoptosis by blocking mitochondrial oxidative stress]]></title><description><![CDATA[This study presents an exosome-derived loaded delivery system targeting mitochondria for maintaining intestinal homeostasis. This actively targetable drug delivery carrier showed protective effects against intestinal inflammation via scavenging excessive reactive oxygen species. Our strategy is a promising foundation for treating inflammatory bowel diseases.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/reprogramming-of-treg-cell-derived-small-extracellular-vesicles-effectively-prevents-intestinal-inflammation-from-panoptosis-by-blocking-mitochondrial-oxidative-stress/</link><pubDate>Mon, 16 Dec 2024 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/reprogramming-of-treg-cell-derived-small-extracellular-vesicles-effectively-prevents-intestinal-inflammation-from-panoptosis-by-blocking-mitochondrial-oxidative-stress/</guid></item><item><title><![CDATA[High-throughput optimisation of protein secretion in yeast via an engineered biosensor]]></title><description><![CDATA[We have developed a fast and simple way to optimise the secretion of different proteins from yeast using a biosensor. This technology can quickly screen thousands of different genetic combinations to find the best secretion signal peptide sequence. This is important because secreting proteins outside the cell is essential for the industrial production of high-value proteins.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/high-throughput-optimisation-of-protein-secretion-in-yeast-via-an-engineered-biosensor/</link><pubDate>Fri, 13 Dec 2024 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/high-throughput-optimisation-of-protein-secretion-in-yeast-via-an-engineered-biosensor/</guid></item><item><title><![CDATA[Advanced strategies for enzyme–electrode interfacing in bioelectrocatalytic systems]]></title><description><![CDATA[Advances in protein engineering-enabled enzyme immobilization technologies have significantly improved enzyme–electrode wiring in enzymatic electrochemical systems, which harness natural biological machinery to either generate electricity or synthesize biochemicals. In this review, we provide guidelines for designing enzyme–electrodes, focusing on how performance variables change depending on electron transfer (ET) mechanisms. Recent advancements in enzyme immobilization technologies are sum]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/advanced-strategies-for-enzymeelectrode-interfacing-in-bioelectrocatalytic-systems/</link><pubDate>Fri, 13 Dec 2024 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/advanced-strategies-for-enzymeelectrode-interfacing-in-bioelectrocatalytic-systems/</guid></item><item><title><![CDATA[Guidelines for selection and application of kinetics models in bioproduction processes]]></title><description><![CDATA[Biotechnology is widely used in bioproduction to transform waste into valuable products. A comprehensive understanding of the kinetics involved is crucial for optimizing system designs. In this review, we explore various kinetics models (e.g., the Gompertz, Logistic, Cone, first-order, Monod, and Andrews models) used in describing bioproduction processes. We focus on their interpretation and applications in microbial growth, bioproduct formation, substrate consumption, and the factors influencin]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/guidelines-for-selection-and-application-of-kinetics-models-in-bioproduction-processes/</link><pubDate>Thu, 12 Dec 2024 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/guidelines-for-selection-and-application-of-kinetics-models-in-bioproduction-processes/</guid></item><item><title><![CDATA[Efficiency and process development for microbial biomass production using oxic bioelectrosynthesis]]></title><description><![CDATA[Oxic microbial electrosynthesis (OMES) using Kyrpidia spormannii can match the electron efficiency of gas fermentation, without producing explosive gas mixtures. It uses solar energy efficiently and has the potential to produce complex products, such as proteins, for food and feed instead of methane and alcohols, which are typical products of anoxic MES.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/efficiency-and-process-development-for-microbial-biomass-production-using-oxic-bioelectrosynthesis/</link><pubDate>Thu, 12 Dec 2024 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/efficiency-and-process-development-for-microbial-biomass-production-using-oxic-bioelectrosynthesis/</guid></item><item><title><![CDATA[Enhancing intestinal absorption of a macromolecule through engineered probiotic yeast in the murine gastrointestinal tract]]></title><description><![CDATA[Oral delivery of therapeutic peptides is limited by poor intestinal absorption. We engineered Saccharomyces boulardii to produce cell-penetrating peptides (CPPs) to increase intestinal permeability. One engineered yeast strain (Sb PN159) notably increased the intestinal permeability of a macromolecule in mice without side effects, offering a novel approach to improve the oral bioavailability of therapeutic peptides.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/enhancing-intestinal-absorption-of-a-macromolecule-through-engineered-probiotic-yeast-in-the-murine-gastrointestinal-tract/</link><pubDate>Mon, 09 Dec 2024 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/enhancing-intestinal-absorption-of-a-macromolecule-through-engineered-probiotic-yeast-in-the-murine-gastrointestinal-tract/</guid></item><item><title><![CDATA[3D-printed microstructured alginate scaffolds for neural tissue engineering]]></title><description><![CDATA[Tetrapod-shaped ZnO (t-ZnO) microparticles create interconnected channels and textured surfaces in 3D-printed microstructured alginate (M-Alg) scaffolds. Primary mouse cortical neurons cultured on the M-Alg scaffolds demonstrate enhanced adhesion and maturation, with extensive 3D neural projections forming, indicating the potential of this scaffold design for advanced neural tissue engineering applications.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/3d-printed-microstructured-alginate-scaffolds-for-neural-tissue-engineering/</link><pubDate>Mon, 09 Dec 2024 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/3d-printed-microstructured-alginate-scaffolds-for-neural-tissue-engineering/</guid></item><item><title><![CDATA[Photocatalytic material–microorganism hybrid systems in water decontamination]]></title><description><![CDATA[Biological processes are widely used technologies for water decontamination, but they are often limited by insufficient bioavailable carbon sources or biorecalcitrant contaminants. The recently developed photocatalytic material–microorganism hybrid (PMH) system combines the light-harvesting capacities of photocatalytic materials with specific enzymatic activities of whole cells, efficiently achieving solar-to-chemical conversion. By integrating the benefits of both photocatalysis and biologica]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/photocatalytic-materialmicroorganism-hybrid-systems-in-water-decontamination/</link><pubDate>Fri, 06 Dec 2024 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/photocatalytic-materialmicroorganism-hybrid-systems-in-water-decontamination/</guid></item><item><title><![CDATA[Stimulus-assisted in situ bioprinting: advancing direct bench-to-bedside delivery]]></title><description><![CDATA[The fabrication of 3D bioconstructs using bioprinters will advance the field of regenerative medicine owing to its ability to facilitate clinical treatments. Additional stimulations have been applied to the bioconstructs to guide cells laden in the bioconstructs. However, the conventional bench-to-bedside delivery based on separate bioprinting and biostimulating processes may increase the risks of contamination and shape discordance owing to the considerably long process involved. In situ biopri]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/stimulus-assisted-in-situ-bioprinting-advancing-direct-bench-to-bedside-delivery/</link><pubDate>Thu, 05 Dec 2024 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/stimulus-assisted-in-situ-bioprinting-advancing-direct-bench-to-bedside-delivery/</guid></item><item><title><![CDATA[Engineering biology approaches to modulate bacterial biofilms]]></title><description><![CDATA[Building on a productive two decades of advancements in synthetic biology, engineering biology now promises to enable the implementation and scale-up of novel biological systems tailored to tackle urgent global challenges. Here we explore the latest engineering biology approaches for the control and modification of bacterial biofilms with exciting new functionalities.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/engineering-biology-approaches-to-modulate-bacterial-biofilms/</link><pubDate>Thu, 05 Dec 2024 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/engineering-biology-approaches-to-modulate-bacterial-biofilms/</guid></item><item><title><![CDATA[Complex waste stream valorization through combined enzymatic hydrolysis and catabolic assimilation by Pseudomonas putida]]></title><description><![CDATA[Pseudomonas putida strains engineered with non-native metabolic capabilities enable the efficient valorization of municipal solid waste-like feedstocks through enzymatic hydrolysis and multicarbon source assimilation. The approach enhances biomanufacturing of polymers and proteins, reducing greenhouse gas emissions by up to 62% while lowering costs, presenting a sustainable waste-to-value pathway.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/complex-waste-stream-valorization-through-combined-enzymatic-hydrolysis-and-catabolic-assimilation-by-pseudomonas-putida/</link><pubDate>Wed, 04 Dec 2024 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/complex-waste-stream-valorization-through-combined-enzymatic-hydrolysis-and-catabolic-assimilation-by-pseudomonas-putida/</guid></item><item><title><![CDATA[The hidden impact of bullying and harassment in biotechnology and biomedical engineering]]></title><description><![CDATA[The adverse effects of academic bullying and harassment, which are longstanding issues within academic environments, on industry sectors have been inadequately addressed. This commentary explores the detrimental impacts of bullying and harassment in the biotech and biomedical engineering industries, including reduced employee morale, increased turnover, impaired collaboration, and hindered innovation.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/the-hidden-impact-of-bullying-and-harassment-in-biotechnology-and-biomedical-engineering/</link><pubDate>Tue, 03 Dec 2024 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/the-hidden-impact-of-bullying-and-harassment-in-biotechnology-and-biomedical-engineering/</guid></item><item><title><![CDATA[Laticifers as in vivo plant cell factories for therapeutic proteins]]></title><description><![CDATA[The demand for therapeutic proteins is growing annually. Novel approaches for the production of these molecules on a large scale are necessary, especially in plants. Plant laticifers could help provide an in vivo cell system for protein production expression that can reduce costs of production and downstream processing.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/laticifers-as-in-vivo-plant-cell-factories-for-therapeutic-proteins/</link><pubDate>Tue, 03 Dec 2024 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/laticifers-as-in-vivo-plant-cell-factories-for-therapeutic-proteins/</guid></item><item><title><![CDATA[Creating novel metabolic pathways by protein engineering for bioproduction]]></title><description><![CDATA[A diverse array of natural products has been produced by cell biofactories through metabolic engineering, in which enzymes play essential roles in the complex metabolic network. However, the scope of such biotransformation can be limited by the capacities of natural enzymes. To broaden their scope, many natural enzymes have recently been engineered to activate non-native substrates and/or to employ new-to-nature reaction mechanisms, but most of these systems are only demonstrated for in vitro ap]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/creating-novel-metabolic-pathways-by-protein-engineering-for-bioproduction/</link><pubDate>Tue, 03 Dec 2024 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/creating-novel-metabolic-pathways-by-protein-engineering-for-bioproduction/</guid></item><item><title><![CDATA[Engineered, environmentally friendly leather-like bio-based materials]]></title><description><![CDATA[Leather is important to the global manufacturing industry, contributing to both the economy and society. However, because of ecological and ethical considerations, alternative bio-based materials to natural leather are now being investigated. Advancements in biotechnology and bio-based materials, combined with flourishing biomanufacturing, have driven product development. In recent years, animal-free, biotechnology-based leather-like material has seen significant growth. Recent progress in leath]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/engineered-environmentally-friendly-leather-like-bio-based-materials/</link><pubDate>Fri, 29 Nov 2024 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/engineered-environmentally-friendly-leather-like-bio-based-materials/</guid></item><item><title><![CDATA[Is Communist China Coming for Your Turkey, Too?]]></title><description><![CDATA[China&rsquo;s push to develop alternative proteins is not a threat to America. It&rsquo;s good for the planet.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/is-communist-china-coming-for-your-turkey-too/</link><pubDate>Thu, 28 Nov 2024 07:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/is-communist-china-coming-for-your-turkey-too/</guid></item><item><title><![CDATA[Drug Companies Face Hostility as They Hope for Allies Among Trump’s Health Picks]]></title><description><![CDATA[Robert F. Kennedy Jr. and other candidates for top health posts are at odds with the drug industry, setting the stage for tense battles over regulatory changes.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/drug-companies-face-hostility-as-they-hope-for-allies-among-trumps-health-picks/</link><pubDate>Wed, 27 Nov 2024 17:30:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/drug-companies-face-hostility-as-they-hope-for-allies-among-trumps-health-picks/</guid></item><item><title><![CDATA[Designing synthetic microbial communities with the capacity to upcycle fermentation byproducts to increase production yields]]></title><description><![CDATA[Biotechnology processes often face reduced production yields due to the presence of byproducts. In this work, we developed a system based on the use of synthetic microbial communities to reduce byproduct formation. This was achieved by creation of an ‘upcycler’ strain that converts byproducts into products of interest.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/designing-synthetic-microbial-communities-with-the-capacity-to-upcycle-fermentation-byproducts-to-increase-production-yields/</link><pubDate>Wed, 27 Nov 2024 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/designing-synthetic-microbial-communities-with-the-capacity-to-upcycle-fermentation-byproducts-to-increase-production-yields/</guid></item><item><title><![CDATA[Plant-inspired building blocks for future plastics]]></title><description><![CDATA[The transition from a linear fossil-based economy to a renewable circular economy requires a new approach to produce building blocks for plastics. This provides opportunities to reshape the plastic landscape and will positively impact the wide range of applications that make use of plastics. We propose that plant enzymes, which underlie the large biochemical diversity present in plant specialized metabolism, will facilitate the production of novel building blocks for new polymers via biotechnolo]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/plant-inspired-building-blocks-for-future-plastics/</link><pubDate>Mon, 25 Nov 2024 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/plant-inspired-building-blocks-for-future-plastics/</guid></item><item><title><![CDATA[A snapshot of biomanufacturing and the need for enabling research infrastructure]]></title><description><![CDATA[Biomanufacturing is crucial for the bioeconomy, with growing investment and attention from industries and governments. Over recent decades numerous biotech companies have been founded, and policies have increasingly prioritised sustainable production methods. However, translation of biotechnological innovations into industrial applications remains challenging, requiring interdisciplinary research infrastructures (RIs) to address gaps in bioprocess development, scalability, and competitiveness. T]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/a-snapshot-of-biomanufacturing-and-the-need-for-enabling-research-infrastructure/</link><pubDate>Mon, 25 Nov 2024 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/a-snapshot-of-biomanufacturing-and-the-need-for-enabling-research-infrastructure/</guid></item><item><title><![CDATA[Producing multiple chemicals through biological upcycling of waste poly(ethylene terephthalate)]]></title><description><![CDATA[Genetic tools were developed to engineer a promising Rhodococcus jostii RPET chassis for the generalizable production of various chemicals from postconsumer PET, advancing the sustainability of PET plastic upcycling. Our results show a paradigm shift from traditional carbohydrate-based bioconversion to utilizing plastic-derived carbon sources as next-generation feedstocks for biomanufacturing.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/producing-multiple-chemicals-through-biological-upcycling-of-waste-polyethylene-terephthalate/</link><pubDate>Sat, 23 Nov 2024 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/producing-multiple-chemicals-through-biological-upcycling-of-waste-polyethylene-terephthalate/</guid></item><item><title><![CDATA[Intracellularly synthesized ssDNA for continuous genome engineering]]></title><description><![CDATA[Despite the prevalence of genome editing tools, there are still some limitations in dynamic and continuous genome editing. In vivo single-stranded DNA (ssDNA)-mediated genome mutation has emerged as a valuable and promising approach for continuous genome editing. In this review, we summarize the various types of intracellular ssDNA production systems and notable achievements in genome engineering in both prokaryotic and eukaryotic cells. We also review progress in the development of applications]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/intracellularly-synthesized-ssdna-for-continuous-genome-engineering/</link><pubDate>Tue, 12 Nov 2024 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/intracellularly-synthesized-ssdna-for-continuous-genome-engineering/</guid></item><item><title><![CDATA[Cas9-PE: a robust multiplex gene editing tool for simultaneous precise editing and site-specific random mutation in rice]]></title><description><![CDATA[This study developed a powerful multiplex gene editor, known as the Cas9-mediated prime editing (Cas9-PE) system, for simultaneous precise editing and site-specific random mutation in rice. Significantly, the herbicide resistance mutation ALSS627I was implemented for co-editing to generate transgene-free gene-edited plants in the T0 generation.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/cas9-pe-a-robust-multiplex-gene-editing-tool-for-simultaneous-precise-editing-and-site-specific-random-mutation-in-rice/</link><pubDate>Tue, 12 Nov 2024 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/cas9-pe-a-robust-multiplex-gene-editing-tool-for-simultaneous-precise-editing-and-site-specific-random-mutation-in-rice/</guid></item><item><title><![CDATA[A high-performance protein preparation approach in a single column-free step]]></title><description><![CDATA[We present the cleavable self-aggregating tag 2.0 (cSAT2.0) scheme, a single-step, column-free scheme for protein purification in Escherichia coli, achieving over 98% purity across a range of peptides and proteins. This versatile approach is scalable from microplates to fermenters, offering significant potential for applications in biological and pharmaceutical research and industry.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/a-high-performance-protein-preparation-approach-in-a-single-column-free-step/</link><pubDate>Tue, 12 Nov 2024 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/a-high-performance-protein-preparation-approach-in-a-single-column-free-step/</guid></item><item><title><![CDATA[Revolutionizing IBD research with on-chip models of disease modeling and drug screening]]></title><description><![CDATA[Inflammatory bowel disease (IBD) comprises chronic inflammatory conditions with complex mechanisms and diverse manifestations, posing significant clinical challenges. Traditional animal models and ethical concerns in human studies necessitate innovative approaches. This review provides an overview of human intestinal architecture in health and inflammation, emphasizing the role of microfluidics and on-chip technologies in IBD research. These technologies allow precise manipulation of cellular an]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/revolutionizing-ibd-research-with-on-chip-models-of-disease-modeling-and-drug-screening/</link><pubDate>Sat, 09 Nov 2024 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/revolutionizing-ibd-research-with-on-chip-models-of-disease-modeling-and-drug-screening/</guid></item><item><title><![CDATA[Rapid point-of-care pathogen sensing in the post-pandemic era]]></title><description><![CDATA[In the post-pandemic era, interest in on-site technologies capable of rapidly and accurately diagnosing viral or bacterial pathogens has significantly increased. Advances in functional nanomaterials and bioengineering have propelled the progress of point-of-care (POC) sensors, enhancing their speed, specificity, sensitivity, affordability, ease of use, and accuracy. Notably, biosensors that utilize surface-enhanced Raman scattering (SERS) technology have revolutionized the rapid and sensitive di]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/rapid-point-of-care-pathogen-sensing-in-the-post-pandemic-era/</link><pubDate>Sat, 09 Nov 2024 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/rapid-point-of-care-pathogen-sensing-in-the-post-pandemic-era/</guid></item><item><title><![CDATA[Small cells with big photosynthetic productivities: biotechnological potential of the Picochlorum genus]]></title><description><![CDATA[The Picochlorum genus is a distinctive eukaryotic green-algal clade that is the focus of several current biotechnological studies. It is capable of extremely rapid growth rates and has exceptional tolerances to high salinity, intense light, and elevated temperatures. Importantly, it has robust stability and high-biomass productivities in outdoor field trials in seawater. These features have propelled Picochlorum into the spotlight as a promising model for both fundamental and biotechnological re]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/small-cells-with-big-photosynthetic-productivities-biotechnological-potential-of-the-picochlorum-genus/</link><pubDate>Fri, 08 Nov 2024 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/small-cells-with-big-photosynthetic-productivities-biotechnological-potential-of-the-picochlorum-genus/</guid></item><item><title><![CDATA[Laws and green incentives: guiding China’s new biomass energy future]]></title><description><![CDATA[In this article, we focus on green incentives and laws guiding China’s new biomass energy future. We offer proposals to reinforce green incentives and legal standards in this field.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/laws-and-green-incentives-guiding-chinas-new-biomass-energy-future/</link><pubDate>Thu, 07 Nov 2024 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/laws-and-green-incentives-guiding-chinas-new-biomass-energy-future/</guid></item><item><title><![CDATA[Challenging plastic pollution with hydrocarbonoclastic lineages]]></title><description><![CDATA[The hydrocarbonoclastic lineages that have existed for millennia are responsible for the degradation of diverse aliphatic and aromatic compounds, regulating the ocean hydrocarbon cycles. Given the metabolic similarities in breaking down plastics and hydrocarbons, a thorough understanding and leveraging of these processes can provide biotechnologically based solutions to tackle global plastic pollution.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/challenging-plastic-pollution-with-hydrocarbonoclastic-lineages/</link><pubDate>Wed, 06 Nov 2024 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/challenging-plastic-pollution-with-hydrocarbonoclastic-lineages/</guid></item><item><title><![CDATA[Advancing biopharmaceutical manufacturing: economic and sustainability assessment of end-to-end continuous production of monoclonal antibodies]]></title><description><![CDATA[The analysis in this report demonstrates that end-to-end continuous processing in a multiproduct monoclonal antibody (mAb) facility can reduce the cost of goods, plastic waste, and CO2 emissions by up to 23%, 57%, and 54%, respectively. This could result in more equitable therapeutic access and reduce the ecological impact of mAb manufacturing.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/advancing-biopharmaceutical-manufacturing-economic-and-sustainability-assessment-of-end-to-end-continuous-production-of-monoclonal-antibodies/</link><pubDate>Wed, 06 Nov 2024 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/advancing-biopharmaceutical-manufacturing-economic-and-sustainability-assessment-of-end-to-end-continuous-production-of-monoclonal-antibodies/</guid></item><item><title><![CDATA[Chairside live biotherapeutic hydrogel for comprehensive periodontitis therapy]]></title><description><![CDATA[A live biotherapeutic hydrogel was constructed through the synergistic integration of living probiotics and material engineering, addressing the multifaceted etiology of periodontitis with comprehensive and sustained antimicrobial, anti-inflammatory, and regenerative therapies. This injectable, dental blue light-responsive design is well suited for chairside dental treatment.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/chairside-live-biotherapeutic-hydrogel-for-comprehensive-periodontitis-therapy/</link><pubDate>Tue, 05 Nov 2024 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/chairside-live-biotherapeutic-hydrogel-for-comprehensive-periodontitis-therapy/</guid></item><item><title><![CDATA[Leveraging the versatile properties of bacterial spores in materials]]></title><description><![CDATA[Inspired by biological functions of living systems, researchers have engineered cells as independent functional materials or integrated them within a natural or synthetic matrix to create engineered living materials (ELMs). However, the ‘livingness’ of cells in such materials poses serious drawbacks, such as a short lifespan and the need for cold-chain logistics. Bacterial spores have emerged as a game changer to bypass these shortcomings as a result of their intrinsic dormancy and resistanc]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/leveraging-the-versatile-properties-of-bacterial-spores-in-materials/</link><pubDate>Tue, 29 Oct 2024 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/leveraging-the-versatile-properties-of-bacterial-spores-in-materials/</guid></item><item><title><![CDATA[Peptides from non-immune proteins target infections through antimicrobial and immunomodulatory properties]]></title><description><![CDATA[Encrypted peptides derived from non-immune proteins exhibit potent antimicrobial and immunomodulatory properties. These peptides effectively kill bacterial pathogens, modulate immune mediators, and show anti-infective efficacy in preclinical models. The findings suggest that host immunity extends beyond traditional immune proteins, potentially broadening our current understanding of the immune system.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/peptides-from-non-immune-proteins-target-infections-through-antimicrobial-and-immunomodulatory-properties/</link><pubDate>Mon, 28 Oct 2024 01:00:00 +0100</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/peptides-from-non-immune-proteins-target-infections-through-antimicrobial-and-immunomodulatory-properties/</guid></item><item><title><![CDATA[Emerging gene editing in industrial microbiology beyond CRISPR-Cas9]]></title><description><![CDATA[The CRISPR-Cas9 system has been widely applied for industrial microbiology but is not effective in certain microorganisms. This forum explores the strategies aimed at overcoming these challenges, including the use of the Cas12a system, Cas9 variants, and non-CRISPR techniques, to provide more effective strategies for expanding applications in microbial engineering.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/emerging-gene-editing-in-industrial-microbiology-beyond-crispr-cas9/</link><pubDate>Sat, 26 Oct 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/emerging-gene-editing-in-industrial-microbiology-beyond-crispr-cas9/</guid></item><item><title><![CDATA[A cell-free bacteriophage synthesis system for directed evolution]]></title><description><![CDATA[This study introduces a robust cell-free synthesis method for M13 phage, enhanced by genome optimization and multicopy protein presynthesis. This approach facilitates the rapid and substantial production of M13 phage and supports phage-assisted evolution within droplets. These innovations significantly advance the frontiers of functional phage synthesis and in vitro screening.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/a-cell-free-bacteriophage-synthesis-system-for-directed-evolution/</link><pubDate>Sat, 26 Oct 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/a-cell-free-bacteriophage-synthesis-system-for-directed-evolution/</guid></item><item><title><![CDATA[In vitro human cell-based models: What can they do and what are their limitations?]]></title><description><![CDATA[It is said that all models are wrong, but some are useful. In vitro human cell-based models are a prime example of this maxim. We asked researchers: when is your model system useful? How can it be made more useful? What are its limitations?]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/invitro-human-cell-based-models-what-can-they-do-and-what-are-their-limitations/</link><pubDate>Fri, 25 Oct 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/invitro-human-cell-based-models-what-can-they-do-and-what-are-their-limitations/</guid></item><item><title><![CDATA[Fabricating an advanced electrogenic chassis by activating microbial metabolism and fine-tuning extracellular electron transfer]]></title><description><![CDATA[An electrogenic chassis has been engineered for robust metabolic activity and adaptability, exhibiting significantly enhanced extracellular electron transfer (EET) capabilities. This improvement led to improved pollutant biodegradation and radionuclide removal, demonstrating its potential as an advanced platform for environmental applications.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/fabricating-an-advanced-electrogenic-chassis-by-activating-microbial-metabolism-and-fine-tuning-extracellular-electron-transfer/</link><pubDate>Fri, 25 Oct 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/fabricating-an-advanced-electrogenic-chassis-by-activating-microbial-metabolism-and-fine-tuning-extracellular-electron-transfer/</guid></item><item><title><![CDATA[Cellobiose lipids: applications, production, and downstream processing]]></title><description><![CDATA[Cellobiose lipids (CBLs) are glycolipid biosurfactants that have garnered attention due to their potential applications in diverse industries. Here, we review the current state of CBL research, from production and purification, to the potential applications of CBLs. We elucidate CBL functionality and consider some commercial applications, as well as how operating conditions (e.g., media and organism, or production approaches) impact productivity. Methodologies based on enzymatic synthesis or pos]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/cellobiose-lipids-applications-production-and-downstream-processing/</link><pubDate>Fri, 25 Oct 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/cellobiose-lipids-applications-production-and-downstream-processing/</guid></item><item><title><![CDATA[In Climate Fight, Scientists Tinker With Bacteria to Replace Corn Fertilizer]]></title><description><![CDATA[By tweaking the DNA of bacteria, scientists aim to cut the use of chemical fertilizers that are worsening global warming. Some worry about unintended consequences.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/in-climate-fight-scientists-tinker-with-bacteria-to-replace-corn-fertilizer/</link><pubDate>Thu, 24 Oct 2024 11:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/in-climate-fight-scientists-tinker-with-bacteria-to-replace-corn-fertilizer/</guid></item><item><title><![CDATA[Comprehensive screening of industrially relevant components at genome scale using a high-quality gene overexpression collection of Corynebacterium glutamicum]]></title><description><![CDATA[A high-quality gene overexpression collection of the industrial workhorse Corynebacterium glutamicum containing 3049 strains was produced. To demonstrate its application, a comprehensive screening of industrially relevant components at a genome scale was conducted. New components for tolerance and transport were identified and used for developing industrial amino acid-producing strains.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/comprehensive-screening-of-industrially-relevant-components-at-genome-scale-using-a-high-quality-gene-overexpression-collection-of-corynebacterium-glutamicum/</link><pubDate>Thu, 24 Oct 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/comprehensive-screening-of-industrially-relevant-components-at-genome-scale-using-a-high-quality-gene-overexpression-collection-of-corynebacterium-glutamicum/</guid></item><item><title><![CDATA[Breaking barriers in obesity research: 3D models of dysfunctional adipose tissue]]></title><description><![CDATA[Obesity is a global health crisis characterised by excessive accumulation of adipose tissue (AT). Under obesogenic conditions, this metabolically active tissue undergoes fibrosis and inflammation, leading to obesity-linked comorbidities. Modelling AT is essential for understanding its pathophysiology and developing treatments to protect against metabolic complications. 3D in vitro AT models are promising tools that address the limitations of traditional 2D in vitro models and in vivo animal mode]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/breaking-barriers-in-obesity-research-3d-models-of-dysfunctional-adipose-tissue/</link><pubDate>Tue, 22 Oct 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/breaking-barriers-in-obesity-research-3d-models-of-dysfunctional-adipose-tissue/</guid></item><item><title><![CDATA[Introducing original research at Trends in Biotechnology]]></title><description><![CDATA[This issue marks a notable departure from the history of Trends in Biotechnology as we publish five original research articles. Over the past few decades, we have been known for publishing accessible, concise, authoritative, timely, and innovative reviews of applied biology. Now, we are expanding our scope to include original research.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/introducing-original-research-at-trends-in-biotechnology/</link><pubDate>Thu, 17 Oct 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/introducing-original-research-at-trends-in-biotechnology/</guid></item><item><title><![CDATA[Gene editing technology: shaping international standards for health and food safety assurance]]></title><description><![CDATA[The emergence of gene editing technologies like CRISPR-Cas9 has revolutionized health and food safety, necessitating robust international standards. This Science &amp; Society examines how these advances have shaped global regulatory frameworks, ethical standards, and international collaborations, emphasizing the need for cohesive and ethical applications across various sectors.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/gene-editing-technology-shaping-international-standards-for-health-and-food-safety-assurance/</link><pubDate>Thu, 17 Oct 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/gene-editing-technology-shaping-international-standards-for-health-and-food-safety-assurance/</guid></item><item><title><![CDATA[Molecular farming for the food sector]]></title><description><![CDATA[Molecular farming, initially developed to produce therapeutic proteins using genetically modified plants, gained renewed interest during the Ebola and COVID-19 outbreaks and has expanded into functional food ingredients. This article evaluates molecular farming technologies, market potential, and startups, and identifies opportunities in dairy proteins, food enzymes, collagen, and cellular agriculture.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/molecular-farming-for-the-food-sector/</link><pubDate>Wed, 16 Oct 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/molecular-farming-for-the-food-sector/</guid></item><item><title><![CDATA[Oil–water interfaces of Pickering emulsions: microhabitats for living cell biocatalysis]]></title><description><![CDATA[Based on the size of bacterial cells and bacterial surface hydrophobicity, some bacteria meet the requirements of Pickering particles to stabilize Pickering emulsions. Here, we discuss the oil–water interfaces of bacteria-stabilized Pickering emulsions as microhabitats for microbial metabolism of oil-soluble chemicals. The correlation between living bacteria-stabilized Pickering emulsions and microhabitats of living bacteria at oil–water interfaces offers a new perspective to study bioproces]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/oilwater-interfaces-of-pickering-emulsions-microhabitats-for-living-cell-biocatalysis/</link><pubDate>Fri, 11 Oct 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/oilwater-interfaces-of-pickering-emulsions-microhabitats-for-living-cell-biocatalysis/</guid></item><item><title><![CDATA[Advancements and regulations of biomanufacturing cell-based cartilage repair therapies]]></title><description><![CDATA[Cell-based therapies for cartilage repair, including autologous chondrocyte implantation and allogeneic stem cell treatments, show great promise but face challenges due to high costs and regulatory hurdles. This review summarizes available and investigational products, focusing on allogeneic therapies and the impact of diverse regulatory landscapes on their clinical translation.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/advancements-and-regulations-of-biomanufacturing-cell-based-cartilage-repair-therapies/</link><pubDate>Thu, 10 Oct 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/advancements-and-regulations-of-biomanufacturing-cell-based-cartilage-repair-therapies/</guid></item><item><title><![CDATA[Rapid manufacturing of CAR-T therapy: strategies and impact]]></title><description><![CDATA[The accessibility of autologous chimeric antigen receptor T cell (CAR-T) therapies is challenged by the complex processes and capacity constraints of manufacturing. Rapid manufacturing capable of shortening manufacturing timelines could transform the CAR-T field. Here, we outline approaches to rapid CAR-T manufacturing, highlighting its impact on various stakeholders in the landscape.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/rapid-manufacturing-of-car-t-therapy-strategies-and-impact/</link><pubDate>Wed, 09 Oct 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/rapid-manufacturing-of-car-t-therapy-strategies-and-impact/</guid></item><item><title><![CDATA[Plant-derived biomass-based hydrogels for biomedical applications]]></title><description><![CDATA[Hydrogels made of plant-derived biomass have gained popularity in biomedical applications because they are frequently affordable, readily available, and biocompatible. Finding the perfect plant-derived biomass-based hydrogels for biomedicine that can replicate essential characteristics of human tissues in regard to structure, function, and performance has proved to be difficult. In this review, we summarize some of the major contributions made to this topic, covering basic ideas and different bi]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/plant-derived-biomass-based-hydrogels-for-biomedical-applications/</link><pubDate>Tue, 08 Oct 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/plant-derived-biomass-based-hydrogels-for-biomedical-applications/</guid></item><item><title><![CDATA[&lsquo;Centre to support setting up of biomfg &amp; bio-AI hub in state&rsquo; - The Times of India]]></title><description><![CDATA[&lsquo;Centre to support setting up of biomfg &amp; bio-AI hub in state&rsquo;&nbsp;&nbsp;The Times of India]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/lsquocentre-to-support-setting-up-of-biomfg-amp-bio-ai-hub-in-statersquo-the-times-of-india/</link><pubDate>Sat, 05 Oct 2024 01:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/lsquocentre-to-support-setting-up-of-biomfg-amp-bio-ai-hub-in-statersquo-the-times-of-india/</guid></item><item><title><![CDATA[U.S. Biotechnology And Pharmaceutical Services Outsourcing Market Size to Reach USD 16.68 Billion By 2033 - BioSpace]]></title><description><![CDATA[U.S. Biotechnology And Pharmaceutical Services Outsourcing Market Size to Reach USD 16.68 Billion By 2033&nbsp;&nbsp;BioSpace]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/us-biotechnology-and-pharmaceutical-services-outsourcing-market-size-to-reach-usd-1668-billion-by-2033-biospace/</link><pubDate>Fri, 04 Oct 2024 19:49:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/us-biotechnology-and-pharmaceutical-services-outsourcing-market-size-to-reach-usd-1668-billion-by-2033-biospace/</guid></item><item><title><![CDATA[SBP AP Biology students master biotechnology skills with micropipettes - Cullman Times Online]]></title><description><![CDATA[SBP AP Biology students master biotechnology skills with micropipettes&nbsp;&nbsp;Cullman Times Online]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/sbp-ap-biology-students-master-biotechnology-skills-with-micropipettes-cullman-times-online/</link><pubDate>Fri, 04 Oct 2024 18:45:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/sbp-ap-biology-students-master-biotechnology-skills-with-micropipettes-cullman-times-online/</guid></item><item><title><![CDATA[EPA, FDA, and USDA Release Tool to Help Companies Developing Microbial Biotechnology Products Navigate Regulatory Landscape - JD Supra]]></title><description><![CDATA[EPA, FDA, and USDA Release Tool to Help Companies Developing Microbial Biotechnology Products Navigate Regulatory Landscape&nbsp;&nbsp;JD Supra]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/epa-fda-and-usda-release-tool-to-help-companies-developing-microbial-biotechnology-products-navigate-regulatory-landscape-jd-supra/</link><pubDate>Fri, 04 Oct 2024 18:24:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/epa-fda-and-usda-release-tool-to-help-companies-developing-microbial-biotechnology-products-navigate-regulatory-landscape-jd-supra/</guid></item><item><title><![CDATA[Recordati acquires rights to Enjaymo - The Pharma Letter]]></title><description><![CDATA[Recordati acquires rights to Enjaymo&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/recordati-acquires-rights-to-enjaymo-the-pharma-letter/</link><pubDate>Fri, 04 Oct 2024 15:45:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/recordati-acquires-rights-to-enjaymo-the-pharma-letter/</guid></item><item><title><![CDATA[BRIEF—Sirnaomics secures $7.5 million in share subscription - The Pharma Letter]]></title><description><![CDATA[BRIEF&mdash;Sirnaomics secures $7.5 million in share subscription&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/briefsirnaomics-secures-75-million-in-share-subscription-the-pharma-letter/</link><pubDate>Fri, 04 Oct 2024 12:54:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/briefsirnaomics-secures-75-million-in-share-subscription-the-pharma-letter/</guid></item><item><title><![CDATA[GigaGen wins $135 million BARDA contract for botulinum toxin treatment - The Pharma Letter]]></title><description><![CDATA[GigaGen wins $135 million BARDA contract for botulinum toxin treatment&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/gigagen-wins-135-million-barda-contract-for-botulinum-toxin-treatment-the-pharma-letter/</link><pubDate>Fri, 04 Oct 2024 12:38:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/gigagen-wins-135-million-barda-contract-for-botulinum-toxin-treatment-the-pharma-letter/</guid></item><item><title><![CDATA[FDA approves Opdivo for lung cancer before and after surgery - The Pharma Letter]]></title><description><![CDATA[FDA approves Opdivo for lung cancer before and after surgery&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/fda-approves-opdivo-for-lung-cancer-before-and-after-surgery-the-pharma-letter/</link><pubDate>Fri, 04 Oct 2024 12:07:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/fda-approves-opdivo-for-lung-cancer-before-and-after-surgery-the-pharma-letter/</guid></item><item><title><![CDATA[A*STAR and Flagship deal to spur biotech innovation in Singapore - The Pharma Letter]]></title><description><![CDATA[A*STAR and Flagship deal to spur biotech innovation in Singapore&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/astar-and-flagship-deal-to-spur-biotech-innovation-in-singapore-the-pharma-letter/</link><pubDate>Fri, 04 Oct 2024 11:36:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/astar-and-flagship-deal-to-spur-biotech-innovation-in-singapore-the-pharma-letter/</guid></item><item><title><![CDATA[FDA lifts hold on Avidity’s delpacibart etedesiran trial - The Pharma Letter]]></title><description><![CDATA[FDA lifts hold on Avidity&rsquo;s delpacibart etedesiran trial&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/fda-lifts-hold-on-aviditys-delpacibart-etedesiran-trial-the-pharma-letter/</link><pubDate>Fri, 04 Oct 2024 11:31:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/fda-lifts-hold-on-aviditys-delpacibart-etedesiran-trial-the-pharma-letter/</guid></item><item><title><![CDATA[Bacteria displaying cytokines heat up the tumor microenvironment - Nature.com]]></title><description><![CDATA[Bacteria displaying cytokines heat up the tumor microenvironment&nbsp;&nbsp;Nature.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/bacteria-displaying-cytokines-heat-up-the-tumor-microenvironment-naturecom/</link><pubDate>Fri, 04 Oct 2024 11:30:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/bacteria-displaying-cytokines-heat-up-the-tumor-microenvironment-naturecom/</guid></item><item><title><![CDATA[White Biotechnology Market 2031 Market Overview: Size, Demand, Trends, and Key Player Forecast - WhaTech]]></title><description><![CDATA[White Biotechnology Market 2031 Market Overview: Size, Demand, Trends, and Key Player Forecast&nbsp;&nbsp;WhaTech]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/white-biotechnology-market-2031-market-overview-size-demand-trends-and-key-player-forecast-whatech/</link><pubDate>Fri, 04 Oct 2024 10:30:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/white-biotechnology-market-2031-market-overview-size-demand-trends-and-key-player-forecast-whatech/</guid></item><item><title><![CDATA[Algert Global LLC Purchases New Position in Vir Biotechnology, Inc. (NASDAQ:VIR) - MarketBeat]]></title><description><![CDATA[Algert Global LLC Purchases New Position in Vir Biotechnology, Inc. (NASDAQ:VIR)&nbsp;&nbsp;MarketBeat]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/algert-global-llc-purchases-new-position-in-vir-biotechnology-inc-nasdaqvir-marketbeat/</link><pubDate>Fri, 04 Oct 2024 10:24:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/algert-global-llc-purchases-new-position-in-vir-biotechnology-inc-nasdaqvir-marketbeat/</guid></item><item><title><![CDATA[First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT) Trading 0.6% Higher - Should You Buy? - MarketBeat]]></title><description><![CDATA[First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT) Trading 0.6% Higher - Should You Buy?&nbsp;&nbsp;MarketBeat]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/first-trust-nyse-arca-biotechnology-ucits-etf-class-a-usd-accumulation-lonfbt-trading-06-higher-should-you-buy-marketbeat/</link><pubDate>Fri, 04 Oct 2024 07:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/first-trust-nyse-arca-biotechnology-ucits-etf-class-a-usd-accumulation-lonfbt-trading-06-higher-should-you-buy-marketbeat/</guid></item><item><title><![CDATA[BRIEF— Enara Bio raises $32.5 million to advance pipeline - The Pharma Letter]]></title><description><![CDATA[BRIEF&mdash; Enara Bio raises $32.5 million to advance pipeline&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/brief-enara-bio-raises-325-million-to-advance-pipeline-the-pharma-letter/</link><pubDate>Fri, 04 Oct 2024 04:25:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/brief-enara-bio-raises-325-million-to-advance-pipeline-the-pharma-letter/</guid></item><item><title><![CDATA[Capturing carbon to mitigate climate change: storage or use?]]></title><description><![CDATA[Reducing atmospheric CO2 is vital to combat climate change. Alongside reducing emissions, it is essential to capture atmospheric CO2 and either use it or store it, depending on which option yields the best outcomes. Government policies should coordinate actions in areas such as the bioeconomy and avoid creating perverse incentives.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/capturing-carbon-to-mitigate-climate-change-storage-or-use/</link><pubDate>Fri, 04 Oct 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/capturing-carbon-to-mitigate-climate-change-storage-or-use/</guid></item><item><title><![CDATA[Wiregrass Institute for Biotechnology welcomes local military veteran from Southeast Health as its first computational biologist - WDHN]]></title><description><![CDATA[Wiregrass Institute for Biotechnology welcomes local military veteran from Southeast Health as its first computational biologist&nbsp;&nbsp;WDHN]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/wiregrass-institute-for-biotechnology-welcomes-local-military-veteran-from-southeast-health-as-its-first-computational-biologist-wdhn/</link><pubDate>Thu, 03 Oct 2024 23:54:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/wiregrass-institute-for-biotechnology-welcomes-local-military-veteran-from-southeast-health-as-its-first-computational-biologist-wdhn/</guid></item><item><title><![CDATA[Vir Biotechnology to Participate in the H.C. Wainwright 5th Annual Viral Hepatitis Virtual Conference - The Bakersfield Californian]]></title><description><![CDATA[Vir Biotechnology to Participate in the H.C. Wainwright 5th Annual Viral Hepatitis Virtual Conference&nbsp;&nbsp;The Bakersfield Californian]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-to-participate-in-the-hc-wainwright-5th-annual-viral-hepatitis-virtual-conference-the-bakersfield-californian/</link><pubDate>Thu, 03 Oct 2024 22:01:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-to-participate-in-the-hc-wainwright-5th-annual-viral-hepatitis-virtual-conference-the-bakersfield-californian/</guid></item><item><title><![CDATA[Vir Biotechnology to Participate in the H.C. Wainwright 5th Annual Viral Hepatitis Virtual Conference - Business Wire]]></title><description><![CDATA[Vir Biotechnology to Participate in the H.C. Wainwright 5th Annual Viral Hepatitis Virtual Conference&nbsp;&nbsp;Business Wire]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-to-participate-in-the-hc-wainwright-5th-annual-viral-hepatitis-virtual-conference-business-wire/</link><pubDate>Thu, 03 Oct 2024 22:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-to-participate-in-the-hc-wainwright-5th-annual-viral-hepatitis-virtual-conference-business-wire/</guid></item><item><title><![CDATA[RMAT designation for Yescarta in first-line high-risk LBCL - The Pharma Letter]]></title><description><![CDATA[RMAT designation for Yescarta in first-line high-risk LBCL&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/rmat-designation-for-yescarta-in-first-line-high-risk-lbcl-the-pharma-letter/</link><pubDate>Thu, 03 Oct 2024 18:42:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/rmat-designation-for-yescarta-in-first-line-high-risk-lbcl-the-pharma-letter/</guid></item><item><title><![CDATA[Kedrion and Biotest agree US distribution deal for Yimmugo - The Pharma Letter]]></title><description><![CDATA[Kedrion and Biotest agree US distribution deal for Yimmugo&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/kedrion-and-biotest-agree-us-distribution-deal-for-yimmugo-the-pharma-letter/</link><pubDate>Thu, 03 Oct 2024 16:51:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/kedrion-and-biotest-agree-us-distribution-deal-for-yimmugo-the-pharma-letter/</guid></item><item><title><![CDATA[Arcus inks deal with AstraZeneca on ccRCC candidates - The Pharma Letter]]></title><description><![CDATA[Arcus inks deal with AstraZeneca on ccRCC candidates&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/arcus-inks-deal-with-astrazeneca-on-ccrcc-candidates-the-pharma-letter/</link><pubDate>Thu, 03 Oct 2024 16:50:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/arcus-inks-deal-with-astrazeneca-on-ccrcc-candidates-the-pharma-letter/</guid></item><item><title><![CDATA[PeptiDream unit and Curium join forces on radiopharma candidates | Biotechnology | The Pharmaletter - The Pharma Letter]]></title><description><![CDATA[PeptiDream unit and Curium join forces on radiopharma candidates | Biotechnology | The Pharmaletter&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/peptidream-unit-and-curium-join-forces-on-radiopharma-candidates-biotechnology-the-pharmaletter-the-pharma-letter/</link><pubDate>Thu, 03 Oct 2024 16:04:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/peptidream-unit-and-curium-join-forces-on-radiopharma-candidates-biotechnology-the-pharmaletter-the-pharma-letter/</guid></item><item><title><![CDATA[Cizzle Biotechnology Holdings plc Updated on Licensing and Partnership Agreement - Marketscreener.com]]></title><description><![CDATA[Cizzle Biotechnology Holdings plc Updated on Licensing and Partnership Agreement&nbsp;&nbsp;Marketscreener.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/cizzle-biotechnology-holdings-plc-updated-on-licensing-and-partnership-agreement-marketscreenercom/</link><pubDate>Thu, 03 Oct 2024 14:12:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/cizzle-biotechnology-holdings-plc-updated-on-licensing-and-partnership-agreement-marketscreenercom/</guid></item><item><title><![CDATA[Spyre Therapeutics lures Abivax exec to be its CMO - The Pharma Letter]]></title><description><![CDATA[Spyre Therapeutics lures Abivax exec to be its CMO&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/spyre-therapeutics-lures-abivax-exec-to-be-its-cmo-the-pharma-letter/</link><pubDate>Thu, 03 Oct 2024 13:40:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/spyre-therapeutics-lures-abivax-exec-to-be-its-cmo-the-pharma-letter/</guid></item><item><title><![CDATA[Triveni Bio raises $115 million Series B financing - The Pharma Letter]]></title><description><![CDATA[Triveni Bio raises $115 million Series B financing&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/triveni-bio-raises-115-million-series-b-financing-the-pharma-letter/</link><pubDate>Thu, 03 Oct 2024 13:15:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/triveni-bio-raises-115-million-series-b-financing-the-pharma-letter/</guid></item><item><title><![CDATA[Prevail Partners to invest again in Hemogenyx - The Pharma Letter]]></title><description><![CDATA[Prevail Partners to invest again in Hemogenyx&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/prevail-partners-to-invest-again-in-hemogenyx-the-pharma-letter/</link><pubDate>Thu, 03 Oct 2024 12:30:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/prevail-partners-to-invest-again-in-hemogenyx-the-pharma-letter/</guid></item><item><title><![CDATA[Resolution Therapeutics scores £63.5 million in series B round - The Pharma Letter]]></title><description><![CDATA[Resolution Therapeutics scores &pound;63.5 million in series B round&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/resolution-therapeutics-scores-635-million-in-series-b-round-the-pharma-letter/</link><pubDate>Thu, 03 Oct 2024 12:02:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/resolution-therapeutics-scores-635-million-in-series-b-round-the-pharma-letter/</guid></item><item><title><![CDATA[Kurma closes new fund at €250m - European Biotechnology News]]></title><description><![CDATA[Kurma closes new fund at &euro;250m&nbsp;&nbsp;European Biotechnology News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/kurma-closes-new-fund-at-250m-european-biotechnology-news/</link><pubDate>Thu, 03 Oct 2024 09:26:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/kurma-closes-new-fund-at-250m-european-biotechnology-news/</guid></item><item><title><![CDATA[KFSHRC: A catalyst for Saudi Arabia's biotechnology revolution - ZAWYA]]></title><description><![CDATA[KFSHRC: A catalyst for Saudi Arabia's biotechnology revolution&nbsp;&nbsp;ZAWYA]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/kfshrc-a-catalyst-for-saudi-arabias-biotechnology-revolution-zawya/</link><pubDate>Thu, 03 Oct 2024 07:16:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/kfshrc-a-catalyst-for-saudi-arabias-biotechnology-revolution-zawya/</guid></item><item><title><![CDATA[CRISPR/Cas: a powerful tool for designing and improving oil crops]]></title><description><![CDATA[Improving oil yield and quality is a major goal for crop breeding, and CRISPR/Cas-mediated genome editing has opened a new era for designing oil crops with enhanced yield and quality. CRISPR/Cas technology can not only increase oil production but also enhance oil quality, including enhancing pharmaceutical and health components, improving oil nutrients, and removing allergic and toxic components. As new molecular targets for oil biosynthesis are discovered and the CRISPR/Cas system is further im]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/crisprcas-a-powerful-tool-for-designing-and-improving-oil-crops/</link><pubDate>Thu, 03 Oct 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/crisprcas-a-powerful-tool-for-designing-and-improving-oil-crops/</guid></item><item><title><![CDATA[Biotechnology company launches cancer vaccine trial for dogs - DVM 360]]></title><description><![CDATA[Biotechnology company launches cancer vaccine trial for dogs&nbsp;&nbsp;DVM 360]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/biotechnology-company-launches-cancer-vaccine-trial-for-dogs-dvm-360/</link><pubDate>Wed, 02 Oct 2024 22:12:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/biotechnology-company-launches-cancer-vaccine-trial-for-dogs-dvm-360/</guid></item><item><title><![CDATA[British biotech industry champions mRNA progress - The Pharma Letter]]></title><description><![CDATA[British biotech industry champions mRNA progress&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/british-biotech-industry-champions-mrna-progress-the-pharma-letter/</link><pubDate>Wed, 02 Oct 2024 15:33:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/british-biotech-industry-champions-mrna-progress-the-pharma-letter/</guid></item><item><title><![CDATA[Shattuck Labs cuts workforce and shifts focus - The Pharma Letter]]></title><description><![CDATA[Shattuck Labs cuts workforce and shifts focus&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/shattuck-labs-cuts-workforce-and-shifts-focus-the-pharma-letter/</link><pubDate>Wed, 02 Oct 2024 15:31:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/shattuck-labs-cuts-workforce-and-shifts-focus-the-pharma-letter/</guid></item><item><title><![CDATA[Curve Therapeutics adds to its leadership team - The Pharma Letter]]></title><description><![CDATA[Curve Therapeutics adds to its leadership team&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/curve-therapeutics-adds-to-its-leadership-team-the-pharma-letter/</link><pubDate>Wed, 02 Oct 2024 14:59:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/curve-therapeutics-adds-to-its-leadership-team-the-pharma-letter/</guid></item><item><title><![CDATA[CAMP4 teams up with BioMarin to advance RNA-targeting meds - The Pharma Letter]]></title><description><![CDATA[CAMP4 teams up with BioMarin to advance RNA-targeting meds&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/camp4-teams-up-with-biomarin-to-advance-rna-targeting-meds-the-pharma-letter/</link><pubDate>Wed, 02 Oct 2024 12:33:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/camp4-teams-up-with-biomarin-to-advance-rna-targeting-meds-the-pharma-letter/</guid></item><item><title><![CDATA[TCR cell therapies vanquish solid tumors — finally - Nature.com]]></title><description><![CDATA[TCR cell therapies vanquish solid tumors &mdash; finally&nbsp;&nbsp;Nature.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/tcr-cell-therapies-vanquish-solid-tumors-finally-naturecom/</link><pubDate>Wed, 02 Oct 2024 12:12:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/tcr-cell-therapies-vanquish-solid-tumors-finally-naturecom/</guid></item><item><title><![CDATA[Well Prepared to Tackle New Pandemics - European Biotechnology News]]></title><description><![CDATA[Well Prepared to Tackle New Pandemics&nbsp;&nbsp;European Biotechnology News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/well-prepared-to-tackle-new-pandemics-european-biotechnology-news/</link><pubDate>Wed, 02 Oct 2024 08:06:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/well-prepared-to-tackle-new-pandemics-european-biotechnology-news/</guid></item><item><title><![CDATA[Light-based microcapillary monitoring sparks innovation in manufacturing and biotechnology - Phys.org]]></title><description><![CDATA[Light-based microcapillary monitoring sparks innovation in manufacturing and biotechnology&nbsp;&nbsp;Phys.org]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/light-based-microcapillary-monitoring-sparks-innovation-in-manufacturing-and-biotechnology-physorg/</link><pubDate>Tue, 01 Oct 2024 16:58:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/light-based-microcapillary-monitoring-sparks-innovation-in-manufacturing-and-biotechnology-physorg/</guid></item><item><title><![CDATA[Judge dismisses $6.4 billion lawsuit against Bristol Myers Squibb - The Pharma Letter]]></title><description><![CDATA[Judge dismisses $6.4 billion lawsuit against Bristol Myers Squibb&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/judge-dismisses-64-billion-lawsuit-against-bristol-myers-squibb-the-pharma-letter/</link><pubDate>Tue, 01 Oct 2024 15:52:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/judge-dismisses-64-billion-lawsuit-against-bristol-myers-squibb-the-pharma-letter/</guid></item><item><title><![CDATA[Setback for Kezar Life Sciences’ Lupus candidate zetomipzomib - The Pharma Letter]]></title><description><![CDATA[Setback for Kezar Life Sciences&rsquo; Lupus candidate zetomipzomib&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/setback-for-kezar-life-sciences-lupus-candidate-zetomipzomib-the-pharma-letter/</link><pubDate>Tue, 01 Oct 2024 13:42:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/setback-for-kezar-life-sciences-lupus-candidate-zetomipzomib-the-pharma-letter/</guid></item><item><title><![CDATA[Fujian Wanchen Biotechnology Group Co., Ltd. (SZSE:300972) Stock Rockets 28% But Many Are Still Ignoring The Company - Simply Wall St]]></title><description><![CDATA[Fujian Wanchen Biotechnology Group Co., Ltd. (SZSE:300972) Stock Rockets 28% But Many Are Still Ignoring The Company&nbsp;&nbsp;Simply Wall St]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/fujian-wanchen-biotechnology-group-co-ltd-szse300972-stock-rockets-28-but-many-are-still-ignoring-the-company-simply-wall-st/</link><pubDate>Tue, 01 Oct 2024 03:44:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/fujian-wanchen-biotechnology-group-co-ltd-szse300972-stock-rockets-28-but-many-are-still-ignoring-the-company-simply-wall-st/</guid></item><item><title><![CDATA[Bioengineered yeast for preventing age-related diseases]]></title><description><![CDATA[The aging process entails a multifaceted decline in the capacity to restore homeostasis in response to stress. A prevalent characteristic of many age-related diseases is the presence of low-grade chronic inflammation, a risk factor contributing significantly to morbidity and mortality in the elderly population. Specific lifestyle interventions, such as regular physical activity, targeted diet, and supplementation, can delay the accumulation of chronic age-associated conditions by mitigating infl]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/bioengineered-yeast-for-preventing-age-related-diseases/</link><pubDate>Tue, 01 Oct 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/bioengineered-yeast-for-preventing-age-related-diseases/</guid></item><item><title><![CDATA[While shareholders of Medicalsystem Biotechnology (SZSE:300439) are in the red over the last three years, underlying earnings have actually grown - Simply Wall St]]></title><description><![CDATA[While shareholders of Medicalsystem Biotechnology (SZSE:300439) are in the red over the last three years, underlying earnings have actually grown&nbsp;&nbsp;Simply Wall St]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/while-shareholders-of-medicalsystem-biotechnology-szse300439-are-in-the-red-over-the-last-three-years-underlying-earnings-have-actually-grown-simply-wall-st/</link><pubDate>Tue, 01 Oct 2024 01:32:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/while-shareholders-of-medicalsystem-biotechnology-szse300439-are-in-the-red-over-the-last-three-years-underlying-earnings-have-actually-grown-simply-wall-st/</guid></item><item><title><![CDATA[After Leaping 40% Bloomage BioTechnology Corporation Limited (SHSE:688363) Shares Are Not Flying Under The Radar - Simply Wall St]]></title><description><![CDATA[After Leaping 40% Bloomage BioTechnology Corporation Limited (SHSE:688363) Shares Are Not Flying Under The Radar&nbsp;&nbsp;Simply Wall St]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/after-leaping-40-bloomage-biotechnology-corporation-limited-shse688363-shares-are-not-flying-under-the-radar-simply-wall-st/</link><pubDate>Tue, 01 Oct 2024 01:32:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/after-leaping-40-bloomage-biotechnology-corporation-limited-shse688363-shares-are-not-flying-under-the-radar-simply-wall-st/</guid></item><item><title><![CDATA[Shenzhen Bioeasy Biotechnology Co., Ltd.'s (SZSE:300942) 28% Price Boost Is Out Of Tune With Revenues - Simply Wall St]]></title><description><![CDATA[Shenzhen Bioeasy Biotechnology Co., Ltd.'s (SZSE:300942) 28% Price Boost Is Out Of Tune With Revenues&nbsp;&nbsp;Simply Wall St]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/shenzhen-bioeasy-biotechnology-co-ltds-szse300942-28-price-boost-is-out-of-tune-with-revenues-simply-wall-st/</link><pubDate>Tue, 01 Oct 2024 00:54:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/shenzhen-bioeasy-biotechnology-co-ltds-szse300942-28-price-boost-is-out-of-tune-with-revenues-simply-wall-st/</guid></item><item><title><![CDATA[Has Shandong Boan Biotechnology Co., Ltd.'s (HKG:6955) Impressive Stock Performance Got Anything to Do With Its Fundamentals? - Simply Wall St]]></title><description><![CDATA[Has Shandong Boan Biotechnology Co., Ltd.'s (HKG:6955) Impressive Stock Performance Got Anything to Do With Its Fundamentals?&nbsp;&nbsp;Simply Wall St]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/has-shandong-boan-biotechnology-co-ltds-hkg6955-impressive-stock-performance-got-anything-to-do-with-its-fundamentals-simply-wall-st/</link><pubDate>Tue, 01 Oct 2024 00:34:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/has-shandong-boan-biotechnology-co-ltds-hkg6955-impressive-stock-performance-got-anything-to-do-with-its-fundamentals-simply-wall-st/</guid></item><item><title><![CDATA[Sana Biotechnology to Present at the Goldman Sachs Cell Therapy Day Conference - GlobeNewswire]]></title><description><![CDATA[Sana Biotechnology to Present at the Goldman Sachs Cell Therapy Day Conference&nbsp;&nbsp;GlobeNewswire]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/sana-biotechnology-to-present-at-the-goldman-sachs-cell-therapy-day-conference-globenewswire/</link><pubDate>Mon, 30 Sep 2024 22:06:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/sana-biotechnology-to-present-at-the-goldman-sachs-cell-therapy-day-conference-globenewswire/</guid></item><item><title><![CDATA[ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Short Interest Update - MarketBeat]]></title><description><![CDATA[ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Short Interest Update&nbsp;&nbsp;MarketBeat]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/proshares-ultra-nasdaq-biotechnology-nasdaqbib-short-interest-update-marketbeat/</link><pubDate>Mon, 30 Sep 2024 21:41:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/proshares-ultra-nasdaq-biotechnology-nasdaqbib-short-interest-update-marketbeat/</guid></item><item><title><![CDATA[Pop an idea into a bio-foundry: A blueprint for revolutionizing biotechnology through AI and automation - The Economic Times]]></title><description><![CDATA[Pop an idea into a bio-foundry: A blueprint for revolutionizing biotechnology through AI and automation&nbsp;&nbsp;The Economic Times]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/pop-an-idea-into-a-bio-foundry-a-blueprint-for-revolutionizing-biotechnology-through-ai-and-automation-the-economic-times/</link><pubDate>Mon, 30 Sep 2024 19:19:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/pop-an-idea-into-a-bio-foundry-a-blueprint-for-revolutionizing-biotechnology-through-ai-and-automation-the-economic-times/</guid></item><item><title><![CDATA[Prime Medicine soars as it inks research collab with BMS - The Pharma Letter]]></title><description><![CDATA[Prime Medicine soars as it inks research collab with BMS&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/prime-medicine-soars-as-it-inks-research-collab-with-bms-the-pharma-letter/</link><pubDate>Mon, 30 Sep 2024 18:54:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/prime-medicine-soars-as-it-inks-research-collab-with-bms-the-pharma-letter/</guid></item><item><title><![CDATA[The importance of disaccharide excipients in biologics - European Biotechnology News]]></title><description><![CDATA[The importance of disaccharide excipients in biologics&nbsp;&nbsp;European Biotechnology News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/the-importance-of-disaccharide-excipients-in-biologics-european-biotechnology-news/</link><pubDate>Mon, 30 Sep 2024 18:30:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/the-importance-of-disaccharide-excipients-in-biologics-european-biotechnology-news/</guid></item><item><title><![CDATA[New Alnylam HELIOS-B vutrisiran data presented at HFSA - The Pharma Letter]]></title><description><![CDATA[New Alnylam HELIOS-B vutrisiran data presented at HFSA&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/new-alnylam-helios-b-vutrisiran-data-presented-at-hfsa-the-pharma-letter/</link><pubDate>Mon, 30 Sep 2024 17:14:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/new-alnylam-helios-b-vutrisiran-data-presented-at-hfsa-the-pharma-letter/</guid></item><item><title><![CDATA[Genentech to acquire Regor's next-gen CDK inhibitors portfolio - The Pharma Letter]]></title><description><![CDATA[Genentech to acquire Regor's next-gen CDK inhibitors portfolio&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/genentech-to-acquire-regors-next-gen-cdk-inhibitors-portfolio-the-pharma-letter/</link><pubDate>Mon, 30 Sep 2024 17:14:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/genentech-to-acquire-regors-next-gen-cdk-inhibitors-portfolio-the-pharma-letter/</guid></item><item><title><![CDATA[Lab Reagents made with ARTES – recombinant Proteins for lab research - European Biotechnology News]]></title><description><![CDATA[Lab Reagents made with ARTES &ndash; recombinant Proteins for lab research&nbsp;&nbsp;European Biotechnology News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/lab-reagents-made-with-artes-recombinant-proteins-for-lab-research-european-biotechnology-news/</link><pubDate>Mon, 30 Sep 2024 16:52:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/lab-reagents-made-with-artes-recombinant-proteins-for-lab-research-european-biotechnology-news/</guid></item><item><title><![CDATA[Positive Phase III results for Roche’s Gazyva/Gazyvaro in lupus - The Pharma Letter]]></title><description><![CDATA[Positive Phase III results for Roche&rsquo;s Gazyva/Gazyvaro in lupus&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/positive-phase-iii-results-for-roches-gazyvagazyvaro-in-lupus-the-pharma-letter/</link><pubDate>Mon, 30 Sep 2024 14:28:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/positive-phase-iii-results-for-roches-gazyvagazyvaro-in-lupus-the-pharma-letter/</guid></item><item><title><![CDATA[GentiBio names Mark Bach as chief medical officer - The Pharma Letter]]></title><description><![CDATA[GentiBio names Mark Bach as chief medical officer&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/gentibio-names-mark-bach-as-chief-medical-officer-the-pharma-letter/</link><pubDate>Mon, 30 Sep 2024 14:28:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/gentibio-names-mark-bach-as-chief-medical-officer-the-pharma-letter/</guid></item><item><title><![CDATA[FDA grants full approval for Retevmo in MTC - The Pharma Letter]]></title><description><![CDATA[FDA grants full approval for Retevmo in MTC&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/fda-grants-full-approval-for-retevmo-in-mtc-the-pharma-letter/</link><pubDate>Mon, 30 Sep 2024 14:28:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/fda-grants-full-approval-for-retevmo-in-mtc-the-pharma-letter/</guid></item><item><title><![CDATA[Cizzle Biotechnology repotrs interim results and key partnerships for lung cancer detection - DirectorsTalk Interviews]]></title><description><![CDATA[Cizzle Biotechnology repotrs interim results and key partnerships for lung cancer detection&nbsp;&nbsp;DirectorsTalk Interviews]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/cizzle-biotechnology-repotrs-interim-results-and-key-partnerships-for-lung-cancer-detection-directorstalk-interviews/</link><pubDate>Mon, 30 Sep 2024 08:47:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/cizzle-biotechnology-repotrs-interim-results-and-key-partnerships-for-lung-cancer-detection-directorstalk-interviews/</guid></item><item><title><![CDATA[Return Trends At Fujian Wanchen Biotechnology Group (SZSE:300972) Aren't Appealing - Simply Wall St]]></title><description><![CDATA[Return Trends At Fujian Wanchen Biotechnology Group (SZSE:300972) Aren't Appealing&nbsp;&nbsp;Simply Wall St]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/return-trends-at-fujian-wanchen-biotechnology-group-szse300972-arent-appealing-simply-wall-st/</link><pubDate>Mon, 30 Sep 2024 02:28:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/return-trends-at-fujian-wanchen-biotechnology-group-szse300972-arent-appealing-simply-wall-st/</guid></item><item><title><![CDATA[MCC’s biotechnology program receives Pathmaker Validation from Mass Life Sciences Center - Lowell Sun]]></title><description><![CDATA[MCC&rsquo;s biotechnology program receives Pathmaker Validation from Mass Life Sciences Center&nbsp;&nbsp;Lowell Sun]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/mccs-biotechnology-program-receives-pathmaker-validation-from-mass-life-sciences-center-lowell-sun/</link><pubDate>Sun, 29 Sep 2024 08:34:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/mccs-biotechnology-program-receives-pathmaker-validation-from-mass-life-sciences-center-lowell-sun/</guid></item><item><title><![CDATA[Engineering next-generation oxygen-generating scaffolds to enhance bone regeneration]]></title><description><![CDATA[In bone, an adequate oxygen (O2) supply is crucial during development, homeostasis, and healing. Oxygen-generating scaffolds (OGS) have demonstrated significant potential to enhance bone regeneration. However, the complexity of O2 delivery and signaling in vivo makes it challenging to tailor the design of OGS to precisely meet this biological requirement. We review recent advances in OGS and analyze persisting engineering and translational hurdles. We also discuss the potential of computational]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/engineering-next-generation-oxygen-generating-scaffolds-to-enhance-bone-regeneration/</link><pubDate>Sat, 28 Sep 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/engineering-next-generation-oxygen-generating-scaffolds-to-enhance-bone-regeneration/</guid></item><item><title><![CDATA[St. Bernard AP Biology students master biotechnology skills with micropipettes - The Cullman Tribune]]></title><description><![CDATA[St. Bernard AP Biology students master biotechnology skills with micropipettes&nbsp;&nbsp;The Cullman Tribune]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/st-bernard-ap-biology-students-master-biotechnology-skills-with-micropipettes-the-cullman-tribune/</link><pubDate>Fri, 27 Sep 2024 19:17:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/st-bernard-ap-biology-students-master-biotechnology-skills-with-micropipettes-the-cullman-tribune/</guid></item><item><title><![CDATA[Biotechnology &amp; Beauty - Happi]]></title><description><![CDATA[Biotechnology &amp; Beauty&nbsp;&nbsp;Happi]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/biotechnology-amp-beauty-happi/</link><pubDate>Fri, 27 Sep 2024 16:54:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/biotechnology-amp-beauty-happi/</guid></item><item><title><![CDATA[Repair and Genevant team up for novel atherosclerosis treatment - The Pharma Letter]]></title><description><![CDATA[Repair and Genevant team up for novel atherosclerosis treatment&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/repair-and-genevant-team-up-for-novel-atherosclerosis-treatment-the-pharma-letter/</link><pubDate>Fri, 27 Sep 2024 15:47:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/repair-and-genevant-team-up-for-novel-atherosclerosis-treatment-the-pharma-letter/</guid></item><item><title><![CDATA[Further $3 billion funding for ARCH Venture - The Pharma Letter]]></title><description><![CDATA[Further $3 billion funding for ARCH Venture&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/further-3-billion-funding-for-arch-venture-the-pharma-letter/</link><pubDate>Fri, 27 Sep 2024 13:25:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/further-3-billion-funding-for-arch-venture-the-pharma-letter/</guid></item><item><title><![CDATA[FDA panel votes against broader use of checkpoint blockers - The Pharma Letter]]></title><description><![CDATA[FDA panel votes against broader use of checkpoint blockers&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/fda-panel-votes-against-broader-use-of-checkpoint-blockers-the-pharma-letter/</link><pubDate>Fri, 27 Sep 2024 12:42:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/fda-panel-votes-against-broader-use-of-checkpoint-blockers-the-pharma-letter/</guid></item><item><title><![CDATA[Flagship unveils another new company, Mirai Bio - The Pharma Letter]]></title><description><![CDATA[Flagship unveils another new company, Mirai Bio&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/flagship-unveils-another-new-company-mirai-bio-the-pharma-letter/</link><pubDate>Fri, 27 Sep 2024 11:21:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/flagship-unveils-another-new-company-mirai-bio-the-pharma-letter/</guid></item><item><title><![CDATA[Surge in China’s antibody-drug conjugates development - The Pharma Letter]]></title><description><![CDATA[Surge in China&rsquo;s antibody-drug conjugates development&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/surge-in-chinas-antibody-drug-conjugates-development-the-pharma-letter/</link><pubDate>Fri, 27 Sep 2024 11:10:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/surge-in-chinas-antibody-drug-conjugates-development-the-pharma-letter/</guid></item><item><title><![CDATA[The Strategic Imperative of Biotechnology: Implications for U.S. National Security - CSIS | Center for Strategic and International Studies]]></title><description><![CDATA[The Strategic Imperative of Biotechnology: Implications for U.S. National Security&nbsp;&nbsp;CSIS | Center for Strategic and International Studies]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/the-strategic-imperative-of-biotechnology-implications-for-us-national-security-csis-center-for-strategic-and-international-studies/</link><pubDate>Fri, 27 Sep 2024 09:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/the-strategic-imperative-of-biotechnology-implications-for-us-national-security-csis-center-for-strategic-and-international-studies/</guid></item><item><title><![CDATA[Asabys Partners close €180m Sabadell Asabys II Fund - European Biotechnology News]]></title><description><![CDATA[Asabys Partners close &euro;180m Sabadell Asabys II Fund&nbsp;&nbsp;European Biotechnology News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/asabys-partners-close-180m-sabadell-asabys-ii-fund-european-biotechnology-news/</link><pubDate>Fri, 27 Sep 2024 08:43:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/asabys-partners-close-180m-sabadell-asabys-ii-fund-european-biotechnology-news/</guid></item><item><title><![CDATA[Maccura Biotechnology Co.Ltd's (SZSE:300463) market cap rose CN&yen;382m last week; retail investors who hold 51% profited and so did insiders - Simply Wall St]]></title><description><![CDATA[Maccura Biotechnology Co.Ltd's (SZSE:300463) market cap rose CN&yen;382m last week; retail investors who hold 51% profited and so did insiders&nbsp;&nbsp;Simply Wall St]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/maccura-biotechnology-coltds-szse300463-market-cap-rose-cnyen382m-last-week-retail-investors-who-hold-51-profited-and-so-did-insiders-simply-wall-st/</link><pubDate>Fri, 27 Sep 2024 04:32:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/maccura-biotechnology-coltds-szse300463-market-cap-rose-cnyen382m-last-week-retail-investors-who-hold-51-profited-and-so-did-insiders-simply-wall-st/</guid></item><item><title><![CDATA[Henghua Guo Anhui Huaheng Biotechnology Co., Ltd.'s (SHSE:688639) CEO is the most bullish insider, and their stock value gained 12%last week - Simply Wall St]]></title><description><![CDATA[Henghua Guo Anhui Huaheng Biotechnology Co., Ltd.'s (SHSE:688639) CEO is the most bullish insider, and their stock value gained 12%last week&nbsp;&nbsp;Simply Wall St]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/henghua-guo-anhui-huaheng-biotechnology-co-ltds-shse688639-ceo-is-the-most-bullish-insider-and-their-stock-value-gained-12last-week-simply-wall-st/</link><pubDate>Fri, 27 Sep 2024 02:52:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/henghua-guo-anhui-huaheng-biotechnology-co-ltds-shse688639-ceo-is-the-most-bullish-insider-and-their-stock-value-gained-12last-week-simply-wall-st/</guid></item><item><title><![CDATA[Sustainable production of porphyrins through synthetic biology]]></title><description><![CDATA[Porphyrin compounds are versatile heterocyclic molecules with diverse applications. However, their high-level production is limited by strict biosynthetic regulation and low catalytic efficiency of pathway enzymes. This forum article focuses on recent breakthroughs in porphyrin biosynthesis across various species, aiming to promote the sustainable production of porphyrins through synthetic biology.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/sustainable-production-of-porphyrins-through-synthetic-biology/</link><pubDate>Fri, 27 Sep 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/sustainable-production-of-porphyrins-through-synthetic-biology/</guid></item><item><title><![CDATA[Phage-guided nanocarriers: a precision strategy against bacterial pathogens]]></title><description><![CDATA[Bacterial infections pose a major threat to human health. Here, we describe the recent development of phage-guided therapeutic agent-loaded engineered nanomaterials for precise elimination of bacterial pathogens. This forum highlights the underexplored potential of bioinspired nano-enabled strategies for managing bacterial infections in a precise and safe manner.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/phage-guided-nanocarriers-a-precision-strategy-against-bacterial-pathogens/</link><pubDate>Fri, 27 Sep 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/phage-guided-nanocarriers-a-precision-strategy-against-bacterial-pathogens/</guid></item><item><title><![CDATA[Extended pegRNAs enhance the editing capability of Prime editing]]></title><description><![CDATA[exPE demonstrates significantly enhanced genome-editing efficiency, particularly in challenging poly-T regions, and enables seamless insertion of large DNA fragments. This advance expands the utility of PE in therapeutic interventions and genetic research, offering new possibilities for correcting complex genetic disorders.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/extended-pegrnas-enhance-the-editing-capability-of-prime-editing/</link><pubDate>Fri, 27 Sep 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/extended-pegrnas-enhance-the-editing-capability-of-prime-editing/</guid></item><item><title><![CDATA[NTI | bio Briefs Capitol Hill on Innovative Solutions to Biotechnology Risks - Nuclear Threat Initiative]]></title><description><![CDATA[NTI | bio Briefs Capitol Hill on Innovative Solutions to Biotechnology Risks&nbsp;&nbsp;Nuclear Threat Initiative]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/nti-bio-briefs-capitol-hill-on-innovative-solutions-to-biotechnology-risks-nuclear-threat-initiative/</link><pubDate>Fri, 27 Sep 2024 01:48:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/nti-bio-briefs-capitol-hill-on-innovative-solutions-to-biotechnology-risks-nuclear-threat-initiative/</guid></item><item><title><![CDATA[Market Participants Recognise Guangdong Marubi Biotechnology Co., Ltd.'s (SHSE:603983) Earnings Pushing Shares 27% Higher - Simply Wall St]]></title><description><![CDATA[Market Participants Recognise Guangdong Marubi Biotechnology Co., Ltd.'s (SHSE:603983) Earnings Pushing Shares 27% Higher&nbsp;&nbsp;Simply Wall St]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/market-participants-recognise-guangdong-marubi-biotechnology-co-ltds-shse603983-earnings-pushing-shares-27-higher-simply-wall-st/</link><pubDate>Fri, 27 Sep 2024 00:14:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/market-participants-recognise-guangdong-marubi-biotechnology-co-ltds-shse603983-earnings-pushing-shares-27-higher-simply-wall-st/</guid></item><item><title><![CDATA[Evaxion significantly expands vaccine deal with MSD - The Pharma Letter]]></title><description><![CDATA[Evaxion significantly expands vaccine deal with MSD&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/evaxion-significantly-expands-vaccine-deal-with-msd-the-pharma-letter/</link><pubDate>Thu, 26 Sep 2024 17:42:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/evaxion-significantly-expands-vaccine-deal-with-msd-the-pharma-letter/</guid></item><item><title><![CDATA[Lundbeck joins forces with Iambic to leverage AI for drug discovery - The Pharma Letter]]></title><description><![CDATA[Lundbeck joins forces with Iambic to leverage AI for drug discovery&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/lundbeck-joins-forces-with-iambic-to-leverage-ai-for-drug-discovery-the-pharma-letter/</link><pubDate>Thu, 26 Sep 2024 16:23:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/lundbeck-joins-forces-with-iambic-to-leverage-ai-for-drug-discovery-the-pharma-letter/</guid></item><item><title><![CDATA[Emergent confirms ~$400 million in orders for smallpox and mpox vaccines - The Pharma Letter]]></title><description><![CDATA[Emergent confirms ~$400 million in orders for smallpox and mpox vaccines&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/emergent-confirms-400-million-in-orders-for-smallpox-and-mpox-vaccines-the-pharma-letter/</link><pubDate>Thu, 26 Sep 2024 13:50:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/emergent-confirms-400-million-in-orders-for-smallpox-and-mpox-vaccines-the-pharma-letter/</guid></item><item><title><![CDATA[Miss for Merck’s favezelimab combo in colorectal cancer - The Pharma Letter]]></title><description><![CDATA[Miss for Merck&rsquo;s favezelimab combo in colorectal cancer&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/miss-for-mercks-favezelimab-combo-in-colorectal-cancer-the-pharma-letter/</link><pubDate>Thu, 26 Sep 2024 12:41:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/miss-for-mercks-favezelimab-combo-in-colorectal-cancer-the-pharma-letter/</guid></item><item><title><![CDATA[Abiologics lures J&amp;J exec to become its CSO - The Pharma Letter]]></title><description><![CDATA[Abiologics lures J&amp;J exec to become its CSO&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/abiologics-lures-jampj-exec-to-become-its-cso-the-pharma-letter/</link><pubDate>Thu, 26 Sep 2024 12:41:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/abiologics-lures-jampj-exec-to-become-its-cso-the-pharma-letter/</guid></item><item><title><![CDATA[Innovation and biotechnology lead Vietnam’s healthcare development - Vietnam Investment Review]]></title><description><![CDATA[Innovation and biotechnology lead Vietnam&rsquo;s healthcare development&nbsp;&nbsp;Vietnam Investment Review]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/innovation-and-biotechnology-lead-vietnams-healthcare-development-vietnam-investment-review/</link><pubDate>Thu, 26 Sep 2024 12:21:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/innovation-and-biotechnology-lead-vietnams-healthcare-development-vietnam-investment-review/</guid></item><item><title><![CDATA[Junshi wins European approval for cheaper checkpoint blocker - The Pharma Letter]]></title><description><![CDATA[Junshi wins European approval for cheaper checkpoint blocker&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/junshi-wins-european-approval-for-cheaper-checkpoint-blocker-the-pharma-letter/</link><pubDate>Thu, 26 Sep 2024 11:24:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/junshi-wins-european-approval-for-cheaper-checkpoint-blocker-the-pharma-letter/</guid></item><item><title><![CDATA[A "Pure Play" Biologics Swiss-based CDMO - European Biotechnology News]]></title><description><![CDATA[A "Pure Play" Biologics Swiss-based CDMO&nbsp;&nbsp;European Biotechnology News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/a-pure-play-biologics-swiss-based-cdmo-european-biotechnology-news/</link><pubDate>Thu, 26 Sep 2024 09:23:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/a-pure-play-biologics-swiss-based-cdmo-european-biotechnology-news/</guid></item><item><title><![CDATA[2seventy bio and BMS to drop KarMMa-9 study - The Pharma Letter]]></title><description><![CDATA[2seventy bio and BMS to drop KarMMa-9 study&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/2seventy-bio-and-bms-to-drop-karmma-9-study-the-pharma-letter/</link><pubDate>Wed, 25 Sep 2024 16:09:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/2seventy-bio-and-bms-to-drop-karmma-9-study-the-pharma-letter/</guid></item><item><title><![CDATA[UCB maintains momentum with Bimzelx in psoriasis - The Pharma Letter]]></title><description><![CDATA[UCB maintains momentum with Bimzelx in psoriasis&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/ucb-maintains-momentum-with-bimzelx-in-psoriasis-the-pharma-letter/</link><pubDate>Wed, 25 Sep 2024 13:37:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/ucb-maintains-momentum-with-bimzelx-in-psoriasis-the-pharma-letter/</guid></item><item><title><![CDATA[Biden offers $500 million for mpox response in Africa - The Pharma Letter]]></title><description><![CDATA[Biden offers $500 million for mpox response in Africa&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/biden-offers-500-million-for-mpox-response-in-africa-the-pharma-letter/</link><pubDate>Wed, 25 Sep 2024 12:47:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/biden-offers-500-million-for-mpox-response-in-africa-the-pharma-letter/</guid></item><item><title><![CDATA[Lonza to produce Casgevy for Vertex - The Pharma Letter]]></title><description><![CDATA[Lonza to produce Casgevy for Vertex&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/lonza-to-produce-casgevy-for-vertex-the-pharma-letter/</link><pubDate>Wed, 25 Sep 2024 12:29:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/lonza-to-produce-casgevy-for-vertex-the-pharma-letter/</guid></item><item><title><![CDATA[Genespire raises US$52m in Series B round - European Biotechnology News]]></title><description><![CDATA[Genespire raises US$52m in Series B round&nbsp;&nbsp;European Biotechnology News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/genespire-raises-us52m-in-series-b-round-european-biotechnology-news/</link><pubDate>Wed, 25 Sep 2024 11:34:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/genespire-raises-us52m-in-series-b-round-european-biotechnology-news/</guid></item><item><title><![CDATA[Multistate and functional protein design using RoseTTAFold sequence space diffusion - Nature.com]]></title><description><![CDATA[Multistate and functional protein design using RoseTTAFold sequence space diffusion&nbsp;&nbsp;Nature.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/multistate-and-functional-protein-design-using-rosettafold-sequence-space-diffusion-naturecom/</link><pubDate>Wed, 25 Sep 2024 11:32:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/multistate-and-functional-protein-design-using-rosettafold-sequence-space-diffusion-naturecom/</guid></item><item><title><![CDATA[Increasing intracellular dNTP levels improves prime editing efficiency - Nature.com]]></title><description><![CDATA[Increasing intracellular dNTP levels improves prime editing efficiency&nbsp;&nbsp;Nature.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/increasing-intracellular-dntp-levels-improves-prime-editing-efficiency-naturecom/</link><pubDate>Wed, 25 Sep 2024 11:32:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/increasing-intracellular-dntp-levels-improves-prime-editing-efficiency-naturecom/</guid></item><item><title><![CDATA[bluebird lets go staff amid financial struggle - The Pharma Letter]]></title><description><![CDATA[bluebird lets go staff amid financial struggle&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/bluebird-lets-go-staff-amid-financial-struggle-the-pharma-letter/</link><pubDate>Wed, 25 Sep 2024 11:25:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/bluebird-lets-go-staff-amid-financial-struggle-the-pharma-letter/</guid></item><item><title><![CDATA[Biotechnology-enhanced genetic controls of the global pest Drosophila suzukii]]></title><description><![CDATA[Spotted wing Drosophila (Drosophila suzukii Matsumura, or SWD), an insect pest of soft-skinned fruits native to East Asia, has rapidly spread worldwide in the past 15 years. Genetic controls such as sterile insect technique (SIT) have been considered for the environmentally friendly and cost-effective management of this pest. In this review, we provide the latest developments for the genetic control strategies of SWD, including sperm-marking strains, CRISPR-based sex-ratio distortion, neoclassic]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/biotechnology-enhanced-genetic-controls-of-the-global-pest-drosophila-suzukii/</link><pubDate>Wed, 25 Sep 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/biotechnology-enhanced-genetic-controls-of-the-global-pest-drosophila-suzukii/</guid></item><item><title><![CDATA[BioAtla out-licenses T cell therapy in $134 million deal - The Pharma Letter]]></title><description><![CDATA[BioAtla out-licenses T cell therapy in $134 million deal&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/bioatla-out-licenses-t-cell-therapy-in-134-million-deal-the-pharma-letter/</link><pubDate>Tue, 24 Sep 2024 15:21:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/bioatla-out-licenses-t-cell-therapy-in-134-million-deal-the-pharma-letter/</guid></item><item><title><![CDATA[New RNA specialist launches in Milan with $1.6 million - The Pharma Letter]]></title><description><![CDATA[New RNA specialist launches in Milan with $1.6 million&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/new-rna-specialist-launches-in-milan-with-16-million-the-pharma-letter/</link><pubDate>Tue, 24 Sep 2024 11:58:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/new-rna-specialist-launches-in-milan-with-16-million-the-pharma-letter/</guid></item><item><title><![CDATA[AMR Accelerator urges long-term funding - European Biotechnology News]]></title><description><![CDATA[AMR Accelerator urges long-term funding&nbsp;&nbsp;European Biotechnology News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/amr-accelerator-urges-long-term-funding-european-biotechnology-news/</link><pubDate>Tue, 24 Sep 2024 06:09:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/amr-accelerator-urges-long-term-funding-european-biotechnology-news/</guid></item><item><title><![CDATA[Biotechnology Market Report Details Size, Share, Trends &amp; Growth 2024-2033 - WhaTech]]></title><description><![CDATA[Biotechnology Market Report Details Size, Share, Trends &amp; Growth 2024-2033&nbsp;&nbsp;WhaTech]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/biotechnology-market-report-details-size-share-trends-amp-growth-2024-2033-whatech/</link><pubDate>Mon, 23 Sep 2024 22:31:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/biotechnology-market-report-details-size-share-trends-amp-growth-2024-2033-whatech/</guid></item><item><title><![CDATA[Positive interim Phase II data for darovasertib - The Pharma Letter]]></title><description><![CDATA[Positive interim Phase II data for darovasertib&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/positive-interim-phase-ii-data-for-darovasertib-the-pharma-letter/</link><pubDate>Mon, 23 Sep 2024 17:01:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/positive-interim-phase-ii-data-for-darovasertib-the-pharma-letter/</guid></item><item><title><![CDATA[PDS Biotechnology: Continuing The Holding Pattern (NASDAQ:PDSB) - Seeking Alpha]]></title><description><![CDATA[PDS Biotechnology: Continuing The Holding Pattern (NASDAQ:PDSB)&nbsp;&nbsp;Seeking Alpha]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/pds-biotechnology-continuing-the-holding-pattern-nasdaqpdsb-seeking-alpha/</link><pubDate>Mon, 23 Sep 2024 16:39:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/pds-biotechnology-continuing-the-holding-pattern-nasdaqpdsb-seeking-alpha/</guid></item><item><title><![CDATA[ARTCLINE appoints Dirk Hessel as managing director - The Pharma Letter]]></title><description><![CDATA[ARTCLINE appoints Dirk Hessel as managing director&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/artcline-appoints-dirk-hessel-as-managing-director-the-pharma-letter/</link><pubDate>Mon, 23 Sep 2024 15:47:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/artcline-appoints-dirk-hessel-as-managing-director-the-pharma-letter/</guid></item><item><title><![CDATA[mRNA vaccines lead next-generation efforts to combat H5N1 - The Pharma Letter]]></title><description><![CDATA[mRNA vaccines lead next-generation efforts to combat H5N1&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/mrna-vaccines-lead-next-generation-efforts-to-combat-h5n1-the-pharma-letter/</link><pubDate>Mon, 23 Sep 2024 14:57:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/mrna-vaccines-lead-next-generation-efforts-to-combat-h5n1-the-pharma-letter/</guid></item><item><title><![CDATA[New FDA approvals for UCB’s Bimzelx - The Pharma Letter]]></title><description><![CDATA[New FDA approvals for UCB&rsquo;s Bimzelx&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/new-fda-approvals-for-ucbs-bimzelx-the-pharma-letter/</link><pubDate>Mon, 23 Sep 2024 14:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/new-fda-approvals-for-ucbs-bimzelx-the-pharma-letter/</guid></item><item><title><![CDATA[Scalable and unsupervised discovery from raw sequencing reads using SPLASH2 - Nature.com]]></title><description><![CDATA[Scalable and unsupervised discovery from raw sequencing reads using SPLASH2&nbsp;&nbsp;Nature.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/scalable-and-unsupervised-discovery-from-raw-sequencing-reads-using-splash2-naturecom/</link><pubDate>Mon, 23 Sep 2024 12:18:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/scalable-and-unsupervised-discovery-from-raw-sequencing-reads-using-splash2-naturecom/</guid></item><item><title><![CDATA[Plastic-eating bacteria boost growing business of bioremediation - Nature.com]]></title><description><![CDATA[Plastic-eating bacteria boost growing business of bioremediation&nbsp;&nbsp;Nature.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/plastic-eating-bacteria-boost-growing-business-of-bioremediation-naturecom/</link><pubDate>Mon, 23 Sep 2024 12:18:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/plastic-eating-bacteria-boost-growing-business-of-bioremediation-naturecom/</guid></item><item><title><![CDATA[Vicebio raises $100 million for next-gen respiratory virus vaccines - The Pharma Letter]]></title><description><![CDATA[Vicebio raises $100 million for next-gen respiratory virus vaccines&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/vicebio-raises-100-million-for-next-gen-respiratory-virus-vaccines-the-pharma-letter/</link><pubDate>Mon, 23 Sep 2024 12:04:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/vicebio-raises-100-million-for-next-gen-respiratory-virus-vaccines-the-pharma-letter/</guid></item><item><title><![CDATA[Building better mRNA for therapeutics - Nature.com]]></title><description><![CDATA[Building better mRNA for therapeutics&nbsp;&nbsp;Nature.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/building-better-mrna-for-therapeutics-naturecom/</link><pubDate>Mon, 23 Sep 2024 11:57:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/building-better-mrna-for-therapeutics-naturecom/</guid></item><item><title><![CDATA[Sanofi’s Sarclisa gains third FDA approval - The Pharma Letter]]></title><description><![CDATA[Sanofi&rsquo;s Sarclisa gains third FDA approval&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/sanofis-sarclisa-gains-third-fda-approval-the-pharma-letter/</link><pubDate>Mon, 23 Sep 2024 11:12:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/sanofis-sarclisa-gains-third-fda-approval-the-pharma-letter/</guid></item><item><title><![CDATA[Perspective Therapeutics, Inc.(NYSEAM:CATX) added to S&amp;P Biotechnology Select Industry Index - Marketscreener.com]]></title><description><![CDATA[Perspective Therapeutics, Inc.(NYSEAM:CATX) added to S&amp;P Biotechnology Select Industry Index&nbsp;&nbsp;Marketscreener.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/perspective-therapeutics-incnyseamcatx-added-to-sampp-biotechnology-select-industry-index-marketscreenercom/</link><pubDate>Mon, 23 Sep 2024 00:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/perspective-therapeutics-incnyseamcatx-added-to-sampp-biotechnology-select-industry-index-marketscreenercom/</guid></item><item><title><![CDATA[Erasca, Inc.(NasdaqGS: ERAS) added to S&amp;P Biotechnology Select Industry Index - Marketscreener.com]]></title><description><![CDATA[Erasca, Inc.(NasdaqGS: ERAS) added to S&amp;P Biotechnology Select Industry Index&nbsp;&nbsp;Marketscreener.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/erasca-incnasdaqgs-eras-added-to-sampp-biotechnology-select-industry-index-marketscreenercom/</link><pubDate>Mon, 23 Sep 2024 00:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/erasca-incnasdaqgs-eras-added-to-sampp-biotechnology-select-industry-index-marketscreenercom/</guid></item><item><title><![CDATA[ArriVent BioPharma, Inc.(NasdaqGM:AVBP) added to S&amp;P Biotechnology Select Industry Index - Marketscreener.com]]></title><description><![CDATA[ArriVent BioPharma, Inc.(NasdaqGM:AVBP) added to S&amp;P Biotechnology Select Industry Index&nbsp;&nbsp;Marketscreener.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/arrivent-biopharma-incnasdaqgmavbp-added-to-sampp-biotechnology-select-industry-index-marketscreenercom/</link><pubDate>Mon, 23 Sep 2024 00:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/arrivent-biopharma-incnasdaqgmavbp-added-to-sampp-biotechnology-select-industry-index-marketscreenercom/</guid></item><item><title><![CDATA[Our Appetite for Meat Is Hurting the Environment. Enter Lab-Grown Meat.]]></title><description><![CDATA[Are we ready for the future of meat?]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/our-appetite-for-meat-is-hurting-the-environment-enter-lab-grown-meat/</link><pubDate>Sat, 21 Sep 2024 18:09:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/our-appetite-for-meat-is-hurting-the-environment-enter-lab-grown-meat/</guid></item><item><title><![CDATA[BeiGene's Tevimbra gains approval in Israel - The Pharma Letter]]></title><description><![CDATA[BeiGene's Tevimbra gains approval in Israel&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/beigenes-tevimbra-gains-approval-in-israel-the-pharma-letter/</link><pubDate>Fri, 20 Sep 2024 13:50:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/beigenes-tevimbra-gains-approval-in-israel-the-pharma-letter/</guid></item><item><title><![CDATA[Edgewise shares jump after positive heart drug data - The Pharma Letter]]></title><description><![CDATA[Edgewise shares jump after positive heart drug data&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/edgewise-shares-jump-after-positive-heart-drug-data-the-pharma-letter/</link><pubDate>Fri, 20 Sep 2024 12:08:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/edgewise-shares-jump-after-positive-heart-drug-data-the-pharma-letter/</guid></item><item><title><![CDATA[Achilles Thera shifts focus to new cancer treatment avenues - The Pharma Letter]]></title><description><![CDATA[Achilles Thera shifts focus to new cancer treatment avenues&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/achilles-thera-shifts-focus-to-new-cancer-treatment-avenues-the-pharma-letter/</link><pubDate>Fri, 20 Sep 2024 12:05:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/achilles-thera-shifts-focus-to-new-cancer-treatment-avenues-the-pharma-letter/</guid></item><item><title><![CDATA[FDA approves new indication for Rybrevant - The Pharma Letter]]></title><description><![CDATA[FDA approves new indication for Rybrevant&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/fda-approves-new-indication-for-rybrevant-the-pharma-letter/</link><pubDate>Fri, 20 Sep 2024 12:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/fda-approves-new-indication-for-rybrevant-the-pharma-letter/</guid></item><item><title><![CDATA[Shaping the Future of Biotechnology: Expression 360’s Creative Vision Shines at Global Bio India 2024 - Ahmedabad Mirror]]></title><description><![CDATA[Shaping the Future of Biotechnology: Expression 360&rsquo;s Creative Vision Shines at Global Bio India 2024&nbsp;&nbsp;Ahmedabad Mirror]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/shaping-the-future-of-biotechnology-expression-360s-creative-vision-shines-at-global-bio-india-2024-ahmedabad-mirror/</link><pubDate>Fri, 20 Sep 2024 10:54:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/shaping-the-future-of-biotechnology-expression-360s-creative-vision-shines-at-global-bio-india-2024-ahmedabad-mirror/</guid></item><item><title><![CDATA[Passaic County Technical Institute in Wayne opens $24M biotechnology center - NorthJersey.com]]></title><description><![CDATA[Passaic County Technical Institute in Wayne opens $24M biotechnology center&nbsp;&nbsp;NorthJersey.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/passaic-county-technical-institute-in-wayne-opens-24m-biotechnology-center-northjerseycom/</link><pubDate>Fri, 20 Sep 2024 10:24:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/passaic-county-technical-institute-in-wayne-opens-24m-biotechnology-center-northjerseycom/</guid></item><item><title><![CDATA[Agricultural Biotechnology Market Hits $232 Billion By 2033 - Market.us Media - United States Market News]]></title><description><![CDATA[Agricultural Biotechnology Market Hits $232 Billion By 2033&nbsp;&nbsp;Market.us Media - United States Market News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/agricultural-biotechnology-market-hits-232-billion-by-2033-marketus-media-united-states-market-news/</link><pubDate>Fri, 20 Sep 2024 09:52:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/agricultural-biotechnology-market-hits-232-billion-by-2033-marketus-media-united-states-market-news/</guid></item><item><title><![CDATA[Biotechnology Market Share Expected to Surge to USD 6.24 Trillion by 2032, Driven by Innovative Advances - openPR]]></title><description><![CDATA[Biotechnology Market Share Expected to Surge to USD 6.24 Trillion by 2032, Driven by Innovative Advances&nbsp;&nbsp;openPR]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/biotechnology-market-share-expected-to-surge-to-usd-624-trillion-by-2032-driven-by-innovative-advances-openpr/</link><pubDate>Fri, 20 Sep 2024 09:14:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/biotechnology-market-share-expected-to-surge-to-usd-624-trillion-by-2032-driven-by-innovative-advances-openpr/</guid></item><item><title><![CDATA[Mesoblast (MESO): Biotechnology Innovator Nearing Critical Milestones for Life-Changing Therapies - Insider Monkey]]></title><description><![CDATA[Mesoblast (MESO): Biotechnology Innovator Nearing Critical Milestones for Life-Changing Therapies&nbsp;&nbsp;Insider Monkey]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/mesoblast-meso-biotechnology-innovator-nearing-critical-milestones-for-life-changing-therapies-insider-monkey/</link><pubDate>Fri, 20 Sep 2024 05:03:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/mesoblast-meso-biotechnology-innovator-nearing-critical-milestones-for-life-changing-therapies-insider-monkey/</guid></item><item><title><![CDATA[Unsecured Loan Facility from Sichuan Hebang Biotechnology - Investing News Network]]></title><description><![CDATA[Unsecured Loan Facility from Sichuan Hebang Biotechnology&nbsp;&nbsp;Investing News Network]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/unsecured-loan-facility-from-sichuan-hebang-biotechnology-investing-news-network/</link><pubDate>Fri, 20 Sep 2024 02:24:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/unsecured-loan-facility-from-sichuan-hebang-biotechnology-investing-news-network/</guid></item><item><title><![CDATA[Evaluating neuroprivacy concerns in human brain organoid research]]></title><description><![CDATA[Neuroprivacy, or the privacy of neural data, has attracted considerable interest. Here, we explore the implications of neuroprivacy in human brain organoid research, detailing different interpretations of this right. Findings suggest a limited connection between neuroprivacy and brain organoid research, underscoring the importance of further examination of this critical issue.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/evaluating-neuroprivacy-concerns-in-human-brain-organoid-research/</link><pubDate>Fri, 20 Sep 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/evaluating-neuroprivacy-concerns-in-human-brain-organoid-research/</guid></item><item><title><![CDATA[Engineering the mangrove soil microbiome for selection of polyethylene terephthalate-transforming bacterial consortia]]></title><description><![CDATA[Engineering microbiomes to effectively transform plastics is an exciting research theme in microbiology and biotechnology. Here, we developed and implemented an approach to artificially select polyethylene terephthalate (PET)-transforming bacterial consortia using mangrove soils. Our results enhanced the ecological understanding of PET transformation and described putative novel PET-degrading enzymes obtained via genome-resolved metagenomics.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/engineering-the-mangrove-soil-microbiome-for-selection-of-polyethylene-terephthalate-transforming-bacterial-consortia/</link><pubDate>Fri, 20 Sep 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/engineering-the-mangrove-soil-microbiome-for-selection-of-polyethylene-terephthalate-transforming-bacterial-consortia/</guid></item><item><title><![CDATA[Engineering large-scale hiPSC-derived vessel-integrated muscle-like lattices for enhanced volumetric muscle regeneration]]></title><description><![CDATA[We developed scalable vessel-integrated muscle-like lattices (VMLs) with dense, aligned human induced pluripotent stem cell (hiPSC)-derived myofibers and vessel-like structures using a novel bioprinting technology. These VMLs significantly improved muscle tissue regeneration and function in mice post-volumetric muscle loss. These modular lattices can be adapted to large-scale muscle defects where native regeneration is impaired.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/engineering-large-scale-hipsc-derived-vessel-integrated-muscle-like-lattices-for-enhanced-volumetric-muscle-regeneration/</link><pubDate>Fri, 20 Sep 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/engineering-large-scale-hipsc-derived-vessel-integrated-muscle-like-lattices-for-enhanced-volumetric-muscle-regeneration/</guid></item><item><title><![CDATA[Bringing carbon to life via one-carbon metabolism]]></title><description><![CDATA[One-carbon (C1) compounds found in greenhouse gases and industrial waste streams are underutilized carbon and energy sources. While various biological and chemical means exist for converting C1 substrates into multicarbon products, major challenges of C1 conversion lie in creating net value. Here, we review metabolic strategies to utilize carbon across oxidation states. Complications arise in biochemical C1-utilization approaches because of the need for cellular energy currency ATP. ATP supports]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/bringing-carbon-to-life-via-one-carbon-metabolism/</link><pubDate>Fri, 20 Sep 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/bringing-carbon-to-life-via-one-carbon-metabolism/</guid></item><item><title><![CDATA[Sana Biotechnology (NASDAQ:SANA) Trading Up 9.6% - MarketBeat]]></title><description><![CDATA[Sana Biotechnology (NASDAQ:SANA) Trading Up 9.6%&nbsp;&nbsp;MarketBeat]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/sana-biotechnology-nasdaqsana-trading-up-96-marketbeat/</link><pubDate>Thu, 19 Sep 2024 22:52:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/sana-biotechnology-nasdaqsana-trading-up-96-marketbeat/</guid></item><item><title><![CDATA[Positive data from pivotal AGAVE-201 trial of Niktimvo published - The Pharma Letter]]></title><description><![CDATA[Positive data from pivotal AGAVE-201 trial of Niktimvo published&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/positive-data-from-pivotal-agave-201-trial-of-niktimvo-published-the-pharma-letter/</link><pubDate>Thu, 19 Sep 2024 18:07:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/positive-data-from-pivotal-agave-201-trial-of-niktimvo-published-the-pharma-letter/</guid></item><item><title><![CDATA[Stalicla names chief scientific and clinical development advisor - The Pharma Letter]]></title><description><![CDATA[Stalicla names chief scientific and clinical development advisor&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/stalicla-names-chief-scientific-and-clinical-development-advisor-the-pharma-letter/</link><pubDate>Thu, 19 Sep 2024 16:20:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/stalicla-names-chief-scientific-and-clinical-development-advisor-the-pharma-letter/</guid></item><item><title><![CDATA[Syed Husain named BioCentriq boss - The Pharma Letter]]></title><description><![CDATA[Syed Husain named BioCentriq boss&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/syed-husain-named-biocentriq-boss-the-pharma-letter/</link><pubDate>Thu, 19 Sep 2024 14:39:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/syed-husain-named-biocentriq-boss-the-pharma-letter/</guid></item><item><title><![CDATA[India launches new Bio-RIDE programme to boost biotechnology - TV BRICS (Eng)]]></title><description><![CDATA[India launches new Bio-RIDE programme to boost biotechnology&nbsp;&nbsp;TV BRICS (Eng)]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/india-launches-new-bio-ride-programme-to-boost-biotechnology-tv-brics-eng/</link><pubDate>Thu, 19 Sep 2024 14:36:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/india-launches-new-bio-ride-programme-to-boost-biotechnology-tv-brics-eng/</guid></item><item><title><![CDATA[Upstream Bio goes public amid spate of IPOs - The Pharma Letter]]></title><description><![CDATA[Upstream Bio goes public amid spate of IPOs&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/upstream-bio-goes-public-amid-spate-of-ipos-the-pharma-letter/</link><pubDate>Thu, 19 Sep 2024 12:16:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/upstream-bio-goes-public-amid-spate-of-ipos-the-pharma-letter/</guid></item><item><title><![CDATA[Cabinet approves &lsquo;Bio-RIDE&rsquo; scheme to support R&amp;D in Biotechnology - Express Pharma]]></title><description><![CDATA[Cabinet approves &lsquo;Bio-RIDE&rsquo; scheme to support R&amp;D in Biotechnology&nbsp;&nbsp;Express Pharma]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/cabinet-approves-lsquobio-ridersquo-scheme-to-support-rampd-in-biotechnology-express-pharma/</link><pubDate>Thu, 19 Sep 2024 12:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/cabinet-approves-lsquobio-ridersquo-scheme-to-support-rampd-in-biotechnology-express-pharma/</guid></item><item><title><![CDATA[French Brenus AS closes US$25m financing - European Biotechnology News]]></title><description><![CDATA[French Brenus AS closes US$25m financing&nbsp;&nbsp;European Biotechnology News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/french-brenus-as-closes-us25m-financing-european-biotechnology-news/</link><pubDate>Thu, 19 Sep 2024 11:30:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/french-brenus-as-closes-us25m-financing-european-biotechnology-news/</guid></item><item><title><![CDATA[Nautilus Biotechnology senior VP sells shares worth over $99k - Investing.com]]></title><description><![CDATA[Nautilus Biotechnology senior VP sells shares worth over $99k&nbsp;&nbsp;Investing.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/nautilus-biotechnology-senior-vp-sells-shares-worth-over-99k-investingcom/</link><pubDate>Thu, 19 Sep 2024 00:40:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/nautilus-biotechnology-senior-vp-sells-shares-worth-over-99k-investingcom/</guid></item><item><title><![CDATA[Nura Bio closes further financing; names new CEO - The Pharma Letter]]></title><description><![CDATA[Nura Bio closes further financing; names new CEO&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/nura-bio-closes-further-financing-names-new-ceo-the-pharma-letter/</link><pubDate>Thu, 19 Sep 2024 00:26:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/nura-bio-closes-further-financing-names-new-ceo-the-pharma-letter/</guid></item><item><title><![CDATA[Passaic County Technical Institute Opens State-of-the-Art John Currie Biotechnology Innovation Center - TAPinto.net]]></title><description><![CDATA[Passaic County Technical Institute Opens State-of-the-Art John Currie Biotechnology Innovation Center&nbsp;&nbsp;TAPinto.net]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/passaic-county-technical-institute-opens-state-of-the-art-john-currie-biotechnology-innovation-center-tapintonet/</link><pubDate>Wed, 18 Sep 2024 21:10:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/passaic-county-technical-institute-opens-state-of-the-art-john-currie-biotechnology-innovation-center-tapintonet/</guid></item><item><title><![CDATA[Govt greenlights ₹9,197 crore Bio-RIDE scheme to advance biotechnology, biomanufacturing - ETEnergyWorld]]></title><description><![CDATA[Govt greenlights &#8377;9,197 crore Bio-RIDE scheme to advance biotechnology, biomanufacturing&nbsp;&nbsp;ETEnergyWorld]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/govt-greenlights-9197-crore-bio-ride-scheme-to-advance-biotechnology-biomanufacturing-etenergyworld/</link><pubDate>Wed, 18 Sep 2024 13:14:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/govt-greenlights-9197-crore-bio-ride-scheme-to-advance-biotechnology-biomanufacturing-etenergyworld/</guid></item><item><title><![CDATA[Positive Ascendis data threatens BioMarin's lead in achondroplasia - The Pharma Letter]]></title><description><![CDATA[Positive Ascendis data threatens BioMarin's lead in achondroplasia&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/positive-ascendis-data-threatens-biomarins-lead-in-achondroplasia-the-pharma-letter/</link><pubDate>Wed, 18 Sep 2024 12:20:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/positive-ascendis-data-threatens-biomarins-lead-in-achondroplasia-the-pharma-letter/</guid></item><item><title><![CDATA[A developmental route to hematopoietic stem cells - Nature.com]]></title><description><![CDATA[A developmental route to hematopoietic stem cells&nbsp;&nbsp;Nature.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/a-developmental-route-to-hematopoietic-stem-cells-naturecom/</link><pubDate>Wed, 18 Sep 2024 11:32:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/a-developmental-route-to-hematopoietic-stem-cells-naturecom/</guid></item><item><title><![CDATA[Von der Leyen names new EU Commissioners - European Biotechnology News]]></title><description><![CDATA[Von der Leyen names new EU Commissioners&nbsp;&nbsp;European Biotechnology News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/von-der-leyen-names-new-eu-commissioners-european-biotechnology-news/</link><pubDate>Wed, 18 Sep 2024 11:25:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/von-der-leyen-names-new-eu-commissioners-european-biotechnology-news/</guid></item><item><title><![CDATA[Von der Leyen names new EU Commisionners - European Biotechnology News]]></title><description><![CDATA[Von der Leyen names new EU Commisionners&nbsp;&nbsp;European Biotechnology News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/von-der-leyen-names-new-eu-commisionners-european-biotechnology-news/</link><pubDate>Wed, 18 Sep 2024 11:25:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/von-der-leyen-names-new-eu-commisionners-european-biotechnology-news/</guid></item><item><title><![CDATA[Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing Officer - BioSpace]]></title><description><![CDATA[Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing Officer&nbsp;&nbsp;BioSpace]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/nautilus-biotechnology-appoints-mass-spectrometry-leader-ken-suzuki-as-chief-marketing-officer-biospace/</link><pubDate>Wed, 18 Sep 2024 09:32:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/nautilus-biotechnology-appoints-mass-spectrometry-leader-ken-suzuki-as-chief-marketing-officer-biospace/</guid></item><item><title><![CDATA[Harnessing the power of Canada’s growing biotechnology industry: a perspective from the West - The Hill Times]]></title><description><![CDATA[Harnessing the power of Canada&rsquo;s growing biotechnology industry: a perspective from the West&nbsp;&nbsp;The Hill Times]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/harnessing-the-power-of-canadas-growing-biotechnology-industry-a-perspective-from-the-west-the-hill-times/</link><pubDate>Wed, 18 Sep 2024 07:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/harnessing-the-power-of-canadas-growing-biotechnology-industry-a-perspective-from-the-west-the-hill-times/</guid></item><item><title><![CDATA[Biotechnology must factor into a broader Canadian industrial policy - The Hill Times]]></title><description><![CDATA[Biotechnology must factor into a broader Canadian industrial policy&nbsp;&nbsp;The Hill Times]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/biotechnology-must-factor-into-a-broader-canadian-industrial-policy-the-hill-times/</link><pubDate>Wed, 18 Sep 2024 07:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/biotechnology-must-factor-into-a-broader-canadian-industrial-policy-the-hill-times/</guid></item><item><title><![CDATA[Biotechnology: an opportunity balanced on a knife’s edge - The Hill Times]]></title><description><![CDATA[Biotechnology: an opportunity balanced on a knife&rsquo;s edge&nbsp;&nbsp;The Hill Times]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/biotechnology-an-opportunity-balanced-on-a-knifes-edge-the-hill-times/</link><pubDate>Wed, 18 Sep 2024 07:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/biotechnology-an-opportunity-balanced-on-a-knifes-edge-the-hill-times/</guid></item><item><title><![CDATA[Artificial design of the genome: from sequences to the 3D structure of chromosomes]]></title><description><![CDATA[Genome design is the foundation of genome synthesis, which provides a new platform for deepening our understanding of biological systems by exploring the fundamental components and structure of the genome. Artificial genome designs can endow unnatural genomes with desired functions. We provide a comprehensive overview of genome design principles ranging from DNA sequences to the 3D structure of chromosomes. Furthermore, we highlight applications of genome design in gene expression, genome struct]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/artificial-design-of-the-genome-from-sequences-to-the-3d-structure-of-chromosomes/</link><pubDate>Wed, 18 Sep 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/artificial-design-of-the-genome-from-sequences-to-the-3d-structure-of-chromosomes/</guid></item><item><title><![CDATA[NevadaFit prepares new College of Agriculture, Biotechnology &amp; Natural Resources students for academic success - University of Nevada, Reno]]></title><description><![CDATA[NevadaFit prepares new College of Agriculture, Biotechnology &amp; Natural Resources students for academic success&nbsp;&nbsp;University of Nevada, Reno]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/nevadafit-prepares-new-college-of-agriculture-biotechnology-amp-natural-resources-students-for-academic-success-university-of-nevada-reno/</link><pubDate>Tue, 17 Sep 2024 18:35:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/nevadafit-prepares-new-college-of-agriculture-biotechnology-amp-natural-resources-students-for-academic-success-university-of-nevada-reno/</guid></item><item><title><![CDATA[Nautilus Biotechnology appoints Ken Suzuki as Chief Marketing Officer - TipRanks]]></title><description><![CDATA[Nautilus Biotechnology appoints Ken Suzuki as Chief Marketing Officer&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/nautilus-biotechnology-appoints-ken-suzuki-as-chief-marketing-officer-tipranks/</link><pubDate>Tue, 17 Sep 2024 14:19:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/nautilus-biotechnology-appoints-ken-suzuki-as-chief-marketing-officer-tipranks/</guid></item><item><title><![CDATA[Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing Officer - StockTitan]]></title><description><![CDATA[Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing Officer&nbsp;&nbsp;StockTitan]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/nautilus-biotechnology-appoints-mass-spectrometry-leader-ken-suzuki-as-chief-marketing-officer-stocktitan/</link><pubDate>Tue, 17 Sep 2024 14:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/nautilus-biotechnology-appoints-mass-spectrometry-leader-ken-suzuki-as-chief-marketing-officer-stocktitan/</guid></item><item><title><![CDATA[MinervaX partners with Wacker to produce vaccine ingredients - The Pharma Letter]]></title><description><![CDATA[MinervaX partners with Wacker to produce vaccine ingredients&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/minervax-partners-with-wacker-to-produce-vaccine-ingredients-the-pharma-letter/</link><pubDate>Tue, 17 Sep 2024 13:32:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/minervax-partners-with-wacker-to-produce-vaccine-ingredients-the-pharma-letter/</guid></item><item><title><![CDATA[Bristol Myers ends cancer drug collab with Immatics - The Pharma Letter]]></title><description><![CDATA[Bristol Myers ends cancer drug collab with Immatics&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/bristol-myers-ends-cancer-drug-collab-with-immatics-the-pharma-letter/</link><pubDate>Tue, 17 Sep 2024 13:32:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/bristol-myers-ends-cancer-drug-collab-with-immatics-the-pharma-letter/</guid></item><item><title><![CDATA[Bicara Therapeutics raises $362 million in Nasdaq debut - The Pharma Letter]]></title><description><![CDATA[Bicara Therapeutics raises $362 million in Nasdaq debut&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/bicara-therapeutics-raises-362-million-in-nasdaq-debut-the-pharma-letter/</link><pubDate>Tue, 17 Sep 2024 12:20:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/bicara-therapeutics-raises-362-million-in-nasdaq-debut-the-pharma-letter/</guid></item><item><title><![CDATA[IMU Biosciences seeks growth with new chief executive - The Pharma Letter]]></title><description><![CDATA[IMU Biosciences seeks growth with new chief executive&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/imu-biosciences-seeks-growth-with-new-chief-executive-the-pharma-letter/</link><pubDate>Tue, 17 Sep 2024 12:19:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/imu-biosciences-seeks-growth-with-new-chief-executive-the-pharma-letter/</guid></item><item><title><![CDATA[ESMO 2024: Eisai and Merck report positive Phase III results - The Pharma Letter]]></title><description><![CDATA[ESMO 2024: Eisai and Merck report positive Phase III results&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/esmo-2024-eisai-and-merck-report-positive-phase-iii-results-the-pharma-letter/</link><pubDate>Tue, 17 Sep 2024 12:18:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/esmo-2024-eisai-and-merck-report-positive-phase-iii-results-the-pharma-letter/</guid></item><item><title><![CDATA[Roche sets out obesity strategy with manufacturing focus - The Pharma Letter]]></title><description><![CDATA[Roche sets out obesity strategy with manufacturing focus&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/roche-sets-out-obesity-strategy-with-manufacturing-focus-the-pharma-letter/</link><pubDate>Tue, 17 Sep 2024 11:08:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/roche-sets-out-obesity-strategy-with-manufacturing-focus-the-pharma-letter/</guid></item><item><title><![CDATA[ImmuneSensor Therapeutics to Participate in the UBS 2024 Virtual Biotechnology Private Company Symposium - Yahoo Finance]]></title><description><![CDATA[ImmuneSensor Therapeutics to Participate in the UBS 2024 Virtual Biotechnology Private Company Symposium&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/immunesensor-therapeutics-to-participate-in-the-ubs-2024-virtual-biotechnology-private-company-symposium-yahoo-finance/</link><pubDate>Mon, 16 Sep 2024 22:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/immunesensor-therapeutics-to-participate-in-the-ubs-2024-virtual-biotechnology-private-company-symposium-yahoo-finance/</guid></item><item><title><![CDATA[NImmune Biopharma to Participate in UBS Virtual Biotechnology Private Company Symposium - BioSpace]]></title><description><![CDATA[NImmune Biopharma to Participate in UBS Virtual Biotechnology Private Company Symposium&nbsp;&nbsp;BioSpace]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/nimmune-biopharma-to-participate-in-ubs-virtual-biotechnology-private-company-symposium-biospace/</link><pubDate>Mon, 16 Sep 2024 20:24:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/nimmune-biopharma-to-participate-in-ubs-virtual-biotechnology-private-company-symposium-biospace/</guid></item><item><title><![CDATA[Roche scores first, with FDA approval of Ocrevus Zunovo for MS - The Pharma Letter]]></title><description><![CDATA[Roche scores first, with FDA approval of Ocrevus Zunovo for MS&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/roche-scores-first-with-fda-approval-of-ocrevus-zunovo-for-ms-the-pharma-letter/</link><pubDate>Mon, 16 Sep 2024 17:21:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/roche-scores-first-with-fda-approval-of-ocrevus-zunovo-for-ms-the-pharma-letter/</guid></item><item><title><![CDATA[Shenzhen Zhongge Biotechnology discloses new STING agonists - BioWorld Online]]></title><description><![CDATA[Shenzhen Zhongge Biotechnology discloses new STING agonists&nbsp;&nbsp;BioWorld Online]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/shenzhen-zhongge-biotechnology-discloses-new-sting-agonists-bioworld-online/</link><pubDate>Mon, 16 Sep 2024 15:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/shenzhen-zhongge-biotechnology-discloses-new-sting-agonists-bioworld-online/</guid></item><item><title><![CDATA[NImmune Biopharma to Participate in UBS Virtual Biotechnology Private Company Symposium - Business Wire]]></title><description><![CDATA[NImmune Biopharma to Participate in UBS Virtual Biotechnology Private Company Symposium&nbsp;&nbsp;Business Wire]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/nimmune-biopharma-to-participate-in-ubs-virtual-biotechnology-private-company-symposium-business-wire/</link><pubDate>Mon, 16 Sep 2024 15:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/nimmune-biopharma-to-participate-in-ubs-virtual-biotechnology-private-company-symposium-business-wire/</guid></item><item><title><![CDATA[Trailhead Biosystems appoints new chief commercial officer - The Pharma Letter]]></title><description><![CDATA[Trailhead Biosystems appoints new chief commercial officer&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/trailhead-biosystems-appoints-new-chief-commercial-officer-the-pharma-letter/</link><pubDate>Mon, 16 Sep 2024 14:25:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/trailhead-biosystems-appoints-new-chief-commercial-officer-the-pharma-letter/</guid></item><item><title><![CDATA[Marine Biotechnology Market Size: Set to Reach USD 10.49 Billion by 2031| SkyQuest Technology - openPR]]></title><description><![CDATA[Marine Biotechnology Market Size: Set to Reach USD 10.49 Billion by 2031| SkyQuest Technology&nbsp;&nbsp;openPR]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/marine-biotechnology-market-size-set-to-reach-usd-1049-billion-by-2031-skyquest-technology-openpr/</link><pubDate>Mon, 16 Sep 2024 14:05:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/marine-biotechnology-market-size-set-to-reach-usd-1049-billion-by-2031-skyquest-technology-openpr/</guid></item><item><title><![CDATA[New RNA manufacturing firm has focus on Asia-Pacific region - The Pharma Letter]]></title><description><![CDATA[New RNA manufacturing firm has focus on Asia-Pacific region&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/new-rna-manufacturing-firm-has-focus-on-asia-pacific-region-the-pharma-letter/</link><pubDate>Mon, 16 Sep 2024 14:03:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/new-rna-manufacturing-firm-has-focus-on-asia-pacific-region-the-pharma-letter/</guid></item><item><title><![CDATA[ESMO 2024: Imfinzi NIAGARA Phase III trial success in bladder cancer - The Pharma Letter]]></title><description><![CDATA[ESMO 2024: Imfinzi NIAGARA Phase III trial success in bladder cancer&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/esmo-2024-imfinzi-niagara-phase-iii-trial-success-in-bladder-cancer-the-pharma-letter/</link><pubDate>Mon, 16 Sep 2024 14:03:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/esmo-2024-imfinzi-niagara-phase-iii-trial-success-in-bladder-cancer-the-pharma-letter/</guid></item><item><title><![CDATA[New gene therapy company emerges with $26 million - The Pharma Letter]]></title><description><![CDATA[New gene therapy company emerges with $26 million&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/new-gene-therapy-company-emerges-with-26-million-the-pharma-letter/</link><pubDate>Mon, 16 Sep 2024 14:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/new-gene-therapy-company-emerges-with-26-million-the-pharma-letter/</guid></item><item><title><![CDATA[PDS Biotechnology announces updates data from VERSATILE-002 trial - TipRanks]]></title><description><![CDATA[PDS Biotechnology announces updates data from VERSATILE-002 trial&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/pds-biotechnology-announces-updates-data-from-versatile-002-trial-tipranks/</link><pubDate>Mon, 16 Sep 2024 13:15:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/pds-biotechnology-announces-updates-data-from-versatile-002-trial-tipranks/</guid></item><item><title><![CDATA[Phase III ESMO data show impact of Incyte's retifanlimab - The Pharma Letter]]></title><description><![CDATA[Phase III ESMO data show impact of Incyte's retifanlimab&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/phase-iii-esmo-data-show-impact-of-incytes-retifanlimab-the-pharma-letter/</link><pubDate>Mon, 16 Sep 2024 11:53:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/phase-iii-esmo-data-show-impact-of-incytes-retifanlimab-the-pharma-letter/</guid></item><item><title><![CDATA[Hong Kong Investment Corp to Invest in Biotechnology, Sustainable Energy, Health - Marketscreener.com]]></title><description><![CDATA[Hong Kong Investment Corp to Invest in Biotechnology, Sustainable Energy, Health&nbsp;&nbsp;Marketscreener.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/hong-kong-investment-corp-to-invest-in-biotechnology-sustainable-energy-health-marketscreenercom/</link><pubDate>Mon, 16 Sep 2024 09:49:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/hong-kong-investment-corp-to-invest-in-biotechnology-sustainable-energy-health-marketscreenercom/</guid></item><item><title><![CDATA[Department of Biotechnology gears up for Swachhata Hi Seva-2024 &amp; Special Campaign 4.0 - CIO News]]></title><description><![CDATA[Department of Biotechnology gears up for Swachhata Hi Seva-2024 &amp; Special Campaign 4.0&nbsp;&nbsp;CIO News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/department-of-biotechnology-gears-up-for-swachhata-hi-seva-2024-amp-special-campaign-40-cio-news/</link><pubDate>Mon, 16 Sep 2024 09:20:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/department-of-biotechnology-gears-up-for-swachhata-hi-seva-2024-amp-special-campaign-40-cio-news/</guid></item><item><title><![CDATA[San Jacinto College announces innovative biotechnology program to grow talent pipeline - The Business Journals]]></title><description><![CDATA[San Jacinto College announces innovative biotechnology program to grow talent pipeline&nbsp;&nbsp;The Business Journals]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/san-jacinto-college-announces-innovative-biotechnology-program-to-grow-talent-pipeline-the-business-journals/</link><pubDate>Mon, 16 Sep 2024 07:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/san-jacinto-college-announces-innovative-biotechnology-program-to-grow-talent-pipeline-the-business-journals/</guid></item><item><title><![CDATA[Viewpoint: Africanising biotechnology: Scientists call for depoliticization of sustainable agriculture research - Genetic Literacy Project]]></title><description><![CDATA[Viewpoint: Africanising biotechnology: Scientists call for depoliticization of sustainable agriculture research&nbsp;&nbsp;Genetic Literacy Project]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/viewpoint-africanising-biotechnology-scientists-call-for-depoliticization-of-sustainable-agriculture-research-genetic-literacy-project/</link><pubDate>Mon, 16 Sep 2024 06:04:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/viewpoint-africanising-biotechnology-scientists-call-for-depoliticization-of-sustainable-agriculture-research-genetic-literacy-project/</guid></item><item><title><![CDATA[Richter-Helm Biologics triples production capacity - European Biotechnology News]]></title><description><![CDATA[Richter-Helm Biologics triples production capacity&nbsp;&nbsp;European Biotechnology News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/richter-helm-biologics-triples-production-capacity-european-biotechnology-news/</link><pubDate>Sun, 15 Sep 2024 14:14:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/richter-helm-biologics-triples-production-capacity-european-biotechnology-news/</guid></item><item><title><![CDATA[Enzymes boost ‘rock weathering’ to trap CO - Nature.com]]></title><description><![CDATA[Enzymes boost &lsquo;rock weathering&rsquo; to trap CO&nbsp;&nbsp;Nature.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/enzymes-boost-rock-weathering-to-trap-co-naturecom/</link><pubDate>Sat, 14 Sep 2024 01:51:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/enzymes-boost-rock-weathering-to-trap-co-naturecom/</guid></item><item><title><![CDATA[The Wild West of spike-in normalization - Nature.com]]></title><description><![CDATA[The Wild West of spike-in normalization&nbsp;&nbsp;Nature.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/the-wild-west-of-spike-in-normalization-naturecom/</link><pubDate>Fri, 13 Sep 2024 17:54:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/the-wild-west-of-spike-in-normalization-naturecom/</guid></item><item><title><![CDATA[BRIEF—Zenas BioPharma prices upsized IPO | Biotechnology | The Pharmaletter - The Pharma Letter]]></title><description><![CDATA[BRIEF&mdash;Zenas BioPharma prices upsized IPO | Biotechnology | The Pharmaletter&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/briefzenas-biopharma-prices-upsized-ipo-biotechnology-the-pharmaletter-the-pharma-letter/</link><pubDate>Fri, 13 Sep 2024 11:12:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/briefzenas-biopharma-prices-upsized-ipo-biotechnology-the-pharmaletter-the-pharma-letter/</guid></item><item><title><![CDATA[Biogenetic Blooms: it’s microbial, and it’s art - Nature.com]]></title><description><![CDATA[Biogenetic Blooms: it&rsquo;s microbial, and it&rsquo;s art&nbsp;&nbsp;Nature.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/biogenetic-blooms-its-microbial-and-its-art-naturecom/</link><pubDate>Fri, 13 Sep 2024 09:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/biogenetic-blooms-its-microbial-and-its-art-naturecom/</guid></item><item><title><![CDATA[Better Living Through Algae Biotechnology - The Scientist]]></title><description><![CDATA[Better Living Through Algae Biotechnology&nbsp;&nbsp;The Scientist]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/better-living-through-algae-biotechnology-the-scientist/</link><pubDate>Fri, 13 Sep 2024 06:11:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/better-living-through-algae-biotechnology-the-scientist/</guid></item><item><title><![CDATA[Semi-continuous biomanufacturing for maximizing the production of complex chemicals and fuels: a case study of amorpha-4,11-diene]]></title><description><![CDATA[A new semi-continuous bioprocess strategy has been developed to improve the production of complex chemicals and fuels. This approach aims to maintain the highest conversion yield and production rate of the producer strain while simultaneously maximizing both batch and reactor productivity.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/semi-continuous-biomanufacturing-for-maximizing-the-production-of-complex-chemicals-and-fuels-a-case-study-of-amorpha-411-diene/</link><pubDate>Fri, 13 Sep 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/semi-continuous-biomanufacturing-for-maximizing-the-production-of-complex-chemicals-and-fuels-a-case-study-of-amorpha-411-diene/</guid></item><item><title><![CDATA[Protein nanocarrier-enabled plant genetic engineering systems]]></title><description><![CDATA[Genetic engineering can enhance crop yields by developing climate-resilient crop varieties. Nanobiotechnology plays a crucial role in precision delivery of genetic materials, nutrients, and stress-responsive agents into plant cells. This forum highlights recent advances in biodegradable protein-based nanocarrier systems for plant genome editing to transform agricultural practices.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/protein-nanocarrier-enabled-plant-genetic-engineering-systems/</link><pubDate>Fri, 13 Sep 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/protein-nanocarrier-enabled-plant-genetic-engineering-systems/</guid></item><item><title><![CDATA[Why House Republicans Are Targeting China Weeks Before the Election]]></title><description><![CDATA[The G.O.P. pushed through an array of legislation to get tough on China, seeking to persuade voters that they are the party that will protect Americans from economic and military threats from Beijing.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/why-house-republicans-are-targeting-china-weeks-before-the-election/</link><pubDate>Thu, 12 Sep 2024 16:59:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/why-house-republicans-are-targeting-china-weeks-before-the-election/</guid></item><item><title><![CDATA[Researchers, media engage to educate farmers on biotechnology - University World News]]></title><description><![CDATA[Researchers, media engage to educate farmers on biotechnology&nbsp;&nbsp;University World News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/researchers-media-engage-to-educate-farmers-on-biotechnology-university-world-news/</link><pubDate>Thu, 12 Sep 2024 16:05:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/researchers-media-engage-to-educate-farmers-on-biotechnology-university-world-news/</guid></item><item><title><![CDATA[Global Bio-India 2024 Summit: India Set To Lead In Biotechnology - NDTV Profit]]></title><description><![CDATA[Global Bio-India 2024 Summit: India Set To Lead In Biotechnology&nbsp;&nbsp;NDTV Profit]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/global-bio-india-2024-summit-india-set-to-lead-in-biotechnology-ndtv-profit/</link><pubDate>Thu, 12 Sep 2024 15:16:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/global-bio-india-2024-summit-india-set-to-lead-in-biotechnology-ndtv-profit/</guid></item><item><title><![CDATA[London Biotechnology Show Makes Grand Return To Unveil Cutting-edge Advances in Health &amp; Medicine - IBTimes UK]]></title><description><![CDATA[London Biotechnology Show Makes Grand Return To Unveil Cutting-edge Advances in Health &amp; Medicine&nbsp;&nbsp;IBTimes UK]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/london-biotechnology-show-makes-grand-return-to-unveil-cutting-edge-advances-in-health-amp-medicine-ibtimes-uk/</link><pubDate>Thu, 12 Sep 2024 11:54:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/london-biotechnology-show-makes-grand-return-to-unveil-cutting-edge-advances-in-health-amp-medicine-ibtimes-uk/</guid></item><item><title><![CDATA[MAIA Biotechnology - The Pharma Letter]]></title><description><![CDATA[MAIA Biotechnology&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/maia-biotechnology-the-pharma-letter/</link><pubDate>Thu, 12 Sep 2024 11:34:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/maia-biotechnology-the-pharma-letter/</guid></item><item><title><![CDATA[Meg Alexander takes on expanded role at Ovid Therapeutics - The Pharma Letter]]></title><description><![CDATA[Meg Alexander takes on expanded role at Ovid Therapeutics&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/meg-alexander-takes-on-expanded-role-at-ovid-therapeutics-the-pharma-letter/</link><pubDate>Thu, 12 Sep 2024 11:25:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/meg-alexander-takes-on-expanded-role-at-ovid-therapeutics-the-pharma-letter/</guid></item><item><title><![CDATA[A' Biotechnology and Bioengineering Design Award Announces Call for Entries for 2024-2025 Competition - openPR]]></title><description><![CDATA[A' Biotechnology and Bioengineering Design Award Announces Call for Entries for 2024-2025 Competition&nbsp;&nbsp;openPR]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/a-biotechnology-and-bioengineering-design-award-announces-call-for-entries-for-2024-2025-competition-openpr/</link><pubDate>Thu, 12 Sep 2024 09:38:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/a-biotechnology-and-bioengineering-design-award-announces-call-for-entries-for-2024-2025-competition-openpr/</guid></item><item><title><![CDATA[Tesla BioHealing and Cell Biotechnology Partner to Advance Stem Cell Therapies - Vancity Buzz]]></title><description><![CDATA[Tesla BioHealing and Cell Biotechnology Partner to Advance Stem Cell Therapies&nbsp;&nbsp;Vancity Buzz]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/tesla-biohealing-and-cell-biotechnology-partner-to-advance-stem-cell-therapies-vancity-buzz/</link><pubDate>Thu, 12 Sep 2024 06:27:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/tesla-biohealing-and-cell-biotechnology-partner-to-advance-stem-cell-therapies-vancity-buzz/</guid></item><item><title><![CDATA[Tesla BioHealing and Cell Biotechnology Co., Ltd. Forge Strategic Partnership to Transform Stem Cell Therapies - AccessWire]]></title><description><![CDATA[Tesla BioHealing and Cell Biotechnology Co., Ltd. Forge Strategic Partnership to Transform Stem Cell Therapies&nbsp;&nbsp;AccessWire]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/tesla-biohealing-and-cell-biotechnology-co-ltd-forge-strategic-partnership-to-transform-stem-cell-therapies-accesswire/</link><pubDate>Thu, 12 Sep 2024 02:01:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/tesla-biohealing-and-cell-biotechnology-co-ltd-forge-strategic-partnership-to-transform-stem-cell-therapies-accesswire/</guid></item><item><title><![CDATA[Towards more realistic cultivated meat by rethinking bioengineering approaches]]></title><description><![CDATA[Cultivated meat (CM) refers to edible lab-grown meat that incorporates cultivated animal cells. It has the potential to address some issues associated with real meat (RM) production, including the ethical and environmental impact of animal farming, and health concerns. Recently, various biomanufacturing methods have been developed to attempt to recreate realistic meat in the laboratory. We therefore overview recent achievements and challenges in the production of CM. We also discuss the issues t]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/towards-more-realistic-cultivated-meat-by-rethinking-bioengineering-approaches/</link><pubDate>Thu, 12 Sep 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/towards-more-realistic-cultivated-meat-by-rethinking-bioengineering-approaches/</guid></item><item><title><![CDATA[Power-to-vitamins: producing folate (vitamin B9) from renewable electric power and CO2 with a microbial protein system]]></title><description><![CDATA[Microbial protein is a promising alternative to conventional agriculture to safeguard the Earth's resources and support a circular economy. In a two-stage bioprocess, acetate served as an intermediate molecule to grow yeast biomass enriched with folate and protein. This versatile fermentation platform can address food scarcity and alleviate micronutrient deficiencies.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/power-to-vitamins-producing-folate-vitamin-b9-from-renewable-electric-power-and-co2-with-a-microbial-protein-system/</link><pubDate>Thu, 12 Sep 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/power-to-vitamins-producing-folate-vitamin-b9-from-renewable-electric-power-and-co2-with-a-microbial-protein-system/</guid></item><item><title><![CDATA[MAIA Biotechnology Reports Promising Interim Results in Lung Cancer Treatment Study - Vancity Buzz]]></title><description><![CDATA[MAIA Biotechnology Reports Promising Interim Results in Lung Cancer Treatment Study&nbsp;&nbsp;Vancity Buzz]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/maia-biotechnology-reports-promising-interim-results-in-lung-cancer-treatment-study-vancity-buzz/</link><pubDate>Wed, 11 Sep 2024 20:58:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/maia-biotechnology-reports-promising-interim-results-in-lung-cancer-treatment-study-vancity-buzz/</guid></item><item><title><![CDATA[Conference on med devices and biotechnology today - The Times of India]]></title><description><![CDATA[Conference on med devices and biotechnology today&nbsp;&nbsp;The Times of India]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/conference-on-med-devices-and-biotechnology-today-the-times-of-india/</link><pubDate>Wed, 11 Sep 2024 19:57:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/conference-on-med-devices-and-biotechnology-today-the-times-of-india/</guid></item><item><title><![CDATA[Recoded gene circuits for multiplexed genetic code expansion - Nature.com]]></title><description><![CDATA[Recoded gene circuits for multiplexed genetic code expansion&nbsp;&nbsp;Nature.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/recoded-gene-circuits-for-multiplexed-genetic-code-expansion-naturecom/</link><pubDate>Wed, 11 Sep 2024 19:45:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/recoded-gene-circuits-for-multiplexed-genetic-code-expansion-naturecom/</guid></item><item><title><![CDATA[NIFA Announces $5.3 Million Investment in Biotechnology Risk Assessment Research - JD Supra]]></title><description><![CDATA[NIFA Announces $5.3 Million Investment in Biotechnology Risk Assessment Research&nbsp;&nbsp;JD Supra]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/nifa-announces-53-million-investment-in-biotechnology-risk-assessment-research-jd-supra/</link><pubDate>Wed, 11 Sep 2024 19:28:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/nifa-announces-53-million-investment-in-biotechnology-risk-assessment-research-jd-supra/</guid></item><item><title><![CDATA[NewCo model gains traction among Chinese biotechs - The Pharma Letter]]></title><description><![CDATA[NewCo model gains traction among Chinese biotechs&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/newco-model-gains-traction-among-chinese-biotechs-the-pharma-letter/</link><pubDate>Wed, 11 Sep 2024 18:18:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/newco-model-gains-traction-among-chinese-biotechs-the-pharma-letter/</guid></item><item><title><![CDATA[Phoremost reports Series B extension - European Biotechnology News]]></title><description><![CDATA[Phoremost reports Series B extension&nbsp;&nbsp;European Biotechnology News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/phoremost-reports-series-b-extension-european-biotechnology-news/</link><pubDate>Wed, 11 Sep 2024 18:04:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/phoremost-reports-series-b-extension-european-biotechnology-news/</guid></item><item><title><![CDATA[BridgeBio Pharma drops gene therapy program for AAV | Biotechnology | The Pharmaletter - The Pharma Letter]]></title><description><![CDATA[BridgeBio Pharma drops gene therapy program for AAV | Biotechnology | The Pharmaletter&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/bridgebio-pharma-drops-gene-therapy-program-for-aav-biotechnology-the-pharmaletter-the-pharma-letter/</link><pubDate>Wed, 11 Sep 2024 17:45:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/bridgebio-pharma-drops-gene-therapy-program-for-aav-biotechnology-the-pharmaletter-the-pharma-letter/</guid></item><item><title><![CDATA[Funding for green insecticides - European Biotechnology News]]></title><description><![CDATA[Funding for green insecticides&nbsp;&nbsp;European Biotechnology News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/funding-for-green-insecticides-european-biotechnology-news/</link><pubDate>Wed, 11 Sep 2024 16:33:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/funding-for-green-insecticides-european-biotechnology-news/</guid></item><item><title><![CDATA[Ionis Pharmaceuticals announces $500 million public offering | Biotechnology | The Pharmaletter - The Pharma Letter]]></title><description><![CDATA[Ionis Pharmaceuticals announces $500 million public offering | Biotechnology | The Pharmaletter&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/ionis-pharmaceuticals-announces-500-million-public-offering-biotechnology-the-pharmaletter-the-pharma-letter/</link><pubDate>Wed, 11 Sep 2024 16:15:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/ionis-pharmaceuticals-announces-500-million-public-offering-biotechnology-the-pharmaletter-the-pharma-letter/</guid></item><item><title><![CDATA[Boston Institute of Biotechnology &amp; BiBo Pharma CEO Wins 2024 Global Biologics CDMO Technology Leadership Award - PR Newswire]]></title><description><![CDATA[Boston Institute of Biotechnology &amp; BiBo Pharma CEO Wins 2024 Global Biologics CDMO Technology Leadership Award&nbsp;&nbsp;PR Newswire]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/boston-institute-of-biotechnology-amp-bibo-pharma-ceo-wins-2024-global-biologics-cdmo-technology-leadership-award-pr-newswire/</link><pubDate>Wed, 11 Sep 2024 16:02:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/boston-institute-of-biotechnology-amp-bibo-pharma-ceo-wins-2024-global-biologics-cdmo-technology-leadership-award-pr-newswire/</guid></item><item><title><![CDATA[Regeneron’s Libtayo shows strong survival rates in lung cancer - The Pharma Letter]]></title><description><![CDATA[Regeneron&rsquo;s Libtayo shows strong survival rates in lung cancer&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/regenerons-libtayo-shows-strong-survival-rates-in-lung-cancer-the-pharma-letter/</link><pubDate>Wed, 11 Sep 2024 13:31:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/regenerons-libtayo-shows-strong-survival-rates-in-lung-cancer-the-pharma-letter/</guid></item><item><title><![CDATA[Atara Therapeutics appoints Cokey Nguyen as chief executive - The Pharma Letter]]></title><description><![CDATA[Atara Therapeutics appoints Cokey Nguyen as chief executive&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/atara-therapeutics-appoints-cokey-nguyen-as-chief-executive-the-pharma-letter/</link><pubDate>Wed, 11 Sep 2024 12:48:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/atara-therapeutics-appoints-cokey-nguyen-as-chief-executive-the-pharma-letter/</guid></item><item><title><![CDATA[Nautilus Biotechnology, Inc.'s (NASDAQ:NAUT) Top Key Executive Parag Mallick is the most upbeat insider, and their holdings increased by 11% last week - Simply Wall St]]></title><description><![CDATA[Nautilus Biotechnology, Inc.'s (NASDAQ:NAUT) Top Key Executive Parag Mallick is the most upbeat insider, and their holdings increased by 11% last week&nbsp;&nbsp;Simply Wall St]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/nautilus-biotechnology-incs-nasdaqnaut-top-key-executive-parag-mallick-is-the-most-upbeat-insider-and-their-holdings-increased-by-11-last-week-simply-wall-st/</link><pubDate>Wed, 11 Sep 2024 12:33:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/nautilus-biotechnology-incs-nasdaqnaut-top-key-executive-parag-mallick-is-the-most-upbeat-insider-and-their-holdings-increased-by-11-last-week-simply-wall-st/</guid></item><item><title><![CDATA[Viridian Therapeutics reports positive results for veligrotug - The Pharma Letter]]></title><description><![CDATA[Viridian Therapeutics reports positive results for veligrotug&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/viridian-therapeutics-reports-positive-results-for-veligrotug-the-pharma-letter/</link><pubDate>Wed, 11 Sep 2024 11:49:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/viridian-therapeutics-reports-positive-results-for-veligrotug-the-pharma-letter/</guid></item><item><title><![CDATA[MAIA Biotech releases Phase II results for THIO - The Pharma Letter]]></title><description><![CDATA[MAIA Biotech releases Phase II results for THIO&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/maia-biotech-releases-phase-ii-results-for-thio-the-pharma-letter/</link><pubDate>Wed, 11 Sep 2024 11:49:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/maia-biotech-releases-phase-ii-results-for-thio-the-pharma-letter/</guid></item><item><title><![CDATA[Affinia Therapeutics appoints Rami Daoud as CB-SFO - The Pharma Letter]]></title><description><![CDATA[Affinia Therapeutics appoints Rami Daoud as CB-SFO&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/affinia-therapeutics-appoints-rami-daoud-as-cb-sfo-the-pharma-letter/</link><pubDate>Wed, 11 Sep 2024 11:24:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/affinia-therapeutics-appoints-rami-daoud-as-cb-sfo-the-pharma-letter/</guid></item><item><title><![CDATA[Efficient genetic code expansion without host genome modifications - Nature.com]]></title><description><![CDATA[Efficient genetic code expansion without host genome modifications&nbsp;&nbsp;Nature.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/efficient-genetic-code-expansion-without-host-genome-modifications-naturecom/</link><pubDate>Wed, 11 Sep 2024 11:21:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/efficient-genetic-code-expansion-without-host-genome-modifications-naturecom/</guid></item><item><title><![CDATA[Dedifferentiating myoblasts back into a satellite cell state in vitro - Nature.com]]></title><description><![CDATA[Dedifferentiating myoblasts back into a satellite cell state in vitro&nbsp;&nbsp;Nature.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/dedifferentiating-myoblasts-back-into-a-satellite-cell-state-in-vitro-naturecom/</link><pubDate>Wed, 11 Sep 2024 11:21:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/dedifferentiating-myoblasts-back-into-a-satellite-cell-state-in-vitro-naturecom/</guid></item><item><title><![CDATA[Vir Biotechnology closes Sanofi licence deal for T-cell engagers - Pharmaceutical Technology]]></title><description><![CDATA[Vir Biotechnology closes Sanofi licence deal for T-cell engagers&nbsp;&nbsp;Pharmaceutical Technology]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-closes-sanofi-licence-deal-for-t-cell-engagers-pharmaceutical-technology/</link><pubDate>Tue, 10 Sep 2024 20:03:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-closes-sanofi-licence-deal-for-t-cell-engagers-pharmaceutical-technology/</guid></item><item><title><![CDATA[Gilead and Genesis link up on small molecules - The Pharma Letter]]></title><description><![CDATA[Gilead and Genesis link up on small molecules&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/gilead-and-genesis-link-up-on-small-molecules-the-pharma-letter/</link><pubDate>Tue, 10 Sep 2024 17:06:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/gilead-and-genesis-link-up-on-small-molecules-the-pharma-letter/</guid></item><item><title><![CDATA[AZ’s lung cancer drug disappoints - European Biotechnology News]]></title><description><![CDATA[AZ&rsquo;s lung cancer drug disappoints&nbsp;&nbsp;European Biotechnology News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/azs-lung-cancer-drug-disappoints-european-biotechnology-news/</link><pubDate>Tue, 10 Sep 2024 16:07:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/azs-lung-cancer-drug-disappoints-european-biotechnology-news/</guid></item><item><title><![CDATA[US House of Representatives passes BIOSECURE Act - The Pharma Letter]]></title><description><![CDATA[US House of Representatives passes BIOSECURE Act&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/us-house-of-representatives-passes-biosecure-act-the-pharma-letter/</link><pubDate>Tue, 10 Sep 2024 15:41:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/us-house-of-representatives-passes-biosecure-act-the-pharma-letter/</guid></item><item><title><![CDATA[GSK reports positive Phase III results for depemokimab - The Pharma Letter]]></title><description><![CDATA[GSK reports positive Phase III results for depemokimab&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/gsk-reports-positive-phase-iii-results-for-depemokimab-the-pharma-letter/</link><pubDate>Tue, 10 Sep 2024 15:34:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/gsk-reports-positive-phase-iii-results-for-depemokimab-the-pharma-letter/</guid></item><item><title><![CDATA[Vir Biotechnology Enhances Portfolio with Sanofi Deal and Executive Appointments - TipRanks]]></title><description><![CDATA[Vir Biotechnology Enhances Portfolio with Sanofi Deal and Executive Appointments&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-enhances-portfolio-with-sanofi-deal-and-executive-appointments-tipranks/</link><pubDate>Tue, 10 Sep 2024 14:46:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-enhances-portfolio-with-sanofi-deal-and-executive-appointments-tipranks/</guid></item><item><title><![CDATA[Transgene reinforces oncology drive with new CMO and CSO - The Pharma Letter]]></title><description><![CDATA[Transgene reinforces oncology drive with new CMO and CSO&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/transgene-reinforces-oncology-drive-with-new-cmo-and-cso-the-pharma-letter/</link><pubDate>Tue, 10 Sep 2024 13:49:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/transgene-reinforces-oncology-drive-with-new-cmo-and-cso-the-pharma-letter/</guid></item><item><title><![CDATA[MAIA Biotechnology Advances with Clinical Trials and Partnerships - TipRanks]]></title><description><![CDATA[MAIA Biotechnology Advances with Clinical Trials and Partnerships&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/maia-biotechnology-advances-with-clinical-trials-and-partnerships-tipranks/</link><pubDate>Tue, 10 Sep 2024 12:50:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/maia-biotechnology-advances-with-clinical-trials-and-partnerships-tipranks/</guid></item><item><title><![CDATA[AAVantgarde Bio appoints new chief medical officer - The Pharma Letter]]></title><description><![CDATA[AAVantgarde Bio appoints new chief medical officer&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/aavantgarde-bio-appoints-new-chief-medical-officer-the-pharma-letter/</link><pubDate>Tue, 10 Sep 2024 12:41:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/aavantgarde-bio-appoints-new-chief-medical-officer-the-pharma-letter/</guid></item><item><title><![CDATA[MAIA Biotechnology Announces Positive Survival Updates in Phase 2 Study of THIO in Non-Small Cell Lung Cancer - StockTitan]]></title><description><![CDATA[MAIA Biotechnology Announces Positive Survival Updates in Phase 2 Study of THIO in Non-Small Cell Lung Cancer&nbsp;&nbsp;StockTitan]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/maia-biotechnology-announces-positive-survival-updates-in-phase-2-study-of-thio-in-non-small-cell-lung-cancer-stocktitan/</link><pubDate>Tue, 10 Sep 2024 12:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/maia-biotechnology-announces-positive-survival-updates-in-phase-2-study-of-thio-in-non-small-cell-lung-cancer-stocktitan/</guid></item><item><title><![CDATA[MAIA Biotechnology Announces Positive Survival Updates in Phase 2 Study of THIO in Non-Small Cell Lung Cancer - Business Wire]]></title><description><![CDATA[MAIA Biotechnology Announces Positive Survival Updates in Phase 2 Study of THIO in Non-Small Cell Lung Cancer&nbsp;&nbsp;Business Wire]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/maia-biotechnology-announces-positive-survival-updates-in-phase-2-study-of-thio-in-non-small-cell-lung-cancer-business-wire/</link><pubDate>Tue, 10 Sep 2024 12:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/maia-biotechnology-announces-positive-survival-updates-in-phase-2-study-of-thio-in-non-small-cell-lung-cancer-business-wire/</guid></item><item><title><![CDATA[Cue Biopharma names J&amp;J vet Lucinda Warren as CBO - The Pharma Letter]]></title><description><![CDATA[Cue Biopharma names J&amp;J vet Lucinda Warren as CBO&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/cue-biopharma-names-jampj-vet-lucinda-warren-as-cbo-the-pharma-letter/</link><pubDate>Tue, 10 Sep 2024 11:18:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/cue-biopharma-names-jampj-vet-lucinda-warren-as-cbo-the-pharma-letter/</guid></item><item><title><![CDATA[Cizzle Biotechnology Advancing Lung Cancer Detection from R&amp;D to Application with Moffitt Cancer Centre (VIDEO) - DirectorsTalk Interviews]]></title><description><![CDATA[Cizzle Biotechnology Advancing Lung Cancer Detection from R&amp;D to Application with Moffitt Cancer Centre (VIDEO)&nbsp;&nbsp;DirectorsTalk Interviews]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/cizzle-biotechnology-advancing-lung-cancer-detection-from-rampd-to-application-with-moffitt-cancer-centre-video-directorstalk-interviews/</link><pubDate>Tue, 10 Sep 2024 09:55:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/cizzle-biotechnology-advancing-lung-cancer-detection-from-rampd-to-application-with-moffitt-cancer-centre-video-directorstalk-interviews/</guid></item><item><title><![CDATA[Anti-biotechnology campaigners embrace classic crops, are suspicious of hybrid varieties and claim genetic modification violates nature. Here’s a primer on the differences - Genetic Literacy Project]]></title><description><![CDATA[Anti-biotechnology campaigners embrace classic crops, are suspicious of hybrid varieties and claim genetic modification violates nature. Here&rsquo;s a primer on the differences&nbsp;&nbsp;Genetic Literacy Project]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/anti-biotechnology-campaigners-embrace-classic-crops-are-suspicious-of-hybrid-varieties-and-claim-genetic-modification-violates-nature-heres-a-primer-on-the-differences-genetic-literacy-project/</link><pubDate>Tue, 10 Sep 2024 06:12:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/anti-biotechnology-campaigners-embrace-classic-crops-are-suspicious-of-hybrid-varieties-and-claim-genetic-modification-violates-nature-heres-a-primer-on-the-differences-genetic-literacy-project/</guid></item><item><title><![CDATA[Vir Biotechnology Announces Closing of Exclusive Worldwide License Agreement With Sanofi for Multiple Potential Best-in-Class Clinical-Stage T-Cell Engagers - StockTitan]]></title><description><![CDATA[Vir Biotechnology Announces Closing of Exclusive Worldwide License Agreement With Sanofi for Multiple Potential Best-in-Class Clinical-Stage T-Cell Engagers&nbsp;&nbsp;StockTitan]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-announces-closing-of-exclusive-worldwide-license-agreement-with-sanofi-for-multiple-potential-best-in-class-clinical-stage-t-cell-engagers-stocktitan/</link><pubDate>Mon, 09 Sep 2024 22:05:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-announces-closing-of-exclusive-worldwide-license-agreement-with-sanofi-for-multiple-potential-best-in-class-clinical-stage-t-cell-engagers-stocktitan/</guid></item><item><title><![CDATA[Vir Biotechnology Announces Closing of Exclusive Worldwide License Agreement With Sanofi for Multiple Potential Best-in-Class Clinical-Stage T-Cell Engagers - Business Wire]]></title><description><![CDATA[Vir Biotechnology Announces Closing of Exclusive Worldwide License Agreement With Sanofi for Multiple Potential Best-in-Class Clinical-Stage T-Cell Engagers&nbsp;&nbsp;Business Wire]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-announces-closing-of-exclusive-worldwide-license-agreement-with-sanofi-for-multiple-potential-best-in-class-clinical-stage-t-cell-engagers-business-wire/</link><pubDate>Mon, 09 Sep 2024 22:05:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-announces-closing-of-exclusive-worldwide-license-agreement-with-sanofi-for-multiple-potential-best-in-class-clinical-stage-t-cell-engagers-business-wire/</guid></item><item><title><![CDATA[Sapience Therapeutics to Participate at UBS Biotechnology Private Company Virtual Symposium - PR Newswire]]></title><description><![CDATA[Sapience Therapeutics to Participate at UBS Biotechnology Private Company Virtual Symposium&nbsp;&nbsp;PR Newswire]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/sapience-therapeutics-to-participate-at-ubs-biotechnology-private-company-virtual-symposium-pr-newswire/</link><pubDate>Mon, 09 Sep 2024 22:05:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/sapience-therapeutics-to-participate-at-ubs-biotechnology-private-company-virtual-symposium-pr-newswire/</guid></item><item><title><![CDATA[NSF Funds 5 Centers to Expand Biotechnology Research - GovCIO Media &amp; Research]]></title><description><![CDATA[NSF Funds 5 Centers to Expand Biotechnology Research&nbsp;&nbsp;GovCIO Media &amp; Research]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/nsf-funds-5-centers-to-expand-biotechnology-research-govcio-media-amp-research/</link><pubDate>Mon, 09 Sep 2024 20:16:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/nsf-funds-5-centers-to-expand-biotechnology-research-govcio-media-amp-research/</guid></item><item><title><![CDATA[2024 35 Innovators Under 35: Biotechnology - MIT Technology Review]]></title><description><![CDATA[2024 35 Innovators Under 35: Biotechnology&nbsp;&nbsp;MIT Technology Review]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/2024-35-innovators-under-35-biotechnology-mit-technology-review/</link><pubDate>Mon, 09 Sep 2024 20:01:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/2024-35-innovators-under-35-biotechnology-mit-technology-review/</guid></item><item><title><![CDATA[IPO announced by MBX - The Pharma Letter]]></title><description><![CDATA[IPO announced by MBX&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/ipo-announced-by-mbx-the-pharma-letter/</link><pubDate>Mon, 09 Sep 2024 18:59:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/ipo-announced-by-mbx-the-pharma-letter/</guid></item><item><title><![CDATA[Positive long-term data for Rybrevant in lung cancer - The Pharma Letter]]></title><description><![CDATA[Positive long-term data for Rybrevant in lung cancer&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/positive-long-term-data-for-rybrevant-in-lung-cancer-the-pharma-letter/</link><pubDate>Mon, 09 Sep 2024 14:37:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/positive-long-term-data-for-rybrevant-in-lung-cancer-the-pharma-letter/</guid></item><item><title><![CDATA[Complete Circle: Biosecure Act could boost Indian biotechnology - CNBC]]></title><description><![CDATA[Complete Circle: Biosecure Act could boost Indian biotechnology&nbsp;&nbsp;CNBC]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/complete-circle-biosecure-act-could-boost-indian-biotechnology-cnbc/</link><pubDate>Mon, 09 Sep 2024 14:23:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/complete-circle-biosecure-act-could-boost-indian-biotechnology-cnbc/</guid></item><item><title><![CDATA[Vor Bio plans pivotal trial following promising Phase I/II trial - The Pharma Letter]]></title><description><![CDATA[Vor Bio plans pivotal trial following promising Phase I/II trial&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/vor-bio-plans-pivotal-trial-following-promising-phase-iii-trial-the-pharma-letter/</link><pubDate>Mon, 09 Sep 2024 11:23:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/vor-bio-plans-pivotal-trial-following-promising-phase-iii-trial-the-pharma-letter/</guid></item><item><title><![CDATA[Phage genome engineering with retrons - Nature.com]]></title><description><![CDATA[Phage genome engineering with retrons&nbsp;&nbsp;Nature.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/phage-genome-engineering-with-retrons-naturecom/</link><pubDate>Mon, 09 Sep 2024 11:12:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/phage-genome-engineering-with-retrons-naturecom/</guid></item><item><title><![CDATA[Cizzle Biotechnology collaborates with Moffitt Cancer Center - DirectorsTalk Interviews]]></title><description><![CDATA[Cizzle Biotechnology collaborates with Moffitt Cancer Center&nbsp;&nbsp;DirectorsTalk Interviews]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/cizzle-biotechnology-collaborates-with-moffitt-cancer-center-directorstalk-interviews/</link><pubDate>Mon, 09 Sep 2024 08:15:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/cizzle-biotechnology-collaborates-with-moffitt-cancer-center-directorstalk-interviews/</guid></item><item><title><![CDATA[Stoke Therapeutics names Eric Olson as CBO - The Pharma Letter]]></title><description><![CDATA[Stoke Therapeutics names Eric Olson as CBO&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/stoke-therapeutics-names-eric-olson-as-cbo-the-pharma-letter/</link><pubDate>Sat, 07 Sep 2024 16:26:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/stoke-therapeutics-names-eric-olson-as-cbo-the-pharma-letter/</guid></item><item><title><![CDATA[Is Puma Biotechnology (NASDAQ:PBYI) A Risky Investment? - Simply Wall St]]></title><description><![CDATA[Is Puma Biotechnology (NASDAQ:PBYI) A Risky Investment?&nbsp;&nbsp;Simply Wall St]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/is-puma-biotechnology-nasdaqpbyi-a-risky-investment-simply-wall-st/</link><pubDate>Sat, 07 Sep 2024 15:12:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/is-puma-biotechnology-nasdaqpbyi-a-risky-investment-simply-wall-st/</guid></item><item><title><![CDATA[Biotechnology Reagents Market Size &amp; Share Analysis - Growth Trends &amp; Forecasts (2024 - 2031) - openPR]]></title><description><![CDATA[Biotechnology Reagents Market Size &amp; Share Analysis - Growth Trends &amp; Forecasts (2024 - 2031)&nbsp;&nbsp;openPR]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/biotechnology-reagents-market-size-amp-share-analysis-growth-trends-amp-forecasts-2024-2031-openpr/</link><pubDate>Sat, 07 Sep 2024 09:26:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/biotechnology-reagents-market-size-amp-share-analysis-growth-trends-amp-forecasts-2024-2031-openpr/</guid></item><item><title><![CDATA[Karnataka eyes tripling bioeconomy to $100 bn by 2030 with new biotechnology policy - The Indian Express]]></title><description><![CDATA[Karnataka eyes tripling bioeconomy to $100 bn by 2030 with new biotechnology policy&nbsp;&nbsp;The Indian Express]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/karnataka-eyes-tripling-bioeconomy-to-100-bn-by-2030-with-new-biotechnology-policy-the-indian-express/</link><pubDate>Fri, 06 Sep 2024 16:52:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/karnataka-eyes-tripling-bioeconomy-to-100-bn-by-2030-with-new-biotechnology-policy-the-indian-express/</guid></item><item><title><![CDATA[Food Biotechnology Market: A Comprehensive Study Explores Huge Growth in Future | Carbios, Syngenta, - EIN News]]></title><description><![CDATA[Food Biotechnology Market: A Comprehensive Study Explores Huge Growth in Future | Carbios, Syngenta,&nbsp;&nbsp;EIN News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/food-biotechnology-market-a-comprehensive-study-explores-huge-growth-in-future-carbios-syngenta-ein-news/</link><pubDate>Fri, 06 Sep 2024 15:24:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/food-biotechnology-market-a-comprehensive-study-explores-huge-growth-in-future-carbios-syngenta-ein-news/</guid></item><item><title><![CDATA[Dr. Timothy M. Block to Present New Book at Pennsylvania Biotechnology Center Event - BioBuzz]]></title><description><![CDATA[Dr. Timothy M. Block to Present New Book at Pennsylvania Biotechnology Center Event&nbsp;&nbsp;BioBuzz]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/dr-timothy-m-block-to-present-new-book-at-pennsylvania-biotechnology-center-event-biobuzz/</link><pubDate>Fri, 06 Sep 2024 15:04:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/dr-timothy-m-block-to-present-new-book-at-pennsylvania-biotechnology-center-event-biobuzz/</guid></item><item><title><![CDATA[‘Depoliticise biotechnology research,’ urge African experts - University World News]]></title><description><![CDATA[&lsquo;Depoliticise biotechnology research,&rsquo; urge African experts&nbsp;&nbsp;University World News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/depoliticise-biotechnology-research-urge-african-experts-university-world-news/</link><pubDate>Fri, 06 Sep 2024 12:25:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/depoliticise-biotechnology-research-urge-african-experts-university-world-news/</guid></item><item><title><![CDATA[Voyager collects milestone as Novartis collab continues - The Pharma Letter]]></title><description><![CDATA[Voyager collects milestone as Novartis collab continues&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/voyager-collects-milestone-as-novartis-collab-continues-the-pharma-letter/</link><pubDate>Fri, 06 Sep 2024 12:08:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/voyager-collects-milestone-as-novartis-collab-continues-the-pharma-letter/</guid></item><item><title><![CDATA[Strategic overhaul as BioMarin targets $4 billion in revenue - The Pharma Letter]]></title><description><![CDATA[Strategic overhaul as BioMarin targets $4 billion in revenue&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/strategic-overhaul-as-biomarin-targets-4-billion-in-revenue-the-pharma-letter/</link><pubDate>Fri, 06 Sep 2024 12:08:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/strategic-overhaul-as-biomarin-targets-4-billion-in-revenue-the-pharma-letter/</guid></item><item><title><![CDATA[Navigating the Biosecure Act: Implications for Biotechnology and Pharmaceutical Companies - JD Supra]]></title><description><![CDATA[Navigating the Biosecure Act: Implications for Biotechnology and Pharmaceutical Companies&nbsp;&nbsp;JD Supra]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/navigating-the-biosecure-act-implications-for-biotechnology-and-pharmaceutical-companies-jd-supra/</link><pubDate>Thu, 05 Sep 2024 17:33:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/navigating-the-biosecure-act-implications-for-biotechnology-and-pharmaceutical-companies-jd-supra/</guid></item><item><title><![CDATA[A chemical revolution: Why biotechnology holds the key to a more sustainable future - Fast Company]]></title><description><![CDATA[A chemical revolution: Why biotechnology holds the key to a more sustainable future&nbsp;&nbsp;Fast Company]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/a-chemical-revolution-why-biotechnology-holds-the-key-to-a-more-sustainable-future-fast-company/</link><pubDate>Thu, 05 Sep 2024 16:10:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/a-chemical-revolution-why-biotechnology-holds-the-key-to-a-more-sustainable-future-fast-company/</guid></item><item><title><![CDATA[IN8bio prioritizes pipeline and sheds jobs - The Pharma Letter]]></title><description><![CDATA[IN8bio prioritizes pipeline and sheds jobs&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/in8bio-prioritizes-pipeline-and-sheds-jobs-the-pharma-letter/</link><pubDate>Thu, 05 Sep 2024 15:49:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/in8bio-prioritizes-pipeline-and-sheds-jobs-the-pharma-letter/</guid></item><item><title><![CDATA[LakeShore changes CEO with new executive appointments - The Pharma Letter]]></title><description><![CDATA[LakeShore changes CEO with new executive appointments&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/lakeshore-changes-ceo-with-new-executive-appointments-the-pharma-letter/</link><pubDate>Thu, 05 Sep 2024 15:04:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/lakeshore-changes-ceo-with-new-executive-appointments-the-pharma-letter/</guid></item><item><title><![CDATA[University of Queensland Launches Quantum Computing Initiative to Advance Biotechnology - HPCwire]]></title><description><![CDATA[University of Queensland Launches Quantum Computing Initiative to Advance Biotechnology&nbsp;&nbsp;HPCwire]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/university-of-queensland-launches-quantum-computing-initiative-to-advance-biotechnology-hpcwire/</link><pubDate>Thu, 05 Sep 2024 14:56:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/university-of-queensland-launches-quantum-computing-initiative-to-advance-biotechnology-hpcwire/</guid></item><item><title><![CDATA[Sonoma Bio gets $45 million milestone from Regeneron - The Pharma Letter]]></title><description><![CDATA[Sonoma Bio gets $45 million milestone from Regeneron&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/sonoma-bio-gets-45-million-milestone-from-regeneron-the-pharma-letter/</link><pubDate>Thu, 05 Sep 2024 13:09:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/sonoma-bio-gets-45-million-milestone-from-regeneron-the-pharma-letter/</guid></item><item><title><![CDATA[EpimAb Biotherapeutics and Vignette Bio collaborate - The Pharma Letter]]></title><description><![CDATA[EpimAb Biotherapeutics and Vignette Bio collaborate&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/epimab-biotherapeutics-and-vignette-bio-collaborate-the-pharma-letter/</link><pubDate>Thu, 05 Sep 2024 12:43:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/epimab-biotherapeutics-and-vignette-bio-collaborate-the-pharma-letter/</guid></item><item><title><![CDATA[Continuous multiplexed phage genome editing using recombitrons - Nature.com]]></title><description><![CDATA[Continuous multiplexed phage genome editing using recombitrons&nbsp;&nbsp;Nature.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/continuous-multiplexed-phage-genome-editing-using-recombitrons-naturecom/</link><pubDate>Thu, 05 Sep 2024 11:28:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/continuous-multiplexed-phage-genome-editing-using-recombitrons-naturecom/</guid></item><item><title><![CDATA[CellCentric expands executive team with new CDO - The Pharma Letter]]></title><description><![CDATA[CellCentric expands executive team with new CDO&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/cellcentric-expands-executive-team-with-new-cdo-the-pharma-letter/</link><pubDate>Thu, 05 Sep 2024 11:23:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/cellcentric-expands-executive-team-with-new-cdo-the-pharma-letter/</guid></item><item><title><![CDATA[China dominates biotechnology, US falls behind: KoreaBIO - KBR]]></title><description><![CDATA[China dominates biotechnology, US falls behind: KoreaBIO&nbsp;&nbsp;KBR]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/china-dominates-biotechnology-us-falls-behind-koreabio-kbr/</link><pubDate>Thu, 05 Sep 2024 11:18:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/china-dominates-biotechnology-us-falls-behind-koreabio-kbr/</guid></item><item><title><![CDATA[Vir Biotechnology stock hits 52-week low at $7.61 - Investing.com]]></title><description><![CDATA[Vir Biotechnology stock hits 52-week low at $7.61&nbsp;&nbsp;Investing.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-stock-hits-52-week-low-at-761-investingcom/</link><pubDate>Wed, 04 Sep 2024 20:28:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-stock-hits-52-week-low-at-761-investingcom/</guid></item><item><title><![CDATA[Swiss RNA maker Haya in huge licence deal - European Biotechnology News]]></title><description><![CDATA[Swiss RNA maker Haya in huge licence deal&nbsp;&nbsp;European Biotechnology News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/swiss-rna-maker-haya-in-huge-licence-deal-european-biotechnology-news/</link><pubDate>Wed, 04 Sep 2024 19:19:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/swiss-rna-maker-haya-in-huge-licence-deal-european-biotechnology-news/</guid></item><item><title><![CDATA[Acepodia partners with Pfizer to advance cell therapies - The Pharma Letter]]></title><description><![CDATA[Acepodia partners with Pfizer to advance cell therapies&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/acepodia-partners-with-pfizer-to-advance-cell-therapies-the-pharma-letter/</link><pubDate>Wed, 04 Sep 2024 17:32:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/acepodia-partners-with-pfizer-to-advance-cell-therapies-the-pharma-letter/</guid></item><item><title><![CDATA[Bioprospecting marine microbial genomes to improve biotechnology - Nature.com]]></title><description><![CDATA[Bioprospecting marine microbial genomes to improve biotechnology&nbsp;&nbsp;Nature.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/bioprospecting-marine-microbial-genomes-to-improve-biotechnology-naturecom/</link><pubDate>Wed, 04 Sep 2024 17:19:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/bioprospecting-marine-microbial-genomes-to-improve-biotechnology-naturecom/</guid></item><item><title><![CDATA[Roche with good interim clinical results - European Biotechnology News]]></title><description><![CDATA[Roche with good interim clinical results&nbsp;&nbsp;European Biotechnology News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/roche-with-good-interim-clinical-results-european-biotechnology-news/</link><pubDate>Wed, 04 Sep 2024 09:55:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/roche-with-good-interim-clinical-results-european-biotechnology-news/</guid></item><item><title><![CDATA[NIFA Invests $5.3M in Biotechnology Risk Assessment Research (BRAG) - National Institute of Food and Agriculture]]></title><description><![CDATA[NIFA Invests $5.3M in Biotechnology Risk Assessment Research (BRAG)&nbsp;&nbsp;National Institute of Food and Agriculture]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/nifa-invests-53m-in-biotechnology-risk-assessment-research-brag-national-institute-of-food-and-agriculture/</link><pubDate>Wed, 04 Sep 2024 09:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/nifa-invests-53m-in-biotechnology-risk-assessment-research-brag-national-institute-of-food-and-agriculture/</guid></item><item><title><![CDATA[Centre’s new BioE3 policy: How can biotechnology be harnessed for economic development? - The Indian Express]]></title><description><![CDATA[Centre&rsquo;s new BioE3 policy: How can biotechnology be harnessed for economic development?&nbsp;&nbsp;The Indian Express]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/centres-new-bioe3-policy-how-can-biotechnology-be-harnessed-for-economic-development-the-indian-express/</link><pubDate>Wed, 04 Sep 2024 05:30:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/centres-new-bioe3-policy-how-can-biotechnology-be-harnessed-for-economic-development-the-indian-express/</guid></item><item><title><![CDATA[Metabolically activated energetic materials mediate cellular anabolism for bone regeneration]]></title><description><![CDATA[The gradual release of 3-hydroxybutyrate (3HB) from the degradation of biosynthesized poly(3-hydroxybutyrate-co-4-hydroxybutyrate) [P(3HB-co-4HB)] implants creates a metabolic microenvironment that promotes cellular anabolism by facilitating ATP production and stimulating the formation of citrate-containing apatite. These effects enhance osteogenesis in human bone marrow-derived mesenchymal stem cells (hBMSCs), leading to osteoblast differentiation and ultimately supporting bone regeneration.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/metabolically-activated-energetic-materials-mediate-cellular-anabolism-for-bone-regeneration/</link><pubDate>Wed, 04 Sep 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/metabolically-activated-energetic-materials-mediate-cellular-anabolism-for-bone-regeneration/</guid></item><item><title><![CDATA[BioE3 Policy: Biotechnology for Economy, Environment and Employment - Daily Good Morning Kashmir]]></title><description><![CDATA[BioE3 Policy: Biotechnology for Economy, Environment and Employment&nbsp;&nbsp;Daily Good Morning Kashmir]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/bioe3-policy-biotechnology-for-economy-environment-and-employment-daily-good-morning-kashmir/</link><pubDate>Tue, 03 Sep 2024 18:54:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/bioe3-policy-biotechnology-for-economy-environment-and-employment-daily-good-morning-kashmir/</guid></item><item><title><![CDATA[Roche nod shakes up market for rare blood disorder - The Pharma Letter]]></title><description><![CDATA[Roche nod shakes up market for rare blood disorder&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/roche-nod-shakes-up-market-for-rare-blood-disorder-the-pharma-letter/</link><pubDate>Tue, 03 Sep 2024 17:28:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/roche-nod-shakes-up-market-for-rare-blood-disorder-the-pharma-letter/</guid></item><item><title><![CDATA[Orbital Therapeutics names biopharma vet Ron Philip as CEO | Biotechnology | The Pharmaletter - The Pharma Letter]]></title><description><![CDATA[Orbital Therapeutics names biopharma vet Ron Philip as CEO | Biotechnology | The Pharmaletter&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/orbital-therapeutics-names-biopharma-vet-ron-philip-as-ceo-biotechnology-the-pharmaletter-the-pharma-letter/</link><pubDate>Tue, 03 Sep 2024 17:05:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/orbital-therapeutics-names-biopharma-vet-ron-philip-as-ceo-biotechnology-the-pharmaletter-the-pharma-letter/</guid></item><item><title><![CDATA[YolTech and Salubris agree China-based gene therapy collab - The Pharma Letter]]></title><description><![CDATA[YolTech and Salubris agree China-based gene therapy collab&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/yoltech-and-salubris-agree-china-based-gene-therapy-collab-the-pharma-letter/</link><pubDate>Tue, 03 Sep 2024 16:45:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/yoltech-and-salubris-agree-china-based-gene-therapy-collab-the-pharma-letter/</guid></item><item><title><![CDATA[USA to lead cancer antibody market amid rising approvals and demand - The Pharma Letter]]></title><description><![CDATA[USA to lead cancer antibody market amid rising approvals and demand&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/usa-to-lead-cancer-antibody-market-amid-rising-approvals-and-demand-the-pharma-letter/</link><pubDate>Tue, 03 Sep 2024 16:45:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/usa-to-lead-cancer-antibody-market-amid-rising-approvals-and-demand-the-pharma-letter/</guid></item><item><title><![CDATA[New EC approval for Keytruda and Padcev combo - The Pharma Letter]]></title><description><![CDATA[New EC approval for Keytruda and Padcev combo&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/new-ec-approval-for-keytruda-and-padcev-combo-the-pharma-letter/</link><pubDate>Tue, 03 Sep 2024 15:08:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/new-ec-approval-for-keytruda-and-padcev-combo-the-pharma-letter/</guid></item><item><title><![CDATA[JOHN BALLANTYNE, FORMER BIOTECHNOLOGY EXECUTIVE, JOINS THE GLUCOTRACK BOARD OF DIRECTORS - StockTitan]]></title><description><![CDATA[JOHN BALLANTYNE, FORMER BIOTECHNOLOGY EXECUTIVE, JOINS THE GLUCOTRACK BOARD OF DIRECTORS&nbsp;&nbsp;StockTitan]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/john-ballantyne-former-biotechnology-executive-joins-the-glucotrack-board-of-directors-stocktitan/</link><pubDate>Tue, 03 Sep 2024 15:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/john-ballantyne-former-biotechnology-executive-joins-the-glucotrack-board-of-directors-stocktitan/</guid></item><item><title><![CDATA[The nervous system's matchmaker - WV News]]></title><description><![CDATA[The nervous system's matchmaker&nbsp;&nbsp;WV News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/the-nervous-systems-matchmaker-wv-news/</link><pubDate>Tue, 03 Sep 2024 13:30:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/the-nervous-systems-matchmaker-wv-news/</guid></item><item><title><![CDATA[C4 Therapeutics Appoints Veteran Biotechnology Leader Stephen Fawell, Ph.D. to Board of Directors - GlobeNewswire]]></title><description><![CDATA[C4 Therapeutics Appoints Veteran Biotechnology Leader Stephen Fawell, Ph.D. to Board of Directors&nbsp;&nbsp;GlobeNewswire]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/c4-therapeutics-appoints-veteran-biotechnology-leader-stephen-fawell-phd-to-board-of-directors-globenewswire/</link><pubDate>Tue, 03 Sep 2024 13:01:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/c4-therapeutics-appoints-veteran-biotechnology-leader-stephen-fawell-phd-to-board-of-directors-globenewswire/</guid></item><item><title><![CDATA[C4 Therapeutics Appoints Veteran Biotechnology Leader Stephen Fawell, Ph.D. to Board of Directors - StockTitan]]></title><description><![CDATA[C4 Therapeutics Appoints Veteran Biotechnology Leader Stephen Fawell, Ph.D. to Board of Directors&nbsp;&nbsp;StockTitan]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/c4-therapeutics-appoints-veteran-biotechnology-leader-stephen-fawell-phd-to-board-of-directors-stocktitan/</link><pubDate>Tue, 03 Sep 2024 13:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/c4-therapeutics-appoints-veteran-biotechnology-leader-stephen-fawell-phd-to-board-of-directors-stocktitan/</guid></item><item><title><![CDATA[Further strong data for Anthos’ abelacimab in atrial fibrillation - The Pharma Letter]]></title><description><![CDATA[Further strong data for Anthos&rsquo; abelacimab in atrial fibrillation&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/further-strong-data-for-anthos-abelacimab-in-atrial-fibrillation-the-pharma-letter/</link><pubDate>Tue, 03 Sep 2024 11:46:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/further-strong-data-for-anthos-abelacimab-in-atrial-fibrillation-the-pharma-letter/</guid></item><item><title><![CDATA[TM Media Wins Elets Pharma Leadership Award for Leading Biotechnology Company - Microbioz India]]></title><description><![CDATA[TM Media Wins Elets Pharma Leadership Award for Leading Biotechnology Company&nbsp;&nbsp;Microbioz India]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/tm-media-wins-elets-pharma-leadership-award-for-leading-biotechnology-company-microbioz-india/</link><pubDate>Tue, 03 Sep 2024 10:32:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/tm-media-wins-elets-pharma-leadership-award-for-leading-biotechnology-company-microbioz-india/</guid></item><item><title><![CDATA[Vir Biotechnology’s License Agreement with Sanofi - Global Legal Chronicle]]></title><description><![CDATA[Vir Biotechnology&rsquo;s License Agreement with Sanofi&nbsp;&nbsp;Global Legal Chronicle]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnologys-license-agreement-with-sanofi-global-legal-chronicle/</link><pubDate>Tue, 03 Sep 2024 08:05:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnologys-license-agreement-with-sanofi-global-legal-chronicle/</guid></item><item><title><![CDATA[TM Media wins Elets Pharma Leadership Award for Leading Biotechnology Company - BSI bureau]]></title><description><![CDATA[TM Media wins Elets Pharma Leadership Award for Leading Biotechnology Company&nbsp;&nbsp;BSI bureau]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/tm-media-wins-elets-pharma-leadership-award-for-leading-biotechnology-company-bsi-bureau/</link><pubDate>Tue, 03 Sep 2024 08:01:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/tm-media-wins-elets-pharma-leadership-award-for-leading-biotechnology-company-bsi-bureau/</guid></item><item><title><![CDATA[Europe’s bioindustry 4.0: ‘The upside of biotechnology is that it can offer a cleaner alternative to traditional chemical manufacturing’ - Genetic Literacy Project]]></title><description><![CDATA[Europe&rsquo;s bioindustry 4.0: &lsquo;The upside of biotechnology is that it can offer a cleaner alternative to traditional chemical manufacturing&rsquo;&nbsp;&nbsp;Genetic Literacy Project]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/europes-bioindustry-40-the-upside-of-biotechnology-is-that-it-can-offer-a-cleaner-alternative-to-traditional-chemical-manufacturing-genetic-literacy-project/</link><pubDate>Tue, 03 Sep 2024 06:04:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/europes-bioindustry-40-the-upside-of-biotechnology-is-that-it-can-offer-a-cleaner-alternative-to-traditional-chemical-manufacturing-genetic-literacy-project/</guid></item><item><title><![CDATA[Nxera Pharma to receive $35 million from Neurocrine | Biotechnology | The Pharmaletter - The Pharma Letter]]></title><description><![CDATA[Nxera Pharma to receive $35 million from Neurocrine | Biotechnology | The Pharmaletter&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/nxera-pharma-to-receive-35-million-from-neurocrine-biotechnology-the-pharmaletter-the-pharma-letter/</link><pubDate>Mon, 02 Sep 2024 14:47:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/nxera-pharma-to-receive-35-million-from-neurocrine-biotechnology-the-pharmaletter-the-pharma-letter/</guid></item><item><title><![CDATA[Grace's Girls' Club: HudsonAlpha Institute of Biotechnology Director of Research Affairs, Flo Behn - WAAY]]></title><description><![CDATA[Grace's Girls' Club: HudsonAlpha Institute of Biotechnology Director of Research Affairs, Flo Behn&nbsp;&nbsp;WAAY]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/graces-girls-club-hudsonalpha-institute-of-biotechnology-director-of-research-affairs-flo-behn-waay/</link><pubDate>Mon, 02 Sep 2024 13:30:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/graces-girls-club-hudsonalpha-institute-of-biotechnology-director-of-research-affairs-flo-behn-waay/</guid></item><item><title><![CDATA[Nxera Pharma Ltd collects clinical US$35m milestone - European Biotechnology News]]></title><description><![CDATA[Nxera Pharma Ltd collects clinical US$35m milestone&nbsp;&nbsp;European Biotechnology News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/nxera-pharma-ltd-collects-clinical-us35m-milestone-european-biotechnology-news/</link><pubDate>Mon, 02 Sep 2024 12:03:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/nxera-pharma-ltd-collects-clinical-us35m-milestone-european-biotechnology-news/</guid></item><item><title><![CDATA[Grit Biotechnology Receives U.S. FDA Clearance of Investigational New Drug Application for GT201, a genetically engineered TIL, following its Chinese IND Approval - BioSpace]]></title><description><![CDATA[Grit Biotechnology Receives U.S. FDA Clearance of Investigational New Drug Application for GT201, a genetically engineered TIL, following its Chinese IND Approval&nbsp;&nbsp;BioSpace]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/grit-biotechnology-receives-us-fda-clearance-of-investigational-new-drug-application-for-gt201-a-genetically-engineered-til-following-its-chinese-ind-approval-biospace/</link><pubDate>Mon, 02 Sep 2024 08:19:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/grit-biotechnology-receives-us-fda-clearance-of-investigational-new-drug-application-for-gt201-a-genetically-engineered-til-following-its-chinese-ind-approval-biospace/</guid></item><item><title><![CDATA[The best tips to succeed in Pharmaceutical Biotechnology, according to a graduate - Study International]]></title><description><![CDATA[The best tips to succeed in Pharmaceutical Biotechnology, according to a graduate&nbsp;&nbsp;Study International]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/the-best-tips-to-succeed-in-pharmaceutical-biotechnology-according-to-a-graduate-study-international/</link><pubDate>Mon, 02 Sep 2024 07:47:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/the-best-tips-to-succeed-in-pharmaceutical-biotechnology-according-to-a-graduate-study-international/</guid></item><item><title><![CDATA[Engineering therapeutical extracellular vesicles for clinical translation]]></title><description><![CDATA[Cell-based therapies are revolutionizing medicine by replacing or modifying dysfunctional cells with healthy cells or engineered derivatives, offering disease reversal and cure. One promising approach is using cell-derived extracellular vesicles (EVs), which offer therapeutic benefits similar to cell transplants without the biosafety risks. Although EV applications face challenges like limited production, inadequate therapeutic loading, and poor targeting efficiency, recent advances in bioengine]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/engineering-therapeutical-extracellular-vesicles-for-clinical-translation/</link><pubDate>Mon, 02 Sep 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/engineering-therapeutical-extracellular-vesicles-for-clinical-translation/</guid></item><item><title><![CDATA[J&amp;J seeks first approval of nipocalimab for gMG - The Pharma Letter]]></title><description><![CDATA[J&amp;J seeks first approval of nipocalimab for gMG&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/jampj-seeks-first-approval-of-nipocalimab-for-gmg-the-pharma-letter/</link><pubDate>Fri, 30 Aug 2024 12:03:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/jampj-seeks-first-approval-of-nipocalimab-for-gmg-the-pharma-letter/</guid></item><item><title><![CDATA[Broader label for GSK's Arexvy after new European nod - The Pharma Letter]]></title><description><![CDATA[Broader label for GSK's Arexvy after new European nod&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/broader-label-for-gsks-arexvy-after-new-european-nod-the-pharma-letter/</link><pubDate>Fri, 30 Aug 2024 11:22:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/broader-label-for-gsks-arexvy-after-new-european-nod-the-pharma-letter/</guid></item><item><title><![CDATA[Anti-payload Antibodies: Facilitating ADC PK studies - European Biotechnology News]]></title><description><![CDATA[Anti-payload Antibodies: Facilitating ADC PK studies&nbsp;&nbsp;European Biotechnology News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/anti-payload-antibodies-facilitating-adc-pk-studies-european-biotechnology-news/</link><pubDate>Fri, 30 Aug 2024 10:46:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/anti-payload-antibodies-facilitating-adc-pk-studies-european-biotechnology-news/</guid></item><item><title><![CDATA[Don advocates Biotechnology Ministry to harness microbe diversity - Vanguard]]></title><description><![CDATA[Don advocates Biotechnology Ministry to harness microbe diversity&nbsp;&nbsp;Vanguard]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/don-advocates-biotechnology-ministry-to-harness-microbe-diversity-vanguard/</link><pubDate>Fri, 30 Aug 2024 10:02:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/don-advocates-biotechnology-ministry-to-harness-microbe-diversity-vanguard/</guid></item><item><title><![CDATA[Biotechnology Market is Expected to Reach USD 3.90 Trillion By 2031 | SkyQuest Technology - Daily News Mirror]]></title><description><![CDATA[Biotechnology Market is Expected to Reach USD 3.90 Trillion By 2031 | SkyQuest Technology&nbsp;&nbsp;Daily News Mirror]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/biotechnology-market-is-expected-to-reach-usd-390-trillion-by-2031-skyquest-technology-daily-news-mirror/</link><pubDate>Fri, 30 Aug 2024 09:20:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/biotechnology-market-is-expected-to-reach-usd-390-trillion-by-2031-skyquest-technology-daily-news-mirror/</guid></item><item><title><![CDATA[Animal Biotechnology Market Size, Growth Opportunities, - openPR]]></title><description><![CDATA[Animal Biotechnology Market Size, Growth Opportunities,&nbsp;&nbsp;openPR]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/animal-biotechnology-market-size-growth-opportunities-openpr/</link><pubDate>Fri, 30 Aug 2024 08:51:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/animal-biotechnology-market-size-growth-opportunities-openpr/</guid></item><item><title><![CDATA[Rajiv Gandhi Centre for Biotechnology to lead BioE3 policy in Kerala - The New Indian Express]]></title><description><![CDATA[Rajiv Gandhi Centre for Biotechnology to lead BioE3 policy in Kerala&nbsp;&nbsp;The New Indian Express]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/rajiv-gandhi-centre-for-biotechnology-to-lead-bioe3-policy-in-kerala-the-new-indian-express/</link><pubDate>Fri, 30 Aug 2024 05:31:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/rajiv-gandhi-centre-for-biotechnology-to-lead-bioe3-policy-in-kerala-the-new-indian-express/</guid></item><item><title><![CDATA[Perfusion fermentation sets a path to democratize biomanufacturing]]></title><description><![CDATA[As the global market for diverse goods made using biotechnology continues to expand, the need for proteins as input materials and commercial products will help transform the bioeconomy of the 21st century. Population growth, chronic and infectious diseases, and climate change, combined with the rapid expansion in knowledge, innovation, and bioengineering capabilities will continue to drive the protein bioeconomy. Biomanufactured proteins provide significant biocompatibility and sustainability ad]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/perfusion-fermentation-sets-a-path-to-democratize-biomanufacturing/</link><pubDate>Fri, 30 Aug 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/perfusion-fermentation-sets-a-path-to-democratize-biomanufacturing/</guid></item><item><title><![CDATA[Sana Biotechnology to Present at September 2024 Investor Conferences - GlobeNewswire]]></title><description><![CDATA[Sana Biotechnology to Present at September 2024 Investor Conferences&nbsp;&nbsp;GlobeNewswire]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/sana-biotechnology-to-present-at-september-2024-investor-conferences-globenewswire/</link><pubDate>Thu, 29 Aug 2024 22:07:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/sana-biotechnology-to-present-at-september-2024-investor-conferences-globenewswire/</guid></item><item><title><![CDATA[Spurring biotechnology innovation - University of Delaware]]></title><description><![CDATA[Spurring biotechnology innovation&nbsp;&nbsp;University of Delaware]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/spurring-biotechnology-innovation-university-of-delaware/</link><pubDate>Thu, 29 Aug 2024 19:26:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/spurring-biotechnology-innovation-university-of-delaware/</guid></item><item><title><![CDATA[3PBioVian partners with Rokote for COVID-19 vaccine trials - The Pharma Letter]]></title><description><![CDATA[3PBioVian partners with Rokote for COVID-19 vaccine trials&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/3pbiovian-partners-with-rokote-for-covid-19-vaccine-trials-the-pharma-letter/</link><pubDate>Thu, 29 Aug 2024 18:33:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/3pbiovian-partners-with-rokote-for-covid-19-vaccine-trials-the-pharma-letter/</guid></item><item><title><![CDATA[20 million euros gift from Paris propels ImCheck - The Pharma Letter]]></title><description><![CDATA[20 million euros gift from Paris propels ImCheck&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/20-million-euros-gift-from-paris-propels-imcheck-the-pharma-letter/</link><pubDate>Thu, 29 Aug 2024 18:02:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/20-million-euros-gift-from-paris-propels-imcheck-the-pharma-letter/</guid></item><item><title><![CDATA[Global Red Biotechnology Market Size - By Product - openPR]]></title><description><![CDATA[Global Red Biotechnology Market Size - By Product&nbsp;&nbsp;openPR]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/global-red-biotechnology-market-size-by-product-openpr/</link><pubDate>Thu, 29 Aug 2024 17:29:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/global-red-biotechnology-market-size-by-product-openpr/</guid></item><item><title><![CDATA[Genentech to cut jobs amid cancer research overhaul - The Pharma Letter]]></title><description><![CDATA[Genentech to cut jobs amid cancer research overhaul&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/genentech-to-cut-jobs-amid-cancer-research-overhaul-the-pharma-letter/</link><pubDate>Thu, 29 Aug 2024 16:43:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/genentech-to-cut-jobs-amid-cancer-research-overhaul-the-pharma-letter/</guid></item><item><title><![CDATA[Novartis secures rights to Lindy Bio’s microglassification technology - The Pharma Letter]]></title><description><![CDATA[Novartis secures rights to Lindy Bio&rsquo;s microglassification technology&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/novartis-secures-rights-to-lindy-bios-microglassification-technology-the-pharma-letter/</link><pubDate>Thu, 29 Aug 2024 15:35:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/novartis-secures-rights-to-lindy-bios-microglassification-technology-the-pharma-letter/</guid></item><item><title><![CDATA[Spurring biotechnology innovation - udel.edu]]></title><description><![CDATA[Spurring biotechnology innovation&nbsp;&nbsp;udel.edu]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/spurring-biotechnology-innovation-udeledu/</link><pubDate>Thu, 29 Aug 2024 09:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/spurring-biotechnology-innovation-udeledu/</guid></item><item><title><![CDATA[NSF funds UCSB-led Biofoundry to revolutionize biotechnology with unexplored microbes - News-Medical.Net]]></title><description><![CDATA[NSF funds UCSB-led Biofoundry to revolutionize biotechnology with unexplored microbes&nbsp;&nbsp;News-Medical.Net]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/nsf-funds-ucsb-led-biofoundry-to-revolutionize-biotechnology-with-unexplored-microbes-news-medicalnet/</link><pubDate>Thu, 29 Aug 2024 08:11:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/nsf-funds-ucsb-led-biofoundry-to-revolutionize-biotechnology-with-unexplored-microbes-news-medicalnet/</guid></item><item><title><![CDATA[Researchers present AI-guided protein design tool - European Biotechnology News]]></title><description><![CDATA[Researchers present AI-guided protein design tool&nbsp;&nbsp;European Biotechnology News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/researchers-present-ai-guided-protein-design-tool-european-biotechnology-news/</link><pubDate>Thu, 29 Aug 2024 07:30:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/researchers-present-ai-guided-protein-design-tool-european-biotechnology-news/</guid></item><item><title><![CDATA[Viewpoint: Science colonialism — Europe and the United Nations are blocking crop biotechnology poised to address global hunger - Genetic Literacy Project]]></title><description><![CDATA[Viewpoint: Science colonialism &mdash; Europe and the United Nations are blocking crop biotechnology poised to address global hunger&nbsp;&nbsp;Genetic Literacy Project]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/viewpoint-science-colonialism-europe-and-the-united-nations-are-blocking-crop-biotechnology-poised-to-address-global-hunger-genetic-literacy-project/</link><pubDate>Thu, 29 Aug 2024 06:05:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/viewpoint-science-colonialism-europe-and-the-united-nations-are-blocking-crop-biotechnology-poised-to-address-global-hunger-genetic-literacy-project/</guid></item><item><title><![CDATA[Local biotechnology company raises money for Badger Challenge, to advance cancer research - WKOW]]></title><description><![CDATA[Local biotechnology company raises money for Badger Challenge, to advance cancer research&nbsp;&nbsp;WKOW]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/local-biotechnology-company-raises-money-for-badger-challenge-to-advance-cancer-research-wkow/</link><pubDate>Thu, 29 Aug 2024 04:30:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/local-biotechnology-company-raises-money-for-badger-challenge-to-advance-cancer-research-wkow/</guid></item><item><title><![CDATA[Unlocking the potential of cyanobacteria: a high-throughput strategy for enhancing biocatalytic performance through genetic optimization]]></title><description><![CDATA[This study advances biocatalysis in cyanobacteria by using a high-throughput method to optimize enzyme expression. Significant improvements were achieved, enhancing biocatalytic efficiency of recombinant Synechocystis sp. PCC 6803 strains. This method accelerates synthetic biology research and provides a foundation for future advancements, making cyanobacteria more viable as production hosts.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/unlocking-the-potential-of-cyanobacteria-a-high-throughput-strategy-for-enhancing-biocatalytic-performance-through-genetic-optimization/</link><pubDate>Thu, 29 Aug 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/unlocking-the-potential-of-cyanobacteria-a-high-throughput-strategy-for-enhancing-biocatalytic-performance-through-genetic-optimization/</guid></item><item><title><![CDATA[Recent progress in one-pot enzymatic synthesis and regeneration of high-value cofactors]]></title><description><![CDATA[One-pot enzymatic synthesis is flourishing in synthetic chemistry, heralding a sustainable and green era. Recent advancements enable the creation of complex enzymatic prosthetic groups and regeneration of enzymatic cofactors such as S-adenosylmethionine. The next frontier is to develop the effective and innovative cofactors for essential micronutrients, metabolic modulators, and biomedicines.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/recent-progress-in-one-pot-enzymatic-synthesis-and-regeneration-of-high-value-cofactors/</link><pubDate>Thu, 29 Aug 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/recent-progress-in-one-pot-enzymatic-synthesis-and-regeneration-of-high-value-cofactors/</guid></item><item><title><![CDATA[Cyanobacterial biofilms: from natural systems to applications]]></title><description><![CDATA[Cyanobacteria are the ancestors of oxygenic photosynthesis. Fueled by light and water, their ability to reduce CO2 to sugar holds potential for carbon-neutral production processes. Due to challenges connected to cultivation and engineering issues, cyanobiotechnology has yet to be able to establish itself broadly in industry. In recent years, applying cyanobacterial biofilms as whole-cell biocatalysts instead of suspension cultures has emerged as a novel concept to counteract low cell densities a]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/cyanobacterial-biofilms-from-natural-systems-to-applications/</link><pubDate>Thu, 29 Aug 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/cyanobacterial-biofilms-from-natural-systems-to-applications/</guid></item><item><title><![CDATA[Sana Biotechnology names its first chief scientific officer - The Business Journals]]></title><description><![CDATA[Sana Biotechnology names its first chief scientific officer&nbsp;&nbsp;The Business Journals]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/sana-biotechnology-names-its-first-chief-scientific-officer-the-business-journals/</link><pubDate>Wed, 28 Aug 2024 23:16:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/sana-biotechnology-names-its-first-chief-scientific-officer-the-business-journals/</guid></item><item><title><![CDATA[Senior U.S. Department of Commerce Official Visits Birmingham Biotechnology Hub in Alabama - Economic Development Administration]]></title><description><![CDATA[Senior U.S. Department of Commerce Official Visits Birmingham Biotechnology Hub in Alabama&nbsp;&nbsp;Economic Development Administration]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/senior-us-department-of-commerce-official-visits-birmingham-biotechnology-hub-in-alabama-economic-development-administration/</link><pubDate>Wed, 28 Aug 2024 21:07:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/senior-us-department-of-commerce-official-visits-birmingham-biotechnology-hub-in-alabama-economic-development-administration/</guid></item><item><title><![CDATA[Marcus Ruscetti featured in Genetic Engineering &amp; Biotechnology News - UMass Medical School]]></title><description><![CDATA[Marcus Ruscetti featured in Genetic Engineering &amp; Biotechnology News&nbsp;&nbsp;UMass Medical School]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/marcus-ruscetti-featured-in-genetic-engineering-amp-biotechnology-news-umass-medical-school/</link><pubDate>Wed, 28 Aug 2024 09:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/marcus-ruscetti-featured-in-genetic-engineering-amp-biotechnology-news-umass-medical-school/</guid></item><item><title><![CDATA[Reducing education inequalities through cloud-enabled live-cell biotechnology]]></title><description><![CDATA[Biotechnology holds the potential to drive innovations across various fields from agriculture to medicine. However, despite numerous interventions, biotechnology education remains highly unequal worldwide. Historically, the high costs and potential exposure to hazardous materials have hindered biotechnology education. Integration of cloud technologies into classrooms has emerged as an alternative solution that is already enabling biotechnology experiments to reach thousands of students globally.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/reducing-education-inequalities-through-cloud-enabled-live-cell-biotechnology/</link><pubDate>Wed, 28 Aug 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/reducing-education-inequalities-through-cloud-enabled-live-cell-biotechnology/</guid></item><item><title><![CDATA[Healing wounds with plasma-activated hydrogel therapy]]></title><description><![CDATA[Chronic wound infections are a silent pandemic in danger of becoming a global healthcare crisis. Innovations to control infections and improve healing are required. In the context of this challenge, researchers are exploiting plasma-activated hydrogel therapy (PAHT) for use either alone or in combination with other antimicrobial strategies. PAHT involves the cold atmospheric pressure plasma activation of hydrogels with reactive oxygen and nitrogen species to decontaminate infections and promote]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/healing-wounds-with-plasma-activated-hydrogel-therapy/</link><pubDate>Wed, 28 Aug 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/healing-wounds-with-plasma-activated-hydrogel-therapy/</guid></item><item><title><![CDATA[Efficient genome-editing tools to engineer the recalcitrant non-model industrial microorganism Zymomonas mobilis]]></title><description><![CDATA[A ‘Swiss Army knife’-like toolkit, genome-wide iterative and continuous editing (GW-ICE) system, for continuous genome editing in Zymomonas mobilis, can be generalized to other recalcitrant microorganisms by mining the genetic components of restriction–modification (R-M), CRISPR/Cas, and toxin–antitoxin (T-A) systems as well as expression systems through the website http://ZymOmics.cn/CRISPR_TA_RM.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/efficient-genome-editing-tools-to-engineer-the-recalcitrant-non-model-industrial-microorganism-zymomonas-mobilis/</link><pubDate>Wed, 28 Aug 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/efficient-genome-editing-tools-to-engineer-the-recalcitrant-non-model-industrial-microorganism-zymomonas-mobilis/</guid></item><item><title><![CDATA[Bioengineering lipid-based synthetic cells for therapeutic protein delivery]]></title><description><![CDATA[Synthetic cells (SCs) offer a promising approach for therapeutic protein delivery, combining principles from synthetic biology and drug delivery. Engineered to mimic natural cells, SCs provide biocompatibility and versatility, with precise control over their architecture and composition. Protein production is essential in living cells, and SCs aim to replicate this process using compartmentalized cell-free protein synthesis systems within lipid bilayers. Lipid bilayers serve as favored membranes]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/bioengineering-lipid-based-synthetic-cells-for-therapeutic-protein-delivery/</link><pubDate>Wed, 28 Aug 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/bioengineering-lipid-based-synthetic-cells-for-therapeutic-protein-delivery/</guid></item><item><title><![CDATA[Doylestown Hosts Dr. Timothy Block’s New Book Event on Biotechnology Success - BUCKSCO.Today]]></title><description><![CDATA[Doylestown Hosts Dr. Timothy Block&rsquo;s New Book Event on Biotechnology Success&nbsp;&nbsp;BUCKSCO.Today]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/doylestown-hosts-dr-timothy-blocks-new-book-event-on-biotechnology-success-buckscotoday/</link><pubDate>Tue, 27 Aug 2024 22:14:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/doylestown-hosts-dr-timothy-blocks-new-book-event-on-biotechnology-success-buckscotoday/</guid></item><item><title><![CDATA[Petrie-Flom Center Open House: Health Law, Biotechnology, and the Future - Harvard Law School]]></title><description><![CDATA[Petrie-Flom Center Open House: Health Law, Biotechnology, and the Future&nbsp;&nbsp;Harvard Law School]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/petrie-flom-center-open-house-health-law-biotechnology-and-the-future-harvard-law-school/</link><pubDate>Tue, 27 Aug 2024 20:36:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/petrie-flom-center-open-house-health-law-biotechnology-and-the-future-harvard-law-school/</guid></item><item><title><![CDATA[Confusion in Germany about useful genetic testing - European Biotechnology News]]></title><description><![CDATA[Confusion in Germany about useful genetic testing&nbsp;&nbsp;European Biotechnology News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/confusion-in-germany-about-useful-genetic-testing-european-biotechnology-news/</link><pubDate>Tue, 27 Aug 2024 13:48:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/confusion-in-germany-about-useful-genetic-testing-european-biotechnology-news/</guid></item><item><title><![CDATA[India aims for global biotechnology leadership with BioE3 policy - Daily News Egypt]]></title><description><![CDATA[India aims for global biotechnology leadership with BioE3 policy&nbsp;&nbsp;Daily News Egypt]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/india-aims-for-global-biotechnology-leadership-with-bioe3-policy-daily-news-egypt/</link><pubDate>Tue, 27 Aug 2024 11:33:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/india-aims-for-global-biotechnology-leadership-with-bioe3-policy-daily-news-egypt/</guid></item><item><title><![CDATA[Sana Biotechnology Appoints Accomplished Drug Developer - GlobeNewswire]]></title><description><![CDATA[Sana Biotechnology Appoints Accomplished Drug Developer&nbsp;&nbsp;GlobeNewswire]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/sana-biotechnology-appoints-accomplished-drug-developer-globenewswire/</link><pubDate>Mon, 26 Aug 2024 22:06:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/sana-biotechnology-appoints-accomplished-drug-developer-globenewswire/</guid></item><item><title><![CDATA[Sana Biotechnology Appoints Accomplished Drug Developer Dhaval Patel, M.D., Ph.D., as Executive Vice President and Chief Scientific Officer - Yahoo Finance]]></title><description><![CDATA[Sana Biotechnology Appoints Accomplished Drug Developer Dhaval Patel, M.D., Ph.D., as Executive Vice President and Chief Scientific Officer&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/sana-biotechnology-appoints-accomplished-drug-developer-dhaval-patel-md-phd-as-executive-vice-president-and-chief-scientific-officer-yahoo-finance/</link><pubDate>Mon, 26 Aug 2024 22:05:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/sana-biotechnology-appoints-accomplished-drug-developer-dhaval-patel-md-phd-as-executive-vice-president-and-chief-scientific-officer-yahoo-finance/</guid></item><item><title><![CDATA[Animal Biotechnology Market Size to Hit USD 65.72 Billion by 2033 - BioSpace]]></title><description><![CDATA[Animal Biotechnology Market Size to Hit USD 65.72 Billion by 2033&nbsp;&nbsp;BioSpace]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/animal-biotechnology-market-size-to-hit-usd-6572-billion-by-2033-biospace/</link><pubDate>Mon, 26 Aug 2024 21:10:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/animal-biotechnology-market-size-to-hit-usd-6572-billion-by-2033-biospace/</guid></item><item><title><![CDATA[Advancements in Biotechnology: A Pivotal Moment for Humanity and Markets - International Policy Digest]]></title><description><![CDATA[Advancements in Biotechnology: A Pivotal Moment for Humanity and Markets&nbsp;&nbsp;International Policy Digest]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/advancements-in-biotechnology-a-pivotal-moment-for-humanity-and-markets-international-policy-digest/</link><pubDate>Mon, 26 Aug 2024 14:15:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/advancements-in-biotechnology-a-pivotal-moment-for-humanity-and-markets-international-policy-digest/</guid></item><item><title><![CDATA[Editor’s pick: Atomic AI - Nature.com]]></title><description><![CDATA[Editor&rsquo;s pick: Atomic AI&nbsp;&nbsp;Nature.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/editors-pick-atomic-ai-naturecom/</link><pubDate>Mon, 26 Aug 2024 09:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/editors-pick-atomic-ai-naturecom/</guid></item><item><title><![CDATA[Guangdong Marubi Biotechnology Second Quarter 2024 Earnings: Misses Expectations - Simply Wall St]]></title><description><![CDATA[Guangdong Marubi Biotechnology Second Quarter 2024 Earnings: Misses Expectations&nbsp;&nbsp;Simply Wall St]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/guangdong-marubi-biotechnology-second-quarter-2024-earnings-misses-expectations-simply-wall-st/</link><pubDate>Sun, 25 Aug 2024 02:48:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/guangdong-marubi-biotechnology-second-quarter-2024-earnings-misses-expectations-simply-wall-st/</guid></item><item><title><![CDATA[Bicara Therapeutics files for a $200 million IPO - The Pharma Letter]]></title><description><![CDATA[Bicara Therapeutics files for a $200 million IPO&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/bicara-therapeutics-files-for-a-200-million-ipo-the-pharma-letter/</link><pubDate>Sat, 24 Aug 2024 15:29:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/bicara-therapeutics-files-for-a-200-million-ipo-the-pharma-letter/</guid></item><item><title><![CDATA[Is Maccura Biotechnology Co.Ltd's (SZSE:300463) Recent Price Movement Underpinned By Its Weak Fundamentals? - Simply Wall St]]></title><description><![CDATA[Is Maccura Biotechnology Co.Ltd's (SZSE:300463) Recent Price Movement Underpinned By Its Weak Fundamentals?&nbsp;&nbsp;Simply Wall St]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/is-maccura-biotechnology-coltds-szse300463-recent-price-movement-underpinned-by-its-weak-fundamentals-simply-wall-st/</link><pubDate>Sat, 24 Aug 2024 03:30:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/is-maccura-biotechnology-coltds-szse300463-recent-price-movement-underpinned-by-its-weak-fundamentals-simply-wall-st/</guid></item><item><title><![CDATA[Using soybean biotechnology to advance profitability - brownfieldagnews.com]]></title><description><![CDATA[Using soybean biotechnology to advance profitability&nbsp;&nbsp;brownfieldagnews.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/using-soybean-biotechnology-to-advance-profitability-brownfieldagnewscom/</link><pubDate>Fri, 23 Aug 2024 22:42:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/using-soybean-biotechnology-to-advance-profitability-brownfieldagnewscom/</guid></item><item><title><![CDATA[Global Biotechnology Industry to Witness Rapid Growth During 2024-2034: Prophecy Market Insights - GlobeNewswire]]></title><description><![CDATA[Global Biotechnology Industry to Witness Rapid Growth During 2024-2034: Prophecy Market Insights&nbsp;&nbsp;GlobeNewswire]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/global-biotechnology-industry-to-witness-rapid-growth-during-2024-2034-prophecy-market-insights-globenewswire/</link><pubDate>Fri, 23 Aug 2024 14:52:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/global-biotechnology-industry-to-witness-rapid-growth-during-2024-2034-prophecy-market-insights-globenewswire/</guid></item><item><title><![CDATA[US FDA panel to review approach to checkpoint blockers - The Pharma Letter]]></title><description><![CDATA[US FDA panel to review approach to checkpoint blockers&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/us-fda-panel-to-review-approach-to-checkpoint-blockers-the-pharma-letter/</link><pubDate>Fri, 23 Aug 2024 14:48:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/us-fda-panel-to-review-approach-to-checkpoint-blockers-the-pharma-letter/</guid></item><item><title><![CDATA[US approvals for updated COVID-19 vaccines targeting new variant - The Pharma Letter]]></title><description><![CDATA[US approvals for updated COVID-19 vaccines targeting new variant&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/us-approvals-for-updated-covid-19-vaccines-targeting-new-variant-the-pharma-letter/</link><pubDate>Fri, 23 Aug 2024 13:54:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/us-approvals-for-updated-covid-19-vaccines-targeting-new-variant-the-pharma-letter/</guid></item><item><title><![CDATA[Genome editing with DNA-dependent polymerases - Nature.com]]></title><description><![CDATA[Genome editing with DNA-dependent polymerases&nbsp;&nbsp;Nature.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/genome-editing-with-dna-dependent-polymerases-naturecom/</link><pubDate>Fri, 23 Aug 2024 11:02:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/genome-editing-with-dna-dependent-polymerases-naturecom/</guid></item><item><title><![CDATA[AI identifies most effective climate policies - European Biotechnology News]]></title><description><![CDATA[AI identifies most effective climate policies&nbsp;&nbsp;European Biotechnology News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/ai-identifies-most-effective-climate-policies-european-biotechnology-news/</link><pubDate>Fri, 23 Aug 2024 10:01:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/ai-identifies-most-effective-climate-policies-european-biotechnology-news/</guid></item><item><title><![CDATA[Harmonizing the symphony of chimeric antigen receptor T cell immunotherapy with the elegance of biomaterials]]></title><description><![CDATA[Chimeric antigen receptor T cell (CAR-T) immunotherapy has become a heated field of cancer research, demonstrating revolutionary efficacy in refractory and relapsed hematologic malignancies. However, CAR-T therapy has still encountered tough challenges, including complicated and lengthy manufacturing procedures, mediocre targeted delivery, limited therapeutic effect against solid tumors and difficulties in real-time in vivo monitoring. To overcome these limitations, various versatile biomaterial]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/harmonizing-the-symphony-of-chimeric-antigen-receptor-t-cell-immunotherapy-with-the-elegance-of-biomaterials/</link><pubDate>Fri, 23 Aug 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/harmonizing-the-symphony-of-chimeric-antigen-receptor-t-cell-immunotherapy-with-the-elegance-of-biomaterials/</guid></item><item><title><![CDATA[AI Impact on Biotechnology Reagents Market growth, set to increase by USD 40.26 billion from 2024-2028, High usage of biotechnology reagents in diagnostic and therapeutic applications to boost the revenue, Technavio - PR Newswire]]></title><description><![CDATA[AI Impact on Biotechnology Reagents Market growth, set to increase by USD 40.26 billion from 2024-2028, High usage of biotechnology reagents in diagnostic and therapeutic applications to boost the revenue, Technavio&nbsp;&nbsp;PR Newswire]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/ai-impact-on-biotechnology-reagents-market-growth-set-to-increase-by-usd-4026-billion-from-2024-2028-high-usage-of-biotechnology-reagents-in-diagnostic-and-therapeutic-applications-to-boost-the-revenue-technavio-pr-newswire/</link><pubDate>Thu, 22 Aug 2024 23:15:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/ai-impact-on-biotechnology-reagents-market-growth-set-to-increase-by-usd-4026-billion-from-2024-2028-high-usage-of-biotechnology-reagents-in-diagnostic-and-therapeutic-applications-to-boost-the-revenue-technavio-pr-newswire/</guid></item><item><title><![CDATA[Requirements to bring a medical device to market]]></title><description><![CDATA[A roadmap for medical device innovators is presented that highlights the essential steps for regulatory authorization, market access, and reimbursement strategies in the USA, with a focus on strategic planning for commercial success, underscoring the integration of regulatory and market access considerations from the initial development of a medical device.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/requirements-to-bring-a-medical-device-to-market/</link><pubDate>Thu, 22 Aug 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/requirements-to-bring-a-medical-device-to-market/</guid></item><item><title><![CDATA[Programming mammalian cell behaviors by physical cues]]></title><description><![CDATA[In recent decades, the field of synthetic biology has witnessed remarkable progress, driving advances in both research and practical applications. One pivotal area of development involves the design of transgene switches capable of precisely regulating specified outputs and controlling cell behaviors in response to physical cues, which encompass light, magnetic fields, temperature, mechanical forces, ultrasound, and electricity. In this review, we delve into the cutting-edge progress made in the]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/programming-mammalian-cell-behaviors-by-physical-cues/</link><pubDate>Thu, 22 Aug 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/programming-mammalian-cell-behaviors-by-physical-cues/</guid></item><item><title><![CDATA[Hong Kong IPO takes TYK Medicines public with $74 million - The Pharma Letter]]></title><description><![CDATA[Hong Kong IPO takes TYK Medicines public with $74 million&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/hong-kong-ipo-takes-tyk-medicines-public-with-74-million-the-pharma-letter/</link><pubDate>Wed, 21 Aug 2024 23:22:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/hong-kong-ipo-takes-tyk-medicines-public-with-74-million-the-pharma-letter/</guid></item><item><title><![CDATA[BioMarin appoints new execs in R&amp;D and business development - The Pharma Letter]]></title><description><![CDATA[BioMarin appoints new execs in R&amp;D and business development&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/biomarin-appoints-new-execs-in-rampd-and-business-development-the-pharma-letter/</link><pubDate>Wed, 21 Aug 2024 22:23:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/biomarin-appoints-new-execs-in-rampd-and-business-development-the-pharma-letter/</guid></item><item><title><![CDATA[Sana Biotechnology (NASDAQ:SANA) Stock Price Up 5.8% - MarketBeat]]></title><description><![CDATA[Sana Biotechnology (NASDAQ:SANA) Stock Price Up 5.8%&nbsp;&nbsp;MarketBeat]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/sana-biotechnology-nasdaqsana-stock-price-up-58-marketbeat/</link><pubDate>Wed, 21 Aug 2024 22:02:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/sana-biotechnology-nasdaqsana-stock-price-up-58-marketbeat/</guid></item><item><title><![CDATA[Regeneron hit with CRL on linvoseltamab filing - The Pharma Letter]]></title><description><![CDATA[Regeneron hit with CRL on linvoseltamab filing&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/regeneron-hit-with-crl-on-linvoseltamab-filing-the-pharma-letter/</link><pubDate>Wed, 21 Aug 2024 18:52:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/regeneron-hit-with-crl-on-linvoseltamab-filing-the-pharma-letter/</guid></item><item><title><![CDATA[Kymera to raise $225 million via share offering - The Pharma Letter]]></title><description><![CDATA[Kymera to raise $225 million via share offering&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/kymera-to-raise-225-million-via-share-offering-the-pharma-letter/</link><pubDate>Wed, 21 Aug 2024 17:11:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/kymera-to-raise-225-million-via-share-offering-the-pharma-letter/</guid></item><item><title><![CDATA[NSF announces 4 new Engineering Research Centers focused on biotechnology, manufacturing, robotics and sustainability - National Science Foundation (.gov)]]></title><description><![CDATA[NSF announces 4 new Engineering Research Centers focused on biotechnology, manufacturing, robotics and sustainability&nbsp;&nbsp;National Science Foundation (.gov)]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/nsf-announces-4-new-engineering-research-centers-focused-on-biotechnology-manufacturing-robotics-and-sustainability-national-science-foundation-gov/</link><pubDate>Wed, 21 Aug 2024 16:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/nsf-announces-4-new-engineering-research-centers-focused-on-biotechnology-manufacturing-robotics-and-sustainability-national-science-foundation-gov/</guid></item><item><title><![CDATA[Raymond James &amp; Associates Buys 7,931 Shares of iShares Biotechnology ETF (NASDAQ:IBB) - Defense World]]></title><description><![CDATA[Raymond James &amp; Associates Buys 7,931 Shares of iShares Biotechnology ETF (NASDAQ:IBB)&nbsp;&nbsp;Defense World]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/raymond-james-amp-associates-buys-7931-shares-of-ishares-biotechnology-etf-nasdaqibb-defense-world/</link><pubDate>Wed, 21 Aug 2024 13:02:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/raymond-james-amp-associates-buys-7931-shares-of-ishares-biotechnology-etf-nasdaqibb-defense-world/</guid></item><item><title><![CDATA[Framework for predicting alloreactivity in hematopoietic cell transplants - Nature.com]]></title><description><![CDATA[Framework for predicting alloreactivity in hematopoietic cell transplants&nbsp;&nbsp;Nature.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/framework-for-predicting-alloreactivity-in-hematopoietic-cell-transplants-naturecom/</link><pubDate>Wed, 21 Aug 2024 11:19:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/framework-for-predicting-alloreactivity-in-hematopoietic-cell-transplants-naturecom/</guid></item><item><title><![CDATA[Vandria closes Series A financing - The Pharma Letter]]></title><description><![CDATA[Vandria closes Series A financing&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/vandria-closes-series-a-financing-the-pharma-letter/</link><pubDate>Wed, 21 Aug 2024 11:14:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/vandria-closes-series-a-financing-the-pharma-letter/</guid></item><item><title><![CDATA[Cidara Thera names biotech vet as new CBO - The Pharma Letter]]></title><description><![CDATA[Cidara Thera names biotech vet as new CBO&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/cidara-thera-names-biotech-vet-as-new-cbo-the-pharma-letter/</link><pubDate>Wed, 21 Aug 2024 11:14:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/cidara-thera-names-biotech-vet-as-new-cbo-the-pharma-letter/</guid></item><item><title><![CDATA[PDS Biotechnology (NASDAQ:PDSB) Given New $7.00 Price Target at Alliance Global Partners - Defense World]]></title><description><![CDATA[PDS Biotechnology (NASDAQ:PDSB) Given New $7.00 Price Target at Alliance Global Partners&nbsp;&nbsp;Defense World]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/pds-biotechnology-nasdaqpdsb-given-new-700-price-target-at-alliance-global-partners-defense-world/</link><pubDate>Wed, 21 Aug 2024 10:10:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/pds-biotechnology-nasdaqpdsb-given-new-700-price-target-at-alliance-global-partners-defense-world/</guid></item><item><title><![CDATA[NSF announces 4 new Engineering Research Centers on biotechnology, manufacturing, robotics and sustainability - National Science Foundation]]></title><description><![CDATA[NSF announces 4 new Engineering Research Centers on biotechnology, manufacturing, robotics and sustainability&nbsp;&nbsp;National Science Foundation]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/nsf-announces-4-new-engineering-research-centers-on-biotechnology-manufacturing-robotics-and-sustainability-national-science-foundation/</link><pubDate>Wed, 21 Aug 2024 09:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/nsf-announces-4-new-engineering-research-centers-on-biotechnology-manufacturing-robotics-and-sustainability-national-science-foundation/</guid></item><item><title><![CDATA[NSF announces 4 new Engineering Research Centers focused on biotechnology, manufacturing, robotics and sustainability - new.nsf.gov]]></title><description><![CDATA[NSF announces 4 new Engineering Research Centers focused on biotechnology, manufacturing, robotics and sustainability&nbsp;&nbsp;new.nsf.gov]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/nsf-announces-4-new-engineering-research-centers-focused-on-biotechnology-manufacturing-robotics-and-sustainability-newnsfgov/</link><pubDate>Wed, 21 Aug 2024 09:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/nsf-announces-4-new-engineering-research-centers-focused-on-biotechnology-manufacturing-robotics-and-sustainability-newnsfgov/</guid></item><item><title><![CDATA[Vandria closes Series A round at CHF28.3m - European Biotechnology News]]></title><description><![CDATA[Vandria closes Series A round at CHF28.3m&nbsp;&nbsp;European Biotechnology News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/vandria-closes-series-a-round-at-chf283m-european-biotechnology-news/</link><pubDate>Wed, 21 Aug 2024 08:59:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/vandria-closes-series-a-round-at-chf283m-european-biotechnology-news/</guid></item><item><title><![CDATA[Investors Purchase Large Volume of iShares Biotechnology ETF Put Options (NASDAQ:IBB) - Defense World]]></title><description><![CDATA[Investors Purchase Large Volume of iShares Biotechnology ETF Put Options (NASDAQ:IBB)&nbsp;&nbsp;Defense World]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/investors-purchase-large-volume-of-ishares-biotechnology-etf-put-options-nasdaqibb-defense-world/</link><pubDate>Wed, 21 Aug 2024 08:54:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/investors-purchase-large-volume-of-ishares-biotechnology-etf-put-options-nasdaqibb-defense-world/</guid></item><item><title><![CDATA[Museum of Life and Science in Durham receives $244K grant for biotechnology lab programming - CBS17.com]]></title><description><![CDATA[Museum of Life and Science in Durham receives $244K grant for biotechnology lab programming&nbsp;&nbsp;CBS17.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/museum-of-life-and-science-in-durham-receives-244k-grant-for-biotechnology-lab-programming-cbs17com/</link><pubDate>Wed, 21 Aug 2024 03:10:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/museum-of-life-and-science-in-durham-receives-244k-grant-for-biotechnology-lab-programming-cbs17com/</guid></item><item><title><![CDATA[Microbial production of an aromatic homopolyester]]></title><description><![CDATA[Lee et al. report the fermentative production of aromatic polyesters, which can serve as sustainable alternatives to petroleum-based plastics. This represents the first instance of homo-aromatic polyester production using glucose. Further pathway engineering facilitated the production of poly(3-hydroxybutyrate-co-d-phenyllactate), achieving the highest titer of aromatic polyester reported using microorganisms thus far.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/microbial-production-of-an-aromatic-homopolyester/</link><pubDate>Wed, 21 Aug 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/microbial-production-of-an-aromatic-homopolyester/</guid></item><item><title><![CDATA[Sweeping biotechnology sector changes emerge as submissions sought on key genetically modified food proposal - Bell Gully]]></title><description><![CDATA[Sweeping biotechnology sector changes emerge as submissions sought on key genetically modified food proposal&nbsp;&nbsp;Bell Gully]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/sweeping-biotechnology-sector-changes-emerge-as-submissions-sought-on-key-genetically-modified-food-proposal-bell-gully/</link><pubDate>Wed, 21 Aug 2024 01:15:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/sweeping-biotechnology-sector-changes-emerge-as-submissions-sought-on-key-genetically-modified-food-proposal-bell-gully/</guid></item><item><title><![CDATA[GSK takes aim at less common lung cancer with novel ADC - The Pharma Letter]]></title><description><![CDATA[GSK takes aim at less common lung cancer with novel ADC&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/gsk-takes-aim-at-less-common-lung-cancer-with-novel-adc-the-pharma-letter/</link><pubDate>Tue, 20 Aug 2024 20:29:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/gsk-takes-aim-at-less-common-lung-cancer-with-novel-adc-the-pharma-letter/</guid></item><item><title><![CDATA[Fasenra receives Chinese nod for severe eosinophilic asthma - The Pharma Letter]]></title><description><![CDATA[Fasenra receives Chinese nod for severe eosinophilic asthma&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/fasenra-receives-chinese-nod-for-severe-eosinophilic-asthma-the-pharma-letter/</link><pubDate>Tue, 20 Aug 2024 20:21:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/fasenra-receives-chinese-nod-for-severe-eosinophilic-asthma-the-pharma-letter/</guid></item><item><title><![CDATA[Adcendo secures ADC rights in billion-dollar deal - The Pharma Letter]]></title><description><![CDATA[Adcendo secures ADC rights in billion-dollar deal&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/adcendo-secures-adc-rights-in-billion-dollar-deal-the-pharma-letter/</link><pubDate>Tue, 20 Aug 2024 19:01:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/adcendo-secures-adc-rights-in-billion-dollar-deal-the-pharma-letter/</guid></item><item><title><![CDATA[Franklin Biotechnology Discovery Fund Q2 2024 Commentary - Seeking Alpha]]></title><description><![CDATA[Franklin Biotechnology Discovery Fund Q2 2024 Commentary&nbsp;&nbsp;Seeking Alpha]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/franklin-biotechnology-discovery-fund-q2-2024-commentary-seeking-alpha/</link><pubDate>Tue, 20 Aug 2024 17:50:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/franklin-biotechnology-discovery-fund-q2-2024-commentary-seeking-alpha/</guid></item><item><title><![CDATA[Agricultural Biotechnology Market Surges to USD 100.32 - GlobeNewswire]]></title><description><![CDATA[Agricultural Biotechnology Market Surges to USD 100.32&nbsp;&nbsp;GlobeNewswire]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/agricultural-biotechnology-market-surges-to-usd-10032-globenewswire/</link><pubDate>Tue, 20 Aug 2024 16:22:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/agricultural-biotechnology-market-surges-to-usd-10032-globenewswire/</guid></item><item><title><![CDATA[Shenzhen Zhongge Biotechnology describes new IRAK-4 inhibitors - BioWorld Online]]></title><description><![CDATA[Shenzhen Zhongge Biotechnology describes new IRAK-4 inhibitors&nbsp;&nbsp;BioWorld Online]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/shenzhen-zhongge-biotechnology-describes-new-irak-4-inhibitors-bioworld-online/</link><pubDate>Tue, 20 Aug 2024 15:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/shenzhen-zhongge-biotechnology-describes-new-irak-4-inhibitors-bioworld-online/</guid></item><item><title><![CDATA[Biotechnology Market Forecast Period 2024-2030: - openPR]]></title><description><![CDATA[Biotechnology Market Forecast Period 2024-2030:&nbsp;&nbsp;openPR]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/biotechnology-market-forecast-period-2024-2030-openpr/</link><pubDate>Tue, 20 Aug 2024 14:47:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/biotechnology-market-forecast-period-2024-2030-openpr/</guid></item><item><title><![CDATA[H.C. Wainwright Reiterates Buy Rating on Vir Biotechnology (VIR) - StreetInsider.com]]></title><description><![CDATA[H.C. Wainwright Reiterates Buy Rating on Vir Biotechnology (VIR)&nbsp;&nbsp;StreetInsider.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/hc-wainwright-reiterates-buy-rating-on-vir-biotechnology-vir-streetinsidercom/</link><pubDate>Tue, 20 Aug 2024 12:46:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/hc-wainwright-reiterates-buy-rating-on-vir-biotechnology-vir-streetinsidercom/</guid></item><item><title><![CDATA[Accenture invests in Earli to advance early cancer detection tech - Pharmaceutical Technology]]></title><description><![CDATA[Accenture invests in Earli to advance early cancer detection tech&nbsp;&nbsp;Pharmaceutical Technology]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/accenture-invests-in-earli-to-advance-early-cancer-detection-tech-pharmaceutical-technology/</link><pubDate>Tue, 20 Aug 2024 12:28:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/accenture-invests-in-earli-to-advance-early-cancer-detection-tech-pharmaceutical-technology/</guid></item><item><title><![CDATA[Adcendo broadens ADC pipeline in US$1bn biobucks deal - European Biotechnology News]]></title><description><![CDATA[Adcendo broadens ADC pipeline in US$1bn biobucks deal&nbsp;&nbsp;European Biotechnology News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/adcendo-broadens-adc-pipeline-in-us1bn-biobucks-deal-european-biotechnology-news/</link><pubDate>Tue, 20 Aug 2024 10:59:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/adcendo-broadens-adc-pipeline-in-us1bn-biobucks-deal-european-biotechnology-news/</guid></item><item><title><![CDATA[Emfret presents novel anticoagulant - European Biotechnology News]]></title><description><![CDATA[Emfret presents novel anticoagulant&nbsp;&nbsp;European Biotechnology News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/emfret-presents-novel-anticoagulant-european-biotechnology-news/</link><pubDate>Tue, 20 Aug 2024 09:45:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/emfret-presents-novel-anticoagulant-european-biotechnology-news/</guid></item><item><title><![CDATA[Synthetic biology approaches and bioseparations in syngas fermentation]]></title><description><![CDATA[Fossil fuel use drives greenhouse gas emissions and climate change, highlighting the need for alternatives like biomass-derived syngas. Syngas, mainly H2 and CO, is produced via biomass gasification and offers a solution to environmental challenges. Syngas fermentation through the Wood-Ljungdahl pathway yields valuable chemicals under mild conditions. However, challenges in scaling up persist due to issues like unpredictable syngas composition and microbial fermentation contamination. This revie]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/synthetic-biology-approaches-and-bioseparations-in-syngas-fermentation/</link><pubDate>Tue, 20 Aug 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/synthetic-biology-approaches-and-bioseparations-in-syngas-fermentation/</guid></item><item><title><![CDATA[Avidity Biosciences raises $345 million for RNA therapeutics - The Pharma Letter]]></title><description><![CDATA[Avidity Biosciences raises $345 million for RNA therapeutics&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/avidity-biosciences-raises-345-million-for-rna-therapeutics-the-pharma-letter/</link><pubDate>Mon, 19 Aug 2024 17:33:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/avidity-biosciences-raises-345-million-for-rna-therapeutics-the-pharma-letter/</guid></item><item><title><![CDATA[BioNTech resumes Phase I trial after FDA lifts partial hold - The Pharma Letter]]></title><description><![CDATA[BioNTech resumes Phase I trial after FDA lifts partial hold&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/biontech-resumes-phase-i-trial-after-fda-lifts-partial-hold-the-pharma-letter/</link><pubDate>Mon, 19 Aug 2024 17:11:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/biontech-resumes-phase-i-trial-after-fda-lifts-partial-hold-the-pharma-letter/</guid></item><item><title><![CDATA[New $2.74M grant to support biotechnology training - WSU News]]></title><description><![CDATA[New $2.74M grant to support biotechnology training&nbsp;&nbsp;WSU News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/new-274m-grant-to-support-biotechnology-training-wsu-news/</link><pubDate>Mon, 19 Aug 2024 15:03:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/new-274m-grant-to-support-biotechnology-training-wsu-news/</guid></item><item><title><![CDATA[LIXTE Biotechnology Provides Update On Recent Activities and Developments - StockTitan]]></title><description><![CDATA[LIXTE Biotechnology Provides Update On Recent Activities and Developments&nbsp;&nbsp;StockTitan]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/lixte-biotechnology-provides-update-on-recent-activities-and-developments-stocktitan/</link><pubDate>Mon, 19 Aug 2024 14:30:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/lixte-biotechnology-provides-update-on-recent-activities-and-developments-stocktitan/</guid></item><item><title><![CDATA[BioNTech: ADC study continues with conditions - European Biotechnology News]]></title><description><![CDATA[BioNTech: ADC study continues with conditions&nbsp;&nbsp;European Biotechnology News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/biontech-adc-study-continues-with-conditions-european-biotechnology-news/</link><pubDate>Mon, 19 Aug 2024 13:59:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/biontech-adc-study-continues-with-conditions-european-biotechnology-news/</guid></item><item><title><![CDATA[Editor’s pick: Cargo Therapeutics - Nature.com]]></title><description><![CDATA[Editor&rsquo;s pick: Cargo Therapeutics&nbsp;&nbsp;Nature.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/editors-pick-cargo-therapeutics-naturecom/</link><pubDate>Mon, 19 Aug 2024 11:33:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/editors-pick-cargo-therapeutics-naturecom/</guid></item><item><title><![CDATA[NSF-funded Plant Biotechnology Boot Camp brings high school students to campus - uwplatt.edu]]></title><description><![CDATA[NSF-funded Plant Biotechnology Boot Camp brings high school students to campus&nbsp;&nbsp;uwplatt.edu]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/nsf-funded-plant-biotechnology-boot-camp-brings-high-school-students-to-campus-uwplattedu/</link><pubDate>Mon, 19 Aug 2024 09:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/nsf-funded-plant-biotechnology-boot-camp-brings-high-school-students-to-campus-uwplattedu/</guid></item><item><title><![CDATA[NSF-funded Plant Biotechnology Boot Camp brings high school students to campus - UW- Platteville Pioneers]]></title><description><![CDATA[NSF-funded Plant Biotechnology Boot Camp brings high school students to campus&nbsp;&nbsp;UW- Platteville Pioneers]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/nsf-funded-plant-biotechnology-boot-camp-brings-high-school-students-to-campus-uw-platteville-pioneers/</link><pubDate>Mon, 19 Aug 2024 09:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/nsf-funded-plant-biotechnology-boot-camp-brings-high-school-students-to-campus-uw-platteville-pioneers/</guid></item><item><title><![CDATA[Vanguard Group Inc. Grows Holdings in PDS Biotechnology Co. (NASDAQ:PDSB) - Defense World]]></title><description><![CDATA[Vanguard Group Inc. Grows Holdings in PDS Biotechnology Co. (NASDAQ:PDSB)&nbsp;&nbsp;Defense World]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/vanguard-group-inc-grows-holdings-in-pds-biotechnology-co-nasdaqpdsb-defense-world/</link><pubDate>Sat, 17 Aug 2024 10:17:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/vanguard-group-inc-grows-holdings-in-pds-biotechnology-co-nasdaqpdsb-defense-world/</guid></item><item><title><![CDATA[Manipulating immune activity of macrophages: a materials and mechanics perspective]]></title><description><![CDATA[Macrophage immune cells exist on a plastic spectrum of phenotypes governed by their physical and biochemical environment. Controlling macrophage function to facilitate immunological regeneration or fighting pathology has emerged as a therapeutic possibility. The rate-limiting step in translating macrophage immunomodulation therapies has been the absence of fundamental knowledge of how physics and biochemistry in the macrophage microenvironment converge to inform phenotype. In this review we expl]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/manipulating-immune-activity-of-macrophages-a-materials-and-mechanics-perspective/</link><pubDate>Sat, 17 Aug 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/manipulating-immune-activity-of-macrophages-a-materials-and-mechanics-perspective/</guid></item><item><title><![CDATA[Sichuan Hebang Biotechnology Corporation Limited's (SHSE:603077) Shares Not Telling The Full Story - Simply Wall St]]></title><description><![CDATA[Sichuan Hebang Biotechnology Corporation Limited's (SHSE:603077) Shares Not Telling The Full Story&nbsp;&nbsp;Simply Wall St]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/sichuan-hebang-biotechnology-corporation-limiteds-shse603077-shares-not-telling-the-full-story-simply-wall-st/</link><pubDate>Sat, 17 Aug 2024 01:25:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/sichuan-hebang-biotechnology-corporation-limiteds-shse603077-shares-not-telling-the-full-story-simply-wall-st/</guid></item><item><title><![CDATA[Arrowhead to advance obesity drug candidates into clinic - The Pharma Letter]]></title><description><![CDATA[Arrowhead to advance obesity drug candidates into clinic&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/arrowhead-to-advance-obesity-drug-candidates-into-clinic-the-pharma-letter/</link><pubDate>Fri, 16 Aug 2024 17:23:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/arrowhead-to-advance-obesity-drug-candidates-into-clinic-the-pharma-letter/</guid></item><item><title><![CDATA[How Beauty Company Debut Biotechnology Is Helping the Pentagon Prepare for War - Thomas Insights]]></title><description><![CDATA[How Beauty Company Debut Biotechnology Is Helping the Pentagon Prepare for War&nbsp;&nbsp;Thomas Insights]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/how-beauty-company-debut-biotechnology-is-helping-the-pentagon-prepare-for-war-thomas-insights/</link><pubDate>Fri, 16 Aug 2024 14:57:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/how-beauty-company-debut-biotechnology-is-helping-the-pentagon-prepare-for-war-thomas-insights/</guid></item><item><title><![CDATA[Positive top-line results for Incyte’s Monjuvi in FL - The Pharma Letter]]></title><description><![CDATA[Positive top-line results for Incyte&rsquo;s Monjuvi in FL&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/positive-top-line-results-for-incytes-monjuvi-in-fl-the-pharma-letter/</link><pubDate>Fri, 16 Aug 2024 14:08:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/positive-top-line-results-for-incytes-monjuvi-in-fl-the-pharma-letter/</guid></item><item><title><![CDATA[Indonesia’s Path to Technological Greatness: AI, Semiconductor and Biotechnology - Modern Diplomacy]]></title><description><![CDATA[Indonesia&rsquo;s Path to Technological Greatness: AI, Semiconductor and Biotechnology&nbsp;&nbsp;Modern Diplomacy]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/indonesias-path-to-technological-greatness-ai-semiconductor-and-biotechnology-modern-diplomacy/</link><pubDate>Fri, 16 Aug 2024 13:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/indonesias-path-to-technological-greatness-ai-semiconductor-and-biotechnology-modern-diplomacy/</guid></item><item><title><![CDATA[Therapeutic applications of cell engineering using mRNA technology]]></title><description><![CDATA[Engineering and reprogramming cells has significant therapeutic potential to treat a wide range of diseases, by replacing missing or defective proteins, to provide transcription factors (TFs) to reprogram cell phenotypes, or to provide enzymes such as RNA-guided Cas9 derivatives for CRISPR-based cell engineering. While viral vector-mediated gene transfer has played an important role in this field, the use of mRNA avoids safety concerns associated with the integration of DNA into the host cell ge]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/therapeutic-applications-of-cell-engineering-using-mrna-technology/</link><pubDate>Fri, 16 Aug 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/therapeutic-applications-of-cell-engineering-using-mrna-technology/</guid></item><item><title><![CDATA[LIXTE Biotechnology Holdings to Present at Two Investor Conferences - GlobeNewswire]]></title><description><![CDATA[LIXTE Biotechnology Holdings to Present at Two Investor Conferences&nbsp;&nbsp;GlobeNewswire]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/lixte-biotechnology-holdings-to-present-at-two-investor-conferences-globenewswire/</link><pubDate>Thu, 15 Aug 2024 14:46:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/lixte-biotechnology-holdings-to-present-at-two-investor-conferences-globenewswire/</guid></item><item><title><![CDATA[Anbio Biotechnology Unveils Comprehensive In-Vitro-Diagnostics Solutions at ADLM 2024 - PR Newswire]]></title><description><![CDATA[Anbio Biotechnology Unveils Comprehensive In-Vitro-Diagnostics Solutions at ADLM 2024&nbsp;&nbsp;PR Newswire]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/anbio-biotechnology-unveils-comprehensive-in-vitro-diagnostics-solutions-at-adlm-2024-pr-newswire/</link><pubDate>Thu, 15 Aug 2024 14:31:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/anbio-biotechnology-unveils-comprehensive-in-vitro-diagnostics-solutions-at-adlm-2024-pr-newswire/</guid></item><item><title><![CDATA[LIXTE Biotechnology Holdings to Present at Two Investor Conferences - StockTitan]]></title><description><![CDATA[LIXTE Biotechnology Holdings to Present at Two Investor Conferences&nbsp;&nbsp;StockTitan]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/lixte-biotechnology-holdings-to-present-at-two-investor-conferences-stocktitan/</link><pubDate>Thu, 15 Aug 2024 14:30:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/lixte-biotechnology-holdings-to-present-at-two-investor-conferences-stocktitan/</guid></item><item><title><![CDATA[Evotec axes 400 jobs worldwide - European Biotechnology News]]></title><description><![CDATA[Evotec axes 400 jobs worldwide&nbsp;&nbsp;European Biotechnology News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/evotec-axes-400-jobs-worldwide-european-biotechnology-news/</link><pubDate>Thu, 15 Aug 2024 12:22:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/evotec-axes-400-jobs-worldwide-european-biotechnology-news/</guid></item><item><title><![CDATA[Lixte Biotechnology Holdings, Inc. to Present at August 20th Virtual Investor Summit Microcap Event - StockTitan]]></title><description><![CDATA[Lixte Biotechnology Holdings, Inc. to Present at August 20th Virtual Investor Summit Microcap Event&nbsp;&nbsp;StockTitan]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/lixte-biotechnology-holdings-inc-to-present-at-august-20th-virtual-investor-summit-microcap-event-stocktitan/</link><pubDate>Thu, 15 Aug 2024 05:07:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/lixte-biotechnology-holdings-inc-to-present-at-august-20th-virtual-investor-summit-microcap-event-stocktitan/</guid></item><item><title><![CDATA[Biotechs take multiplexing into animal models to accelerate drug discovery - Nature.com]]></title><description><![CDATA[Biotechs take multiplexing into animal models to accelerate drug discovery&nbsp;&nbsp;Nature.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/biotechs-take-multiplexing-into-animal-models-to-accelerate-drug-discovery-naturecom/</link><pubDate>Thu, 15 Aug 2024 04:17:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/biotechs-take-multiplexing-into-animal-models-to-accelerate-drug-discovery-naturecom/</guid></item><item><title><![CDATA[Biotechnology company Amgen expands global reach with technology innovation center in Hyderabad, India - BioProcess Insider]]></title><description><![CDATA[Biotechnology company Amgen expands global reach with technology innovation center in Hyderabad, India&nbsp;&nbsp;BioProcess Insider]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/biotechnology-company-amgen-expands-global-reach-with-technology-innovation-center-in-hyderabad-india-bioprocess-insider/</link><pubDate>Thu, 15 Aug 2024 00:36:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/biotechnology-company-amgen-expands-global-reach-with-technology-innovation-center-in-hyderabad-india-bioprocess-insider/</guid></item><item><title><![CDATA[Wharton San Diego Presents: The Future of Biotechnology in San Diego - Procopio]]></title><description><![CDATA[Wharton San Diego Presents: The Future of Biotechnology in San Diego&nbsp;&nbsp;Procopio]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/wharton-san-diego-presents-the-future-of-biotechnology-in-san-diego-procopio/</link><pubDate>Wed, 14 Aug 2024 20:22:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/wharton-san-diego-presents-the-future-of-biotechnology-in-san-diego-procopio/</guid></item><item><title><![CDATA[A new class of mRNA drugs targets poison exons - Nature.com]]></title><description><![CDATA[A new class of mRNA drugs targets poison exons&nbsp;&nbsp;Nature.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/a-new-class-of-mrna-drugs-targets-poison-exons-naturecom/</link><pubDate>Wed, 14 Aug 2024 19:40:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/a-new-class-of-mrna-drugs-targets-poison-exons-naturecom/</guid></item><item><title><![CDATA[Spanish tortillas go vegan - Nature.com]]></title><description><![CDATA[Spanish tortillas go vegan&nbsp;&nbsp;Nature.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/spanish-tortillas-go-vegan-naturecom/</link><pubDate>Wed, 14 Aug 2024 17:37:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/spanish-tortillas-go-vegan-naturecom/</guid></item><item><title><![CDATA[The rise of teamwork and career prospects in academic science - Nature.com]]></title><description><![CDATA[The rise of teamwork and career prospects in academic science&nbsp;&nbsp;Nature.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/the-rise-of-teamwork-and-career-prospects-in-academic-science-naturecom/</link><pubDate>Wed, 14 Aug 2024 17:06:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/the-rise-of-teamwork-and-career-prospects-in-academic-science-naturecom/</guid></item><item><title><![CDATA[Strategic overhaul at Acelyrin after late-stage success - The Pharma Letter]]></title><description><![CDATA[Strategic overhaul at Acelyrin after late-stage success&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/strategic-overhaul-at-acelyrin-after-late-stage-success-the-pharma-letter/</link><pubDate>Wed, 14 Aug 2024 15:52:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/strategic-overhaul-at-acelyrin-after-late-stage-success-the-pharma-letter/</guid></item><item><title><![CDATA[Small Cap Stocks: Mind Medicine (MNMD) Is a Psychedelic Biotechnology Bet - Nasdaq]]></title><description><![CDATA[Small Cap Stocks: Mind Medicine (MNMD) Is a Psychedelic Biotechnology Bet&nbsp;&nbsp;Nasdaq]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/small-cap-stocks-mind-medicine-mnmd-is-a-psychedelic-biotechnology-bet-nasdaq/</link><pubDate>Wed, 14 Aug 2024 11:16:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/small-cap-stocks-mind-medicine-mnmd-is-a-psychedelic-biotechnology-bet-nasdaq/</guid></item><item><title><![CDATA[Challenging anti-biotechnology disinformation fog strangling Nigeria’s efforts to achieve food security - Genetic Literacy Project]]></title><description><![CDATA[Challenging anti-biotechnology disinformation fog strangling Nigeria&rsquo;s efforts to achieve food security&nbsp;&nbsp;Genetic Literacy Project]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/challenging-anti-biotechnology-disinformation-fog-strangling-nigerias-efforts-to-achieve-food-security-genetic-literacy-project/</link><pubDate>Wed, 14 Aug 2024 06:06:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/challenging-anti-biotechnology-disinformation-fog-strangling-nigerias-efforts-to-achieve-food-security-genetic-literacy-project/</guid></item><item><title><![CDATA[Puma Biotechnology director sells over $81k in company stock - Investing.com]]></title><description><![CDATA[Puma Biotechnology director sells over $81k in company stock&nbsp;&nbsp;Investing.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/puma-biotechnology-director-sells-over-81k-in-company-stock-investingcom/</link><pubDate>Wed, 14 Aug 2024 03:38:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/puma-biotechnology-director-sells-over-81k-in-company-stock-investingcom/</guid></item><item><title><![CDATA[PDS Biotechnology Enhances and Modulates Stock Sales Agreement - TipRanks]]></title><description><![CDATA[PDS Biotechnology Enhances and Modulates Stock Sales Agreement&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/pds-biotechnology-enhances-and-modulates-stock-sales-agreement-tipranks/</link><pubDate>Tue, 13 Aug 2024 22:45:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/pds-biotechnology-enhances-and-modulates-stock-sales-agreement-tipranks/</guid></item><item><title><![CDATA[PDSB Stock Earnings: PDS Biotechnology Beats EPS for Q2 2024 - MSN]]></title><description><![CDATA[PDSB Stock Earnings: PDS Biotechnology Beats EPS for Q2 2024&nbsp;&nbsp;MSN]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/pdsb-stock-earnings-pds-biotechnology-beats-eps-for-q2-2024-msn/</link><pubDate>Tue, 13 Aug 2024 20:11:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/pdsb-stock-earnings-pds-biotechnology-beats-eps-for-q2-2024-msn/</guid></item><item><title><![CDATA[PDSB Stock Earnings: PDS Biotechnology Beats EPS for Q2 2024 - InvestorPlace]]></title><description><![CDATA[PDSB Stock Earnings: PDS Biotechnology Beats EPS for Q2 2024&nbsp;&nbsp;InvestorPlace]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/pdsb-stock-earnings-pds-biotechnology-beats-eps-for-q2-2024-investorplace/</link><pubDate>Tue, 13 Aug 2024 19:57:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/pdsb-stock-earnings-pds-biotechnology-beats-eps-for-q2-2024-investorplace/</guid></item><item><title><![CDATA[Biotechnology and agricultural productivity - The Financial Express BD]]></title><description><![CDATA[Biotechnology and agricultural productivity&nbsp;&nbsp;The Financial Express BD]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/biotechnology-and-agricultural-productivity-the-financial-express-bd/</link><pubDate>Tue, 13 Aug 2024 18:20:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/biotechnology-and-agricultural-productivity-the-financial-express-bd/</guid></item><item><title><![CDATA[Cuba and China recall Fidel Castro’s contributions to biotechnology - Prensa Latina]]></title><description><![CDATA[Cuba and China recall Fidel Castro&rsquo;s contributions to biotechnology&nbsp;&nbsp;Prensa Latina]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/cuba-and-china-recall-fidel-castros-contributions-to-biotechnology-prensa-latina/</link><pubDate>Tue, 13 Aug 2024 18:04:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/cuba-and-china-recall-fidel-castros-contributions-to-biotechnology-prensa-latina/</guid></item><item><title><![CDATA[Tina Albertson named Caribou CMO - The Pharma Letter]]></title><description><![CDATA[Tina Albertson named Caribou CMO&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/tina-albertson-named-caribou-cmo-the-pharma-letter/</link><pubDate>Tue, 13 Aug 2024 17:54:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/tina-albertson-named-caribou-cmo-the-pharma-letter/</guid></item><item><title><![CDATA[PDS Biotechnology: Q2 Earnings Snapshot - Press of Atlantic City]]></title><description><![CDATA[PDS Biotechnology: Q2 Earnings Snapshot&nbsp;&nbsp;Press of Atlantic City]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/pds-biotechnology-q2-earnings-snapshot-press-of-atlantic-city/</link><pubDate>Tue, 13 Aug 2024 17:21:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/pds-biotechnology-q2-earnings-snapshot-press-of-atlantic-city/</guid></item><item><title><![CDATA[Marine Biotechnology Market Size to Grow USD 13.59 Billion by 2034 - BioSpace]]></title><description><![CDATA[Marine Biotechnology Market Size to Grow USD 13.59 Billion by 2034&nbsp;&nbsp;BioSpace]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/marine-biotechnology-market-size-to-grow-usd-1359-billion-by-2034-biospace/</link><pubDate>Tue, 13 Aug 2024 17:21:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/marine-biotechnology-market-size-to-grow-usd-1359-billion-by-2034-biospace/</guid></item><item><title><![CDATA[Octapharma updates on Balfaxar | Biotechnology | The Pharmaletter - The Pharma Letter]]></title><description><![CDATA[Octapharma updates on Balfaxar | Biotechnology | The Pharmaletter&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/octapharma-updates-on-balfaxar-biotechnology-the-pharmaletter-the-pharma-letter/</link><pubDate>Tue, 13 Aug 2024 15:56:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/octapharma-updates-on-balfaxar-biotechnology-the-pharmaletter-the-pharma-letter/</guid></item><item><title><![CDATA[Enhertu gains new approval in China - The Pharma Letter]]></title><description><![CDATA[Enhertu gains new approval in China&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/enhertu-gains-new-approval-in-china-the-pharma-letter/</link><pubDate>Tue, 13 Aug 2024 15:56:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/enhertu-gains-new-approval-in-china-the-pharma-letter/</guid></item><item><title><![CDATA[Actinogen decimated by depression data - The Pharma Letter]]></title><description><![CDATA[Actinogen decimated by depression data&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/actinogen-decimated-by-depression-data-the-pharma-letter/</link><pubDate>Tue, 13 Aug 2024 15:18:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/actinogen-decimated-by-depression-data-the-pharma-letter/</guid></item><item><title><![CDATA[PDS Biotechnology: Q2 Earnings Snapshot - Greenwich Time]]></title><description><![CDATA[PDS Biotechnology: Q2 Earnings Snapshot&nbsp;&nbsp;Greenwich Time]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/pds-biotechnology-q2-earnings-snapshot-greenwich-time/</link><pubDate>Tue, 13 Aug 2024 14:21:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/pds-biotechnology-q2-earnings-snapshot-greenwich-time/</guid></item><item><title><![CDATA[Halda Therapeutics secures $126 million financing - The Pharma Letter]]></title><description><![CDATA[Halda Therapeutics secures $126 million financing&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/halda-therapeutics-secures-126-million-financing-the-pharma-letter/</link><pubDate>Tue, 13 Aug 2024 13:25:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/halda-therapeutics-secures-126-million-financing-the-pharma-letter/</guid></item><item><title><![CDATA[Australia’s CSL reports strong performance led by Ig - The Pharma Letter]]></title><description><![CDATA[Australia&rsquo;s CSL reports strong performance led by Ig&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/australias-csl-reports-strong-performance-led-by-ig-the-pharma-letter/</link><pubDate>Tue, 13 Aug 2024 11:41:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/australias-csl-reports-strong-performance-led-by-ig-the-pharma-letter/</guid></item><item><title><![CDATA[Puma Biotechnology (NASDAQ:PBYI) Rating Lowered to Buy at StockNews.com - Defense World]]></title><description><![CDATA[Puma Biotechnology (NASDAQ:PBYI) Rating Lowered to Buy at StockNews.com&nbsp;&nbsp;Defense World]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/puma-biotechnology-nasdaqpbyi-rating-lowered-to-buy-at-stocknewscom-defense-world/</link><pubDate>Tue, 13 Aug 2024 08:36:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/puma-biotechnology-nasdaqpbyi-rating-lowered-to-buy-at-stocknewscom-defense-world/</guid></item><item><title><![CDATA[Investors in iNtRON Biotechnology (KOSDAQ:048530) from three years ago are still down 71%, even after 25% gain this past week - Simply Wall St]]></title><description><![CDATA[Investors in iNtRON Biotechnology (KOSDAQ:048530) from three years ago are still down 71%, even after 25% gain this past week&nbsp;&nbsp;Simply Wall St]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/investors-in-intron-biotechnology-kosdaq048530-from-three-years-ago-are-still-down-71-even-after-25-gain-this-past-week-simply-wall-st/</link><pubDate>Tue, 13 Aug 2024 06:35:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/investors-in-intron-biotechnology-kosdaq048530-from-three-years-ago-are-still-down-71-even-after-25-gain-this-past-week-simply-wall-st/</guid></item><item><title><![CDATA[Is Walvax Biotechnology Co., Ltd.'s (SZSE:300142) Recent Price Movement Underpinned By Its Weak Fundamentals? - Simply Wall St]]></title><description><![CDATA[Is Walvax Biotechnology Co., Ltd.'s (SZSE:300142) Recent Price Movement Underpinned By Its Weak Fundamentals?&nbsp;&nbsp;Simply Wall St]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/is-walvax-biotechnology-co-ltds-szse300142-recent-price-movement-underpinned-by-its-weak-fundamentals-simply-wall-st/</link><pubDate>Tue, 13 Aug 2024 02:36:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/is-walvax-biotechnology-co-ltds-szse300142-recent-price-movement-underpinned-by-its-weak-fundamentals-simply-wall-st/</guid></item><item><title><![CDATA[Biotechnology Contract Manufacturing Market Building a Skilled Workforce for the Future: CDMOs as Leaders i... - WhaTech]]></title><description><![CDATA[Biotechnology Contract Manufacturing Market Building a Skilled Workforce for the Future: CDMOs as Leaders i...&nbsp;&nbsp;WhaTech]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/biotechnology-contract-manufacturing-market-building-a-skilled-workforce-for-the-future-cdmos-as-leaders-i-whatech/</link><pubDate>Tue, 13 Aug 2024 00:25:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/biotechnology-contract-manufacturing-market-building-a-skilled-workforce-for-the-future-cdmos-as-leaders-i-whatech/</guid></item><item><title><![CDATA[Prakash Bhuyan named SpyBiotech CMO - The Pharma Letter]]></title><description><![CDATA[Prakash Bhuyan named SpyBiotech CMO&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/prakash-bhuyan-named-spybiotech-cmo-the-pharma-letter/</link><pubDate>Mon, 12 Aug 2024 18:57:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/prakash-bhuyan-named-spybiotech-cmo-the-pharma-letter/</guid></item><item><title><![CDATA[FDA approves Yorvipath - The Pharma Letter]]></title><description><![CDATA[FDA approves Yorvipath&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/fda-approves-yorvipath-the-pharma-letter/</link><pubDate>Mon, 12 Aug 2024 17:30:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/fda-approves-yorvipath-the-pharma-letter/</guid></item><item><title><![CDATA[FDA lifts 4DMT clinical hold - The Pharma Letter]]></title><description><![CDATA[FDA lifts 4DMT clinical hold&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/fda-lifts-4dmt-clinical-hold-the-pharma-letter/</link><pubDate>Mon, 12 Aug 2024 14:19:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/fda-lifts-4dmt-clinical-hold-the-pharma-letter/</guid></item><item><title><![CDATA[UNITY Biotechnology to Participate in Upcoming Investor Conferences - StockTitan]]></title><description><![CDATA[UNITY Biotechnology to Participate in Upcoming Investor Conferences&nbsp;&nbsp;StockTitan]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/unity-biotechnology-to-participate-in-upcoming-investor-conferences-stocktitan/</link><pubDate>Mon, 12 Aug 2024 14:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/unity-biotechnology-to-participate-in-upcoming-investor-conferences-stocktitan/</guid></item><item><title><![CDATA[Sphingotec secures Series C financing - European Biotechnology News]]></title><description><![CDATA[Sphingotec secures Series C financing&nbsp;&nbsp;European Biotechnology News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/sphingotec-secures-series-c-financing-european-biotechnology-news/</link><pubDate>Mon, 12 Aug 2024 10:34:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/sphingotec-secures-series-c-financing-european-biotechnology-news/</guid></item><item><title><![CDATA[Vanguard Group Inc. Reduces Holdings in Puma Biotechnology, Inc. (NASDAQ:PBYI) - Defense World]]></title><description><![CDATA[Vanguard Group Inc. Reduces Holdings in Puma Biotechnology, Inc. (NASDAQ:PBYI)&nbsp;&nbsp;Defense World]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/vanguard-group-inc-reduces-holdings-in-puma-biotechnology-inc-nasdaqpbyi-defense-world/</link><pubDate>Mon, 12 Aug 2024 10:24:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/vanguard-group-inc-reduces-holdings-in-puma-biotechnology-inc-nasdaqpbyi-defense-world/</guid></item><item><title><![CDATA[HC Wainwright Cuts Sana Biotechnology (NASDAQ:SANA) Price Target to $11.00 - Defense World]]></title><description><![CDATA[HC Wainwright Cuts Sana Biotechnology (NASDAQ:SANA) Price Target to $11.00&nbsp;&nbsp;Defense World]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/hc-wainwright-cuts-sana-biotechnology-nasdaqsana-price-target-to-1100-defense-world/</link><pubDate>Mon, 12 Aug 2024 09:59:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/hc-wainwright-cuts-sana-biotechnology-nasdaqsana-price-target-to-1100-defense-world/</guid></item><item><title><![CDATA[Citigroup Raises Sana Biotechnology (NASDAQ:SANA) Price Target to $15.00 - Defense World]]></title><description><![CDATA[Citigroup Raises Sana Biotechnology (NASDAQ:SANA) Price Target to $15.00&nbsp;&nbsp;Defense World]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/citigroup-raises-sana-biotechnology-nasdaqsana-price-target-to-1500-defense-world/</link><pubDate>Mon, 12 Aug 2024 09:59:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/citigroup-raises-sana-biotechnology-nasdaqsana-price-target-to-1500-defense-world/</guid></item><item><title><![CDATA[Ropes &amp; Gray Advises Vir Biotechnology in Global License Agreement with Sanofi - Ropes &amp; Gray LLP]]></title><description><![CDATA[Ropes &amp; Gray Advises Vir Biotechnology in Global License Agreement with Sanofi&nbsp;&nbsp;Ropes &amp; Gray LLP]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/ropes-amp-gray-advises-vir-biotechnology-in-global-license-agreement-with-sanofi-ropes-amp-gray-llp/</link><pubDate>Sun, 11 Aug 2024 09:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/ropes-amp-gray-advises-vir-biotechnology-in-global-license-agreement-with-sanofi-ropes-amp-gray-llp/</guid></item><item><title><![CDATA[Sana Biotechnology Target of Unusually High Options Trading (NASDAQ:SANA) - Defense World]]></title><description><![CDATA[Sana Biotechnology Target of Unusually High Options Trading (NASDAQ:SANA)&nbsp;&nbsp;Defense World]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/sana-biotechnology-target-of-unusually-high-options-trading-nasdaqsana-defense-world/</link><pubDate>Sat, 10 Aug 2024 08:33:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/sana-biotechnology-target-of-unusually-high-options-trading-nasdaqsana-defense-world/</guid></item><item><title><![CDATA[Valorization of lignin from aqueous-based lignocellulosic biorefineries]]></title><description><![CDATA[An additional 100 million tons/year of lignin coproduct will result when lignocellulosic biomass is processed in biorefineries to fiber, sugars, biofuels, and bioproducts. This will double the amount of lignin already generated from pulping and paper production. Unlike pulping that results in lignosulphonate (88% of total) or Kraft lignin (9%), aqueous-based biorefining leaves behind non-sulfonated lignin and aromatic molecules. This new type of lignin provides opportunities for large volume agr]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/valorization-of-lignin-from-aqueous-based-lignocellulosic-biorefineries/</link><pubDate>Sat, 10 Aug 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/valorization-of-lignin-from-aqueous-based-lignocellulosic-biorefineries/</guid></item><item><title><![CDATA[Sana Biotechnology rises 6% as data from several studies will be released by year-end - Seeking Alpha]]></title><description><![CDATA[Sana Biotechnology rises 6% as data from several studies will be released by year-end&nbsp;&nbsp;Seeking Alpha]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/sana-biotechnology-rises-6-as-data-from-several-studies-will-be-released-by-year-end-seeking-alpha/</link><pubDate>Fri, 09 Aug 2024 20:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/sana-biotechnology-rises-6-as-data-from-several-studies-will-be-released-by-year-end-seeking-alpha/</guid></item><item><title><![CDATA[The Galien Foundation Announces 2024 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Product" and "Best Product for Rare/Orphan Diseases" - PR Newswire]]></title><description><![CDATA[The Galien Foundation Announces 2024 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Product" and "Best Product for Rare/Orphan Diseases"&nbsp;&nbsp;PR Newswire]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/the-galien-foundation-announces-2024-prix-galien-usa-nominees-for-best-biotechnology-product-best-pharmaceutical-product-and-best-product-for-rareorphan-diseases-pr-newswire/</link><pubDate>Fri, 09 Aug 2024 15:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/the-galien-foundation-announces-2024-prix-galien-usa-nominees-for-best-biotechnology-product-best-pharmaceutical-product-and-best-product-for-rareorphan-diseases-pr-newswire/</guid></item><item><title><![CDATA[2nd-qtr 2024 Gilead financials beat expectations - The Pharma Letter]]></title><description><![CDATA[2nd-qtr 2024 Gilead financials beat expectations&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/2nd-qtr-2024-gilead-financials-beat-expectations-the-pharma-letter/</link><pubDate>Fri, 09 Aug 2024 12:22:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/2nd-qtr-2024-gilead-financials-beat-expectations-the-pharma-letter/</guid></item><item><title><![CDATA[Fast, sensitive detection of protein homologs using deep dense retrieval - Nature.com]]></title><description><![CDATA[Fast, sensitive detection of protein homologs using deep dense retrieval&nbsp;&nbsp;Nature.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/fast-sensitive-detection-of-protein-homologs-using-deep-dense-retrieval-naturecom/</link><pubDate>Fri, 09 Aug 2024 11:35:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/fast-sensitive-detection-of-protein-homologs-using-deep-dense-retrieval-naturecom/</guid></item><item><title><![CDATA[Protein language model enables fast and sensitive remote homolog detection - Nature.com]]></title><description><![CDATA[Protein language model enables fast and sensitive remote homolog detection&nbsp;&nbsp;Nature.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/protein-language-model-enables-fast-and-sensitive-remote-homolog-detection-naturecom/</link><pubDate>Fri, 09 Aug 2024 09:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/protein-language-model-enables-fast-and-sensitive-remote-homolog-detection-naturecom/</guid></item><item><title><![CDATA[Biotechnology Guidance and Resources - aphis.usda.gov]]></title><description><![CDATA[Biotechnology Guidance and Resources&nbsp;&nbsp;aphis.usda.gov]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/biotechnology-guidance-and-resources-aphisusdagov/</link><pubDate>Fri, 09 Aug 2024 09:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/biotechnology-guidance-and-resources-aphisusdagov/</guid></item><item><title><![CDATA[Sana Biotechnology Reports Second Quarter 2024 Financial Results and Business Updates - GlobeNewswire]]></title><description><![CDATA[Sana Biotechnology Reports Second Quarter 2024 Financial Results and Business Updates&nbsp;&nbsp;GlobeNewswire]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/sana-biotechnology-reports-second-quarter-2024-financial-results-and-business-updates-globenewswire/</link><pubDate>Thu, 08 Aug 2024 22:09:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/sana-biotechnology-reports-second-quarter-2024-financial-results-and-business-updates-globenewswire/</guid></item><item><title><![CDATA[New antibiotic breaks resistance - European Biotechnology News]]></title><description><![CDATA[New antibiotic breaks resistance&nbsp;&nbsp;European Biotechnology News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/new-antibiotic-breaks-resistance-european-biotechnology-news/</link><pubDate>Thu, 08 Aug 2024 18:23:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/new-antibiotic-breaks-resistance-european-biotechnology-news/</guid></item><item><title><![CDATA[Biotech financing: darkest before the dawn - Nature.com]]></title><description><![CDATA[Biotech financing: darkest before the dawn&nbsp;&nbsp;Nature.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/biotech-financing-darkest-before-the-dawn-naturecom/</link><pubDate>Thu, 08 Aug 2024 16:41:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/biotech-financing-darkest-before-the-dawn-naturecom/</guid></item><item><title><![CDATA[Microbial electrosynthesis from CO2 reaches productivity of syngas and chain elongation fermentations]]></title><description><![CDATA[Carbon-based products are crucial to society. However, their production from fossil-based carbon is unsustainable. We developed a scalable microbial electrosynthesis process that produces medium-chain carboxylic acids from CO2 and renewable electricity, using microorganisms as a catalyst. This represents a promising avenue for generating low CO2-footprint precursors for the chemical, fuel, feed, and food industries.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/microbial-electrosynthesis-from-co2-reaches-productivity-of-syngas-and-chain-elongation-fermentations/</link><pubDate>Thu, 08 Aug 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/microbial-electrosynthesis-from-co2-reaches-productivity-of-syngas-and-chain-elongation-fermentations/</guid></item><item><title><![CDATA[Calibre Scientific Acquires Spanish Biotechnology Laboratory Consumables and Equipment Supplier - European Pharmaceutical Manufacturer]]></title><description><![CDATA[Calibre Scientific Acquires Spanish Biotechnology Laboratory Consumables and Equipment Supplier&nbsp;&nbsp;European Pharmaceutical Manufacturer]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/calibre-scientific-acquires-spanish-biotechnology-laboratory-consumables-and-equipment-supplier-european-pharmaceutical-manufacturer/</link><pubDate>Wed, 07 Aug 2024 14:01:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/calibre-scientific-acquires-spanish-biotechnology-laboratory-consumables-and-equipment-supplier-european-pharmaceutical-manufacturer/</guid></item><item><title><![CDATA[Ayana Bio Welcomes Biotechnology Veteran Jill Zullo to its Board of Directors - Food Industry Executive]]></title><description><![CDATA[Ayana Bio Welcomes Biotechnology Veteran Jill Zullo to its Board of Directors&nbsp;&nbsp;Food Industry Executive]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/ayana-bio-welcomes-biotechnology-veteran-jill-zullo-to-its-board-of-directors-food-industry-executive/</link><pubDate>Wed, 07 Aug 2024 09:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/ayana-bio-welcomes-biotechnology-veteran-jill-zullo-to-its-board-of-directors-food-industry-executive/</guid></item><item><title><![CDATA[Microbial messengers: nucleic acid delivery by bacteria]]></title><description><![CDATA[The demand for diverse nucleic acid delivery vectors, driven by recent biotechnological breakthroughs, offers opportunities for continuous improvements in efficiency, safety, and delivery capacity. With their enhanced safety and substantial cargo capacity, bacterial vectors offer significant potential across a variety of applications. In this review, we explore methods to engineer bacteria for nucleic acid delivery, including strategies such as engineering attenuated strains, lysis circuits, and]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/microbial-messengers-nucleic-acid-delivery-by-bacteria/</link><pubDate>Wed, 07 Aug 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/microbial-messengers-nucleic-acid-delivery-by-bacteria/</guid></item><item><title><![CDATA[Global Red Biotechnology Market Size To Worth USD 699.31 Billion By 2033 | CAGR of 6.26% - GlobeNewswire]]></title><description><![CDATA[Global Red Biotechnology Market Size To Worth USD 699.31 Billion By 2033 | CAGR of 6.26%&nbsp;&nbsp;GlobeNewswire]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/global-red-biotechnology-market-size-to-worth-usd-69931-billion-by-2033-cagr-of-626-globenewswire/</link><pubDate>Tue, 06 Aug 2024 09:02:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/global-red-biotechnology-market-size-to-worth-usd-69931-billion-by-2033-cagr-of-626-globenewswire/</guid></item><item><title><![CDATA[Puma Biotechnology (NASDAQ:PBYI) Upgraded by StockNews.com to "Strong-Buy" - MarketBeat]]></title><description><![CDATA[Puma Biotechnology (NASDAQ:PBYI) Upgraded by StockNews.com to "Strong-Buy"&nbsp;&nbsp;MarketBeat]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/puma-biotechnology-nasdaqpbyi-upgraded-by-stocknewscom-to-strong-buy-marketbeat/</link><pubDate>Tue, 06 Aug 2024 05:34:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/puma-biotechnology-nasdaqpbyi-upgraded-by-stocknewscom-to-strong-buy-marketbeat/</guid></item><item><title><![CDATA[Vir Biotechnology (NASDAQ:VIR) Trading Down 7.9% - MarketBeat]]></title><description><![CDATA[Vir Biotechnology (NASDAQ:VIR) Trading Down 7.9%&nbsp;&nbsp;MarketBeat]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-nasdaqvir-trading-down-79-marketbeat/</link><pubDate>Tue, 06 Aug 2024 03:31:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-nasdaqvir-trading-down-79-marketbeat/</guid></item><item><title><![CDATA[Systematic development of a highly efficient cell factory for 5-aminolevulinic acid production]]></title><description><![CDATA[A systematic engineering framework was demonstrated to construct a 5-aminolevulinic acid (5-ALA) cell factory, achieving the economic viability of biomanufacturing this compound with an unprecedented production performance (63.39 g/l). This comprehensive framework encompasses enzyme mining, multitarget engineering, artificial homeostasis design, and collaborative optimization.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/systematic-development-of-a-highly-efficient-cell-factory-for-5-aminolevulinic-acid-production/</link><pubDate>Tue, 06 Aug 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/systematic-development-of-a-highly-efficient-cell-factory-for-5-aminolevulinic-acid-production/</guid></item><item><title><![CDATA[Bioprinted, spatially defined breast tumor microenvironment models of intratumoral heterogeneity and drug resistance]]></title><description><![CDATA[Applied bioprinted vascularized breast tumor models recapturing tumor–stroma structures of human breast tumors to study intratumoral heterogeneity and drug resistance. Bioprinted tumor models recapitulated spatially distinct pathological features and identified potential intercellular interactions regulating these pathological changes. Bioprinted tumor models also demonstrated microenvironmentally mediated drug resistance.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/bioprinted-spatially-defined-breast-tumor-microenvironment-models-of-intratumoral-heterogeneity-and-drug-resistance/</link><pubDate>Tue, 06 Aug 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/bioprinted-spatially-defined-breast-tumor-microenvironment-models-of-intratumoral-heterogeneity-and-drug-resistance/</guid></item><item><title><![CDATA[Sana Biotechnology Opens New Biomanufacturing Facility - Genetic Engineering &amp; Biotechnology News]]></title><description><![CDATA[Sana Biotechnology Opens New Biomanufacturing Facility&nbsp;&nbsp;Genetic Engineering &amp; Biotechnology News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/sana-biotechnology-opens-new-biomanufacturing-facility-genetic-engineering-amp-biotechnology-news/</link><pubDate>Mon, 05 Aug 2024 22:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/sana-biotechnology-opens-new-biomanufacturing-facility-genetic-engineering-amp-biotechnology-news/</guid></item><item><title><![CDATA[Cetera Investment Advisers Purchases 79,541 Shares of iShares Biotechnology ETF (NASDAQ:IBB) - Defense World]]></title><description><![CDATA[Cetera Investment Advisers Purchases 79,541 Shares of iShares Biotechnology ETF (NASDAQ:IBB)&nbsp;&nbsp;Defense World]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/cetera-investment-advisers-purchases-79541-shares-of-ishares-biotechnology-etf-nasdaqibb-defense-world/</link><pubDate>Mon, 05 Aug 2024 18:45:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/cetera-investment-advisers-purchases-79541-shares-of-ishares-biotechnology-etf-nasdaqibb-defense-world/</guid></item><item><title><![CDATA[iTeos appoints David Feltquate as chief medical officer - The Pharma Letter]]></title><description><![CDATA[iTeos appoints David Feltquate as chief medical officer&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/iteos-appoints-david-feltquate-as-chief-medical-officer-the-pharma-letter/</link><pubDate>Mon, 05 Aug 2024 18:14:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/iteos-appoints-david-feltquate-as-chief-medical-officer-the-pharma-letter/</guid></item><item><title><![CDATA[BMS returns AGEN1777 rights to Agenus - The Pharma Letter]]></title><description><![CDATA[BMS returns AGEN1777 rights to Agenus&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/bms-returns-agen1777-rights-to-agenus-the-pharma-letter/</link><pubDate>Mon, 05 Aug 2024 18:14:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/bms-returns-agen1777-rights-to-agenus-the-pharma-letter/</guid></item><item><title><![CDATA[BioNTech sales downturn continues - The Pharma Letter]]></title><description><![CDATA[BioNTech sales downturn continues&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/biontech-sales-downturn-continues-the-pharma-letter/</link><pubDate>Mon, 05 Aug 2024 16:54:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/biontech-sales-downturn-continues-the-pharma-letter/</guid></item><item><title><![CDATA[USA funds animal health firm for work on valley fever vaccine - The Pharma Letter]]></title><description><![CDATA[USA funds animal health firm for work on valley fever vaccine&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/usa-funds-animal-health-firm-for-work-on-valley-fever-vaccine-the-pharma-letter/</link><pubDate>Mon, 05 Aug 2024 15:44:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/usa-funds-animal-health-firm-for-work-on-valley-fever-vaccine-the-pharma-letter/</guid></item><item><title><![CDATA[Jade Biosciences raises $80 million for autoimmune work - The Pharma Letter]]></title><description><![CDATA[Jade Biosciences raises $80 million for autoimmune work&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/jade-biosciences-raises-80-million-for-autoimmune-work-the-pharma-letter/</link><pubDate>Mon, 05 Aug 2024 14:24:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/jade-biosciences-raises-80-million-for-autoimmune-work-the-pharma-letter/</guid></item><item><title><![CDATA[Genmab regains rights to acasunlimab - The Pharma Letter]]></title><description><![CDATA[Genmab regains rights to acasunlimab&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/genmab-regains-rights-to-acasunlimab-the-pharma-letter/</link><pubDate>Mon, 05 Aug 2024 14:24:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/genmab-regains-rights-to-acasunlimab-the-pharma-letter/</guid></item><item><title><![CDATA[New Bimzelx injections gain approval in Europe - The Pharma Letter]]></title><description><![CDATA[New Bimzelx injections gain approval in Europe&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/new-bimzelx-injections-gain-approval-in-europe-the-pharma-letter/</link><pubDate>Mon, 05 Aug 2024 13:04:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/new-bimzelx-injections-gain-approval-in-europe-the-pharma-letter/</guid></item><item><title><![CDATA[Dr. David Liu Receives the 2024 Gabbay Award in Biotechnology and Medicine - brandeis.edu]]></title><description><![CDATA[Dr. David Liu Receives the 2024 Gabbay Award in Biotechnology and Medicine&nbsp;&nbsp;brandeis.edu]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/dr-david-liu-receives-the-2024-gabbay-award-in-biotechnology-and-medicine-brandeisedu/</link><pubDate>Mon, 05 Aug 2024 09:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/dr-david-liu-receives-the-2024-gabbay-award-in-biotechnology-and-medicine-brandeisedu/</guid></item><item><title><![CDATA[FDA approves cell therapy for solid tumours - European Biotechnology News]]></title><description><![CDATA[FDA approves cell therapy for solid tumours&nbsp;&nbsp;European Biotechnology News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/fda-approves-cell-therapy-for-solid-tumours-european-biotechnology-news/</link><pubDate>Mon, 05 Aug 2024 08:43:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/fda-approves-cell-therapy-for-solid-tumours-european-biotechnology-news/</guid></item><item><title><![CDATA[Puma Biotechnology Second Quarter 2024 Earnings: Beats Expectations - Yahoo Finance]]></title><description><![CDATA[Puma Biotechnology Second Quarter 2024 Earnings: Beats Expectations&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/puma-biotechnology-second-quarter-2024-earnings-beats-expectations-yahoo-finance/</link><pubDate>Sun, 04 Aug 2024 15:52:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/puma-biotechnology-second-quarter-2024-earnings-beats-expectations-yahoo-finance/</guid></item><item><title><![CDATA[Vir Biotechnology Slashes 25% Workforce Amid Restructuring Despite Positive Clinical Study in San Francisco - Hoodline]]></title><description><![CDATA[Vir Biotechnology Slashes 25% Workforce Amid Restructuring Despite Positive Clinical Study in San Francisco&nbsp;&nbsp;Hoodline]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-slashes-25-workforce-amid-restructuring-despite-positive-clinical-study-in-san-francisco-hoodline/</link><pubDate>Sat, 03 Aug 2024 21:10:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-slashes-25-workforce-amid-restructuring-despite-positive-clinical-study-in-san-francisco-hoodline/</guid></item><item><title><![CDATA[Earnings call: Puma Biotechnology reported a total revenue reaching $47.1 million - Investing.com]]></title><description><![CDATA[Earnings call: Puma Biotechnology reported a total revenue reaching $47.1 million&nbsp;&nbsp;Investing.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/earnings-call-puma-biotechnology-reported-a-total-revenue-reaching-471-million-investingcom/</link><pubDate>Sat, 03 Aug 2024 01:37:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/earnings-call-puma-biotechnology-reported-a-total-revenue-reaching-471-million-investingcom/</guid></item><item><title><![CDATA[Sana Biotechnology cuts the ribbon at new manufacturing facility near Seattle - GeekWire]]></title><description><![CDATA[Sana Biotechnology cuts the ribbon at new manufacturing facility near Seattle&nbsp;&nbsp;GeekWire]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/sana-biotechnology-cuts-the-ribbon-at-new-manufacturing-facility-near-seattle-geekwire/</link><pubDate>Sat, 03 Aug 2024 01:12:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/sana-biotechnology-cuts-the-ribbon-at-new-manufacturing-facility-near-seattle-geekwire/</guid></item><item><title><![CDATA[Earnings call: Vir Biotechnology reports progress in T-cell engager therapy - Investing.com]]></title><description><![CDATA[Earnings call: Vir Biotechnology reports progress in T-cell engager therapy&nbsp;&nbsp;Investing.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/earnings-call-vir-biotechnology-reports-progress-in-t-cell-engager-therapy-investingcom/</link><pubDate>Fri, 02 Aug 2024 23:03:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/earnings-call-vir-biotechnology-reports-progress-in-t-cell-engager-therapy-investingcom/</guid></item><item><title><![CDATA[Biotechnology student Parag Shinde gains industry experience through summer pharma role - UMBC News]]></title><description><![CDATA[Biotechnology student Parag Shinde gains industry experience through summer pharma role&nbsp;&nbsp;UMBC News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/biotechnology-student-parag-shinde-gains-industry-experience-through-summer-pharma-role-umbc-news/</link><pubDate>Fri, 02 Aug 2024 21:32:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/biotechnology-student-parag-shinde-gains-industry-experience-through-summer-pharma-role-umbc-news/</guid></item><item><title><![CDATA[Sino-American deal in immuno-oncology - The Pharma Letter]]></title><description><![CDATA[Sino-American deal in immuno-oncology&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/sino-american-deal-in-immuno-oncology-the-pharma-letter/</link><pubDate>Fri, 02 Aug 2024 17:03:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/sino-american-deal-in-immuno-oncology-the-pharma-letter/</guid></item><item><title><![CDATA[FibroGen to scrap pamrevlumab program, slash workforce - The Pharma Letter]]></title><description><![CDATA[FibroGen to scrap pamrevlumab program, slash workforce&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/fibrogen-to-scrap-pamrevlumab-program-slash-workforce-the-pharma-letter/</link><pubDate>Fri, 02 Aug 2024 17:03:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/fibrogen-to-scrap-pamrevlumab-program-slash-workforce-the-pharma-letter/</guid></item><item><title><![CDATA[Breaking Down Vir Biotechnology: 6 Analysts Share Their Views - Benzinga]]></title><description><![CDATA[Breaking Down Vir Biotechnology: 6 Analysts Share Their Views&nbsp;&nbsp;Benzinga]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/breaking-down-vir-biotechnology-6-analysts-share-their-views-benzinga/</link><pubDate>Fri, 02 Aug 2024 17:01:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/breaking-down-vir-biotechnology-6-analysts-share-their-views-benzinga/</guid></item><item><title><![CDATA[Vir trims pipeline and workforce - The Pharma Letter]]></title><description><![CDATA[Vir trims pipeline and workforce&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/vir-trims-pipeline-and-workforce-the-pharma-letter/</link><pubDate>Fri, 02 Aug 2024 15:31:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/vir-trims-pipeline-and-workforce-the-pharma-letter/</guid></item><item><title><![CDATA[Puma Biotechnology's (PBYI) Q2 Loss Narrower Than Expected - Zacks Investment Research]]></title><description><![CDATA[Puma Biotechnology's (PBYI) Q2 Loss Narrower Than Expected&nbsp;&nbsp;Zacks Investment Research]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/puma-biotechnologys-pbyi-q2-loss-narrower-than-expected-zacks-investment-research/</link><pubDate>Fri, 02 Aug 2024 15:14:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/puma-biotechnologys-pbyi-q2-loss-narrower-than-expected-zacks-investment-research/</guid></item><item><title><![CDATA[PDS Biotechnology Corporation (PDSB) Clinical Program Update Conference Call (Transcript) - Seeking Alpha]]></title><description><![CDATA[PDS Biotechnology Corporation (PDSB) Clinical Program Update Conference Call (Transcript)&nbsp;&nbsp;Seeking Alpha]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/pds-biotechnology-corporation-pdsb-clinical-program-update-conference-call-transcript-seeking-alpha/</link><pubDate>Fri, 02 Aug 2024 15:12:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/pds-biotechnology-corporation-pdsb-clinical-program-update-conference-call-transcript-seeking-alpha/</guid></item><item><title><![CDATA[Zacks.com featured highlights Abercrombie &amp; Fitch, Puma Biotechnology, Spotify and Oddity - Yahoo Finance]]></title><description><![CDATA[Zacks.com featured highlights Abercrombie &amp; Fitch, Puma Biotechnology, Spotify and Oddity&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/zackscom-featured-highlights-abercrombie-amp-fitch-puma-biotechnology-spotify-and-oddity-yahoo-finance/</link><pubDate>Fri, 02 Aug 2024 14:51:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/zackscom-featured-highlights-abercrombie-amp-fitch-puma-biotechnology-spotify-and-oddity-yahoo-finance/</guid></item><item><title><![CDATA[Valneva and LimmaTech agree license deal for Shigella vaccine - The Pharma Letter]]></title><description><![CDATA[Valneva and LimmaTech agree license deal for Shigella vaccine&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/valneva-and-limmatech-agree-license-deal-for-shigella-vaccine-the-pharma-letter/</link><pubDate>Fri, 02 Aug 2024 13:17:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/valneva-and-limmatech-agree-license-deal-for-shigella-vaccine-the-pharma-letter/</guid></item><item><title><![CDATA[FDA expands endometrial cancer indication for GSK’s Jemperli - The Pharma Letter]]></title><description><![CDATA[FDA expands endometrial cancer indication for GSK&rsquo;s Jemperli&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/fda-expands-endometrial-cancer-indication-for-gsks-jemperli-the-pharma-letter/</link><pubDate>Fri, 02 Aug 2024 13:15:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/fda-expands-endometrial-cancer-indication-for-gsks-jemperli-the-pharma-letter/</guid></item><item><title><![CDATA[Half billion dollar fund ready to invest in biotech start-ups - The Pharma Letter]]></title><description><![CDATA[Half billion dollar fund ready to invest in biotech start-ups&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/half-billion-dollar-fund-ready-to-invest-in-biotech-start-ups-the-pharma-letter/</link><pubDate>Fri, 02 Aug 2024 11:53:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/half-billion-dollar-fund-ready-to-invest-in-biotech-start-ups-the-pharma-letter/</guid></item><item><title><![CDATA[Outpace Bio raises $144 million in Series B financing - The Pharma Letter]]></title><description><![CDATA[Outpace Bio raises $144 million in Series B financing&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/outpace-bio-raises-144-million-in-series-b-financing-the-pharma-letter/</link><pubDate>Fri, 02 Aug 2024 11:43:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/outpace-bio-raises-144-million-in-series-b-financing-the-pharma-letter/</guid></item><item><title><![CDATA[Breakthrough for Adaptimmune as Tecelra gains US approval - The Pharma Letter]]></title><description><![CDATA[Breakthrough for Adaptimmune as Tecelra gains US approval&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/breakthrough-for-adaptimmune-as-tecelra-gains-us-approval-the-pharma-letter/</link><pubDate>Fri, 02 Aug 2024 11:43:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/breakthrough-for-adaptimmune-as-tecelra-gains-us-approval-the-pharma-letter/</guid></item><item><title><![CDATA[ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Share Price Cross Above 50 Day Moving Average of $60.85 - MarketBeat]]></title><description><![CDATA[ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Share Price Cross Above 50 Day Moving Average of $60.85&nbsp;&nbsp;MarketBeat]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/proshares-ultra-nasdaq-biotechnology-nasdaqbib-share-price-cross-above-50-day-moving-average-of-6085-marketbeat/</link><pubDate>Fri, 02 Aug 2024 11:18:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/proshares-ultra-nasdaq-biotechnology-nasdaqbib-share-price-cross-above-50-day-moving-average-of-6085-marketbeat/</guid></item><item><title><![CDATA[Puma Biotechnology, Inc. (PBYI) Q2 2024 Earnings Call Transcript - Seeking Alpha]]></title><description><![CDATA[Puma Biotechnology, Inc. (PBYI) Q2 2024 Earnings Call Transcript&nbsp;&nbsp;Seeking Alpha]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/puma-biotechnology-inc-pbyi-q2-2024-earnings-call-transcript-seeking-alpha/</link><pubDate>Fri, 02 Aug 2024 04:54:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/puma-biotechnology-inc-pbyi-q2-2024-earnings-call-transcript-seeking-alpha/</guid></item><item><title><![CDATA[Vir Biotechnology, Inc. (VIR) Q2 2024 Earnings Call Transcript - Seeking Alpha]]></title><description><![CDATA[Vir Biotechnology, Inc. (VIR) Q2 2024 Earnings Call Transcript&nbsp;&nbsp;Seeking Alpha]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-inc-vir-q2-2024-earnings-call-transcript-seeking-alpha/</link><pubDate>Fri, 02 Aug 2024 04:10:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-inc-vir-q2-2024-earnings-call-transcript-seeking-alpha/</guid></item><item><title><![CDATA[Vir Biotechnology, Inc. (VIR) Reports Q2 Loss, Lags Revenue Estimates - MSN]]></title><description><![CDATA[Vir Biotechnology, Inc. (VIR) Reports Q2 Loss, Lags Revenue Estimates&nbsp;&nbsp;MSN]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-inc-vir-reports-q2-loss-lags-revenue-estimates-msn/</link><pubDate>Fri, 02 Aug 2024 01:06:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-inc-vir-reports-q2-loss-lags-revenue-estimates-msn/</guid></item><item><title><![CDATA[Vir Biotechnology, Inc. (VIR) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance]]></title><description><![CDATA[Vir Biotechnology, Inc. (VIR) Reports Q2 Loss, Lags Revenue Estimates&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-inc-vir-reports-q2-loss-lags-revenue-estimates-yahoo-finance/</link><pubDate>Thu, 01 Aug 2024 23:50:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-inc-vir-reports-q2-loss-lags-revenue-estimates-yahoo-finance/</guid></item><item><title><![CDATA[S.F. biotech Vir to cut roughly quarter of workforce - The Business Journals]]></title><description><![CDATA[S.F. biotech Vir to cut roughly quarter of workforce&nbsp;&nbsp;The Business Journals]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/sf-biotech-vir-to-cut-roughly-quarter-of-workforce-the-business-journals/</link><pubDate>Thu, 01 Aug 2024 23:37:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/sf-biotech-vir-to-cut-roughly-quarter-of-workforce-the-business-journals/</guid></item><item><title><![CDATA[Vir Biotechnology to Cut 140 Jobs in Restructuring to Focus on Hepatitis Drug Development - MarketWatch]]></title><description><![CDATA[Vir Biotechnology to Cut 140 Jobs in Restructuring to Focus on Hepatitis Drug Development&nbsp;&nbsp;MarketWatch]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-to-cut-140-jobs-in-restructuring-to-focus-on-hepatitis-drug-development-marketwatch/</link><pubDate>Thu, 01 Aug 2024 23:16:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-to-cut-140-jobs-in-restructuring-to-focus-on-hepatitis-drug-development-marketwatch/</guid></item><item><title><![CDATA[Vir Biotechnology Inc. (VIR) Misses Q2 EPS by 13c ; Provides outlook - StreetInsider.com]]></title><description><![CDATA[Vir Biotechnology Inc. (VIR) Misses Q2 EPS by 13c ; Provides outlook&nbsp;&nbsp;StreetInsider.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-inc-vir-misses-q2-eps-by-13c-provides-outlook-streetinsidercom/</link><pubDate>Thu, 01 Aug 2024 22:25:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-inc-vir-misses-q2-eps-by-13c-provides-outlook-streetinsidercom/</guid></item><item><title><![CDATA[Puma Biotechnology Reports Second Quarter Financial Results - businesswire.com]]></title><description><![CDATA[Puma Biotechnology Reports Second Quarter Financial Results&nbsp;&nbsp;businesswire.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/puma-biotechnology-reports-second-quarter-financial-results-businesswirecom/</link><pubDate>Thu, 01 Aug 2024 22:05:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/puma-biotechnology-reports-second-quarter-financial-results-businesswirecom/</guid></item><item><title><![CDATA[Vir Biotechnology Reports Second Quarter 2024 Financial Results and Announces Strategic Restructuring to Prioritize Clinical-Stage Pipeline Opportunities - StockTitan]]></title><description><![CDATA[Vir Biotechnology Reports Second Quarter 2024 Financial Results and Announces Strategic Restructuring to Prioritize Clinical-Stage Pipeline Opportunities&nbsp;&nbsp;StockTitan]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-reports-second-quarter-2024-financial-results-and-announces-strategic-restructuring-to-prioritize-clinical-stage-pipeline-opportunities-stocktitan/</link><pubDate>Thu, 01 Aug 2024 22:02:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-reports-second-quarter-2024-financial-results-and-announces-strategic-restructuring-to-prioritize-clinical-stage-pipeline-opportunities-stocktitan/</guid></item><item><title><![CDATA[Vir Biotechnology Reports Second Quarter 2024 Financial Results and Announces Strategic Restructuring to Prioritize Clinical-Stage Pipeline Opportunities - businesswire.com]]></title><description><![CDATA[Vir Biotechnology Reports Second Quarter 2024 Financial Results and Announces Strategic Restructuring to Prioritize Clinical-Stage Pipeline Opportunities&nbsp;&nbsp;businesswire.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-reports-second-quarter-2024-financial-results-and-announces-strategic-restructuring-to-prioritize-clinical-stage-pipeline-opportunities-businesswirecom/</link><pubDate>Thu, 01 Aug 2024 22:02:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-reports-second-quarter-2024-financial-results-and-announces-strategic-restructuring-to-prioritize-clinical-stage-pipeline-opportunities-businesswirecom/</guid></item><item><title><![CDATA[Vir Biotechnology Reports Second Quarter 2024 Financial Results and Announces Strategic Restructuring to Prioritize Clinical-Stage Pipeline Opportunities - Business Wire]]></title><description><![CDATA[Vir Biotechnology Reports Second Quarter 2024 Financial Results and Announces Strategic Restructuring to Prioritize Clinical-Stage Pipeline Opportunities&nbsp;&nbsp;Business Wire]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-reports-second-quarter-2024-financial-results-and-announces-strategic-restructuring-to-prioritize-clinical-stage-pipeline-opportunities-business-wire/</link><pubDate>Thu, 01 Aug 2024 22:02:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-reports-second-quarter-2024-financial-results-and-announces-strategic-restructuring-to-prioritize-clinical-stage-pipeline-opportunities-business-wire/</guid></item><item><title><![CDATA[Vir Biotechnology Acts on Expanded Strategy of Powering the Immune System Through Exclusive Worldwide License Agreement with Sanofi for Multiple Potential Best-in-Class Clinical-Stage T-cell Engagers - businesswire.com]]></title><description><![CDATA[Vir Biotechnology Acts on Expanded Strategy of Powering the Immune System Through Exclusive Worldwide License Agreement with Sanofi for Multiple Potential Best-in-Class Clinical-Stage T-cell Engagers&nbsp;&nbsp;businesswire.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-acts-on-expanded-strategy-of-powering-the-immune-system-through-exclusive-worldwide-license-agreement-with-sanofi-for-multiple-potential-best-in-class-clinical-stage-t-cell-engagers-businesswirecom/</link><pubDate>Thu, 01 Aug 2024 22:01:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-acts-on-expanded-strategy-of-powering-the-immune-system-through-exclusive-worldwide-license-agreement-with-sanofi-for-multiple-potential-best-in-class-clinical-stage-t-cell-engagers-businesswirecom/</guid></item><item><title><![CDATA[Vir Biotechnology Acts on Expanded Strategy of Powering the Immune System Through Exclusive Worldwide License Agreement with Sanofi for Multiple Potential Best-in-Class Clinical-Stage T-cell Engagers - Business Wire]]></title><description><![CDATA[Vir Biotechnology Acts on Expanded Strategy of Powering the Immune System Through Exclusive Worldwide License Agreement with Sanofi for Multiple Potential Best-in-Class Clinical-Stage T-cell Engagers&nbsp;&nbsp;Business Wire]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-acts-on-expanded-strategy-of-powering-the-immune-system-through-exclusive-worldwide-license-agreement-with-sanofi-for-multiple-potential-best-in-class-clinical-stage-t-cell-engagers-business-wire/</link><pubDate>Thu, 01 Aug 2024 22:01:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-acts-on-expanded-strategy-of-powering-the-immune-system-through-exclusive-worldwide-license-agreement-with-sanofi-for-multiple-potential-best-in-class-clinical-stage-t-cell-engagers-business-wire/</guid></item><item><title><![CDATA[Vir Biotechnology enters exclusive global license agreement with Sanofi - TipRanks]]></title><description><![CDATA[Vir Biotechnology enters exclusive global license agreement with Sanofi&nbsp;&nbsp;TipRanks]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-enters-exclusive-global-license-agreement-with-sanofi-tipranks/</link><pubDate>Thu, 01 Aug 2024 21:52:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-enters-exclusive-global-license-agreement-with-sanofi-tipranks/</guid></item><item><title><![CDATA[WuXi Biologics receives EMA approval for five facilities in China - The Pharma Letter]]></title><description><![CDATA[WuXi Biologics receives EMA approval for five facilities in China&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/wuxi-biologics-receives-ema-approval-for-five-facilities-in-china-the-pharma-letter/</link><pubDate>Thu, 01 Aug 2024 18:30:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/wuxi-biologics-receives-ema-approval-for-five-facilities-in-china-the-pharma-letter/</guid></item><item><title><![CDATA[Dannielle Appelhans to succeed John Puisis as Cour CEO - The Pharma Letter]]></title><description><![CDATA[Dannielle Appelhans to succeed John Puisis as Cour CEO&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/dannielle-appelhans-to-succeed-john-puisis-as-cour-ceo-the-pharma-letter/</link><pubDate>Thu, 01 Aug 2024 17:28:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/dannielle-appelhans-to-succeed-john-puisis-as-cour-ceo-the-pharma-letter/</guid></item><item><title><![CDATA[Otsuka to buy Jnana in deal that may exceed $1 billion - The Pharma Letter]]></title><description><![CDATA[Otsuka to buy Jnana in deal that may exceed $1 billion&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/otsuka-to-buy-jnana-in-deal-that-may-exceed-1-billion-the-pharma-letter/</link><pubDate>Thu, 01 Aug 2024 17:22:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/otsuka-to-buy-jnana-in-deal-that-may-exceed-1-billion-the-pharma-letter/</guid></item><item><title><![CDATA[GNT, Plume Biotechnology partnership to create fermented colors - Food Business News]]></title><description><![CDATA[GNT, Plume Biotechnology partnership to create fermented colors&nbsp;&nbsp;Food Business News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/gnt-plume-biotechnology-partnership-to-create-fermented-colors-food-business-news/</link><pubDate>Thu, 01 Aug 2024 17:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/gnt-plume-biotechnology-partnership-to-create-fermented-colors-food-business-news/</guid></item><item><title><![CDATA[Unique Properties of Jaw Stem Cells Could Help Repair Damage - WV News]]></title><description><![CDATA[Unique Properties of Jaw Stem Cells Could Help Repair Damage&nbsp;&nbsp;WV News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/unique-properties-of-jaw-stem-cells-could-help-repair-damage-wv-news/</link><pubDate>Thu, 01 Aug 2024 15:27:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/unique-properties-of-jaw-stem-cells-could-help-repair-damage-wv-news/</guid></item><item><title><![CDATA[Biogen beats estimates and ups guidance - The Pharma Letter]]></title><description><![CDATA[Biogen beats estimates and ups guidance&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/biogen-beats-estimates-and-ups-guidance-the-pharma-letter/</link><pubDate>Thu, 01 Aug 2024 15:02:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/biogen-beats-estimates-and-ups-guidance-the-pharma-letter/</guid></item><item><title><![CDATA[Moderna invests in R&amp;D as Spikevax sales fall - The Pharma Letter]]></title><description><![CDATA[Moderna invests in R&amp;D as Spikevax sales fall&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/moderna-invests-in-rampd-as-spikevax-sales-fall-the-pharma-letter/</link><pubDate>Thu, 01 Aug 2024 14:32:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/moderna-invests-in-rampd-as-spikevax-sales-fall-the-pharma-letter/</guid></item><item><title><![CDATA[Sanofi sues Sarepta over alleged patent infringement - The Pharma Letter]]></title><description><![CDATA[Sanofi sues Sarepta over alleged patent infringement&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/sanofi-sues-sarepta-over-alleged-patent-infringement-the-pharma-letter/</link><pubDate>Thu, 01 Aug 2024 13:27:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/sanofi-sues-sarepta-over-alleged-patent-infringement-the-pharma-letter/</guid></item><item><title><![CDATA[ProMIS Neurosciences to Participate in BTIG Virtual Biotechnology Conference 2024 - Yahoo Finance]]></title><description><![CDATA[ProMIS Neurosciences to Participate in BTIG Virtual Biotechnology Conference 2024&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/promis-neurosciences-to-participate-in-btig-virtual-biotechnology-conference-2024-yahoo-finance/</link><pubDate>Thu, 01 Aug 2024 13:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/promis-neurosciences-to-participate-in-btig-virtual-biotechnology-conference-2024-yahoo-finance/</guid></item><item><title><![CDATA[ProMIS Neurosciences to Participate in BTIG Virtual Biotechnology Conference 2024 - StockTitan]]></title><description><![CDATA[ProMIS Neurosciences to Participate in BTIG Virtual Biotechnology Conference 2024&nbsp;&nbsp;StockTitan]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/promis-neurosciences-to-participate-in-btig-virtual-biotechnology-conference-2024-stocktitan/</link><pubDate>Thu, 01 Aug 2024 13:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/promis-neurosciences-to-participate-in-btig-virtual-biotechnology-conference-2024-stocktitan/</guid></item><item><title><![CDATA[HilleVax hobbling on but cuts 40% of workers - The Pharma Letter]]></title><description><![CDATA[HilleVax hobbling on but cuts 40% of workers&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/hillevax-hobbling-on-but-cuts-40-of-workers-the-pharma-letter/</link><pubDate>Thu, 01 Aug 2024 12:29:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/hillevax-hobbling-on-but-cuts-40-of-workers-the-pharma-letter/</guid></item><item><title><![CDATA[Enhancing siRNA efficacy in vivo with extended nucleic acid backbones - Nature.com]]></title><description><![CDATA[Enhancing siRNA efficacy in vivo with extended nucleic acid backbones&nbsp;&nbsp;Nature.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/enhancing-sirna-efficacy-in-vivo-with-extended-nucleic-acid-backbones-naturecom/</link><pubDate>Thu, 01 Aug 2024 11:21:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/enhancing-sirna-efficacy-in-vivo-with-extended-nucleic-acid-backbones-naturecom/</guid></item><item><title><![CDATA[Valneva licences LimmaTech’s Shigella vaccine - European Biotechnology News]]></title><description><![CDATA[Valneva licences LimmaTech&rsquo;s Shigella vaccine&nbsp;&nbsp;European Biotechnology News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/valneva-licences-limmatechs-shigella-vaccine-european-biotechnology-news/</link><pubDate>Thu, 01 Aug 2024 10:44:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/valneva-licences-limmatechs-shigella-vaccine-european-biotechnology-news/</guid></item><item><title><![CDATA[5 reasons to study biotechnology at BOKU University - Study International]]></title><description><![CDATA[5 reasons to study biotechnology at BOKU University&nbsp;&nbsp;Study International]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/5-reasons-to-study-biotechnology-at-boku-university-study-international/</link><pubDate>Thu, 01 Aug 2024 09:44:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/5-reasons-to-study-biotechnology-at-boku-university-study-international/</guid></item><item><title><![CDATA[Trends in developing one-pot CRISPR diagnostics strategies]]></title><description><![CDATA[The integration of nucleic acid amplification (NAA) with the CRISPR detection system has led to significant advancements and opportunities for development in molecular diagnostics. Nevertheless, the incompatibility between CRISPR cleavage and NAA has significantly impeded the commercialization of this technology. Currently, several one-pot detection strategies based on CRISPR systems have been devised to address concerns regarding aerosol contamination risk and operational complexity associated]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/trends-in-developing-one-pot-crispr-diagnostics-strategies/</link><pubDate>Thu, 01 Aug 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/trends-in-developing-one-pot-crispr-diagnostics-strategies/</guid></item><item><title><![CDATA[Harnessing microbes to pioneer environmental biophotoelectrochemistry]]></title><description><![CDATA[In seeking sustainable environmental strategies, microbial biophotoelectrochemistry (BPEC) systems represent a significant advancement. In this review, we underscore the shift from conventional bioenergy systems to sophisticated BPEC applications, emphasizing their utility in leveraging solar energy for essential biochemical conversions. Recent progress in BPEC technology has facilitated improved photoelectron transfer and system stability, resulting in substantial advancements in carbon and nit]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/harnessing-microbes-to-pioneer-environmental-biophotoelectrochemistry/</link><pubDate>Thu, 01 Aug 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/harnessing-microbes-to-pioneer-environmental-biophotoelectrochemistry/</guid></item><item><title><![CDATA[Concepts and new developments in droplet-based single cell multi-omics]]></title><description><![CDATA[Single cell sequencing technologies have become a fixture in the molecular profiling of cells due to their ease, flexibility, and commercial availability. In particular, partitioning individual cells inside oil droplets via microfluidic reactions enables transcriptomic or multi-omic measurements for thousands of cells in parallel. Complementing the multitude of biological discoveries from genomics analyses, the past decade has brought new capabilities from assay baselines to enable a deeper unde]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/concepts-and-new-developments-in-droplet-based-single-cell-multi-omics/</link><pubDate>Thu, 01 Aug 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/concepts-and-new-developments-in-droplet-based-single-cell-multi-omics/</guid></item><item><title><![CDATA[LTZ Therapeutics raises over $20 million - The Pharma Letter]]></title><description><![CDATA[LTZ Therapeutics raises over $20 million&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/ltz-therapeutics-raises-over-20-million-the-pharma-letter/</link><pubDate>Wed, 31 Jul 2024 16:34:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/ltz-therapeutics-raises-over-20-million-the-pharma-letter/</guid></item><item><title><![CDATA[Tvardi Therapeutics to Participate at the 2024 BTIG Virtual Biotechnology Conference - Business Wire]]></title><description><![CDATA[Tvardi Therapeutics to Participate at the 2024 BTIG Virtual Biotechnology Conference&nbsp;&nbsp;Business Wire]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/tvardi-therapeutics-to-participate-at-the-2024-btig-virtual-biotechnology-conference-business-wire/</link><pubDate>Wed, 31 Jul 2024 15:30:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/tvardi-therapeutics-to-participate-at-the-2024-btig-virtual-biotechnology-conference-business-wire/</guid></item><item><title><![CDATA[Genedata Selector 10 Revolutionizes R&amp;D Workflows in Agricultural Biotechnology - PR Web]]></title><description><![CDATA[Genedata Selector 10 Revolutionizes R&amp;D Workflows in Agricultural Biotechnology&nbsp;&nbsp;PR Web]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/genedata-selector-10-revolutionizes-rampd-workflows-in-agricultural-biotechnology-pr-web/</link><pubDate>Wed, 31 Jul 2024 14:30:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/genedata-selector-10-revolutionizes-rampd-workflows-in-agricultural-biotechnology-pr-web/</guid></item><item><title><![CDATA[GNT Partners with Plume Biotechnology to Create &ldquo;Exciting&rdquo; Fermented Colors for F&amp;B - vegconomist - the vegan business magazine]]></title><description><![CDATA[GNT Partners with Plume Biotechnology to Create &ldquo;Exciting&rdquo; Fermented Colors for F&amp;B&nbsp;&nbsp;vegconomist - the vegan business magazine]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/gnt-partners-with-plume-biotechnology-to-create-ldquoexcitingrdquo-fermented-colors-for-fampb-vegconomist-the-vegan-business-magazine/</link><pubDate>Wed, 31 Jul 2024 13:56:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/gnt-partners-with-plume-biotechnology-to-create-ldquoexcitingrdquo-fermented-colors-for-fampb-vegconomist-the-vegan-business-magazine/</guid></item><item><title><![CDATA[Chugai opts in on Roche’s inavolisib - The Pharma Letter]]></title><description><![CDATA[Chugai opts in on Roche&rsquo;s inavolisib&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/chugai-opts-in-on-roches-inavolisib-the-pharma-letter/</link><pubDate>Wed, 31 Jul 2024 13:34:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/chugai-opts-in-on-roches-inavolisib-the-pharma-letter/</guid></item><item><title><![CDATA[AAIC 2024: long-term Leqembi use safe and effective - The Pharma Letter]]></title><description><![CDATA[AAIC 2024: long-term Leqembi use safe and effective&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/aaic-2024-long-term-leqembi-use-safe-and-effective-the-pharma-letter/</link><pubDate>Wed, 31 Jul 2024 11:53:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/aaic-2024-long-term-leqembi-use-safe-and-effective-the-pharma-letter/</guid></item><item><title><![CDATA[Can Biotech Heal Itself? - ETFdb.com]]></title><description><![CDATA[Can Biotech Heal Itself?&nbsp;&nbsp;ETFdb.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/can-biotech-heal-itself-etfdbcom/</link><pubDate>Tue, 30 Jul 2024 22:47:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/can-biotech-heal-itself-etfdbcom/</guid></item><item><title><![CDATA[Nautilus Biotechnology, Inc. (NAUT) Q2 2024 Earnings Call Transcript - Seeking Alpha]]></title><description><![CDATA[Nautilus Biotechnology, Inc. (NAUT) Q2 2024 Earnings Call Transcript&nbsp;&nbsp;Seeking Alpha]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/nautilus-biotechnology-inc-naut-q2-2024-earnings-call-transcript-seeking-alpha/</link><pubDate>Tue, 30 Jul 2024 21:16:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/nautilus-biotechnology-inc-naut-q2-2024-earnings-call-transcript-seeking-alpha/</guid></item><item><title><![CDATA[Biotech API manufacturing market growing fast - The Pharma Letter]]></title><description><![CDATA[Biotech API manufacturing market growing fast&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/biotech-api-manufacturing-market-growing-fast-the-pharma-letter/</link><pubDate>Tue, 30 Jul 2024 16:30:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/biotech-api-manufacturing-market-growing-fast-the-pharma-letter/</guid></item><item><title><![CDATA[Outlook Therapeutics® to Present at the BTIG Virtual Biotechnology Conference 2024 - Yahoo Finance]]></title><description><![CDATA[Outlook Therapeutics&reg; to Present at the BTIG Virtual Biotechnology Conference 2024&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/outlook-therapeutics-to-present-at-the-btig-virtual-biotechnology-conference-2024-yahoo-finance/</link><pubDate>Tue, 30 Jul 2024 15:10:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/outlook-therapeutics-to-present-at-the-btig-virtual-biotechnology-conference-2024-yahoo-finance/</guid></item><item><title><![CDATA[Outlook Therapeutics® to Present at the BTIG Virtual Biotechnology Conference 2024 - StockTitan]]></title><description><![CDATA[Outlook Therapeutics&reg; to Present at the BTIG Virtual Biotechnology Conference 2024&nbsp;&nbsp;StockTitan]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/outlook-therapeutics-to-present-at-the-btig-virtual-biotechnology-conference-2024-stocktitan/</link><pubDate>Tue, 30 Jul 2024 15:10:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/outlook-therapeutics-to-present-at-the-btig-virtual-biotechnology-conference-2024-stocktitan/</guid></item><item><title><![CDATA[Nautilus Biotechnology Reports Second Quarter 2024 Financial Results - Yahoo Finance]]></title><description><![CDATA[Nautilus Biotechnology Reports Second Quarter 2024 Financial Results&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/nautilus-biotechnology-reports-second-quarter-2024-financial-results-yahoo-finance/</link><pubDate>Tue, 30 Jul 2024 14:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/nautilus-biotechnology-reports-second-quarter-2024-financial-results-yahoo-finance/</guid></item><item><title><![CDATA[Nautilus Biotechnology Reports Second Quarter 2024 Financial Results - StockTitan]]></title><description><![CDATA[Nautilus Biotechnology Reports Second Quarter 2024 Financial Results&nbsp;&nbsp;StockTitan]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/nautilus-biotechnology-reports-second-quarter-2024-financial-results-stocktitan/</link><pubDate>Tue, 30 Jul 2024 14:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/nautilus-biotechnology-reports-second-quarter-2024-financial-results-stocktitan/</guid></item><item><title><![CDATA[Funding gap a major challenge for India’s biotechnology sector - Moneycontrol]]></title><description><![CDATA[Funding gap a major challenge for India&rsquo;s biotechnology sector&nbsp;&nbsp;Moneycontrol]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/funding-gap-a-major-challenge-for-indias-biotechnology-sector-moneycontrol/</link><pubDate>Tue, 30 Jul 2024 13:16:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/funding-gap-a-major-challenge-for-indias-biotechnology-sector-moneycontrol/</guid></item><item><title><![CDATA[Boehringer punts $1.3 billion on expanding oncology pipeline - The Pharma Letter]]></title><description><![CDATA[Boehringer punts $1.3 billion on expanding oncology pipeline&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/boehringer-punts-13-billion-on-expanding-oncology-pipeline-the-pharma-letter/</link><pubDate>Tue, 30 Jul 2024 13:06:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/boehringer-punts-13-billion-on-expanding-oncology-pipeline-the-pharma-letter/</guid></item><item><title><![CDATA[Genelux Corporation to Participate in Fireside Chat at BTIG’s Virtual Biotechnology Conference 2024 - Yahoo Finance]]></title><description><![CDATA[Genelux Corporation to Participate in Fireside Chat at BTIG&rsquo;s Virtual Biotechnology Conference 2024&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/genelux-corporation-to-participate-in-fireside-chat-at-btigs-virtual-biotechnology-conference-2024-yahoo-finance/</link><pubDate>Tue, 30 Jul 2024 13:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/genelux-corporation-to-participate-in-fireside-chat-at-btigs-virtual-biotechnology-conference-2024-yahoo-finance/</guid></item><item><title><![CDATA[Genelux Corporation to Participate in Fireside Chat at BTIG’s Virtual Biotechnology Conference 2024 - StockTitan]]></title><description><![CDATA[Genelux Corporation to Participate in Fireside Chat at BTIG&rsquo;s Virtual Biotechnology Conference 2024&nbsp;&nbsp;StockTitan]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/genelux-corporation-to-participate-in-fireside-chat-at-btigs-virtual-biotechnology-conference-2024-stocktitan/</link><pubDate>Tue, 30 Jul 2024 13:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/genelux-corporation-to-participate-in-fireside-chat-at-btigs-virtual-biotechnology-conference-2024-stocktitan/</guid></item><item><title><![CDATA[Animal Biotechnology Market Size, Share, Growth Trends and Forecast 2023 - 2032 - openPR]]></title><description><![CDATA[Animal Biotechnology Market Size, Share, Growth Trends and Forecast 2023 - 2032&nbsp;&nbsp;openPR]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/animal-biotechnology-market-size-share-growth-trends-and-forecast-2023-2032-openpr/</link><pubDate>Tue, 30 Jul 2024 12:05:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/animal-biotechnology-market-size-share-growth-trends-and-forecast-2023-2032-openpr/</guid></item><item><title><![CDATA[MindMed appoints chief corporate affairs officer - The Pharma Letter]]></title><description><![CDATA[MindMed appoints chief corporate affairs officer&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/mindmed-appoints-chief-corporate-affairs-officer-the-pharma-letter/</link><pubDate>Tue, 30 Jul 2024 11:45:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/mindmed-appoints-chief-corporate-affairs-officer-the-pharma-letter/</guid></item><item><title><![CDATA[Roche gains EC approval for Vabysmo as RVO treatment - The Pharma Letter]]></title><description><![CDATA[Roche gains EC approval for Vabysmo as RVO treatment&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/roche-gains-ec-approval-for-vabysmo-as-rvo-treatment-the-pharma-letter/</link><pubDate>Tue, 30 Jul 2024 11:44:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/roche-gains-ec-approval-for-vabysmo-as-rvo-treatment-the-pharma-letter/</guid></item><item><title><![CDATA[Xirui Huang ’25 Bridges Biotechnology and Statistics Masters Degrees to Help Others - Azusa Pacific University]]></title><description><![CDATA[Xirui Huang &rsquo;25 Bridges Biotechnology and Statistics Masters Degrees to Help Others&nbsp;&nbsp;Azusa Pacific University]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/xirui-huang-25-bridges-biotechnology-and-statistics-masters-degrees-to-help-others-azusa-pacific-university/</link><pubDate>Tue, 30 Jul 2024 10:36:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/xirui-huang-25-bridges-biotechnology-and-statistics-masters-degrees-to-help-others-azusa-pacific-university/</guid></item><item><title><![CDATA[How Innovative Is China in Biotechnology? - Information Technology and Innovation Foundation]]></title><description><![CDATA[How Innovative Is China in Biotechnology?&nbsp;&nbsp;Information Technology and Innovation Foundation]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/how-innovative-is-china-in-biotechnology-information-technology-and-innovation-foundation/</link><pubDate>Tue, 30 Jul 2024 09:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/how-innovative-is-china-in-biotechnology-information-technology-and-innovation-foundation/</guid></item><item><title><![CDATA[MOEA, ASOA stage biotechnology medical industry event - Taiwan Today]]></title><description><![CDATA[MOEA, ASOA stage biotechnology medical industry event&nbsp;&nbsp;Taiwan Today]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/moea-asoa-stage-biotechnology-medical-industry-event-taiwan-today/</link><pubDate>Tue, 30 Jul 2024 08:30:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/moea-asoa-stage-biotechnology-medical-industry-event-taiwan-today/</guid></item><item><title><![CDATA[OneCarbonBio: industrial biotechnology 3.0]]></title><description><![CDATA[The main concept of OneCarbonBioTM (OCB) is the efficient conversion of methanol to various chemical products through a patent-protected microbial cell factory. Utilizing advanced genetic tools tailored for the OCB bacteria, synthetic metabolic pathways are engineered to channel methanol through the existing metabolism towards the production of the targeted chemical products. These include biopolymers such as polylactic acid and polyhydroxyalkanoates (PHAs), organic acids such as L-malic acid an]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/onecarbonbio-industrial-biotechnology-30/</link><pubDate>Tue, 30 Jul 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/onecarbonbio-industrial-biotechnology-30/</guid></item><item><title><![CDATA[Biotechnology Regulatory Services Will Hold Annual Stakeholder Meeting on November 14, 2024; Stakeholders Can Suggest Topics until September 13 - The National Law Review]]></title><description><![CDATA[Biotechnology Regulatory Services Will Hold Annual Stakeholder Meeting on November 14, 2024; Stakeholders Can Suggest Topics until September 13&nbsp;&nbsp;The National Law Review]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/biotechnology-regulatory-services-will-hold-annual-stakeholder-meeting-on-november-14-2024-stakeholders-can-suggest-topics-until-september-13-the-national-law-review/</link><pubDate>Tue, 30 Jul 2024 01:43:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/biotechnology-regulatory-services-will-hold-annual-stakeholder-meeting-on-november-14-2024-stakeholders-can-suggest-topics-until-september-13-the-national-law-review/</guid></item><item><title><![CDATA[Government Biotechnology Innovation Summit - BioBuzz]]></title><description><![CDATA[Government Biotechnology Innovation Summit&nbsp;&nbsp;BioBuzz]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/government-biotechnology-innovation-summit-biobuzz/</link><pubDate>Tue, 30 Jul 2024 00:09:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/government-biotechnology-innovation-summit-biobuzz/</guid></item><item><title><![CDATA[NewAmsterdam Phase III obicetrapib trial meets endpoint, but disappoints - The Pharma Letter]]></title><description><![CDATA[NewAmsterdam Phase III obicetrapib trial meets endpoint, but disappoints&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/newamsterdam-phase-iii-obicetrapib-trial-meets-endpoint-but-disappoints-the-pharma-letter/</link><pubDate>Mon, 29 Jul 2024 17:22:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/newamsterdam-phase-iii-obicetrapib-trial-meets-endpoint-but-disappoints-the-pharma-letter/</guid></item><item><title><![CDATA[Companies unleash broadside again after NICE’s final Enhertu guidance - The Pharma Letter]]></title><description><![CDATA[Companies unleash broadside again after NICE&rsquo;s final Enhertu guidance&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/companies-unleash-broadside-again-after-nices-final-enhertu-guidance-the-pharma-letter/</link><pubDate>Mon, 29 Jul 2024 16:54:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/companies-unleash-broadside-again-after-nices-final-enhertu-guidance-the-pharma-letter/</guid></item><item><title><![CDATA[Flagship Pioneering inks research partnership with GSK - The Pharma Letter]]></title><description><![CDATA[Flagship Pioneering inks research partnership with GSK&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/flagship-pioneering-inks-research-partnership-with-gsk-the-pharma-letter/</link><pubDate>Mon, 29 Jul 2024 16:34:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/flagship-pioneering-inks-research-partnership-with-gsk-the-pharma-letter/</guid></item><item><title><![CDATA[10th International Conference on Bioengineering and Biotechnology - The Pharma Letter]]></title><description><![CDATA[10th International Conference on Bioengineering and Biotechnology&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/10th-international-conference-on-bioengineering-and-biotechnology-the-pharma-letter/</link><pubDate>Mon, 29 Jul 2024 15:16:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/10th-international-conference-on-bioengineering-and-biotechnology-the-pharma-letter/</guid></item><item><title><![CDATA[Veru to Participate in the BTIG Virtual Biotechnology Conference - GlobeNewswire]]></title><description><![CDATA[Veru to Participate in the BTIG Virtual Biotechnology Conference&nbsp;&nbsp;GlobeNewswire]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/veru-to-participate-in-the-btig-virtual-biotechnology-conference-globenewswire/</link><pubDate>Mon, 29 Jul 2024 14:36:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/veru-to-participate-in-the-btig-virtual-biotechnology-conference-globenewswire/</guid></item><item><title><![CDATA[Veru to Participate in the BTIG Virtual Biotechnology Conference - StockTitan]]></title><description><![CDATA[Veru to Participate in the BTIG Virtual Biotechnology Conference&nbsp;&nbsp;StockTitan]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/veru-to-participate-in-the-btig-virtual-biotechnology-conference-stocktitan/</link><pubDate>Mon, 29 Jul 2024 14:30:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/veru-to-participate-in-the-btig-virtual-biotechnology-conference-stocktitan/</guid></item><item><title><![CDATA[Pyxis Oncology to Participate in the BTIG Virtual Biotechnology Conference - Yahoo Finance]]></title><description><![CDATA[Pyxis Oncology to Participate in the BTIG Virtual Biotechnology Conference&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/pyxis-oncology-to-participate-in-the-btig-virtual-biotechnology-conference-yahoo-finance/</link><pubDate>Mon, 29 Jul 2024 14:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/pyxis-oncology-to-participate-in-the-btig-virtual-biotechnology-conference-yahoo-finance/</guid></item><item><title><![CDATA[Pyxis Oncology to Participate in the BTIG Virtual Biotechnology Conference - StockTitan]]></title><description><![CDATA[Pyxis Oncology to Participate in the BTIG Virtual Biotechnology Conference&nbsp;&nbsp;StockTitan]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/pyxis-oncology-to-participate-in-the-btig-virtual-biotechnology-conference-stocktitan/</link><pubDate>Mon, 29 Jul 2024 14:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/pyxis-oncology-to-participate-in-the-btig-virtual-biotechnology-conference-stocktitan/</guid></item><item><title><![CDATA[PDS Biotech to Participate at BTIG Virtual Biotechnology Conference - StockTitan]]></title><description><![CDATA[PDS Biotech to Participate at BTIG Virtual Biotechnology Conference&nbsp;&nbsp;StockTitan]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/pds-biotech-to-participate-at-btig-virtual-biotechnology-conference-stocktitan/</link><pubDate>Mon, 29 Jul 2024 14:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/pds-biotech-to-participate-at-btig-virtual-biotechnology-conference-stocktitan/</guid></item><item><title><![CDATA[Change in focus for Cue prompts little investor interest - The Pharma Letter]]></title><description><![CDATA[Change in focus for Cue prompts little investor interest&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/change-in-focus-for-cue-prompts-little-investor-interest-the-pharma-letter/</link><pubDate>Mon, 29 Jul 2024 11:43:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/change-in-focus-for-cue-prompts-little-investor-interest-the-pharma-letter/</guid></item><item><title><![CDATA[Epigenome editing technologies for discovery and medicine - Nature.com]]></title><description><![CDATA[Epigenome editing technologies for discovery and medicine&nbsp;&nbsp;Nature.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/epigenome-editing-technologies-for-discovery-and-medicine-naturecom/</link><pubDate>Mon, 29 Jul 2024 11:23:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/epigenome-editing-technologies-for-discovery-and-medicine-naturecom/</guid></item><item><title><![CDATA[iShares Biotechnology ETF: Significant Upside Potential As Sector Gains Momentum - Seeking Alpha]]></title><description><![CDATA[iShares Biotechnology ETF: Significant Upside Potential As Sector Gains Momentum&nbsp;&nbsp;Seeking Alpha]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/ishares-biotechnology-etf-significant-upside-potential-as-sector-gains-momentum-seeking-alpha/</link><pubDate>Sun, 28 Jul 2024 18:25:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/ishares-biotechnology-etf-significant-upside-potential-as-sector-gains-momentum-seeking-alpha/</guid></item><item><title><![CDATA[Sana Biotechnology (NASDAQ:SANA) Trading 6.8% Higher - Defense World]]></title><description><![CDATA[Sana Biotechnology (NASDAQ:SANA) Trading 6.8% Higher&nbsp;&nbsp;Defense World]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/sana-biotechnology-nasdaqsana-trading-68-higher-defense-world/</link><pubDate>Sun, 28 Jul 2024 10:02:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/sana-biotechnology-nasdaqsana-trading-68-higher-defense-world/</guid></item><item><title><![CDATA[iShares Biotechnology ETF (NASDAQ:IBB) Sets New 52-Week High at $149.27 - Defense World]]></title><description><![CDATA[iShares Biotechnology ETF (NASDAQ:IBB) Sets New 52-Week High at $149.27&nbsp;&nbsp;Defense World]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/ishares-biotechnology-etf-nasdaqibb-sets-new-52-week-high-at-14927-defense-world/</link><pubDate>Sat, 27 Jul 2024 13:51:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/ishares-biotechnology-etf-nasdaqibb-sets-new-52-week-high-at-14927-defense-world/</guid></item><item><title><![CDATA[Sustainable biofabrication: from bioprinting to AI-driven predictive methods]]></title><description><![CDATA[Biofabrication is potentially an inherently sustainable manufacturing process of bio-hybrid systems based on biomaterials embedded with cell communities. These bio-hybrids promise to augment the sustainability of various human activities, ranging from tissue engineering and robotics to civil engineering and ecology. However, as routine biofabrication practices are laborious and energetically disadvantageous, our society must refine production and validation processes in biomanufacturing. This op]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/sustainable-biofabrication-from-bioprinting-to-ai-driven-predictive-methods/</link><pubDate>Sat, 27 Jul 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/sustainable-biofabrication-from-bioprinting-to-ai-driven-predictive-methods/</guid></item><item><title><![CDATA[Where Puma Biotechnology Stands With Analysts - Benzinga]]></title><description><![CDATA[Where Puma Biotechnology Stands With Analysts&nbsp;&nbsp;Benzinga]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/where-puma-biotechnology-stands-with-analysts-benzinga/</link><pubDate>Fri, 26 Jul 2024 23:01:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/where-puma-biotechnology-stands-with-analysts-benzinga/</guid></item><item><title><![CDATA[Puma Biotechnology (NASDAQ:PBYI) Given Buy Rating at HC Wainwright - MarketBeat]]></title><description><![CDATA[Puma Biotechnology (NASDAQ:PBYI) Given Buy Rating at HC Wainwright&nbsp;&nbsp;MarketBeat]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/puma-biotechnology-nasdaqpbyi-given-buy-rating-at-hc-wainwright-marketbeat/</link><pubDate>Fri, 26 Jul 2024 22:42:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/puma-biotechnology-nasdaqpbyi-given-buy-rating-at-hc-wainwright-marketbeat/</guid></item><item><title><![CDATA[Vir Biotechnology Stock Reaches 80-Plus RS Rating Benchmark - Investor's Business Daily]]></title><description><![CDATA[Vir Biotechnology Stock Reaches 80-Plus RS Rating Benchmark&nbsp;&nbsp;Investor's Business Daily]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-stock-reaches-80-plus-rs-rating-benchmark-investors-business-daily/</link><pubDate>Fri, 26 Jul 2024 20:53:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-stock-reaches-80-plus-rs-rating-benchmark-investors-business-daily/</guid></item><item><title><![CDATA[Former AquaBounty CEO Sylvia Wulf Announces New Position At Biotechnology Innovation Organization - SeafoodNews]]></title><description><![CDATA[Former AquaBounty CEO Sylvia Wulf Announces New Position At Biotechnology Innovation Organization&nbsp;&nbsp;SeafoodNews]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/former-aquabounty-ceo-sylvia-wulf-announces-new-position-at-biotechnology-innovation-organization-seafoodnews/</link><pubDate>Fri, 26 Jul 2024 17:08:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/former-aquabounty-ceo-sylvia-wulf-announces-new-position-at-biotechnology-innovation-organization-seafoodnews/</guid></item><item><title><![CDATA[Approval of Leqembi in early Alzheimer’s disease rejected by CHMP - The Pharma Letter]]></title><description><![CDATA[Approval of Leqembi in early Alzheimer&rsquo;s disease rejected by CHMP&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/approval-of-leqembi-in-early-alzheimers-disease-rejected-by-chmp-the-pharma-letter/</link><pubDate>Fri, 26 Jul 2024 15:36:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/approval-of-leqembi-in-early-alzheimers-disease-rejected-by-chmp-the-pharma-letter/</guid></item><item><title><![CDATA[Confo Therapeutics raises 60 million euros in Series B financing - The Pharma Letter]]></title><description><![CDATA[Confo Therapeutics raises 60 million euros in Series B financing&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/confo-therapeutics-raises-60-million-euros-in-series-b-financing-the-pharma-letter/</link><pubDate>Fri, 26 Jul 2024 14:43:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/confo-therapeutics-raises-60-million-euros-in-series-b-financing-the-pharma-letter/</guid></item><item><title><![CDATA[Immunome licenses novel antibodies from Nectin - The Pharma Letter]]></title><description><![CDATA[Immunome licenses novel antibodies from Nectin&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/immunome-licenses-novel-antibodies-from-nectin-the-pharma-letter/</link><pubDate>Fri, 26 Jul 2024 14:11:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/immunome-licenses-novel-antibodies-from-nectin-the-pharma-letter/</guid></item><item><title><![CDATA[ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Sees Large Increase in Short Interest - Defense World]]></title><description><![CDATA[ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Sees Large Increase in Short Interest&nbsp;&nbsp;Defense World]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/proshares-ultra-nasdaq-biotechnology-nasdaqbib-sees-large-increase-in-short-interest-defense-world/</link><pubDate>Fri, 26 Jul 2024 12:59:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/proshares-ultra-nasdaq-biotechnology-nasdaqbib-sees-large-increase-in-short-interest-defense-world/</guid></item><item><title><![CDATA[FDA panel confirms Imfinzi benefit but queries study design - The Pharma Letter]]></title><description><![CDATA[FDA panel confirms Imfinzi benefit but queries study design&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/fda-panel-confirms-imfinzi-benefit-but-queries-study-design-the-pharma-letter/</link><pubDate>Fri, 26 Jul 2024 12:36:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/fda-panel-confirms-imfinzi-benefit-but-queries-study-design-the-pharma-letter/</guid></item><item><title><![CDATA[Sanyou Bio Congratulates Eluminex Biosciences and Foreseen Biotechnology on Major Breakthroughs in Innovative Drug Project - Citizentribune]]></title><description><![CDATA[Sanyou Bio Congratulates Eluminex Biosciences and Foreseen Biotechnology on Major Breakthroughs in Innovative Drug Project&nbsp;&nbsp;Citizentribune]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/sanyou-bio-congratulates-eluminex-biosciences-and-foreseen-biotechnology-on-major-breakthroughs-in-innovative-drug-project-citizentribune/</link><pubDate>Fri, 26 Jul 2024 12:09:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/sanyou-bio-congratulates-eluminex-biosciences-and-foreseen-biotechnology-on-major-breakthroughs-in-innovative-drug-project-citizentribune/</guid></item><item><title><![CDATA[Zymeworks appoints Leone Patterson as CBO and CFO - The Pharma Letter]]></title><description><![CDATA[Zymeworks appoints Leone Patterson as CBO and CFO&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/zymeworks-appoints-leone-patterson-as-cbo-and-cfo-the-pharma-letter/</link><pubDate>Fri, 26 Jul 2024 11:56:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/zymeworks-appoints-leone-patterson-as-cbo-and-cfo-the-pharma-letter/</guid></item><item><title><![CDATA[Gourmey files first EU application for cell-based meat - European Biotechnology News]]></title><description><![CDATA[Gourmey files first EU application for cell-based meat&nbsp;&nbsp;European Biotechnology News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/gourmey-files-first-eu-application-for-cell-based-meat-european-biotechnology-news/</link><pubDate>Fri, 26 Jul 2024 11:49:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/gourmey-files-first-eu-application-for-cell-based-meat-european-biotechnology-news/</guid></item><item><title><![CDATA[Confo Therapeutics closes €60m Series B financing - European Biotechnology News]]></title><description><![CDATA[Confo Therapeutics closes &euro;60m Series B financing&nbsp;&nbsp;European Biotechnology News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/confo-therapeutics-closes-60m-series-b-financing-european-biotechnology-news/</link><pubDate>Fri, 26 Jul 2024 08:12:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/confo-therapeutics-closes-60m-series-b-financing-european-biotechnology-news/</guid></item><item><title><![CDATA[Apical Meristem Manipulation for Biotechnology Approaches in Plants - Frontiers]]></title><description><![CDATA[Apical Meristem Manipulation for Biotechnology Approaches in Plants&nbsp;&nbsp;Frontiers]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/apical-meristem-manipulation-for-biotechnology-approaches-in-plants-frontiers/</link><pubDate>Fri, 26 Jul 2024 00:30:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/apical-meristem-manipulation-for-biotechnology-approaches-in-plants-frontiers/</guid></item><item><title><![CDATA[[Latest] US Biotechnology Market Size/Share Worth USD - GlobeNewswire]]></title><description><![CDATA[[Latest] US Biotechnology Market Size/Share Worth USD&nbsp;&nbsp;GlobeNewswire]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/latest-us-biotechnology-market-sizeshare-worth-usd-globenewswire/</link><pubDate>Thu, 25 Jul 2024 19:31:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/latest-us-biotechnology-market-sizeshare-worth-usd-globenewswire/</guid></item><item><title><![CDATA[5 Stocks to Buy for the Rotation Into Small-Cap Biotechnology - TheStreet]]></title><description><![CDATA[5 Stocks to Buy for the Rotation Into Small-Cap Biotechnology&nbsp;&nbsp;TheStreet]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/5-stocks-to-buy-for-the-rotation-into-small-cap-biotechnology-thestreet/</link><pubDate>Thu, 25 Jul 2024 17:53:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/5-stocks-to-buy-for-the-rotation-into-small-cap-biotechnology-thestreet/</guid></item><item><title><![CDATA[Hélène Sicard joins DiogenX as chief development officer - The Pharma Letter]]></title><description><![CDATA[H&eacute;l&egrave;ne Sicard joins DiogenX as chief development officer&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/hlne-sicard-joins-diogenx-as-chief-development-officer-the-pharma-letter/</link><pubDate>Thu, 25 Jul 2024 16:48:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/hlne-sicard-joins-diogenx-as-chief-development-officer-the-pharma-letter/</guid></item><item><title><![CDATA[Pinetree could pocket more than $500 million from AstraZeneca deal - The Pharma Letter]]></title><description><![CDATA[Pinetree could pocket more than $500 million from AstraZeneca deal&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/pinetree-could-pocket-more-than-500-million-from-astrazeneca-deal-the-pharma-letter/</link><pubDate>Thu, 25 Jul 2024 16:40:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/pinetree-could-pocket-more-than-500-million-from-astrazeneca-deal-the-pharma-letter/</guid></item><item><title><![CDATA[Iaso Biotechnology cleared for clinical studies of IASO-782 in systemic lupus erythematosus - BioWorld Online]]></title><description><![CDATA[Iaso Biotechnology cleared for clinical studies of IASO-782 in systemic lupus erythematosus&nbsp;&nbsp;BioWorld Online]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/iaso-biotechnology-cleared-for-clinical-studies-of-iaso-782-in-systemic-lupus-erythematosus-bioworld-online/</link><pubDate>Thu, 25 Jul 2024 15:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/iaso-biotechnology-cleared-for-clinical-studies-of-iaso-782-in-systemic-lupus-erythematosus-bioworld-online/</guid></item><item><title><![CDATA[BioMarin bags Brineura nod for broader patient population - The Pharma Letter]]></title><description><![CDATA[BioMarin bags Brineura nod for broader patient population&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/biomarin-bags-brineura-nod-for-broader-patient-population-the-pharma-letter/</link><pubDate>Thu, 25 Jul 2024 14:55:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/biomarin-bags-brineura-nod-for-broader-patient-population-the-pharma-letter/</guid></item><item><title><![CDATA[AC Immune bags FDA fast track designation - European Biotechnology News]]></title><description><![CDATA[AC Immune bags FDA fast track designation&nbsp;&nbsp;European Biotechnology News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/ac-immune-bags-fda-fast-track-designation-european-biotechnology-news/</link><pubDate>Thu, 25 Jul 2024 13:14:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/ac-immune-bags-fda-fast-track-designation-european-biotechnology-news/</guid></item><item><title><![CDATA[A mini-colon models colon cancer and its microenvironment - Nature.com]]></title><description><![CDATA[A mini-colon models colon cancer and its microenvironment&nbsp;&nbsp;Nature.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/a-mini-colon-models-colon-cancer-and-its-microenvironment-naturecom/</link><pubDate>Thu, 25 Jul 2024 11:28:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/a-mini-colon-models-colon-cancer-and-its-microenvironment-naturecom/</guid></item><item><title><![CDATA[Vir Biotechnology (VIR) to Release Earnings on Thursday - Defense World]]></title><description><![CDATA[Vir Biotechnology (VIR) to Release Earnings on Thursday&nbsp;&nbsp;Defense World]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-vir-to-release-earnings-on-thursday-defense-world/</link><pubDate>Thu, 25 Jul 2024 10:16:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-vir-to-release-earnings-on-thursday-defense-world/</guid></item><item><title><![CDATA[Puma Biotechnology (PBYI) Scheduled to Post Quarterly Earnings on Thursday - Defense World]]></title><description><![CDATA[Puma Biotechnology (PBYI) Scheduled to Post Quarterly Earnings on Thursday&nbsp;&nbsp;Defense World]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/puma-biotechnology-pbyi-scheduled-to-post-quarterly-earnings-on-thursday-defense-world/</link><pubDate>Thu, 25 Jul 2024 10:16:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/puma-biotechnology-pbyi-scheduled-to-post-quarterly-earnings-on-thursday-defense-world/</guid></item><item><title><![CDATA[Retail investors invested in Anhui Anke Biotechnology (Group) Co., Ltd. (SZSE:300009) copped the brunt of last week's CN&yen;686m market cap decline - Simply Wall St]]></title><description><![CDATA[Retail investors invested in Anhui Anke Biotechnology (Group) Co., Ltd. (SZSE:300009) copped the brunt of last week's CN&yen;686m market cap decline&nbsp;&nbsp;Simply Wall St]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/retail-investors-invested-in-anhui-anke-biotechnology-group-co-ltd-szse300009-copped-the-brunt-of-last-weeks-cnyen686m-market-cap-decline-simply-wall-st/</link><pubDate>Thu, 25 Jul 2024 09:15:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/retail-investors-invested-in-anhui-anke-biotechnology-group-co-ltd-szse300009-copped-the-brunt-of-last-weeks-cnyen686m-market-cap-decline-simply-wall-st/</guid></item><item><title><![CDATA[Cizzle Biotechnology updates on planned strategic and exclusive licensing partner in the USA - DirectorsTalk Interviews]]></title><description><![CDATA[Cizzle Biotechnology updates on planned strategic and exclusive licensing partner in the USA&nbsp;&nbsp;DirectorsTalk Interviews]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/cizzle-biotechnology-updates-on-planned-strategic-and-exclusive-licensing-partner-in-the-usa-directorstalk-interviews/</link><pubDate>Thu, 25 Jul 2024 08:26:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/cizzle-biotechnology-updates-on-planned-strategic-and-exclusive-licensing-partner-in-the-usa-directorstalk-interviews/</guid></item><item><title><![CDATA[Steve Becker named CCO of Broken String - The Pharma Letter]]></title><description><![CDATA[Steve Becker named CCO of Broken String&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/steve-becker-named-cco-of-broken-string-the-pharma-letter/</link><pubDate>Wed, 24 Jul 2024 18:34:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/steve-becker-named-cco-of-broken-string-the-pharma-letter/</guid></item><item><title><![CDATA[You Can Buy Meat Grown in a Lab in This Country]]></title><description><![CDATA[Singapore, which subsists on imported food, is looking to secure its future with new ways of feeding its people.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/you-can-buy-meat-grown-in-a-lab-in-this-country/</link><pubDate>Wed, 24 Jul 2024 16:07:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/you-can-buy-meat-grown-in-a-lab-in-this-country/</guid></item><item><title><![CDATA[Industry heavyweights back new T cell research in Boston - The Pharma Letter]]></title><description><![CDATA[Industry heavyweights back new T cell research in Boston&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/industry-heavyweights-back-new-t-cell-research-in-boston-the-pharma-letter/</link><pubDate>Wed, 24 Jul 2024 12:27:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/industry-heavyweights-back-new-t-cell-research-in-boston-the-pharma-letter/</guid></item><item><title><![CDATA[Exposing biotechnology - Wright State Newsroom]]></title><description><![CDATA[Exposing biotechnology&nbsp;&nbsp;Wright State Newsroom]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/exposing-biotechnology-wright-state-newsroom/</link><pubDate>Wed, 24 Jul 2024 09:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/exposing-biotechnology-wright-state-newsroom/</guid></item><item><title><![CDATA[Reprogramming naturally evolved switches for Streptomyces chassis development]]></title><description><![CDATA[The Streptomyces chassis serves as an important platform for efficient biomanufacture of diverse secondary metabolite (SM) compounds, but the current chassis lacks compatibility for integration of these SM biosynthetic pathways reliably and consistently. This forum discusses harnessing naturally evolved multifaceted switches to reprogram the Streptomyces chassis for biomanufacturing applications.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/reprogramming-naturally-evolved-switches-for-streptomyces-chassis-development/</link><pubDate>Wed, 24 Jul 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/reprogramming-naturally-evolved-switches-for-streptomyces-chassis-development/</guid></item><item><title><![CDATA[Danaher (DHR) Q2 Earnings Beat, Biotechnology Sales Dip Y/Y - Yahoo Finance]]></title><description><![CDATA[Danaher (DHR) Q2 Earnings Beat, Biotechnology Sales Dip Y/Y&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/danaher-dhr-q2-earnings-beat-biotechnology-sales-dip-yy-yahoo-finance/</link><pubDate>Tue, 23 Jul 2024 18:22:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/danaher-dhr-q2-earnings-beat-biotechnology-sales-dip-yy-yahoo-finance/</guid></item><item><title><![CDATA[BeiGene opens flagship US site - The Pharma Letter]]></title><description><![CDATA[BeiGene opens flagship US site&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/beigene-opens-flagship-us-site-the-pharma-letter/</link><pubDate>Tue, 23 Jul 2024 17:42:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/beigene-opens-flagship-us-site-the-pharma-letter/</guid></item><item><title><![CDATA[What did biotechnology ever do for us? - The University of Manchester]]></title><description><![CDATA[What did biotechnology ever do for us?&nbsp;&nbsp;The University of Manchester]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/what-did-biotechnology-ever-do-for-us-the-university-of-manchester/</link><pubDate>Tue, 23 Jul 2024 17:27:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/what-did-biotechnology-ever-do-for-us-the-university-of-manchester/</guid></item><item><title><![CDATA[Flagship Pioneering unveils yet another new company, Abiologics - The Pharma Letter]]></title><description><![CDATA[Flagship Pioneering unveils yet another new company, Abiologics&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/flagship-pioneering-unveils-yet-another-new-company-abiologics-the-pharma-letter/</link><pubDate>Tue, 23 Jul 2024 17:22:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/flagship-pioneering-unveils-yet-another-new-company-abiologics-the-pharma-letter/</guid></item><item><title><![CDATA[MAIA Biotechnology's Lung Cancer Drug Shows Promising Long-Term Benefits In Advanced Patients - Benzinga]]></title><description><![CDATA[MAIA Biotechnology's Lung Cancer Drug Shows Promising Long-Term Benefits In Advanced Patients&nbsp;&nbsp;Benzinga]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/maia-biotechnologys-lung-cancer-drug-shows-promising-long-term-benefits-in-advanced-patients-benzinga/</link><pubDate>Tue, 23 Jul 2024 16:38:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/maia-biotechnologys-lung-cancer-drug-shows-promising-long-term-benefits-in-advanced-patients-benzinga/</guid></item><item><title><![CDATA[Touchlight and GSK ink mRNA tech deal - The Pharma Letter]]></title><description><![CDATA[Touchlight and GSK ink mRNA tech deal&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/touchlight-and-gsk-ink-mrna-tech-deal-the-pharma-letter/</link><pubDate>Tue, 23 Jul 2024 15:42:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/touchlight-and-gsk-ink-mrna-tech-deal-the-pharma-letter/</guid></item><item><title><![CDATA[Should Value Investors Buy Puma Biotechnology (PBYI) Stock? - Yahoo Finance]]></title><description><![CDATA[Should Value Investors Buy Puma Biotechnology (PBYI) Stock?&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/should-value-investors-buy-puma-biotechnology-pbyi-stock-yahoo-finance/</link><pubDate>Tue, 23 Jul 2024 15:40:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/should-value-investors-buy-puma-biotechnology-pbyi-stock-yahoo-finance/</guid></item><item><title><![CDATA[Biotechnology company raises $18 million - Food Business News]]></title><description><![CDATA[Biotechnology company raises $18 million&nbsp;&nbsp;Food Business News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/biotechnology-company-raises-18-million-food-business-news/</link><pubDate>Tue, 23 Jul 2024 15:35:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/biotechnology-company-raises-18-million-food-business-news/</guid></item><item><title><![CDATA[Nima Farzan named Latigo CEO - The Pharma Letter]]></title><description><![CDATA[Nima Farzan named Latigo CEO&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/nima-farzan-named-latigo-ceo-the-pharma-letter/</link><pubDate>Tue, 23 Jul 2024 14:08:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/nima-farzan-named-latigo-ceo-the-pharma-letter/</guid></item><item><title><![CDATA[Ludân Biotechnology revolutionizes skincare with biotech innovations - EIN News]]></title><description><![CDATA[Lud&acirc;n Biotechnology revolutionizes skincare with biotech innovations&nbsp;&nbsp;EIN News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/ludn-biotechnology-revolutionizes-skincare-with-biotech-innovations-ein-news/</link><pubDate>Tue, 23 Jul 2024 13:12:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/ludn-biotechnology-revolutionizes-skincare-with-biotech-innovations-ein-news/</guid></item><item><title><![CDATA[Aligos pairs hep B drug with novel biologic in China - The Pharma Letter]]></title><description><![CDATA[Aligos pairs hep B drug with novel biologic in China&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/aligos-pairs-hep-b-drug-with-novel-biologic-in-china-the-pharma-letter/</link><pubDate>Tue, 23 Jul 2024 12:27:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/aligos-pairs-hep-b-drug-with-novel-biologic-in-china-the-pharma-letter/</guid></item><item><title><![CDATA[Agilent to acquire North American CDMO Biovectra - The Pharma Letter]]></title><description><![CDATA[Agilent to acquire North American CDMO Biovectra&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/agilent-to-acquire-north-american-cdmo-biovectra-the-pharma-letter/</link><pubDate>Tue, 23 Jul 2024 11:31:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/agilent-to-acquire-north-american-cdmo-biovectra-the-pharma-letter/</guid></item><item><title><![CDATA[MAIA Biotechnology Announces New Updates from Phase 2 Trial of Novel Cancer Treatment Agent - Yahoo Finance]]></title><description><![CDATA[MAIA Biotechnology Announces New Updates from Phase 2 Trial of Novel Cancer Treatment Agent&nbsp;&nbsp;Yahoo Finance]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/maia-biotechnology-announces-new-updates-from-phase-2-trial-of-novel-cancer-treatment-agent-yahoo-finance/</link><pubDate>Tue, 23 Jul 2024 10:11:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/maia-biotechnology-announces-new-updates-from-phase-2-trial-of-novel-cancer-treatment-agent-yahoo-finance/</guid></item><item><title><![CDATA[MAIA Biotechnology Announces New Updates from Phase 2 Trial of Novel Cancer Treatment Agent - StockTitan]]></title><description><![CDATA[MAIA Biotechnology Announces New Updates from Phase 2 Trial of Novel Cancer Treatment Agent&nbsp;&nbsp;StockTitan]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/maia-biotechnology-announces-new-updates-from-phase-2-trial-of-novel-cancer-treatment-agent-stocktitan/</link><pubDate>Tue, 23 Jul 2024 10:11:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/maia-biotechnology-announces-new-updates-from-phase-2-trial-of-novel-cancer-treatment-agent-stocktitan/</guid></item><item><title><![CDATA[PDS Biotechnology (NASDAQ:PDSB) Stock Price Up 0.8% - Defense World]]></title><description><![CDATA[PDS Biotechnology (NASDAQ:PDSB) Stock Price Up 0.8%&nbsp;&nbsp;Defense World]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/pds-biotechnology-nasdaqpdsb-stock-price-up-08-defense-world/</link><pubDate>Tue, 23 Jul 2024 09:56:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/pds-biotechnology-nasdaqpdsb-stock-price-up-08-defense-world/</guid></item><item><title><![CDATA[New targets for incurable blood cancer - European Biotechnology News]]></title><description><![CDATA[New targets for incurable blood cancer&nbsp;&nbsp;European Biotechnology News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/new-targets-for-incurable-blood-cancer-european-biotechnology-news/</link><pubDate>Tue, 23 Jul 2024 09:10:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/new-targets-for-incurable-blood-cancer-european-biotechnology-news/</guid></item><item><title><![CDATA[SynaptixBio Ltd and Evotec SE expand collaboration - European Biotechnology News]]></title><description><![CDATA[SynaptixBio Ltd and Evotec SE expand collaboration&nbsp;&nbsp;European Biotechnology News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/synaptixbio-ltd-and-evotec-se-expand-collaboration-european-biotechnology-news/</link><pubDate>Tue, 23 Jul 2024 07:33:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/synaptixbio-ltd-and-evotec-se-expand-collaboration-european-biotechnology-news/</guid></item><item><title><![CDATA[Red Biotechnology Market to Reach USD 1,172.3 Billion by 2030 - MENAFN.COM]]></title><description><![CDATA[Red Biotechnology Market to Reach USD 1,172.3 Billion by 2030&nbsp;&nbsp;MENAFN.COM]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/red-biotechnology-market-to-reach-usd-11723-billion-by-2030-menafncom/</link><pubDate>Tue, 23 Jul 2024 07:23:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/red-biotechnology-market-to-reach-usd-11723-billion-by-2030-menafncom/</guid></item><item><title><![CDATA[Integrating bicarbonate-based microalgal production with alkaline sewage for ocean negative carbon emissions]]></title><description><![CDATA[Using sewage (wastewater) for ocean alkalinity enhancement (OAE) has been considered as one promising ocean negative carbon emissions (ONCE) approach due to its high carbon sequestration efficiency and low environmental risk. To make this process more profitable and sustainable, this perspective proposes to integrate bicarbonate-based microalgal production and sewage alkalinity enhancement for ONCE. In this concept, the spent aqueous alkaline bicarbonate-based microalgal medium is cheap or even]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/integrating-bicarbonate-based-microalgal-production-with-alkaline-sewage-for-ocean-negative-carbon-emissions/</link><pubDate>Tue, 23 Jul 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/integrating-bicarbonate-based-microalgal-production-with-alkaline-sewage-for-ocean-negative-carbon-emissions/</guid></item><item><title><![CDATA[Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny - Simply Wall St]]></title><description><![CDATA[Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny&nbsp;&nbsp;Simply Wall St]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/anhui-huaheng-biotechnology-co-ltd-shse688639-stocks-26-dive-might-signal-an-opportunity-but-it-requires-some-scrutiny-simply-wall-st/</link><pubDate>Tue, 23 Jul 2024 00:24:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/anhui-huaheng-biotechnology-co-ltd-shse688639-stocks-26-dive-might-signal-an-opportunity-but-it-requires-some-scrutiny-simply-wall-st/</guid></item><item><title><![CDATA[UNITY Biotechnology names new chief strategy officer - Investing.com]]></title><description><![CDATA[UNITY Biotechnology names new chief strategy officer&nbsp;&nbsp;Investing.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/unity-biotechnology-names-new-chief-strategy-officer-investingcom/</link><pubDate>Mon, 22 Jul 2024 22:20:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/unity-biotechnology-names-new-chief-strategy-officer-investingcom/</guid></item><item><title><![CDATA[Two-Step Secret: Scientists Solve Electrochemical Biotechnology Mystery - SciTechDaily]]></title><description><![CDATA[Two-Step Secret: Scientists Solve Electrochemical Biotechnology Mystery&nbsp;&nbsp;SciTechDaily]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/two-step-secret-scientists-solve-electrochemical-biotechnology-mystery-scitechdaily/</link><pubDate>Mon, 22 Jul 2024 18:20:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/two-step-secret-scientists-solve-electrochemical-biotechnology-mystery-scitechdaily/</guid></item><item><title><![CDATA[Traders Purchase Large Volume of Put Options on Sana Biotechnology (NASDAQ:SANA) - Defense World]]></title><description><![CDATA[Traders Purchase Large Volume of Put Options on Sana Biotechnology (NASDAQ:SANA)&nbsp;&nbsp;Defense World]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/traders-purchase-large-volume-of-put-options-on-sana-biotechnology-nasdaqsana-defense-world/</link><pubDate>Mon, 22 Jul 2024 17:43:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/traders-purchase-large-volume-of-put-options-on-sana-biotechnology-nasdaqsana-defense-world/</guid></item><item><title><![CDATA[MAIA Biotechnology (MAIA) is one of the earliest pioneers of telomere targeting as a therapeutic strategy - Barchart]]></title><description><![CDATA[MAIA Biotechnology (MAIA) is one of the earliest pioneers of telomere targeting as a therapeutic strategy&nbsp;&nbsp;Barchart]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/maia-biotechnology-maia-is-one-of-the-earliest-pioneers-of-telomere-targeting-as-a-therapeutic-strategy-barchart/</link><pubDate>Mon, 22 Jul 2024 16:57:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/maia-biotechnology-maia-is-one-of-the-earliest-pioneers-of-telomere-targeting-as-a-therapeutic-strategy-barchart/</guid></item><item><title><![CDATA[Japanese scientists see stem cell potential for spinal degeneration - The Pharma Letter]]></title><description><![CDATA[Japanese scientists see stem cell potential for spinal degeneration&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/japanese-scientists-see-stem-cell-potential-for-spinal-degeneration-the-pharma-letter/</link><pubDate>Mon, 22 Jul 2024 15:53:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/japanese-scientists-see-stem-cell-potential-for-spinal-degeneration-the-pharma-letter/</guid></item><item><title><![CDATA[Artiva IPO exceeds estimates - The Pharma Letter]]></title><description><![CDATA[Artiva IPO exceeds estimates&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/artiva-ipo-exceeds-estimates-the-pharma-letter/</link><pubDate>Mon, 22 Jul 2024 15:11:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/artiva-ipo-exceeds-estimates-the-pharma-letter/</guid></item><item><title><![CDATA[UNITY Biotechnology Announces Appointment of Alicia Tozier as Chief Strategy Officer - GlobeNewswire]]></title><description><![CDATA[UNITY Biotechnology Announces Appointment of Alicia Tozier as Chief Strategy Officer&nbsp;&nbsp;GlobeNewswire]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/unity-biotechnology-announces-appointment-of-alicia-tozier-as-chief-strategy-officer-globenewswire/</link><pubDate>Mon, 22 Jul 2024 14:05:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/unity-biotechnology-announces-appointment-of-alicia-tozier-as-chief-strategy-officer-globenewswire/</guid></item><item><title><![CDATA[UNITY Biotechnology Announces Appointment of Alicia Tozier as Chief Strategy Officer - StockTitan]]></title><description><![CDATA[UNITY Biotechnology Announces Appointment of Alicia Tozier as Chief Strategy Officer&nbsp;&nbsp;StockTitan]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/unity-biotechnology-announces-appointment-of-alicia-tozier-as-chief-strategy-officer-stocktitan/</link><pubDate>Mon, 22 Jul 2024 14:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/unity-biotechnology-announces-appointment-of-alicia-tozier-as-chief-strategy-officer-stocktitan/</guid></item><item><title><![CDATA[ICER reports on Vyndaqel, suggests lower price - The Pharma Letter]]></title><description><![CDATA[ICER reports on Vyndaqel, suggests lower price&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/icer-reports-on-vyndaqel-suggests-lower-price-the-pharma-letter/</link><pubDate>Mon, 22 Jul 2024 13:32:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/icer-reports-on-vyndaqel-suggests-lower-price-the-pharma-letter/</guid></item><item><title><![CDATA[Protagonist Therapeutics to Participate in the BTIG Virtual Biotechnology Conference 2024 - AccessWire]]></title><description><![CDATA[Protagonist Therapeutics to Participate in the BTIG Virtual Biotechnology Conference 2024&nbsp;&nbsp;AccessWire]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/protagonist-therapeutics-to-participate-in-the-btig-virtual-biotechnology-conference-2024-accesswire/</link><pubDate>Mon, 22 Jul 2024 13:01:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/protagonist-therapeutics-to-participate-in-the-btig-virtual-biotechnology-conference-2024-accesswire/</guid></item><item><title><![CDATA[Protagonist Therapeutics to Participate in the BTIG Virtual Biotechnology Conference 2024 - StockTitan]]></title><description><![CDATA[Protagonist Therapeutics to Participate in the BTIG Virtual Biotechnology Conference 2024&nbsp;&nbsp;StockTitan]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/protagonist-therapeutics-to-participate-in-the-btig-virtual-biotechnology-conference-2024-stocktitan/</link><pubDate>Mon, 22 Jul 2024 13:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/protagonist-therapeutics-to-participate-in-the-btig-virtual-biotechnology-conference-2024-stocktitan/</guid></item><item><title><![CDATA[Editor’s pick: Indapta Therapeutics - Nature.com]]></title><description><![CDATA[Editor&rsquo;s pick: Indapta Therapeutics&nbsp;&nbsp;Nature.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/editors-pick-indapta-therapeutics-naturecom/</link><pubDate>Mon, 22 Jul 2024 12:03:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/editors-pick-indapta-therapeutics-naturecom/</guid></item><item><title><![CDATA[GRO Biosciences closes $60 million Series B financing - The Pharma Letter]]></title><description><![CDATA[GRO Biosciences closes $60 million Series B financing&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/gro-biosciences-closes-60-million-series-b-financing-the-pharma-letter/</link><pubDate>Mon, 22 Jul 2024 11:32:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/gro-biosciences-closes-60-million-series-b-financing-the-pharma-letter/</guid></item><item><title><![CDATA[Precise and versatile genome editing with click editors - Nature.com]]></title><description><![CDATA[Precise and versatile genome editing with click editors&nbsp;&nbsp;Nature.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/precise-and-versatile-genome-editing-with-click-editors-naturecom/</link><pubDate>Mon, 22 Jul 2024 11:29:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/precise-and-versatile-genome-editing-with-click-editors-naturecom/</guid></item><item><title><![CDATA[Rona Therapeutics raises $35 million Series A+ financing - The Pharma Letter]]></title><description><![CDATA[Rona Therapeutics raises $35 million Series A+ financing&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/rona-therapeutics-raises-35-million-series-a-financing-the-pharma-letter/</link><pubDate>Mon, 22 Jul 2024 11:20:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/rona-therapeutics-raises-35-million-series-a-financing-the-pharma-letter/</guid></item><item><title><![CDATA[Von der Leyen: no mention of biotechnology - European Biotechnology News]]></title><description><![CDATA[Von der Leyen: no mention of biotechnology&nbsp;&nbsp;European Biotechnology News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/von-der-leyen-no-mention-of-biotechnology-european-biotechnology-news/</link><pubDate>Sun, 21 Jul 2024 13:19:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/von-der-leyen-no-mention-of-biotechnology-european-biotechnology-news/</guid></item><item><title><![CDATA[Avantax Advisory Services Inc. Raises Holdings in iShares Biotechnology ETF (NASDAQ:IBB) - Defense World]]></title><description><![CDATA[Avantax Advisory Services Inc. Raises Holdings in iShares Biotechnology ETF (NASDAQ:IBB)&nbsp;&nbsp;Defense World]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/avantax-advisory-services-inc-raises-holdings-in-ishares-biotechnology-etf-nasdaqibb-defense-world/</link><pubDate>Sat, 20 Jul 2024 16:41:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/avantax-advisory-services-inc-raises-holdings-in-ishares-biotechnology-etf-nasdaqibb-defense-world/</guid></item><item><title><![CDATA[Vir Biotechnology, Inc. (NASDAQ:VIR) Shares Sold by Mirae Asset Global Investments Co. Ltd. - Defense World]]></title><description><![CDATA[Vir Biotechnology, Inc. (NASDAQ:VIR) Shares Sold by Mirae Asset Global Investments Co. Ltd.&nbsp;&nbsp;Defense World]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-inc-nasdaqvir-shares-sold-by-mirae-asset-global-investments-co-ltd-defense-world/</link><pubDate>Sat, 20 Jul 2024 11:46:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-inc-nasdaqvir-shares-sold-by-mirae-asset-global-investments-co-ltd-defense-world/</guid></item><item><title><![CDATA[ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Stock Price Pass Above Fifty Day Moving Average of $59.28 - Defense World]]></title><description><![CDATA[ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Stock Price Pass Above Fifty Day Moving Average of $59.28&nbsp;&nbsp;Defense World]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/proshares-ultra-nasdaq-biotechnology-nasdaqbib-stock-price-pass-above-fifty-day-moving-average-of-5928-defense-world/</link><pubDate>Sat, 20 Jul 2024 10:10:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/proshares-ultra-nasdaq-biotechnology-nasdaqbib-stock-price-pass-above-fifty-day-moving-average-of-5928-defense-world/</guid></item><item><title><![CDATA[MAIA Biotechnology (NYSEAMERICAN:MAIA) Trading Up 6.1% - MarketBeat]]></title><description><![CDATA[MAIA Biotechnology (NYSEAMERICAN:MAIA) Trading Up 6.1%&nbsp;&nbsp;MarketBeat]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/maia-biotechnology-nyseamericanmaia-trading-up-61-marketbeat/</link><pubDate>Sat, 20 Jul 2024 08:48:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/maia-biotechnology-nyseamericanmaia-trading-up-61-marketbeat/</guid></item><item><title><![CDATA[MAIA Biotechnology (NYSEAMERICAN:MAIA) Trading 6.1% Higher - Defense World]]></title><description><![CDATA[MAIA Biotechnology (NYSEAMERICAN:MAIA) Trading 6.1% Higher&nbsp;&nbsp;Defense World]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/maia-biotechnology-nyseamericanmaia-trading-61-higher-defense-world/</link><pubDate>Sat, 20 Jul 2024 08:25:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/maia-biotechnology-nyseamericanmaia-trading-61-higher-defense-world/</guid></item><item><title><![CDATA[One-pot diagnostic methods based on CRISPR/Cas and Argonaute nucleases: strategies and perspectives]]></title><description><![CDATA[CRISPR/Cas and Argonaute (Ago) proteins, which target specific nucleic acid sequences, can be applied as diagnostic tools. Despite high specificity and efficiency, achieving sensitive detection often necessitates a preamplification step that involves opening the lid and multistep operation, which may elevate the risk of contamination and prove inadequate for point-of-care testing. Hence, various one-pot detection strategies have been developed that enable preamplification and sensing in a single]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/one-pot-diagnostic-methods-based-on-crisprcas-and-argonaute-nucleases-strategies-and-perspectives/</link><pubDate>Sat, 20 Jul 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/one-pot-diagnostic-methods-based-on-crisprcas-and-argonaute-nucleases-strategies-and-perspectives/</guid></item><item><title><![CDATA[Teva data could open up Ajovy as migraine option to children - The Pharma Letter]]></title><description><![CDATA[Teva data could open up Ajovy as migraine option to children&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/teva-data-could-open-up-ajovy-as-migraine-option-to-children-the-pharma-letter/</link><pubDate>Fri, 19 Jul 2024 17:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/teva-data-could-open-up-ajovy-as-migraine-option-to-children-the-pharma-letter/</guid></item><item><title><![CDATA[Job losses as Caribou pursues core CAR-T programs - The Pharma Letter]]></title><description><![CDATA[Job losses as Caribou pursues core CAR-T programs&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/job-losses-as-caribou-pursues-core-car-t-programs-the-pharma-letter/</link><pubDate>Fri, 19 Jul 2024 14:31:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/job-losses-as-caribou-pursues-core-car-t-programs-the-pharma-letter/</guid></item><item><title><![CDATA[International Biotechnology (LON:IBT) Stock Price Passes Above 200 Day Moving Average of $649.16 - American Banking and Market News]]></title><description><![CDATA[International Biotechnology (LON:IBT) Stock Price Passes Above 200 Day Moving Average of $649.16&nbsp;&nbsp;American Banking and Market News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/international-biotechnology-lonibt-stock-price-passes-above-200-day-moving-average-of-64916-american-banking-and-market-news/</link><pubDate>Fri, 19 Jul 2024 09:17:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/international-biotechnology-lonibt-stock-price-passes-above-200-day-moving-average-of-64916-american-banking-and-market-news/</guid></item><item><title><![CDATA[Bacillus methanolicus: an emerging chassis for low-carbon biomanufacturing]]></title><description><![CDATA[Bacillus methanolicus is a thermophilic methylotrophic bacterium that grows quickly on methanol in sea water–based media. It has been engineered for chemical bioproduction from methanol, but its efficiency needs improvement for industrialization. Synthetic biology approaches such as metabolic modeling and genome editing can reprogram B. methanolicus for low-carbon biomanufacturing.]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/bacillus-methanolicus-an-emerging-chassis-for-low-carbon-biomanufacturing/</link><pubDate>Fri, 19 Jul 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/bacillus-methanolicus-an-emerging-chassis-for-low-carbon-biomanufacturing/</guid></item><item><title><![CDATA[Puma Biotechnology executive sells over $9,600 in stock - Investing.com]]></title><description><![CDATA[Puma Biotechnology executive sells over $9,600 in stock&nbsp;&nbsp;Investing.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/puma-biotechnology-executive-sells-over-9600-in-stock-investingcom/</link><pubDate>Fri, 19 Jul 2024 01:58:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/puma-biotechnology-executive-sells-over-9600-in-stock-investingcom/</guid></item><item><title><![CDATA[Global Agricultural Biotechnology Market Size To Worth USD 268.32 Billion By 2033 | CAGR of 8.27% - GlobeNewswire]]></title><description><![CDATA[Global Agricultural Biotechnology Market Size To Worth USD 268.32 Billion By 2033 | CAGR of 8.27%&nbsp;&nbsp;GlobeNewswire]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/global-agricultural-biotechnology-market-size-to-worth-usd-26832-billion-by-2033-cagr-of-827-globenewswire/</link><pubDate>Thu, 18 Jul 2024 23:02:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/global-agricultural-biotechnology-market-size-to-worth-usd-26832-billion-by-2033-cagr-of-827-globenewswire/</guid></item><item><title><![CDATA[Vir Biotechnology to Report Second Quarter 2024 Financial Results on August 1, 2024 - StockTitan]]></title><description><![CDATA[Vir Biotechnology to Report Second Quarter 2024 Financial Results on August 1, 2024&nbsp;&nbsp;StockTitan]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-to-report-second-quarter-2024-financial-results-on-august-1-2024-stocktitan/</link><pubDate>Thu, 18 Jul 2024 22:12:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-to-report-second-quarter-2024-financial-results-on-august-1-2024-stocktitan/</guid></item><item><title><![CDATA[Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2024 Financial Results - businesswire.com]]></title><description><![CDATA[Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2024 Financial Results&nbsp;&nbsp;businesswire.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/puma-biotechnology-to-host-conference-call-to-discuss-second-quarter-2024-financial-results-businesswirecom/</link><pubDate>Thu, 18 Jul 2024 22:10:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/puma-biotechnology-to-host-conference-call-to-discuss-second-quarter-2024-financial-results-businesswirecom/</guid></item><item><title><![CDATA[Vir Biotechnology to Report Second Quarter 2024 Financial Results on August 1, 2024 - businesswire.com]]></title><description><![CDATA[Vir Biotechnology to Report Second Quarter 2024 Financial Results on August 1, 2024&nbsp;&nbsp;businesswire.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-to-report-second-quarter-2024-financial-results-on-august-1-2024-businesswirecom/</link><pubDate>Thu, 18 Jul 2024 22:05:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-to-report-second-quarter-2024-financial-results-on-august-1-2024-businesswirecom/</guid></item><item><title><![CDATA[Vir Biotechnology to Report Second Quarter 2024 Financial Results on August 1, 2024 - Business Wire]]></title><description><![CDATA[Vir Biotechnology to Report Second Quarter 2024 Financial Results on August 1, 2024&nbsp;&nbsp;Business Wire]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-to-report-second-quarter-2024-financial-results-on-august-1-2024-business-wire/</link><pubDate>Thu, 18 Jul 2024 22:05:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-to-report-second-quarter-2024-financial-results-on-august-1-2024-business-wire/</guid></item><item><title><![CDATA[Biotechnology Market: Surging Investments and Infrastructure Development Propel 13.9% CAGR by 2031| SkyQuest Technology - PR Newswire]]></title><description><![CDATA[Biotechnology Market: Surging Investments and Infrastructure Development Propel 13.9% CAGR by 2031| SkyQuest Technology&nbsp;&nbsp;PR Newswire]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/biotechnology-market-surging-investments-and-infrastructure-development-propel-139-cagr-by-2031-skyquest-technology-pr-newswire/</link><pubDate>Thu, 18 Jul 2024 16:30:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/biotechnology-market-surging-investments-and-infrastructure-development-propel-139-cagr-by-2031-skyquest-technology-pr-newswire/</guid></item><item><title><![CDATA[Small Swedish firm looks to take cold protection spray global - The Pharma Letter]]></title><description><![CDATA[Small Swedish firm looks to take cold protection spray global&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/small-swedish-firm-looks-to-take-cold-protection-spray-global-the-pharma-letter/</link><pubDate>Thu, 18 Jul 2024 15:57:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/small-swedish-firm-looks-to-take-cold-protection-spray-global-the-pharma-letter/</guid></item><item><title><![CDATA[Largest long-term DME study supports ongoing Vabysmo benefit - The Pharma Letter]]></title><description><![CDATA[Largest long-term DME study supports ongoing Vabysmo benefit&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/largest-long-term-dme-study-supports-ongoing-vabysmo-benefit-the-pharma-letter/</link><pubDate>Thu, 18 Jul 2024 11:09:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/largest-long-term-dme-study-supports-ongoing-vabysmo-benefit-the-pharma-letter/</guid></item><item><title><![CDATA[Exploring the Wide World of Biotechnology - Northwestern Engineering]]></title><description><![CDATA[Exploring the Wide World of Biotechnology&nbsp;&nbsp;Northwestern Engineering]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/exploring-the-wide-world-of-biotechnology-northwestern-engineering/</link><pubDate>Thu, 18 Jul 2024 09:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/exploring-the-wide-world-of-biotechnology-northwestern-engineering/</guid></item><item><title><![CDATA[Engineered bacterial therapeutics with material solutions]]></title><description><![CDATA[Recent advances in engineered bacterial therapeutics underscore their potential in treating diseases via targeted, live interventions. Despite their promising performance in early clinical phases, no engineered therapeutic bacteria have yet received approval, primarily due to challenges in proving efficacy while ensuring biosafety. Material science innovations, particularly the encapsulation of bacteria within hydrogels, present a promising avenue to enhance bacterial survival, efficacy, and saf]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/engineered-bacterial-therapeutics-with-material-solutions/</link><pubDate>Thu, 18 Jul 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/engineered-bacterial-therapeutics-with-material-solutions/</guid></item><item><title><![CDATA[Pioneering Biotechnology and Digital Health in Healthcare - Healthcare Digital]]></title><description><![CDATA[Pioneering Biotechnology and Digital Health in Healthcare&nbsp;&nbsp;Healthcare Digital]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/pioneering-biotechnology-and-digital-health-in-healthcare-healthcare-digital/</link><pubDate>Wed, 17 Jul 2024 19:43:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/pioneering-biotechnology-and-digital-health-in-healthcare-healthcare-digital/</guid></item><item><title><![CDATA[SOTIO partners with Biocytogen to expand ADC pipeline - European Biotechnology News]]></title><description><![CDATA[SOTIO partners with Biocytogen to expand ADC pipeline&nbsp;&nbsp;European Biotechnology News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/sotio-partners-with-biocytogen-to-expand-adc-pipeline-european-biotechnology-news/</link><pubDate>Wed, 17 Jul 2024 12:54:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/sotio-partners-with-biocytogen-to-expand-adc-pipeline-european-biotechnology-news/</guid></item><item><title><![CDATA[Draupnir Bio ApS raises further equity - European Biotechnology News]]></title><description><![CDATA[Draupnir Bio ApS raises further equity&nbsp;&nbsp;European Biotechnology News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/draupnir-bio-aps-raises-further-equity-european-biotechnology-news/</link><pubDate>Wed, 17 Jul 2024 11:19:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/draupnir-bio-aps-raises-further-equity-european-biotechnology-news/</guid></item><item><title><![CDATA[EURO BIOTECH GUIDE - European Biotechnology News]]></title><description><![CDATA[EURO BIOTECH GUIDE&nbsp;&nbsp;European Biotechnology News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/euro-biotech-guide-european-biotechnology-news/</link><pubDate>Wed, 17 Jul 2024 09:06:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/euro-biotech-guide-european-biotechnology-news/</guid></item><item><title><![CDATA[CATALYSER – the Start-up-Magazine 2/24 - European Biotechnology News]]></title><description><![CDATA[CATALYSER &ndash; the Start-up-Magazine 2/24&nbsp;&nbsp;European Biotechnology News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/catalyser-the-start-up-magazine-224-european-biotechnology-news/</link><pubDate>Wed, 17 Jul 2024 09:05:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/catalyser-the-start-up-magazine-224-european-biotechnology-news/</guid></item><item><title><![CDATA[Five questions with Ryan Flynn - Nature.com]]></title><description><![CDATA[Five questions with Ryan Flynn&nbsp;&nbsp;Nature.com]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/five-questions-with-ryan-flynn-naturecom/</link><pubDate>Wed, 17 Jul 2024 09:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/five-questions-with-ryan-flynn-naturecom/</guid></item><item><title><![CDATA[Applications and evolution of 3D cancer-immune cell models]]></title><description><![CDATA[Understanding the highly complex tumor-immune landscape is an important goal for developing novel immune therapies for solid cancers. To this end, 3D cancer-immune models have emerged as patient-relevant in vitro tools for modeling the tumor-immune landscape and the cellular interactions within it. In this review, we provide an overview of the components and applications of 3D cancer-immune models and discuss their evolution from 2015 to 2023. Specifically, we observe trends in primary cell-sour]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/applications-and-evolution-of-3d-cancer-immune-cell-models/</link><pubDate>Wed, 17 Jul 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/applications-and-evolution-of-3d-cancer-immune-cell-models/</guid></item><item><title><![CDATA[Agricultural Biotechnology Market Size to Worth Around USD 293.35 billion by 2034 - BioSpace]]></title><description><![CDATA[Agricultural Biotechnology Market Size to Worth Around USD 293.35 billion by 2034&nbsp;&nbsp;BioSpace]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/agricultural-biotechnology-market-size-to-worth-around-usd-29335-billion-by-2034-biospace/</link><pubDate>Wed, 17 Jul 2024 00:20:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/agricultural-biotechnology-market-size-to-worth-around-usd-29335-billion-by-2034-biospace/</guid></item><item><title><![CDATA[ICoB24: Agricultural Biotechnology Key To Agrifood Systems Transformation – FAO - Science Nigeria]]></title><description><![CDATA[ICoB24: Agricultural Biotechnology Key To Agrifood Systems Transformation &ndash; FAO&nbsp;&nbsp;Science Nigeria]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/icob24-agricultural-biotechnology-key-to-agrifood-systems-transformation-fao-science-nigeria/</link><pubDate>Wed, 17 Jul 2024 00:11:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/icob24-agricultural-biotechnology-key-to-agrifood-systems-transformation-fao-science-nigeria/</guid></item><item><title><![CDATA[Beyond Air® To Participate in the BTIG Virtual Biotechnology Conference 2024 - StockTitan]]></title><description><![CDATA[Beyond Air&reg; To Participate in the BTIG Virtual Biotechnology Conference 2024&nbsp;&nbsp;StockTitan]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/beyond-air-to-participate-in-the-btig-virtual-biotechnology-conference-2024-stocktitan/</link><pubDate>Tue, 16 Jul 2024 22:18:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/beyond-air-to-participate-in-the-btig-virtual-biotechnology-conference-2024-stocktitan/</guid></item><item><title><![CDATA[SOTIO to use Biocytogen platform to develop ADCs - The Pharma Letter]]></title><description><![CDATA[SOTIO to use Biocytogen platform to develop ADCs&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/sotio-to-use-biocytogen-platform-to-develop-adcs-the-pharma-letter/</link><pubDate>Tue, 16 Jul 2024 19:03:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/sotio-to-use-biocytogen-platform-to-develop-adcs-the-pharma-letter/</guid></item><item><title><![CDATA[Nigeria: Government commends stakeholders for advancing biotechnology - Alliance for Science]]></title><description><![CDATA[Nigeria: Government commends stakeholders for advancing biotechnology&nbsp;&nbsp;Alliance for Science]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/nigeria-government-commends-stakeholders-for-advancing-biotechnology-alliance-for-science/</link><pubDate>Tue, 16 Jul 2024 18:16:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/nigeria-government-commends-stakeholders-for-advancing-biotechnology-alliance-for-science/</guid></item><item><title><![CDATA[Cardurion bags $260 million in Series B financing - The Pharma Letter]]></title><description><![CDATA[Cardurion bags $260 million in Series B financing&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/cardurion-bags-260-million-in-series-b-financing-the-pharma-letter/</link><pubDate>Tue, 16 Jul 2024 18:07:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/cardurion-bags-260-million-in-series-b-financing-the-pharma-letter/</guid></item><item><title><![CDATA[CatalYm takes in $150 million in series D financing - The Pharma Letter]]></title><description><![CDATA[CatalYm takes in $150 million in series D financing&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/catalym-takes-in-150-million-in-series-d-financing-the-pharma-letter/</link><pubDate>Tue, 16 Jul 2024 17:11:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/catalym-takes-in-150-million-in-series-d-financing-the-pharma-letter/</guid></item><item><title><![CDATA[Even after rising 23% this past week, Puma Biotechnology (NASDAQ:PBYI) shareholders are still down 63% over the past five years - Simply Wall St]]></title><description><![CDATA[Even after rising 23% this past week, Puma Biotechnology (NASDAQ:PBYI) shareholders are still down 63% over the past five years&nbsp;&nbsp;Simply Wall St]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/even-after-rising-23-this-past-week-puma-biotechnology-nasdaqpbyi-shareholders-are-still-down-63-over-the-past-five-years-simply-wall-st/</link><pubDate>Tue, 16 Jul 2024 17:07:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/even-after-rising-23-this-past-week-puma-biotechnology-nasdaqpbyi-shareholders-are-still-down-63-over-the-past-five-years-simply-wall-st/</guid></item><item><title><![CDATA[Mark Bodmer takes top job at Nucleome - The Pharma Letter]]></title><description><![CDATA[Mark Bodmer takes top job at Nucleome&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/mark-bodmer-takes-top-job-at-nucleome-the-pharma-letter/</link><pubDate>Tue, 16 Jul 2024 15:43:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/mark-bodmer-takes-top-job-at-nucleome-the-pharma-letter/</guid></item><item><title><![CDATA[Reasons to be hopeful in the fight against malaria - The Pharma Letter]]></title><description><![CDATA[Reasons to be hopeful in the fight against malaria&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/reasons-to-be-hopeful-in-the-fight-against-malaria-the-pharma-letter/</link><pubDate>Tue, 16 Jul 2024 13:22:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/reasons-to-be-hopeful-in-the-fight-against-malaria-the-pharma-letter/</guid></item><item><title><![CDATA[Sobi reports strong 2nd quarter 2024 sales growth - The Pharma Letter]]></title><description><![CDATA[Sobi reports strong 2nd quarter 2024 sales growth&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/sobi-reports-strong-2nd-quarter-2024-sales-growth-the-pharma-letter/</link><pubDate>Tue, 16 Jul 2024 12:58:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/sobi-reports-strong-2nd-quarter-2024-sales-growth-the-pharma-letter/</guid></item><item><title><![CDATA[Asceneuron to pump newly-raised $100 million into Alzheimer’s asset - The Pharma Letter]]></title><description><![CDATA[Asceneuron to pump newly-raised $100 million into Alzheimer&rsquo;s asset&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/asceneuron-to-pump-newly-raised-100-million-into-alzheimers-asset-the-pharma-letter/</link><pubDate>Tue, 16 Jul 2024 12:57:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/asceneuron-to-pump-newly-raised-100-million-into-alzheimers-asset-the-pharma-letter/</guid></item><item><title><![CDATA[SG Americas Securities LLC Purchases 3,044 Shares of iShares Biotechnology ETF (NASDAQ:IBB) - Defense World]]></title><description><![CDATA[SG Americas Securities LLC Purchases 3,044 Shares of iShares Biotechnology ETF (NASDAQ:IBB)&nbsp;&nbsp;Defense World]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/sg-americas-securities-llc-purchases-3044-shares-of-ishares-biotechnology-etf-nasdaqibb-defense-world/</link><pubDate>Tue, 16 Jul 2024 12:31:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/sg-americas-securities-llc-purchases-3044-shares-of-ishares-biotechnology-etf-nasdaqibb-defense-world/</guid></item><item><title><![CDATA[CordenPharma invests €900m in peptide patform expansion - European Biotechnology News]]></title><description><![CDATA[CordenPharma invests &euro;900m in peptide patform expansion&nbsp;&nbsp;European Biotechnology News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/cordenpharma-invests-900m-in-peptide-patform-expansion-european-biotechnology-news/</link><pubDate>Tue, 16 Jul 2024 11:23:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/cordenpharma-invests-900m-in-peptide-patform-expansion-european-biotechnology-news/</guid></item><item><title><![CDATA[Catalym raises US$150m - European Biotechnology News]]></title><description><![CDATA[Catalym raises US$150m&nbsp;&nbsp;European Biotechnology News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/catalym-raises-us150m-european-biotechnology-news/</link><pubDate>Tue, 16 Jul 2024 11:23:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/catalym-raises-us150m-european-biotechnology-news/</guid></item><item><title><![CDATA[Biotechnology Corn and Soybean Varieties Planted in Ohio - Morning Ag Clips -]]></title><description><![CDATA[Biotechnology Corn and Soybean Varieties Planted in Ohio&nbsp;&nbsp;Morning Ag Clips -]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/biotechnology-corn-and-soybean-varieties-planted-in-ohio-morning-ag-clips-/</link><pubDate>Tue, 16 Jul 2024 10:22:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/biotechnology-corn-and-soybean-varieties-planted-in-ohio-morning-ag-clips-/</guid></item><item><title><![CDATA[Tatyana Barthold ’23: Young Alumna Thrives in Biotechnology Career - WPI News]]></title><description><![CDATA[Tatyana Barthold &rsquo;23: Young Alumna Thrives in Biotechnology Career&nbsp;&nbsp;WPI News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/tatyana-barthold-23-young-alumna-thrives-in-biotechnology-career-wpi-news/</link><pubDate>Tue, 16 Jul 2024 09:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/tatyana-barthold-23-young-alumna-thrives-in-biotechnology-career-wpi-news/</guid></item><item><title><![CDATA[The past three years for Walvax Biotechnology (SZSE:300142) investors has not been profitable - Simply Wall St]]></title><description><![CDATA[The past three years for Walvax Biotechnology (SZSE:300142) investors has not been profitable&nbsp;&nbsp;Simply Wall St]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/the-past-three-years-for-walvax-biotechnology-szse300142-investors-has-not-been-profitable-simply-wall-st/</link><pubDate>Tue, 16 Jul 2024 08:13:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/the-past-three-years-for-walvax-biotechnology-szse300142-investors-has-not-been-profitable-simply-wall-st/</guid></item><item><title><![CDATA[Head-To-Head Analysis: Vir Biotechnology (NASDAQ:VIR) &amp; Vaxart (NASDAQ:VXRT) - Defense World]]></title><description><![CDATA[Head-To-Head Analysis: Vir Biotechnology (NASDAQ:VIR) &amp; Vaxart (NASDAQ:VXRT)&nbsp;&nbsp;Defense World]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/head-to-head-analysis-vir-biotechnology-nasdaqvir-amp-vaxart-nasdaqvxrt-defense-world/</link><pubDate>Tue, 16 Jul 2024 07:40:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/head-to-head-analysis-vir-biotechnology-nasdaqvir-amp-vaxart-nasdaqvxrt-defense-world/</guid></item><item><title><![CDATA[Comparing Lixte Biotechnology (NASDAQ:LIXT) and GH Research (NASDAQ:GHRS) - American Banking and Market News]]></title><description><![CDATA[Comparing Lixte Biotechnology (NASDAQ:LIXT) and GH Research (NASDAQ:GHRS)&nbsp;&nbsp;American Banking and Market News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/comparing-lixte-biotechnology-nasdaqlixt-and-gh-research-nasdaqghrs-american-banking-and-market-news/</link><pubDate>Tue, 16 Jul 2024 07:17:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/comparing-lixte-biotechnology-nasdaqlixt-and-gh-research-nasdaqghrs-american-banking-and-market-news/</guid></item><item><title><![CDATA[Biotechnological approaches for producing natural pigments in yeasts]]></title><description><![CDATA[Pigments are widely used in the food, cosmetic, textile, pharmaceutical, and materials industries. Demand for natural pigments has been increasing due to concerns regarding potential health problems and environmental pollution from synthetic pigments. Microbial production of natural pigments is a promising alternative to chemical synthesis or extraction from natural sources. Here, we discuss yeasts as promising chassis for producing natural pigments with their advantageous traits such as genetic]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/biotechnological-approaches-for-producing-natural-pigments-in-yeasts/</link><pubDate>Tue, 16 Jul 2024 02:00:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/biotechnological-approaches-for-producing-natural-pigments-in-yeasts/</guid></item><item><title><![CDATA[Environment science, biotech favoured for Master’s abroad - The Times of India]]></title><description><![CDATA[Environment science, biotech favoured for Master&rsquo;s abroad&nbsp;&nbsp;The Times of India]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/environment-science-biotech-favoured-for-masters-abroad-the-times-of-india/</link><pubDate>Tue, 16 Jul 2024 01:36:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/environment-science-biotech-favoured-for-masters-abroad-the-times-of-india/</guid></item><item><title><![CDATA[Vir Biotechnology Insiders Sold US$1.3m Of Shares Suggesting Hesitancy - Simply Wall St]]></title><description><![CDATA[Vir Biotechnology Insiders Sold US$1.3m Of Shares Suggesting Hesitancy&nbsp;&nbsp;Simply Wall St]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-insiders-sold-us13m-of-shares-suggesting-hesitancy-simply-wall-st/</link><pubDate>Mon, 15 Jul 2024 18:47:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/vir-biotechnology-insiders-sold-us13m-of-shares-suggesting-hesitancy-simply-wall-st/</guid></item><item><title><![CDATA[Mount Marty University joins state biotechnology board - South Dakota Public Broadcasting]]></title><description><![CDATA[Mount Marty University joins state biotechnology board&nbsp;&nbsp;South Dakota Public Broadcasting]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/mount-marty-university-joins-state-biotechnology-board-south-dakota-public-broadcasting/</link><pubDate>Mon, 15 Jul 2024 18:15:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/mount-marty-university-joins-state-biotechnology-board-south-dakota-public-broadcasting/</guid></item><item><title><![CDATA[Legend leaps on rumors of possible takeover - The Pharma Letter]]></title><description><![CDATA[Legend leaps on rumors of possible takeover&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/legend-leaps-on-rumors-of-possible-takeover-the-pharma-letter/</link><pubDate>Mon, 15 Jul 2024 17:38:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/legend-leaps-on-rumors-of-possible-takeover-the-pharma-letter/</guid></item><item><title><![CDATA[LSV Asset Management Sells 56,251 Shares of Puma Biotechnology, Inc. (NASDAQ:PBYI) - American Banking and Market News]]></title><description><![CDATA[LSV Asset Management Sells 56,251 Shares of Puma Biotechnology, Inc. (NASDAQ:PBYI)&nbsp;&nbsp;American Banking and Market News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/lsv-asset-management-sells-56251-shares-of-puma-biotechnology-inc-nasdaqpbyi-american-banking-and-market-news/</link><pubDate>Mon, 15 Jul 2024 13:03:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/lsv-asset-management-sells-56251-shares-of-puma-biotechnology-inc-nasdaqpbyi-american-banking-and-market-news/</guid></item><item><title><![CDATA[Sensorion achieves milestones in Phase II trial - European Biotechnology News]]></title><description><![CDATA[Sensorion achieves milestones in Phase II trial&nbsp;&nbsp;European Biotechnology News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/sensorion-achieves-milestones-in-phase-ii-trial-european-biotechnology-news/</link><pubDate>Mon, 15 Jul 2024 11:48:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/sensorion-achieves-milestones-in-phase-ii-trial-european-biotechnology-news/</guid></item><item><title><![CDATA[Head to Head Comparison: Puma Biotechnology (NASDAQ:PBYI) versus Gyre Therapeutics (NASDAQ:GYRE) - Defense World]]></title><description><![CDATA[Head to Head Comparison: Puma Biotechnology (NASDAQ:PBYI) versus Gyre Therapeutics (NASDAQ:GYRE)&nbsp;&nbsp;Defense World]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/head-to-head-comparison-puma-biotechnology-nasdaqpbyi-versus-gyre-therapeutics-nasdaqgyre-defense-world/</link><pubDate>Mon, 15 Jul 2024 09:21:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/head-to-head-comparison-puma-biotechnology-nasdaqpbyi-versus-gyre-therapeutics-nasdaqgyre-defense-world/</guid></item><item><title><![CDATA[Sana Biotechnology: Early-Stage Biotech With Promising Allogeneic CAR-T Pipeline - Seeking Alpha]]></title><description><![CDATA[Sana Biotechnology: Early-Stage Biotech With Promising Allogeneic CAR-T Pipeline&nbsp;&nbsp;Seeking Alpha]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/sana-biotechnology-early-stage-biotech-with-promising-allogeneic-car-t-pipeline-seeking-alpha/</link><pubDate>Sun, 14 Jul 2024 16:23:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/sana-biotechnology-early-stage-biotech-with-promising-allogeneic-car-t-pipeline-seeking-alpha/</guid></item><item><title><![CDATA[The Motley Fool: Moderna’s biotechnology advances are quite promising - The Dallas Morning News]]></title><description><![CDATA[The Motley Fool: Moderna&rsquo;s biotechnology advances are quite promising&nbsp;&nbsp;The Dallas Morning News]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/the-motley-fool-modernas-biotechnology-advances-are-quite-promising-the-dallas-morning-news/</link><pubDate>Sun, 14 Jul 2024 12:35:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/the-motley-fool-modernas-biotechnology-advances-are-quite-promising-the-dallas-morning-news/</guid></item><item><title><![CDATA[INOVIO wins Innovation Passport from UK medicines regulator - The Pharma Letter]]></title><description><![CDATA[INOVIO wins Innovation Passport from UK medicines regulator&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/inovio-wins-innovation-passport-from-uk-medicines-regulator-the-pharma-letter/</link><pubDate>Sat, 13 Jul 2024 18:13:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/inovio-wins-innovation-passport-from-uk-medicines-regulator-the-pharma-letter/</guid></item><item><title><![CDATA[Geneos Wealth Management Inc. Buys 502 Shares of iShares Biotechnology ETF (NASDAQ:IBB) - Defense World]]></title><description><![CDATA[Geneos Wealth Management Inc. Buys 502 Shares of iShares Biotechnology ETF (NASDAQ:IBB)&nbsp;&nbsp;Defense World]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/geneos-wealth-management-inc-buys-502-shares-of-ishares-biotechnology-etf-nasdaqibb-defense-world/</link><pubDate>Sat, 13 Jul 2024 12:59:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/geneos-wealth-management-inc-buys-502-shares-of-ishares-biotechnology-etf-nasdaqibb-defense-world/</guid></item><item><title><![CDATA[FDA setback for Novo Nordisk’s once-weekly basal insulin icodec - The Pharma Letter]]></title><description><![CDATA[FDA setback for Novo Nordisk&rsquo;s once-weekly basal insulin icodec&nbsp;&nbsp;The Pharma Letter]]></description><link>https://www.newslocker.com/en-us/profession/biotechnology/fda-setback-for-novo-nordisks-once-weekly-basal-insulin-icodec-the-pharma-letter/</link><pubDate>Sat, 13 Jul 2024 05:07:00 +0200</pubDate><guid>https://www.newslocker.com/en-us/profession/biotechnology/fda-setback-for-novo-nordisks-once-weekly-basal-insulin-icodec-the-pharma-letter/</guid></item></channel></rss>